<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">35214566</PMID><DateRevised><Year>2022</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1424-8220</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Machine Learning Approach to Minimize Nocturnal Hypoglycemic Events in Type 1 Diabetic Patients under Multiple Doses of Insulin.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1665</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/s22041665</ELocationID><Abstract><AbstractText>Nocturnal hypoglycemia (NH) is one of the most challenging events for multiple dose insulin therapy (MDI) in people with type 1 diabetes (T1D). The goal of this study is to design a method to reduce the incidence of NH in people with T1D under MDI therapy, providing a decision-support system and improving confidence toward self-management of the disease considering the dataset used by Bertachi et al. Different machine learning (ML) algorithms, data sources, optimization metrics and mitigation measures to predict and avoid NH events have been studied. In addition, we have designed population and personalized models and studied the generalizability of the models and the influence of physical activity (PA) on them. Obtaining 30 g of rescue carbohydrates (CHO) is the optimal value for preventing NH, so it can be asserted that this is the value with which the time under 70 mg/dL decreases the most, with almost a 35% reduction, while increasing the time in the target range by 1.3%. This study supports the feasibility of using ML techniques to address the prediction of NH in patients with T1D under MDI therapy, using continuous glucose monitoring (CGM) and a PA tracker. The results obtained prove that BG predictions can not only be critical in achieving safer diabetes management, but also assist physicians and patients to make better and safer decisions regarding insulin therapy and their day-to-day lives.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Parcerisas</LastName><ForeName>Adri..</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4364-1601</Identifier><AffiliationInfo><Affiliation>Institut d'Inform..tica i Aplicacions, Universitat de Girona, 17003 Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-6896-818X</Identifier><AffiliationInfo><Affiliation>Institut d'Inform..tica i Aplicacions, Universitat de Girona, 17003 Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delecourt</LastName><ForeName>Alexia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institut d'Inform..tica i Aplicacions, Universitat de Girona, 17003 Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertachi</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Campus Guarapuava, Federal University of Technology-Paran.. (UTFPR), Guarapuava 85053-525, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beneyto</LastName><ForeName>Aleix</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8207-2259</Identifier><AffiliationInfo><Affiliation>Institut d'Inform..tica i Aplicacions, Universitat de Girona, 17003 Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conget</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Endocrinology and Diabetes Unit, Hospital Cl..nic, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom..diques August Pi i Sunyer, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vi..als</LastName><ForeName>Clara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6888-0396</Identifier><AffiliationInfo><Affiliation>Endocrinology and Diabetes Unit, Hospital Cl..nic, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gim..nez</LastName><ForeName>Marga</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2976-1690</Identifier><AffiliationInfo><Affiliation>Endocrinology and Diabetes Unit, Hospital Cl..nic, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom..diques August Pi i Sunyer, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vehi</LastName><ForeName>Josep</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6884-9789</Identifier><AffiliationInfo><Affiliation>Institut d'Inform..tica i Aplicacions, Universitat de Girona, 17003 Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PID2019-107722RB</GrantID><Agency>Spanish Ministry of Science and Innovation</Agency><Country/></Grant><Grant><GrantID>PID2020-117171RA-I00</GrantID><Agency>Spanish Ministry of Science and Innovation</Agency><Country/></Grant><Grant><GrantID>2017SGR1551</GrantID><Agency>Government of Catalonia</Agency><Country/></Grant><Grant><GrantID>PROD 00041</GrantID><Agency>European Regional Development Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hypoglycemia</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">multiple daily injections</Keyword><Keyword MajorTopicYN="N">prediction model</Keyword><Keyword MajorTopicYN="N">support vector machine</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>01</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>02</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>02</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35214566</ArticleId><ArticleId IdType="pii">s22041665</ArticleId><ArticleId IdType="doi">10.3390/s22041665</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Diabetes Sci Technol. 2020 Mar;14(2):250-256</Citation><ArticleIdList><ArticleId IdType="pubmed">31390891</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Med Inform. 2019 Jun;126:1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">31029250</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2020 Nov;22(11):801-811</Citation><ArticleIdList><ArticleId IdType="pubmed">32297795</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Med Devices. 2013 Sep;10(5):661-73</Citation><ArticleIdList><ArticleId IdType="pubmed">23972072</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Jan 1;8(1):26-34</Citation><ArticleIdList><ArticleId IdType="pubmed">24876534</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2020 May;24(5):1439-1446</Citation><ArticleIdList><ArticleId IdType="pubmed">31536025</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2019 Oct;21(10):589-601</Citation><ArticleIdList><ArticleId IdType="pubmed">31335196</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2017 Nov;133:30-39</Citation><ArticleIdList><ArticleId IdType="pubmed">28888993</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Nov 7;12(11):e0187754</Citation><ArticleIdList><ArticleId IdType="pubmed">29112978</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2021 Jul;15(4):842-855</Citation><ArticleIdList><ArticleId IdType="pubmed">32476492</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Mhealth Uhealth. 2019 Mar 07;7(3):e11933</Citation><ArticleIdList><ArticleId IdType="pubmed">30843865</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2018 May 30;20(5):e10775</Citation><ArticleIdList><ArticleId IdType="pubmed">29848472</ArticleId></ArticleIdList></Reference><Reference><Citation>J Chem Inf Comput Sci. 2004 Jan-Feb;44(1):1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">14741005</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Meas. 2004 Aug;25(4):905-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15382830</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Mar;12(2):533-534</Citation><ArticleIdList><ArticleId IdType="pubmed">28918653</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Endocrinol Metab. 2013 Sep;17(5):819-34</Citation><ArticleIdList><ArticleId IdType="pubmed">24083163</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Behav. 2017 Jul 1;176:139-148</Citation><ArticleIdList><ArticleId IdType="pubmed">28363838</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2019 Sep;178:175-180</Citation><ArticleIdList><ArticleId IdType="pubmed">31416546</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2020 Mar 19;20(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">32204318</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35169690</PMID><DateRevised><Year>2022</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Development and validation of a machine learning model for classification of next glucose measurement in hospitalized patients.</ArticleTitle><Pagination><MedlinePgn>101290</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2022.101290</ELocationID><Abstract><AbstractText Label="Background" NlmCategory="UNASSIGNED">Inpatient glucose management can be challenging due to evolving factors that influence a patient's blood glucose (BG) throughout hospital admission. The purpose of our study was to predict the category of a patient's next BG measurement based on electronic medical record (EMR) data.</AbstractText><AbstractText Label="Methods" NlmCategory="UNASSIGNED">EMR data from 184,361 admissions containing 4,538,418 BG measurements from five hospitals in the Johns Hopkins Health System were collected from patients who were discharged between January 1, 2015 and May 31, 2019. Index BGs used for prediction included the 5th to penultimate BG measurements (<i>N</i>..=..2,740,539). The outcome was category of next BG measurement: hypoglycemic (BG.. <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mo>...</mml:mo></mml:math> ..70..mg/dl), controlled (BG 71-180..mg/dl), or hyperglycemic (BG..&gt;..180..mg/dl). A random forest algorithm that included a broad range of clinical covariates predicted the outcome and was validated internally and externally.</AbstractText><AbstractText Label="Findings" NlmCategory="UNASSIGNED">In our internal validation test set, 72..8%, 25..7%, and 1..5% of BG measurements occurring after the index BG were controlled, hyperglycemic, and hypoglycemic respectively. The sensitivity/specificity for prediction of controlled, hyperglycemic, and hypoglycemic were 0..77/0..81, 0..77/0..89, and 0..73/0..91, respectively. On external validation in four hospitals, the ranges of sensitivity/specificity for prediction of controlled, hyperglycemic, and hypoglycemic were 0..64-0..70/0..80-0..87, 0..75-0..80/0..82-0..84, and 0..76-0..78/0..87-0..90, respectively.</AbstractText><AbstractText Label="Interpretation" NlmCategory="UNASSIGNED">A machine learning algorithm using EMR data can accurately predict the category of a hospitalized patient's next BG measurement. Further studies should determine the effectiveness of integration of this model into the EMR in reducing rates of hypoglycemia and hyperglycemia.</AbstractText><CopyrightInformation>.. 2022 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zale</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Associate Professor of Medicine, Division of Endocrinology, Diabetes &amp; Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, 1830 E. Monument Street Suite 333, Baltimore, MD 21287, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abusamaan</LastName><ForeName>Mohammed S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Associate Professor of Medicine, Division of Endocrinology, Diabetes &amp; Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, 1830 E. Monument Street Suite 333, Baltimore, MD 21287, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGready</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathioudakis</LastName><ForeName>Nestoras</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Associate Professor of Medicine, Division of Endocrinology, Diabetes &amp; Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, 1830 E. Monument Street Suite 333, Baltimore, MD 21287, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AUC, area under receiver operating curve</Keyword><Keyword MajorTopicYN="N">BG, blood glucose</Keyword><Keyword MajorTopicYN="N">BMI, body mass index</Keyword><Keyword MajorTopicYN="N">CGM, continuous glucose monitor</Keyword><Keyword MajorTopicYN="N">EMR, electronic medical record</Keyword><Keyword MajorTopicYN="N">ICD, International Classification of Diseases</Keyword><Keyword MajorTopicYN="N">ICU, intensive care unit</Keyword><Keyword MajorTopicYN="N">NLR, negative likelihood ratio</Keyword><Keyword MajorTopicYN="N">NPO, nil per os</Keyword><Keyword MajorTopicYN="N">NPV, negative predictive value</Keyword><Keyword MajorTopicYN="N">PLR, positive likelihood ratio</Keyword><Keyword MajorTopicYN="N">PPV, positive predictive value</Keyword><Keyword MajorTopicYN="N">T1DM, type 1 diabetes mellitus</Keyword><Keyword MajorTopicYN="N">T2DM, type 2 diabetes mellitus</Keyword></KeywordList><CoiStatement>The authors declared that there is no potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>01</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>01</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>16</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35169690</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2022.101290</ArticleId><ArticleId IdType="pii">S2589-5370(22)00020-7</ArticleId><ArticleId IdType="pmc">PMC8829081</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>JMIR Diabetes. 2021 Jan 29;6(1):e22458</Citation><ArticleIdList><ArticleId IdType="pubmed">33512324</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Diabetes. 2021 Apr 29;6(2):e26909</Citation><ArticleIdList><ArticleId IdType="pubmed">33913816</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2002 Nov;62(5):1839-47</Citation><ArticleIdList><ArticleId IdType="pubmed">12371987</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1994 Mar 2;271(9):703-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8309035</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hosp Med. 2006 May;1(3):145-50</Citation><ArticleIdList><ArticleId IdType="pubmed">17219488</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Ther. 2020 Mar;11(3):681-699</Citation><ArticleIdList><ArticleId IdType="pubmed">32009223</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2004 Nov;57(11):1196-201</Citation><ArticleIdList><ArticleId IdType="pubmed">15567637</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2021 Jan 4;4(1):e2030913</Citation><ArticleIdList><ArticleId IdType="pubmed">33416883</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Clin Endocrinol Diabetes. 2018 Feb;126(2):123-129</Citation><ArticleIdList><ArticleId IdType="pubmed">28750430</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2020 Jul;43(7):1504-1511</Citation><ArticleIdList><ArticleId IdType="pubmed">32350021</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2007 Sep;1(5):624-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19885130</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Diabetes. 2021 Mar;45(2):114-121.e3</Citation><ArticleIdList><ArticleId IdType="pubmed">33011129</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 May 01;4(3):577-82</Citation><ArticleIdList><ArticleId IdType="pubmed">20513323</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open Diabetes Res Care. 2018 Mar 2;6(1):e000499</Citation><ArticleIdList><ArticleId IdType="pubmed">29527311</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Med Res Opin. 2013 Feb;29(2):101-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23198978</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2006 Nov 2;355(18):1903-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17079764</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2005 May;28(5):1231-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15855600</ArticleId></ArticleIdList></Reference><Reference><Citation>Transplantation. 1991 Feb;51(2):374-7</Citation><ArticleIdList><ArticleId IdType="pubmed">1994531</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Ophthalmol. 2009 May-Jun;57(3):217-21</Citation><ArticleIdList><ArticleId IdType="pubmed">19384017</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Diab Rep. 2013 Feb;13(1):155-62</Citation><ArticleIdList><ArticleId IdType="pubmed">23065369</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2000 Nov;85(11):4287-92</Citation><ArticleIdList><ArticleId IdType="pubmed">11095469</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp Pract (1995). 2014 Oct;42(4):163-72</Citation><ArticleIdList><ArticleId IdType="pubmed">25502140</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutr Metab Cardiovasc Dis. 2012 Jul;22(7):605-12</Citation><ArticleIdList><ArticleId IdType="pubmed">21333508</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 Jun;33(6):1249-54</Citation><ArticleIdList><ArticleId IdType="pubmed">20508231</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jan;9(1):86-90</Citation><ArticleIdList><ArticleId IdType="pubmed">25316712</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2018 Feb;131(2):129-133</Citation><ArticleIdList><ArticleId IdType="pubmed">29126825</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Health Syst Pharm. 2018 Nov 1;75(21):1714-1728</Citation><ArticleIdList><ArticleId IdType="pubmed">30279185</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1998 Nov;21(11):1870-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9802735</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2004 Mar;27(3):834-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14988313</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2003 Sep;61(3):161-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12965105</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2021 Jan;171:108611</Citation><ArticleIdList><ArticleId IdType="pubmed">33290718</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">35099288</PMID><DateRevised><Year>2022</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8593</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2022</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Diabetes technology &amp; therapeutics</Title><ISOAbbreviation>Diabetes Technol Ther</ISOAbbreviation></Journal><ArticleTitle>Identifying Continuous Glucose Monitoring Data Using Machine Learning.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1089/dia.2021.0498</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">The recent increase in wearable devices for diabetes care, and in particular the use of continuous glucose monitoring (CGM), generates large datasets and associated cybersecurity challenges. In this work, we demonstrate that it is possible to identify CGM data at an individual level by using standard machine learning techniques.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The publicly available REPLACE-BG dataset containing 226 adult participants with type 1 diabetes (T1D) wearing CGM over 6 months was used. A support vector machine (SVM) binary classifier aiming to determine if a CGM data stream belongs to an individual participant was trained and tested for each of the subjects in the dataset. To generate the feature vector used for classification, 12 standard glycaemic metrics were selected and evaluated at different time periods of the day (24h, day, night, breakfast, lunch, dinner). Different window lengths of CGM data (3, 7, 15, and 30 days) were chosen to evaluate their impact on the classification performance. A recursive feature selection method was employed to select the minimum subset of features that did not significantly degrade performance.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 40 features were generated as a result of evaluating the glycemic metrics over the selected time periods (24h, day, night, breakfast, lunch, dinner). A window length of 15 days was found to perform the best in terms of accuracy (86.8..12.8%) and F1 score (0.86..0.16). The corresponding sensitivity and specificity were 85.7..19.5% and 87.9..17.5%, respectively. Through recursive feature selection, a subset of 11 features was shown to perform similarly to the 40 features.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">It is possible to determine with a relatively high accuracy if a CGM data stream belongs to an individual. The proposed approach can be used as a digital CGM 'fingerprint' or for detecting glycaemic changes within an individual, for example during intercurrent illness.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Herrero</LastName><ForeName>Pau</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Imperial College London, Institute of Biomedical Engineering, Bessemer Building, South Kensington Campus, London, England, United Kingdom of Great Britain and Northern Ireland, SW7 2AZ; pherrero@imperial.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Imperial College London, Division of Diabetes, Endocrinology and Metabolism, St Mary's Campus, Norfolk Place, Room G3, Ground Floor Medical School Building, London, London, United Kingdom of Great Britain and Northern Ireland, W2 1PG; m.reddy@imperial.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Georgiou</LastName><ForeName>Pantelis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Imperial College London, Institute of Biomedical Engineering, London, England, United Kingdom of Great Britain and Northern Ireland; pantelis@imperial.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliver</LastName><ForeName>Nick</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Imperial College, Faculty of Medicine, Department of Diabetes, 9th Floor, Charing Cross Campus, London, United Kingdom of Great Britain and Northern Ireland, SW6 8RF; nick.oliver@imperial.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Diabetes Technol Ther</MedlineTA><NlmUniqueID>100889084</NlmUniqueID><ISSNLinking>1520-9156</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>31</Day><Hour>12</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35099288</ArticleId><ArticleId IdType="doi">10.1089/dia.2021.0498</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">35077372</PMID><DateRevised><Year>2022</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2168-2208</ISSN><JournalIssue CitedMedium="Internet"><Volume>PP</Volume><PubDate><Year>2022</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>IEEE journal of biomedical and health informatics</Title><ISOAbbreviation>IEEE J Biomed Health Inform</ISOAbbreviation></Journal><ArticleTitle>Blood Glucose Level Prediction: Advanced Deep-Ensemble Learning Approach.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1109/JBHI.2022.3144870</ELocationID><Abstract><AbstractText>Optimal and sustainable control of blood glucose levels (BGLs) is the aim of type-1 diabetes management. The automated prediction of BGL using machine learning (ML) algorithms is considered as a promising tool that can support this aim. In this context, this paper proposes new advanced ML architectures to predict BGL leveraging deep learning and ensemble learning. The deep-ensemble models are developed with novel meta-learning approaches, where the feasibility of changing the dimension of a univariate time series forecasting task is investigated. The models are evaluated regression-wise and clinical-wise. The performance of the proposed ensemble models are compared with benchmark non-ensemble models. The results show the superior performance of the developed ensemble models over developed non-ensemble benchmark models and also show the efficacy of the proposed meta-learning approaches.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nemat</LastName><ForeName>Hoda</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Khadem</LastName><ForeName>Heydar</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Eissa</LastName><ForeName>Mohammad R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Elliott</LastName><ForeName>Jackie</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Benaissa</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE J Biomed Health Inform</MedlineTA><NlmUniqueID>101604520</NlmUniqueID><ISSNLinking>2168-2194</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>25</Day><Hour>17</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35077372</ArticleId><ArticleId IdType="doi">10.1109/JBHI.2022.3144870</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">35062427</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1424-8220</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>08</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Deep Learning Framework for Automatic Meal Detection and Estimation in Artificial Pancreas Systems.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">466</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/s22020466</ELocationID><Abstract><AbstractText>Current artificial pancreas (AP) systems are hybrid closed-loop systems that require manual meal announcements to manage postprandial glucose control effectively. This poses a cognitive burden and challenge to users with T1D since this relies on frequent user engagement to maintain tight glucose control. In order to move towards fully automated closed-loop glucose control, we propose an algorithm based on a deep learning framework that performs multitask quantile regression, for both meal detection and carbohydrate estimation. Our proposed method is evaluated in silico on 10 adult subjects from the UVa/Padova simulator with a Bio-inspired Artificial Pancreas (BiAP) control algorithm over a 2 month period. Three different configurations of the AP are evaluated -BiAP without meal announcement (BiAP-NMA), BiAP with meal announcement (BiAP-MA), and BiAP with meal detection (BiAP-MD). We present results showing an improvement of BiAP-MD over BiAP-NMA, demonstrating 144.5 .. 6.8 mg/dL mean blood glucose level (-4.4 mg/dL, p&lt; 0.01) and 77.8 .. 6.3% mean time between 70 and 180 mg/dL (+3.9%, p&lt; 0.001). This improvement in control is realised without a significant increase in mean in hypoglycaemia (+0.1%, p= 0.4). In terms of detection of meals and snacks, the proposed method on average achieves 93% precision and 76% recall with a detection delay time of 38 .. 15 min (92% precision, 92% recall, and 37 min detection time for meals only). Furthermore, BiAP-MD handles hypoglycaemia better than BiAP-MA based on CVGA assessment with fewer control errors (10% vs. 20%). This study suggests that multitask quantile regression can improve the capability of AP systems for postprandial glucose control without increasing hypoglycaemia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Daniels</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4464-2625</Identifier><AffiliationInfo><Affiliation>Centre for Bio-Inspired Technology, Department of Electrical and Electronic Engineering, Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrero</LastName><ForeName>Pau</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-7088-5807</Identifier><AffiliationInfo><Affiliation>Centre for Bio-Inspired Technology, Department of Electrical and Electronic Engineering, Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Georgiou</LastName><ForeName>Pantelis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre for Bio-Inspired Technology, Department of Electrical and Electronic Engineering, Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>EP/P0093X/1</GrantID><Agency>Engineering and Physical Sciences Research Council</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062407" MajorTopicYN="N">Meals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019397" MajorTopicYN="Y">Pancreas, Artificial</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial pancreas</Keyword><Keyword MajorTopicYN="N">carbohydrate estimation</Keyword><Keyword MajorTopicYN="N">deep learning</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">meal detection</Keyword><Keyword MajorTopicYN="N">multitask learning</Keyword><Keyword MajorTopicYN="N">neural network</Keyword><Keyword MajorTopicYN="N">quantile regression</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>01</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35062427</ArticleId><ArticleId IdType="pii">s22020466</ArticleId><ArticleId IdType="doi">10.3390/s22020466</ArticleId><ArticleId IdType="pmc">PMC8781086</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Nurs Scholarsh. 2018 Nov;50(6):676-686</Citation><ArticleIdList><ArticleId IdType="pubmed">30246919</ArticleId></ArticleIdList></Reference><Reference><Citation>Drugs. 2019 Jul;79(10):1089-1101</Citation><ArticleIdList><ArticleId IdType="pubmed">31190305</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Mar;12(2):349-355</Citation><ArticleIdList><ArticleId IdType="pubmed">28895431</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Pract. 2017 Oct;23(10):1201-1209</Citation><ArticleIdList><ArticleId IdType="pubmed">28704103</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2021 Dec;23(12):844-856</Citation><ArticleIdList><ArticleId IdType="pubmed">34270324</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:706-712</Citation><ArticleIdList><ArticleId IdType="pubmed">31945995</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2019 Oct 08;19(19):</Citation><ArticleIdList><ArticleId IdType="pubmed">31597288</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2013 Jan;99(1):19-23</Citation><ArticleIdList><ArticleId IdType="pubmed">23146371</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Med Res Opin. 2017 Apr;33(4):639-645</Citation><ArticleIdList><ArticleId IdType="pubmed">28008782</ArticleId></ArticleIdList></Reference><Reference><Citation>Biostatistics. 2020 Apr 1;21(2):345-352</Citation><ArticleIdList><ArticleId IdType="pubmed">31742354</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2021 Jul;25(7):2744-2757</Citation><ArticleIdList><ArticleId IdType="pubmed">33232247</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2017 Sep;34(9):1228-1234</Citation><ArticleIdList><ArticleId IdType="pubmed">28498610</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hum Nutr Diet. 2018 Oct;31(5):597-602</Citation><ArticleIdList><ArticleId IdType="pubmed">29766593</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Comput. 1997 Nov 15;9(8):1735-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9377276</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2018 Mar 16;18(3):</Citation><ArticleIdList><ArticleId IdType="pubmed">29547553</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2017 Jun;64(6):1249-1260</Citation><ArticleIdList><ArticleId IdType="pubmed">28541188</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2017 May;21(3):619-627</Citation><ArticleIdList><ArticleId IdType="pubmed">28278487</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Jul;39(7):1175-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27330126</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2019 Dec 1;26(12):1592-1599</Citation><ArticleIdList><ArticleId IdType="pubmed">31562509</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2021 Aug 15;:</Citation><ArticleIdList><ArticleId IdType="pubmed">34400480</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Diabetes. 2016 Jul;34(3):142-7</Citation><ArticleIdList><ArticleId IdType="pubmed">27621531</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Jul;2(4):630-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19885239</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Sep 01;3(5):1022-30</Citation><ArticleIdList><ArticleId IdType="pubmed">20144415</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2013 Apr;36(4):801-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23193210</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Nov 17;10(2):405-13</Citation><ArticleIdList><ArticleId IdType="pubmed">26581881</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2008 Feb;31(2):295-300</Citation><ArticleIdList><ArticleId IdType="pubmed">17977934</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2018 Mar;20(3):235-246</Citation><ArticleIdList><ArticleId IdType="pubmed">29406789</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35025756</PMID><DateRevised><Year>2022</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1929-0748</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>11</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>Predicting Real-world Hypoglycemia Risk in American Adults With Type 1 or 2 Diabetes Mellitus Prescribed Insulin and/or Secretagogues: Protocol for a Prospective, 12-Wave Internet-Based Panel Survey With Email Support (the iNPHORM [Investigating Novel Predictions of Hypoglycemia Occurrence Using Real-world Models] Study).</ArticleTitle><Pagination><MedlinePgn>e33726</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/33726</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hypoglycemia prognostic models contingent on prospective, self-reported survey data offer a powerful avenue for determining real-world event susceptibility and interventional targets.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This protocol describes the design and implementation of the 1-year iNPHORM (Investigating Novel Predictions of Hypoglycemia Occurrence Using Real-world Models) study, which aims to measure real-world self-reported severe and nonsevere hypoglycemia incidence (daytime and nocturnal) in American adults with type 1 or 2 diabetes mellitus prescribed insulin and/or secretagogues, and develop and internally validate prognostic models for severe, nonsevere daytime, and nonsevere nocturnal hypoglycemia. As a secondary objective, iNPHORM aims to quantify the effects of different antihyperglycemics on hypoglycemia rates.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">iNPHORM is a prospective, 12-wave internet-based panel survey that was conducted across the United States. Americans (aged 18-90 years) with self-reported type 1 or 2 diabetes mellitus prescribed insulin and/or secretagogues were conveniently sampled via the web from a pre-existing, closed, probability-based internet panel (sample frame). A sample size of 521 baseline responders was calculated for this study. Prospective data on hypoglycemia and potential prognostic factors were self-assessed across 14 closed, fully automated questionnaires (screening, baseline, and 12 monthly follow-ups) that were piloted using semistructured interviews (n=3) before fielding; no face-to-face contact was required as part of the data collection. Participant responses will be analyzed using multivariable count regression and machine learning techniques to develop and internally validate prognostic models for 1-year severe and 30-day nonsevere daytime and nocturnal hypoglycemia. The causal effects of different antihyperglycemics on hypoglycemia rates will also be investigated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Recruitment and data collection occurred between February 2020 and March 2021 (ethics approval was obtained on December 17, 2019). A total of 1694 participants completed the baseline questionnaire, of whom 1206 (71.19%) were followed up for 12 months. Most follow-up waves (10,470/14,472, 72.35%) were completed, translating to a participation rate of 179% relative to our target sample size. Over 70.98% (856/1206) completed wave 12. Analyses of sample characteristics, quality metrics, and hypoglycemia incidence and prognostication are currently underway with published results anticipated by fall 2022.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">iNPHORM is the first hypoglycemia prognostic study in the United States to leverage prospective, longitudinal self-reports. The results will contribute to improved real-world hypoglycemia risk estimation and potentially safer, more effective clinical diabetes management.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT04219514; https://clinicaltrials.gov/ct2/show/NCT04219514.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">DERR1-10.2196/33726.</AbstractText><CopyrightInformation>..Alexandria Ratzki-Leewing, Bridget L Ryan, Guangyong Zou, Susan Webster-Bogaert, Jason E Black, Kathryn Stirling, Kristina Timcevska, Nadia Khan, John D Buchenberger, Stewart B Harris. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 11.02.2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ratzki-Leewing</LastName><ForeName>Alexandria</ForeName><Initials>A</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-9474-7900</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Bridget L</ForeName><Initials>BL</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-9080-5635</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Guangyong</ForeName><Initials>G</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-5773-4185</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robarts Research Institute, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webster-Bogaert</LastName><ForeName>Susan</ForeName><Initials>S</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-9938-7492</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Jason E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-3762-3231</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stirling</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-3882-1149</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timcevska</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-9365-772X</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-4659-2772</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buchenberger</LastName><ForeName>John D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-8247-0342</Identifier><AffiliationInfo><Affiliation>Ipsos Healthcare, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Stewart B</ForeName><Initials>SB</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-1794-6551</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04219514</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adverse event</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">hypoglycemia</Keyword><Keyword MajorTopicYN="N">insulin</Keyword><Keyword MajorTopicYN="N">internet survey</Keyword><Keyword MajorTopicYN="N">model</Keyword><Keyword MajorTopicYN="N">nonsevere hypoglycemia</Keyword><Keyword MajorTopicYN="N">protocol</Keyword><Keyword MajorTopicYN="N">real-world</Keyword><Keyword MajorTopicYN="N">risk</Keyword><Keyword MajorTopicYN="N">risk model</Keyword><Keyword MajorTopicYN="N">risk prediction</Keyword><Keyword MajorTopicYN="N">secretagogue</Keyword><Keyword MajorTopicYN="N">severe hypoglycemia</Keyword><Keyword MajorTopicYN="N">survey</Keyword><Keyword MajorTopicYN="N">symptom</Keyword><Keyword MajorTopicYN="N">type 1 diabetes mellitus</Keyword><Keyword MajorTopicYN="N">type 2 diabetes mellitus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>09</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>01</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>13</Day><Hour>17</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35025756</ArticleId><ArticleId IdType="pii">v11i2e33726</ArticleId><ArticleId IdType="doi">10.2196/33726</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">34986790</PMID><DateRevised><Year>2022</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2342</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>01</Month><Day>05</Day></PubDate></JournalIssue><Title>BMC medical imaging</Title><ISOAbbreviation>BMC Med Imaging</ISOAbbreviation></Journal><ArticleTitle>Deep learning-based pancreas volume assessment in individuals with type 1 diabetes.</ArticleTitle><Pagination><MedlinePgn>5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12880-021-00729-7</ELocationID><Abstract><AbstractText>Pancreas volume is reduced in individuals with diabetes and in autoantibody positive individuals at high risk for developing type 1 diabetes (T1D). Studies investigating pancreas volume are underway to assess pancreas volume in large clinical databases and studies, but manual pancreas annotation is time-consuming and subjective, preventing extension to large studies and databases. This study develops deep learning for automated pancreas volume measurement in individuals with diabetes. A convolutional neural network was trained using manual pancreas annotation on 160 abdominal magnetic resonance imaging (MRI) scans from individuals with T1D, controls, or a combination thereof. Models trained using each cohort were then tested on scans of 25 individuals with T1D. Deep learning and manual segmentations of the pancreas displayed high overlap (Dice coefficient = 0.81) and excellent correlation of pancreas volume measurements (R<sup>2</sup> = 0.94). Correlation was highest when training data included individuals both with and without T1D. The pancreas of individuals with T1D can be automatically segmented to measure pancreas volume. This algorithm can be applied to large imaging datasets to quantify the spectrum of human pancreas volume.</AbstractText><CopyrightInformation>.. 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roger</LastName><ForeName>Raphael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Medicine, Dell Medical School, University of Texas at Austin, 1701 Trinity St., Stop C0200, Austin, TX, 78712, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilmes</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Jonathan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Immunology, and Microbiology, Vanderbilt University, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Powers</LastName><ForeName>Alvin C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Tennessee Valley Healthcare System, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Craddock</LastName><ForeName>R Cameron</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Medicine, Dell Medical School, University of Texas at Austin, 1701 Trinity St., Stop C0200, Austin, TX, 78712, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virostko</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Medicine, Dell Medical School, University of Texas at Austin, 1701 Trinity St., Stop C0200, Austin, TX, 78712, USA. jack.virostko@austin.utexas.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Livestrong Cancer Institutes, University of Texas at Austin, Austin, TX, USA. jack.virostko@austin.utexas.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology, University of Texas at Austin, Austin, TX, USA. jack.virostko@austin.utexas.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oden Institute for Computational Engineering and Sciences, University of Texas at Austin, Austin, TX, USA. jack.virostko@austin.utexas.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DK-129979</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Imaging</MedlineTA><NlmUniqueID>100968553</NlmUniqueID><ISSNLinking>1471-2342</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Artificial intelligence</Keyword><Keyword MajorTopicYN="Y">Auto-segmentation</Keyword><Keyword MajorTopicYN="Y">Automatic segmentation</Keyword><Keyword MajorTopicYN="Y">MRI</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Neural network</Keyword><Keyword MajorTopicYN="Y">Semantic</Keyword><Keyword MajorTopicYN="Y">Size</Keyword><Keyword MajorTopicYN="Y">T1D</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>09</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34986790</ArticleId><ArticleId IdType="doi">10.1186/s12880-021-00729-7</ArticleId><ArticleId IdType="pii">10.1186/s12880-021-00729-7</ArticleId><ArticleId IdType="pmc">PMC8734282</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hippocampus. 2009 Jun;19(6):579-87</Citation><ArticleIdList><ArticleId IdType="pubmed">19437497</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Feb;42(2):248-257</Citation><ArticleIdList><ArticleId IdType="pubmed">30552135</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2021 Aug 24;16(8):e0256029</Citation><ArticleIdList><ArticleId IdType="pubmed">34428220</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc SPIE Int Soc Opt Eng. 2018 Mar;10574:</Citation><ArticleIdList><ArticleId IdType="pubmed">29887665</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Jul 24;12(7):e0180911</Citation><ArticleIdList><ArticleId IdType="pubmed">28742102</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2020 Dec;8(12):939-948</Citation><ArticleIdList><ArticleId IdType="pubmed">33031736</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Math Methods Med. 2021 Sep 12;2021:8036304</Citation><ArticleIdList><ArticleId IdType="pubmed">34552660</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2021 Feb;68:101884</Citation><ArticleIdList><ArticleId IdType="pubmed">33246228</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2021 Jun 15;10:</Citation><ArticleIdList><ArticleId IdType="pubmed">34128465</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Phys. 2021 May;48(5):2468-2481</Citation><ArticleIdList><ArticleId IdType="pubmed">33595105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Digit Health. 2020 Jun;2(6):e303-e313</Citation><ArticleIdList><ArticleId IdType="pubmed">33328124</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2021 Feb 3;11(1):2885</Citation><ArticleIdList><ArticleId IdType="pubmed">33536451</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Feb;42(2):281-287</Citation><ArticleIdList><ArticleId IdType="pubmed">30552130</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2020 Mar 16;10(1):4767</Citation><ArticleIdList><ArticleId IdType="pubmed">32179809</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Syst. 2018 Oct 8;42(11):226</Citation><ArticleIdList><ArticleId IdType="pubmed">30298337</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Comput Comput Assist Interv. 2016 Oct;9901:442-450</Citation><ArticleIdList><ArticleId IdType="pubmed">28083570</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34943504</PMID><DateRevised><Year>2021</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4418</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>03</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Performance Analysis of Conventional Machine Learning Algorithms for Identification of Chronic Kidney Disease in Type 1 Diabetes Mellitus Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2267</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diagnostics11122267</ELocationID><Abstract><AbstractText>Chronic kidney disease (CKD) is one of the severe side effects of type 1 diabetes mellitus (T1DM). However, the detection and diagnosis of CKD are often delayed because of its asymptomatic nature. In addition, patients often tend to bypass the traditional urine protein (urinary albumin)-based CKD detection test. Even though disease detection using machine learning (ML) is a well-established field of study, it is rarely used to diagnose CKD in T1DM patients. This research aimed to employ and evaluate several ML algorithms to develop models to quickly predict CKD in patients with T1DM using easily available routine checkup data. This study analyzed 16 years of data of 1375 T1DM patients, obtained from the Epidemiology of Diabetes Interventions and Complications (EDIC) clinical trials directed by the National Institute of Diabetes, Digestive, and Kidney Diseases, USA. Three data imputation techniques (RF, KNN, and MICE) and the SMOTETomek resampling technique were used to preprocess the primary dataset. Ten ML algorithms including logistic regression (LR), k-nearest neighbor (KNN), Gaussian na..ve Bayes (GNB), support vector machine (SVM), stochastic gradient descent (SGD), decision tree (DT), gradient boosting (GB), random forest (RF), extreme gradient boosting (XGB), and light gradient-boosted machine (LightGBM) were applied to developed prediction models. Each model included 19 demographic, medical history, behavioral, and biochemical features, and every feature's effect was ranked using three feature ranking techniques (XGB, RF, and Extra Tree). Lastly, each model's ROC, sensitivity (recall), specificity, accuracy, precision, and F-1 score were estimated to find the best-performing model. The RF classifier model exhibited the best performance with 0.96 (..0.01) accuracy, 0.98 (..0.01) sensitivity, and 0.93 (..0.02) specificity. LightGBM performed second best and was quite close to RF with 0.95 (..0.06) accuracy. In addition to these two models, KNN, SVM, DT, GB, and XGB models also achieved more than 90% accuracy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chowdhury</LastName><ForeName>Nakib Hayat</ForeName><Initials>NH</Initials><Identifier Source="ORCID">0000-0002-1223-8556</Identifier><AffiliationInfo><Affiliation>Department of Electrical, Electronic and Systems Engineering, Universiti Kebangsaan Malaysia, Bangi 43600, Selangor, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, Bangladesh Army University of Science and Technology (BAUST), Saidpur Cantonment, Saidpur 5310, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reaz</LastName><ForeName>Mamun Bin Ibne</ForeName><Initials>MBI</Initials><AffiliationInfo><Affiliation>Department of Electrical, Electronic and Systems Engineering, Universiti Kebangsaan Malaysia, Bangi 43600, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haque</LastName><ForeName>Fahmida</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Electrical, Electronic and Systems Engineering, Universiti Kebangsaan Malaysia, Bangi 43600, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Shamim</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, University of Rajshahi, Rajshahi 6205, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Sawal Hamid Md</ForeName><Initials>SHM</Initials><Identifier Source="ORCID">0000-0002-4819-863X</Identifier><AffiliationInfo><Affiliation>Department of Electrical, Electronic and Systems Engineering, Universiti Kebangsaan Malaysia, Bangi 43600, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>A Bakar</LastName><ForeName>Ahmad Ashrif</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-9060-0346</Identifier><AffiliationInfo><Affiliation>Department of Electrical, Electronic and Systems Engineering, Universiti Kebangsaan Malaysia, Bangi 43600, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhuiyan</LastName><ForeName>Mohammad Arif Sobhan</ForeName><Initials>MAS</Initials><Identifier Source="ORCID">0000-0003-0772-0556</Identifier><AffiliationInfo><Affiliation>Department of Electrical and Electronics Engineering, Xiamen University Malaysia, Bandar Sunsuria, Sepang 43900, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>XMUMRF/2021-C8/IECE/0021</GrantID><Agency>Xiamen University Malaysia</Agency><Country/></Grant><Grant><GrantID>DPK-2021-001</GrantID><Agency>Universiti Kebangsaan Malaysia</Agency><Country/></Grant><Grant><GrantID>GUP-2021-019</GrantID><Agency>Universiti Kebangsaan Malaysia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic kidney disease</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">prediction model</Keyword><Keyword MajorTopicYN="N">type 1 diabetes mellitus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>24</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34943504</ArticleId><ArticleId IdType="pii">diagnostics11122267</ArticleId><ArticleId IdType="doi">10.3390/diagnostics11122267</ArticleId><ArticleId IdType="pmc">PMC8700037</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>JAMA. 2015 Feb 24;313(8):837-46</Citation><ArticleIdList><ArticleId IdType="pubmed">25710660</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2020 Mar;63(3):636-647</Citation><ArticleIdList><ArticleId IdType="pubmed">31807796</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8</Citation><ArticleIdList><ArticleId IdType="pubmed">28236831</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2017 Jan;123:49-54</Citation><ArticleIdList><ArticleId IdType="pubmed">27923172</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Biol Med. 2021 Dec;139:104954</Citation><ArticleIdList><ArticleId IdType="pubmed">34715551</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Investig. 2017 Jan;8(1):6-18</Citation><ArticleIdList><ArticleId IdType="pubmed">27181363</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Methods Psychiatr Res. 2011 Mar;20(1):40-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21499542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2017 Mar 25;389(10075):1238-1252</Citation><ArticleIdList><ArticleId IdType="pubmed">27887750</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem. 1971 Aug;17(8):696-700</Citation><ArticleIdList><ArticleId IdType="pubmed">5562281</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnostics (Basel). 2020 Jun 18;10(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">32570782</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2021 May;44(5):1211-1218</Citation><ArticleIdList><ArticleId IdType="pubmed">33653822</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2013 Apr 16;158(8):596-603</Citation><ArticleIdList><ArticleId IdType="pubmed">23588748</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Res Rev. 2019 Nov;35(8):e3197</Citation><ArticleIdList><ArticleId IdType="pubmed">31222888</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnostics (Basel). 2021 May 07;11(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">34067203</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2010 Sep;123(9):836-846.e2</Citation><ArticleIdList><ArticleId IdType="pubmed">20800153</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2011 Nov;34(11):2353-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21926286</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Res Rev. 2017 Feb;33(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">27457509</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014 Feb;37(2):381-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24026564</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2011 Mar 14;171(5):412-20</Citation><ArticleIdList><ArticleId IdType="pubmed">21403038</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 May;42(5):883-890</Citation><ArticleIdList><ArticleId IdType="pubmed">30833370</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Mar;12(2):295-302</Citation><ArticleIdList><ArticleId IdType="pubmed">28494618</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1371-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26175542</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnostics (Basel). 2021 Apr 28;11(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">33925190</ArticleId></ArticleIdList></Reference><Reference><Citation>J Periodontal Res. 2011 Apr;46(2):164-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21108647</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 Jul;33(7):1536-43</Citation><ArticleIdList><ArticleId IdType="pubmed">20413518</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Mar;41(3):434-439</Citation><ArticleIdList><ArticleId IdType="pubmed">29263163</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Nephrol. 2020 Nov 27;21(1):518</Citation><ArticleIdList><ArticleId IdType="pubmed">33246427</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2011 Dec 22;365(25):2366-76</Citation><ArticleIdList><ArticleId IdType="pubmed">22077236</ArticleId></ArticleIdList></Reference><Reference><Citation>J Transl Med. 2019 Apr 11;17(1):119</Citation><ArticleIdList><ArticleId IdType="pubmed">30971285</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1999 Jan;22(1):99-111</Citation><ArticleIdList><ArticleId IdType="pubmed">10333910</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Mar;41(3):426-433</Citation><ArticleIdList><ArticleId IdType="pubmed">28931542</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">34891642</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2694-0604</ISSN><JournalIssue CitedMedium="Internet"><Volume>2021</Volume><PubDate><Year>2021</Year><Month>11</Month></PubDate></JournalIssue><Title>Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference</Title><ISOAbbreviation>Annu Int Conf IEEE Eng Med Biol Soc</ISOAbbreviation></Journal><ArticleTitle>An Ensemble Learning Algorithm Based on Dynamic Voting for Targeting the Optimal Insulin Dosage in Type 1 Diabetes Management.</ArticleTitle><Pagination><MedlinePgn>1828-1831</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/EMBC46164.2021.9630843</ELocationID><Abstract><AbstractText>People with type 1 diabetes (T1D) need exogenous insulin administrations several times a day. The amount of injected insulin is key for maintaining the concentration of blood glucose (BG) within a physiological safe range. According to well-established clinical guidelines, insulin dosing at mealtime is calculated through an empirical formula which, however, does not take advantage of the knowledge of BG trend provided in real-time by continuous glucose monitoring (CGM) sensors. To overcome suboptimal insulin dosage, we recently used machine learning techniques to build two new models, one linear and one nonlinear, which incorporate BG trend information.In this work, we propose an ensemble learning method for mealtime insulin bolus estimation based on dynamic voting, which combines the two models by taking advantage of where each alternative performs better. Being the resulting model black-box, a tool that enables its interpretability was applied to evaluate the contribution of each feature. The proposed model was trained using a synthetic dataset having information on 100 virtual subjects with different mealtime conditions, and its performance was evaluated within a simulated environment.The benefit given by the ensemble method compared to the single models was confirmed by the high time within the target glycemic range, and the trade-off reached in terms of time spent below and above this range. Moreover, the model interpretation pointed out the key role played by the information on BG dynamics in the estimation of insulin dosage.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Noaro</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Cappon</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Sparacino</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Facchinetti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Int Conf IEEE Eng Med Biol Soc</MedlineTA><NlmUniqueID>101763872</NlmUniqueID><ISSNLinking>2375-7477</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011057" MajorTopicYN="N">Politics</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>11</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34891642</ArticleId><ArticleId IdType="doi">10.1109/EMBC46164.2021.9630843</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">34793168</PMID><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1549-9626</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of chemical theory and computation</Title><ISOAbbreviation>J Chem Theory Comput</ISOAbbreviation></Journal><ArticleTitle>Dynamics-Based Peptide-MHC Binding Optimization by a Convolutional Variational Autoencoder: A Use-Case Model for CASTELO.</ArticleTitle><Pagination><MedlinePgn>7962-7971</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jctc.1c00870</ELocationID><Abstract><AbstractText>An unsolved challenge in the development of antigen-specific immunotherapies is determining the optimal antigens to target. Comprehension of antigen-major histocompatibility complex (MHC) binding is paramount toward achieving this goal. Here, we apply CASTELO, a combined machine learning-molecular dynamics (ML-MD) approach, to identify per-residue antigen binding contributions and then design novel antigens of increased MHC-II binding affinity for a type 1 diabetes-implicated system. We build upon a small-molecule lead optimization algorithm by training a convolutional variational autoencoder (CVAE) on MD trajectories of 48 different systems across four antigens and four HLA serotypes. We develop several new machine learning metrics including a structure-based anchor residue classification model as well as cluster comparison scores. ML-MD predictions agree well with experimental binding results and free energy perturbation-predicted binding affinities. Moreover, ML-MD metrics are independent of traditional MD stability metrics such as contact area and root-mean-square fluctuations (RMSF), which do not reflect binding affinity data. Our work supports the role of structure-based deep learning techniques in antigen-specific immunotherapy design.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>IBM Thomas J. Watson Research Center, Yorktown Heights, New York 10598, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21701, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Domeniconi</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IBM Thomas J. Watson Research Center, Yorktown Heights, New York 10598, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Chih-Chieh</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>IBM Thomas J. Watson Research Center, Yorktown Heights, New York 10598, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ruhong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>IBM Thomas J. Watson Research Center, Yorktown Heights, New York 10598, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zhejiang University, 688 Yuhangtang Road, Hangzhou 310027, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Leili</ForeName><Initials>L</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-2952-4858</Identifier><AffiliationInfo><Affiliation>IBM Thomas J. Watson Research Center, Yorktown Heights, New York 10598, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cong</LastName><ForeName>Guojing</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IBM Thomas J. Watson Research Center, Yorktown Heights, New York 10598, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oak Ridge National Laboratory, 1 Bethel Valley Road, Oak Ridge, Tennessee 37830, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Chem Theory Comput</MedlineTA><NlmUniqueID>101232704</NlmUniqueID><ISSNLinking>1549-9618</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>18</Day><Hour>17</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34793168</ArticleId><ArticleId IdType="doi">10.1021/acs.jctc.1c00870</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">34751904</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-0444</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Medical &amp; biological engineering &amp; computing</Title><ISOAbbreviation>Med Biol Eng Comput</ISOAbbreviation></Journal><ArticleTitle>GLYFE: review and benchmark of personalized glucose predictive models in type 1 diabetes.</ArticleTitle><Pagination><MedlinePgn>1-17</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11517-021-02437-4</ELocationID><Abstract><AbstractText>Due to the sensitive nature of diabetes-related data, preventing them from being easily shared between studies, and the wide discrepancies in their data processing pipeline, progress in the field of glucose prediction is hard to assess. To address this issue, we introduce GLYFE (GLYcemia Forecasting Evaluation), a benchmark of machine learning-based glucose predictive models. We present the accuracy and clinical acceptability of nine different models coming from the literature, from standard autoregressive to more complex neural network-based models. These results are obtained on two different datasets, namely UVA/Padova Type 1 Diabetes Metabolic Simulator (T1DMS) and Ohio Type-1 Diabetes Mellitus (OhioT1DM), featuring artificial and real type 1 diabetic patients respectively. By providing extensive details about the data flow as well as by providing the whole source code of the benchmarking process, we ensure the reproducibility of the results and the usability of the benchmark by the community. Those results serve as a basis of comparison for future studies. In a field where data are hard to obtain, and where the comparison of results from different studies is often irrelevant, GLYFE gives the opportunity of gathering researchers around a standardized common environment.</AbstractText><CopyrightInformation>.. 2021. International Federation for Medical and Biological Engineering.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Bois</LastName><ForeName>Maxime</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-4181-2422</Identifier><AffiliationInfo><Affiliation>CNRS-LIMSI and Universit.. Paris-Saclay, Orsay, France. maxime.debois@limsi.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yacoubi</LastName><ForeName>Moun..m A El</ForeName><Initials>MAE</Initials><AffiliationInfo><Affiliation>Samovar, CNRS, T..l..com SudParis, Institut Polytechnique de Paris, ..vry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ammi</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universit.. Paris 8, Saint-Denis, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ANR-11-IDEX-0003-02</GrantID><Agency>ANR</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med Biol Eng Comput</MedlineTA><NlmUniqueID>7704869</NlmUniqueID><ISSNLinking>0140-0118</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019985" MajorTopicYN="N">Benchmarking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Benchmark</Keyword><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">Glucose prediction</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Time-series forecasting</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>03</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>08</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>9</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34751904</ArticleId><ArticleId IdType="doi">10.1007/s11517-021-02437-4</ArticleId><ArticleId IdType="pii">10.1007/s11517-021-02437-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization et al (2016) Global report on diabetes. World Health Organization</Citation></Reference><Reference><Citation>..lafsd..ttir AF, Attvall S, Sandgren U, Dahlqvist S, Pivodic A, Skrtic S, Theodorsson E, Lind M (2017) A clinical trial of the accuracy and treatment experience of the flash glucose monitor freestyle libre in adults with type 1 diabetes. Diabetes Technol Therapeut 19(3):164...172</Citation></Reference><Reference><Citation>Rose K, Koenig M, Wiesbauer F (2013) Evaluating success for behavioral change in diabetes via mhealth and gamification: Mysugr...s keys to retention and patient engagement. Diabetes Technol Therapeut 15:A114</Citation></Reference><Reference><Citation>Bequette BW (2012) Challenges and recent progress in the development of a closed-loop artificial pancreas. Ann Rev Control 36(2):255...266</Citation></Reference><Reference><Citation>Man CD, Micheletto F, Lv D, Breton M, Kovatchev B, Cobelli C (2014) The uva/padova type 1 diabetes simulator: new features. J Diabetes Sci Technol 8(1):26...34</Citation><ArticleIdList><ArticleId IdType="pubmed">24876534</ArticleId><ArticleId IdType="pmcid">4454102</ArticleId></ArticleIdList></Reference><Reference><Citation>Marling C, Bunescu RC (2018) The ohiot1dm dataset for blood glucose level prediction. In: KHD@ IJCAI, pp 60...63</Citation></Reference><Reference><Citation>Oviedo S, Veh.. J, Calm R, Armengol J (2017) A review of personalized blood glucose prediction strategies for t1dm patients. Int J Numer Methods Biomed Eng 33(6):e2833</Citation></Reference><Reference><Citation>Huzooree G, Khedo KK, Joonas N (2017) Glucose prediction data analytics for diabetic patients monitoring, pp 188...195</Citation></Reference><Reference><Citation>Woldaregay AZ, ..rsand E, Walderhaug S, Albers D, Mamykina L, Botsis T, Hartvigsen G (2019) Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes. Artif Intell Med 98:109...134</Citation><ArticleIdList><ArticleId IdType="pubmed">31383477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovatchev BP, Breton M, Dalla Man C, Cobelli C (2009) In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol</Citation></Reference><Reference><Citation>Ruedy KJ, Beck RW, Xing D, Kollman C (2007) Diabetes research in children network: availability of protocol data sets. J Diabetes Sci Technol 1(5):738...745</Citation><ArticleIdList><ArticleId IdType="pubmed">18490965</ArticleId><ArticleId IdType="pmcid">2387002</ArticleId></ArticleIdList></Reference><Reference><Citation>J. C. for Health Research. Study information. [Online]. Available: http://direcnet.jaeb.org/Studies.aspx</Citation></Reference><Reference><Citation>Bazaev NA, Pozhar KV (2017) Blood glucose predir ...artificial pancreas... system. In: Gluconeogenesis InTech</Citation></Reference><Reference><Citation>Rudenko P, Bazaev N, Pozhar K, Litinskaia E, Grinvald V, Chekasin A (2018) Getting daily blood glucose tracks using clinical protocols of the direcnet database. Biomed Eng 51(5):346...349</Citation></Reference><Reference><Citation>Balakrishnan NP, Samavedham L, Rangaiah GP (2014) Personalized mechanistic models for exercise, meal and insulin interventions in children and adolescents with type 1 diabetes. J Theoret Biol 357:62...73</Citation></Reference><Reference><Citation>Mhaskar HN, Pereverzyev SV, van der Walt MD (2017) A deep learning approach to diabetic blood glucose prediction. Front Appl Math Stat 3:14</Citation></Reference><Reference><Citation>Jones TW, Davis EA (2003) Hypoglycemia in children with type 1 diabetes: current issues and controversies. Pediat Diabetes 4(3):143...150</Citation></Reference><Reference><Citation>Kahn M Uci machine learning repository: Diabetes data set. [Online]. Available: https://archive.ics.uci.edu/ml/datasets/diabetes</Citation></Reference><Reference><Citation>Khan T, Masud M, Mamun KA (2017) Methods to predict blood glucose level for type 2 diabetes patients. In: Humanitarian technology conference (r10-HTC), 2017, IEEE Region 10. IEEE, pp 392...395</Citation></Reference><Reference><Citation>Aibinu A, Salami M, Shafie A (2010) Blood glucose level prediction using intelligent based modeling techniques</Citation></Reference><Reference><Citation>Tomczak JM (2016) Gaussian process regression with categorical inputs for predicting the blood glucose level, pp 98...108</Citation></Reference><Reference><Citation>Lehmann ED, Deutsch T Aida freeware diabetes software simulator program of glucose - insulin action. [Online]. Available: http://www.2aida.org/online/</Citation></Reference><Reference><Citation>Lehmann E, Deutsch T, Carson E, S..nksen P (1994) Aida: an interactive diabetes advisor. Comput Methods Prog Biomed 41(3-4):183...203</Citation></Reference><Reference><Citation>Hidalgo JI, Colmenar JM, Risco-Martin JL, Cuesta-Infante A, Maqueda E, Botella M, Rubio JA (2014) Modeling glycemia in humans by means of grammatical evolution. Appl Soft Comput 20:40...53</Citation></Reference><Reference><Citation>Reymann MP, Dorschky E, Groh BH, Martindale C, Blank P, Eskofier BM (2016) Blood glucose level prediction based on support vector regression using mobile platforms. In: 2016 IEEE 38th annual international conference of the engineering in medicine and biology society (EMBC). IEEE, pp 2990...2993</Citation></Reference><Reference><Citation>Assadi K, Hamdi T, Fnaiech F, Ginoux JM, Moreau E (2017) Estimation of blood glucose levels techniques. In: 2017 international conference on smart, monitored and controlled cities (SM2c). IEEE, pp 75...80</Citation></Reference><Reference><Citation>Bamgbose SO, Li X, Qian L (2017) Closed loop control of blood glucose level with neural network predictor for diabetic patients. In: IEEE 19th international conference on e-Health networking, applications and services (Healthcom), 2017. IEEE, pp 1...6</Citation></Reference><Reference><Citation>Mirshekarian S, Shen H, Bunescu R, Marling C (2019) Lstms and neural attention models for blood glucose prediction: Comparative experiments on real and synthetic data. In: 2019 41st annual international conference of the IEEE engineering in medicine and biology society (EMBC). IEEE, pp 706...712</Citation></Reference><Reference><Citation>Wilinska ME, Chassin LJ, Acerini CL, Allen JM, Dunger DB, Hovorka R (2010) Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes. J Diabetes Sci Technol 4(1):132...144</Citation><ArticleIdList><ArticleId IdType="pubmed">20167177</ArticleId><ArticleId IdType="pmcid">2825634</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovorka R, Canonico V, Chassin LJ, Haueter U, Massi-Benedetti M, Federici MO, Pieber TR, Schaller HC, Schaupp L, Vering T et al (2004) Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas 25(4):905</Citation><ArticleIdList><ArticleId IdType="pubmed">15382830</ArticleId></ArticleIdList></Reference><Reference><Citation>Laguna AJ, Rossetti P, Ampudia-Blasco FJ, Veh.. J, Bondia J (2014) Experimental blood glucose interval identification of patients with type 1 diabetes. J Process Control 24(1):171...181</Citation></Reference><Reference><Citation>Szalay P, Beny.. Z, Kov..cs L (2016) Long-term prediction for t1dm model during state-feedback control. In: 2016 12th IEEE international conference on control and automation (ICCA). IEEE, pp 311...316</Citation></Reference><Reference><Citation>Boiroux D, Duun-Henriksen AK, Schmidt S, N..rgaard K, Poulsen NK, Madsen H, J..rgensen JB (2017) Adaptive control in an artificial pancreas for people with type 1 diabetes. Control Eng Pract 58:332...342</Citation></Reference><Reference><Citation>Visentin R, Campos-N....ez E, Schiavon M, Lv D, Vettoretti M, Breton M, Kovatchev BP, Dalla Man C, Cobelli C (2018) The uva/padova type 1 diabetes simulator goes from single meal to single day. J Diabetes Sci Technol 12(2):273...281</Citation><ArticleIdList><ArticleId IdType="pubmed">29451021</ArticleId><ArticleId IdType="pmcid">5851236</ArticleId></ArticleIdList></Reference><Reference><Citation>Laguna Sanz AJ, Doyle III FJ, Dassau E (2017) An enhanced model predictive control for the artificial pancreas using a confidence index based on residual analysis of past predictions. J Diabetes Sci Technol 11(3):537...544</Citation><ArticleIdList><ArticleId IdType="pubmed">28745095</ArticleId></ArticleIdList></Reference><Reference><Citation>Turksoy K, Samadi S, Feng J, Littlejohn E, Quinn L, Cinar A (2016) Meal detection in patients with type 1 diabetes: a new module for the multivariable adaptive artificial pancreas control system. IEEE J Biomed Health Inform 20(1):47...54</Citation><ArticleIdList><ArticleId IdType="pubmed">26087510</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J, Turksoy K, Cinar A (2016) Performance assessment of model-based artificial pancreas control systems. In: Prediction methods for blood glucose concentration. Springer, pp 243...265</Citation></Reference><Reference><Citation>Li C, Zhao C, Zhao H, Yu C (2017) Blood glucose control based on rapid model identification with particle swarm optimization method. In: 29th Chinese control and decision conference (CCDC), 2017. IEEE, pp 947...952</Citation></Reference><Reference><Citation>Contreras I, Oviedo S, Vettoretti M, Visentin R, Veh.. J (2017) Personalized blood glucose prediction: A hybrid approach using grammatical evolution and physiological models. PloS One 12 (11):e0187754</Citation><ArticleIdList><ArticleId IdType="pubmed">29112978</ArticleId><ArticleId IdType="pmcid">5675457</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras I, Veh.. J, Visentin R, Vettoretti M (2017) A hybrid clustering prediction for type 1 diabetes aid: towards decision support systems based upon scenario profile analysis. In: Proceedings of the second IEEE/ACM international conference on connected health: applications, systems and engineering technologies. IEEE Press, pp 64...69</Citation></Reference><Reference><Citation>Zhao H, Zhao C, Yu C, Dassau E (2018) Multiple order model migration and optimal model selection for online glucose prediction in type 1 diabetes. AIChE J 64(3):822...834</Citation></Reference><Reference><Citation>Yu X, Turksoy K, Rashid M, Feng J, Hobbs N, Hajizadeh I, Samadi S, Sevil M, Lazaro C, Maloney Z et al (2018) Model-fusion-based online glucose concentration predictions in people with type 1 diabetes. Control Eng Pract 71:129...141</Citation><ArticleIdList><ArticleId IdType="pubmed">29276347</ArticleId><ArticleId IdType="pmcid">5736323</ArticleId></ArticleIdList></Reference><Reference><Citation>Zecchin C, Facchinetti A, Sparacino G, De Nicolao G, Cobelli C (2012) Neural network incorporating meal information improves accuracy of short-time prediction of glucose concentration. IEEE Trans Biomed Eng 59(6):1550...1560</Citation><ArticleIdList><ArticleId IdType="pubmed">22374344</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Yu X, Liu J, Wang H (2017) Glucose prediction for type 1 diabetes using klms algorithm. In: 2017 36th Chines control conference (CCC). IEEE, pp 1124...1128</Citation></Reference><Reference><Citation>Sun Q, Jankovic MV, Bally L, Mougiakakou SG (2018) Predicting blood glucose with an lstm and bi-lstm based deep neural network. In: 2018 14th symposium on neural networks and applications (NEUREL), pp 1...5</Citation></Reference><Reference><Citation>Veh.. J, Contreras I, Oviedo S, Biagi L, Bertachi A (2019) Prediction and prevention of hypoglycaemic events in type-1 diabetic patients using machine learning. Health Inf J: 1460458219850682</Citation></Reference><Reference><Citation>Li K, Liu C, Zhu T, Herrero P, Georgiou P (2019) Glunet: A deep learning framework for accurate glucose forecasting. IEEE J Biomed Health Inf</Citation></Reference><Reference><Citation>Zhu T, Li K, Herrero P, Chen J, Georgiou P (2018) A deep learning algorithm for personalized blood glucose prediction. In: KHD@ IJCAI, pp 64...78</Citation></Reference><Reference><Citation>Bertachi A, Biagi L, Contreras I, Luo N, Veh.. J (2018) Prediction of blood glucose levels and nocturnal hypoglycemia using physiological models and artificial neural networks. In: KHD@ IJCAI, pp 85...90</Citation></Reference><Reference><Citation>Contreras I, Bertachi A, Biagi L, Veh.. J, Oviedo S (2018) Using grammatical evolution to generate short-term blood glucose prediction models. In: KHD@ IJCAI, pp 91...96</Citation></Reference><Reference><Citation>Midroni C, Leimbigler PJ, Baruah G, Kolla M, Whitehead AJ, Fossat Y (2018) Predicting glycemia in type 1 diabetes patients:, experiments with xgboost. Heart 60(90):120</Citation></Reference><Reference><Citation>Jeon J, Leimbigler PJ, Baruah G, Li MH, Fossat Y, Whitehead AJ (2019) Predicting glycaemia in type 1 diabetes patients: Experiments in feature engineering and data imputation. J Healthcare Inf Res: 1...20</Citation></Reference><Reference><Citation>Mayo M, Chepulis L, Paul RG (2019) Glycemic-aware metrics and oversampling techniques for predicting blood glucose levels using machine learning. PloS One 12:14</Citation></Reference><Reference><Citation>De Bois M, El Yacoubi MA, Ammi M (2019) Prediction-coherent lstm-based recurrent neural network for safer glucose predictions in diabetic people. In: International conference on neural information processing. Springer, pp 510...521</Citation></Reference><Reference><Citation>Martinsson J, Schliep A, Eliasson B, Mogren O (2019) Blood glucose prediction with variance estimation using recurrent neural networks. J Healthcare Inf Res 1...18</Citation></Reference><Reference><Citation>Akbari M, Chunara R (2019) Using contextual information to improve blood glucose prediction. arXiv: 1909.01735</Citation></Reference><Reference><Citation>Dalla Man C, Rizza RA, Cobelli C (2007) Meal simulation model of the glucose-insulin system. IEEE Trans Biomed Eng 54(10):1740...1749</Citation><ArticleIdList><ArticleId IdType="pubmed">17926672</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergman RN, Ider YZ, Bowden CR, Cobelli C (1979) Quantitative estimation of insulin sensitivity. Amer J Physiol Endocrinol Metabol 236(6):E667</Citation></Reference><Reference><Citation>Bergman RN (2005) Minimal model: perspective from 2005. Hormone Res Paediat 164(Suppl. 3):8...15</Citation></Reference><Reference><Citation>Calm R, Garc..a-Jaramillo M, Bondia J, Sainz M, Veh.. J (2011) Comparison of interval and monte carlo simulation for the prediction of postprandial glucose under uncertainty in type 1 diabetes mellitus. Comput Methods Prog Biomed 104(3):325...332</Citation></Reference><Reference><Citation>Duun-Henriksen AK, Schmidt S, R..ge RM, M..ller JB, N..rgaard K, J..rgensen JB, Madsen H (2013) Model identification using stochastic differential equation grey-box models in diabetes. J Diabetes Sci Technol 7(2):431...440</Citation><ArticleIdList><ArticleId IdType="pubmed">23567002</ArticleId><ArticleId IdType="pmcid">3737645</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparacino G, Zanderigo F, Corazza S, Maran A, Facchinetti A, Cobelli C (2007) Glucose concentration can be predicted ahead in time from continuous glucose monitoring sensor time-series. IEEE Trans Biomed Eng 54(5):931...937</Citation><ArticleIdList><ArticleId IdType="pubmed">17518291</ArticleId></ArticleIdList></Reference><Reference><Citation>Eren-Oruklu M, Cinar A, Quinn L, Smith D (2009) Estimation of future glucose concentrations with subject-specific recursive linear models. Diabetes Technol Therap 11(4):243...253</Citation></Reference><Reference><Citation>Eren-Oruklu M, Cinar A, Rollins DK, Quinn L (2012) Adaptive system identification for estimating future glucose concentrations and hypoglycemia alarms. Automatica 48(8):1892...1897</Citation><ArticleIdList><ArticleId IdType="pubmed">22865931</ArticleId><ArticleId IdType="pmcid">3409594</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Li L, Shi Y, Xie X (2018) An arima model with adaptive orders for predicting blood glucose concentrations and hypoglycemia. IEEE J Biomed Health Inf</Citation></Reference><Reference><Citation>Daskalaki E, N..rgaard K, Z..ger T, Prountzou A, Diem P, Mougiakakou S (2013) An early warning system for hypoglycemic/hyperglycemic events based on fusion of adaptive prediction models. J Diabetes Sci Technol 7(3):689...698</Citation><ArticleIdList><ArticleId IdType="pubmed">23759402</ArticleId><ArticleId IdType="pmcid">3869137</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankovic MV, Mosimann S, Bally L, Stettler C, Mougiakakou S (2016) Deep prediction model:, The case of online adaptive prediction of subcutaneous glucose 1...5</Citation></Reference><Reference><Citation>Wang Q, Molenaar P, Harsh S, Freeman K, Xie J, Gold C, Rovine M, Ulbrecht J (2014) Personalized state-space modeling of glucose dynamics for type 1 diabetes using continuously monitored glucose, insulin dose, and meal intake: an extended kalman filter approach. J Diabetes Sci Technol 8 (2):331...345</Citation><ArticleIdList><ArticleId IdType="pubmed">24876585</ArticleId><ArticleId IdType="pmcid">4455398</ArticleId></ArticleIdList></Reference><Reference><Citation>Macas M, Lhotska L, Stechova K, Pithova P, Saiti K (2017) Particle swarm optimization based adaptable predictor of glycemia values. In: 2017 3rd IEEE international conference on cybernetics (CYBCONF). IEEE, pp 1...6</Citation></Reference><Reference><Citation>Novara C, Pour NM, Vincent T, Grassi G (2016) A nonlinear blind identification approach to modeling of diabetic patients. IEEE Trans Control Syst Technol 24(3):1092...1100</Citation></Reference><Reference><Citation>Zarkogianni K, Mitsis K, Litsa E, Arredondo M-T, Fico G, Fioravanti A, Nikita KS (2015) Comparative assessment of glucose prediction models for patients with type 1 diabetes mellitus applying sensors for glucose and physical activity monitoring. Med Biol Eng Comput 53(12):1333...1343</Citation><ArticleIdList><ArticleId IdType="pubmed">26049412</ArticleId></ArticleIdList></Reference><Reference><Citation>Georga EI, Protopappas VC, Ardig.. D, Polyzos D, Fotiadis DI (2013) A glucose model based on support vector regression for the prediction of hypoglycemic events under free-living conditions. Diabetes Technol Therap 15(8):634...643</Citation></Reference><Reference><Citation>Ali JB, Hamdi T, Fnaiech N, Di Costanzo V, Fnaiech F, Ginoux J-M (2018) Continuous blood glucose level prediction of type 1 diabetes based on artificial neural network. Biocybern Biomed Eng 38(4):828...840</Citation></Reference><Reference><Citation>Sandham W, Nikoletou D, Hamilton D, Paterson K, Japp A, MacGregor C (1998) Blood glucose prediction for diabetes therapy using a recurrent artificial neural network. In: 9th European signal processing conference (EUSIPCO 1998). IEEE, pp 1...4</Citation></Reference><Reference><Citation>Fiorini S, Martini C, Malpassi D, Cordera R, Maggi D, Verri A, Barla A (2017) Data-driven strategies for robust forecast of continuous glucose monitoring time-series. In: 2017 39th annual international conference of the IEEE engineering in medicine and biology society (EMBC). IEEE, pp 1680...1683</Citation></Reference><Reference><Citation>Mirshekarian S, Bunescu R, Marling C, Schwartz F (2017) Using lstms to learn physiological models of blood glucose behavior. In: 2017 39th annual international conference of the IEEE engineering in medicine and biology society (EMBC). IEEE, pp 2887...2891</Citation></Reference><Reference><Citation>Gers FA, Schmidhuber J, Cummins F (1999) Learning to forget: Continual prediction with lstm</Citation></Reference><Reference><Citation>Huang G-B, Zhu Q-Y, Siew C-K (2004) Extreme learning machine: a new learning scheme of feedforward neural networks. In: IEEE International Joint Conference on Neural Networks, 2004. Proceedings 2004, vol 2. IEEE, pp 985...990</Citation></Reference><Reference><Citation>Pao Y-H, Park G-H, Sobajic DJ (1994) Learning and generalization characteristics of the random vector functional-link net. Neurocomputing 6(2):163...180</Citation></Reference><Reference><Citation>Georga EI, Protopappas VC, Polyzos D, Fotiadis DI (2015) Online prediction of glucose concentration in type 1 diabetes using extreme learning machines. In: 2015 37th annual international conference of the engineering in medicine and biology society (EMBC). IEEE, pp 3262...3265</Citation></Reference><Reference><Citation>Ling SH, San PP, Nguyen HT (2016) Non-invasive hypoglycemia monitoring system using extreme learning machine for type 1 diabetes. ISA Trans 64:440...446</Citation><ArticleIdList><ArticleId IdType="pubmed">27311357</ArticleId></ArticleIdList></Reference><Reference><Citation>Zecchin C, Facchinetti A, Sparacino G, Cobelli C (2014) Jump neural network for online short-time prediction of blood glucose from continuous monitoring sensors and meal information. Comput Methods Prog Biomed 113(1):144...152</Citation></Reference><Reference><Citation>Li K, Daniels J, Liu C, Herrero-Vinas P, Georgiou P (2019) Convolutional recurrent neural networks for glucose prediction. IEEE J Biomed Health Inf</Citation></Reference><Reference><Citation>Zhu T, Li K, Chen J, Herrero P, Georgiou P (2020) Dilated recurrent neural networks for glucose forecasting in type 1 diabetes. J Healthcare Inf Res 4(3):308...324</Citation></Reference><Reference><Citation>De Bois M, El Yacoubi MA, Ammi M (2021) Adversarial multi-source transfer learning in healthcare: Application to glucose prediction for diabetic people. Comput Methods Prog Biomed 199:105874</Citation></Reference><Reference><Citation>Li N, Tuo J, Wang Y (2018) Chaotic time series analysis approach for prediction blood glucose concentration based on echo state networks. In: 2018 Chinese control and decision conference (CCDC). IEEE, pp 2017...2022</Citation></Reference><Reference><Citation>Hofmann T, Sch..lkopf B, Smola AJ (2008) Kernel methods in machine learning. Ann Stat 1171...1220</Citation></Reference><Reference><Citation>De Paula M, Avila LO, Martinez EC (2015) Controlling blood glucose variability under uncertainty using reinforcement learning and gaussian processes. Appl Soft Comput 35:310...332</Citation></Reference><Reference><Citation>Bunescu R, Struble N, Marling C, Shubrook J, Schwartz F (2013) Blood glucose level prediction using physiological models and support vector regression. In: 12th international conference on machine learning and applications (ICMLA), 2013, vol 1. IEEE, pp 135...140</Citation></Reference><Reference><Citation>Georga EI, Protopappas VC, Ardig.. D, Marina M, Zavaroni I, Polyzos D, Fotiadis DI (2013) Multivariate prediction of subcutaneous glucose concentration in type 1 diabetes patients based on support vector regression. IEEE J Biomed Health Inf 17(1):71...81</Citation></Reference><Reference><Citation>Hamdi T, Ali JB, Di Costanzo V, Fnaiech F, Moreau E, Ginoux J-M (2018) Accurate prediction of continuous blood glucose based on support vector regression and differential evolution algorithm. Biocybern Biomed Eng 38(2):362...372</Citation></Reference><Reference><Citation>Naumova V, Nita L, Poulsen JU, Pereverzyev SV (2016) Meta-learning based blood glucose predictor for diabetic smartphone app. In: Prediction methods for blood glucose concentration. Springer, pp 93...105</Citation></Reference><Reference><Citation>Yu X, Rashid M, Feng J, Hobbs N, Hajizadeh I, Samadi S, Sevil M, Lazaro C, Maloney Z, Littlejohn E et al (2018) Online glucose prediction using computationally efficient sparse kernel filtering algorithms in type-1 diabetes. IEEE Trans Control Syst Technol 99:1...13</Citation></Reference><Reference><Citation>Georga EI, Principe JC, Polyzos D, Fotiadis DI (2016) Non-linear dynamic modeling of glucose in type 1 diabetes with kernel adaptive filters. In: 2016 IEEE 38th annual international conference of the engineering in medicine and biology society (EMBC). IEEE, pp 5897...5900</Citation></Reference><Reference><Citation>Georga EI, Pr..ncipe JC, Rizos EC, Fotiadis DI (2017) Kernel-based adaptive learning improves accuracy of glucose predictive modelling in type 1 diabetes:, A proof-of-concept study. In: 2017 39th annual international conference of the IEEE engineering in medicine and biology society (EMBC). IEEE, pp 2765...2768</Citation></Reference><Reference><Citation>Georga EI, Pr..ncipe JC, Fotiadis DI (2019) Short-term prediction of glucose in type 1 diabetes using kernel adaptive filters. Med Biol Eng Comput 57(1):27...46</Citation><ArticleIdList><ArticleId IdType="pubmed">29967934</ArticleId></ArticleIdList></Reference><Reference><Citation>Zecchin C, Facchinetti A, Sparacino G, Dalla Man C, Manohar C, Levine JA, Basu A, Kudva YC, Cobelli C (2013) Physical activity measured by physical activity monitoring system correlates with glucose trends reconstructed from continuous glucose monitoring. Diabetes Technol Therap 15(10):836...844</Citation></Reference><Reference><Citation>Mougiakakou SG, Prountzou A, Iliopoulou D, Nikita KS, Vazeou A, Bartsocas CS (2006) Neural network based glucose-insulin metabolism models for children with type 1 diabetes. In: 28th annual international conference of the engineering in medicine and biology society, 2006. EMBS...06. IEEE, pp 3545...3548</Citation></Reference><Reference><Citation>Daskalaki E, Prountzou A, Diem P, Mougiakakou SG (2012) Real-time adaptive models for the personalized prediction of glycemic profile in type 1 diabetes patients. Diabetes Technol Therap 14 (2):168...174</Citation></Reference><Reference><Citation>Zarkogianni K, Vazeou A, Mougiakakou SG, Prountzou A, Nikita KS (2011) An insulin infusion advisory system based on autotuning nonlinear model-predictive control. IEEE Trans Biomed Eng 58 (9):2467...2477</Citation><ArticleIdList><ArticleId IdType="pubmed">21622071</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparacino G, Zanderigo F, Maran A, Cobelli C (2006) Continuous glucose monitoring and hypo/hyperglycaemia prediction. Diabetes Res Clin Pract 74:S160...S163</Citation></Reference><Reference><Citation>De Bois M, El Yacoubi MA, Ammi M Study of short-term personalized glucose predictive models on type-1 diabetic children, accepted at IJCNN 2019, date to be determined</Citation></Reference><Reference><Citation>Klambauer G, Unterthiner T, Mayr A, Hochreiter S (2017) Self-normalizing neural networks. In: Advances in neural information processing systems, pp 971...980</Citation></Reference><Reference><Citation>Kingma DP, Ba J (2014) Adam: A method for stochastic optimization. arXiv: 1412.6980</Citation></Reference><Reference><Citation>Gani A, Gribok AV, Rajaraman S, Ward WK, Reifman J (2009) Predicting subcutaneous glucose concentration in humans: data-driven glucose modeling. IEEE Trans Biomed Eng 56(2):246</Citation><ArticleIdList><ArticleId IdType="pubmed">19272928</ArticleId></ArticleIdList></Reference><Reference><Citation>Facchinetti A, Sparacino G, Trifoglio E, Cobelli C (2011) A new index to optimally design and compare continuous glucose monitoring glucose prediction algorithms. Diabetes Technol Therap 13(2):111...119</Citation></Reference><Reference><Citation>Kovatchev BP, Gonder-Frederick LA, Cox DJ, Clarke WL (2004) Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose...error grid analysis illustrated by therasense freestyle navigator data. Diabetes Care 27(8):1922...1928</Citation><ArticleIdList><ArticleId IdType="pubmed">15277418</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke WL (2005) The original clarke error grid analysis (ega). Diabetes Technol Therap 7 (5):776...779</Citation></Reference><Reference><Citation>Parkes JL, Slatin SL, Pardo S, Ginsberg BH (2000) A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care 23(8):1143...1148</Citation><ArticleIdList><ArticleId IdType="pubmed">10937512</ArticleId></ArticleIdList></Reference><Reference><Citation>De Bois M Glyfe 2019, doi: https://doi.org/10.5281/zenodo.3497408 . [Online]. Available: https://github.com/dotXem/GLYFE</Citation></Reference><Reference><Citation>Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M, Prettenhofer P, Weiss R, Dubourg V et al (2011) Scikit-learn: Machine learning in python. J Mach Learn Res 12(Oct):2825...2830</Citation></Reference><Reference><Citation>McKinney W, Perktold J, Seabold S (2011) Time series analysis in python with statsmodels. Jarrodmillman Com 96...102</Citation></Reference><Reference><Citation>Paszke A, Gross S, Chintala S, Chanan G, Yang E, DeVito Z, Lin Z, Desmaison A, Antiga L, Lerer A (2017) Automatic differentiation in pytorch</Citation></Reference><Reference><Citation>Gers FA, Eck D, Schmidhuber J (2002) Applying lstm to time series predictable through time-window approaches. In: Neural nets WIRN Vietri-01. Springer, pp 193...200</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">34711639</PMID><DateRevised><Year>2021</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1935-5548</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>Oct</Month><Day>28</Day></PubDate></JournalIssue><Title>Diabetes care</Title><ISOAbbreviation>Diabetes Care</ISOAbbreviation></Journal><ArticleTitle>Prediction of Personal Glycemic Responses to Food for Individuals With Type 1 Diabetes Through Integration of Clinical and Microbial Data.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">dc211048</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2337/dc21-1048</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Despite technological advances, results from various clinical trials have repeatedly shown that many individuals with type 1 diabetes (T1D) do not achieve their glycemic goals. One of the major challenges in disease management is the administration of an accurate amount of insulin for each meal that will match the expected postprandial glycemic response (PPGR). The objective of this study was to develop a prediction model for PPGR in individuals with T1D.</AbstractText><AbstractText Label="RESEARCH DESIGN AND METHODS" NlmCategory="METHODS">We recruited individuals with T1D who were using continuous glucose monitoring and continuous subcutaneous insulin infusion devices simultaneously to a prospective cohort and profiled them for 2 weeks. Participants were asked to report real-time dietary intake using a designated mobile app. We measured their PPGRs and devised machine learning algorithms for PPGR prediction, which integrate glucose measurements, insulin dosages, dietary habits, blood parameters, anthropometrics, exercise, and gut microbiota. Data of the PPGR of 900 healthy individuals to 41,371 meals were also integrated into the model. The performance of the models was evaluated with 10-fold cross validation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 121 individuals with T1D, 75 adults and 46 children, were included in the study. PPGR to 6,377 meals was measured. Our PPGR prediction model substantially outperforms a baseline model with emulation of standard of care (correlation of R = 0.59 compared with R = 0.40 for predicted and observed PPGR respectively; <i>P</i> &lt; 10<sup>-10</sup>). The model was robust across different subpopulations. Feature attribution analysis revealed that glucose levels at meal initiation, glucose trend 30 min prior to meal, meal carbohydrate content, and meal's carbohydrate-to-fat ratio were the most influential features for the model.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our model enables a more accurate prediction of PPGR and therefore may allow a better adjustment of the required insulin dosage for meals. It can be further implemented in closed loop systems and may lead to rationally designed nutritional interventions personally tailored for individuals with T1D on the basis of meals with expected low glycemic response.</AbstractText><CopyrightInformation>.. 2021 by the American Diabetes Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shilo</LastName><ForeName>Smadar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godneva</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rachmiel</LastName><ForeName>Marianna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Endocrinology Unit, Shamir Medical Center, Zerifin, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korem</LastName><ForeName>Tal</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Systems Biology, Columbia University, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolobkov</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karady</LastName><ForeName>Tal</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bar</LastName><ForeName>Noam</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolf</LastName><ForeName>Bat Chen</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glantz-Gashai</LastName><ForeName>Yitav</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Pediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuckerman Levin</LastName><ForeName>Nehama</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shehadeh</LastName><ForeName>Naim</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gruber</LastName><ForeName>Noah</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat-Gan, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levran</LastName><ForeName>Neriya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat-Gan, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koren</LastName><ForeName>Shlomit</ForeName><Initials>S</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-0676-8865</Identifier><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Diabetes Unit, Shamir Medical Center, Zerifin, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weinberger</LastName><ForeName>Adina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinhas-Hamiel</LastName><ForeName>Orit</ForeName><Initials>O</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-8365-8091</Identifier><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel eran.segal@weizmann.ac.il orit.hamiel@sheba.health.gov.il.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat-Gan, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segal</LastName><ForeName>Eran</ForeName><Initials>E</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-6859-1164</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel eran.segal@weizmann.ac.il orit.hamiel@sheba.health.gov.il.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Diabetes Care</MedlineTA><NlmUniqueID>7805975</NlmUniqueID><ISSNLinking>0149-5992</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>05</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>09</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>5</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34711639</ArticleId><ArticleId IdType="pii">dc21-1048</ArticleId><ArticleId IdType="doi">10.2337/dc21-1048</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34652277</PMID><DateRevised><Year>2021</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2371-4379</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>JMIR diabetes</Title><ISOAbbreviation>JMIR Diabetes</ISOAbbreviation></Journal><ArticleTitle>Mapping Individual Differences on the Internet: Case Study of the Type 1 Diabetes Community.</ArticleTitle><Pagination><MedlinePgn>e30756</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/30756</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Social media platforms, such as Twitter, are increasingly popular among communities of people with chronic conditions, including those with type 1 diabetes (T1D). There is some evidence that social media confers emotional and health-related benefits to people with T1D, including emotional support and practical information regarding health maintenance. Research on social media has primarily relied on self-reports of web-based behavior and qualitative assessment of web-based content, which can be expensive and time-consuming. Meanwhile, recent advances in natural language processing have allowed for large-scale assessment of social media behavior.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study attempts to document the major themes of Twitter posts using a natural language processing method to identify topics of interest in the T1D web-based community. We also seek to map social relations on Twitter as they relate to these topics of interest, to determine whether Twitter users in the T1D community post in "echo chambers," which reflect their own topics back to them, or whether users typically see a mix of topics on the internet.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Through Twitter scraping, we gathered a data set of 691,691 tweets from 8557 accounts, spanning a date range from 2008 to 2020, which includes people with T1D, their caregivers, health practitioners, and advocates. Tweet content was analyzed for sentiment and topic, using Latent Dirichlet Allocation. We used social network analysis to examine the degree to which identified topics are siloed within specific groups or disseminated through the broader T1D web-based community.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Tweets were, on average, positive in sentiment. Through topic modeling, we identified 6 broad-bandwidth topics, ranging from clinical to advocacy to daily management to emotional health, which can inform researchers and practitioners interested in the needs of people with T1D. These analyses also replicate prior work using machine learning methods to map social behavior on the internet. We extend these results through social network analysis, indicating that users are likely to see a mix of these topics discussed by the accounts they follow.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Twitter communities are sources of information for people with T1D and members related to that community. Topics identified reveal key concerns of the T1D community and may be useful to practitioners and researchers alike. The methods used are efficient (low cost) while providing researchers with enormous amounts of data. We provide code to facilitate the use of these methods with other populations.</AbstractText><CopyrightInformation>..Cianna Bedford-Petersen, Sara J Weston. Originally published in JMIR Diabetes (https://diabetes.jmir.org), 15.10.2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bedford-Petersen</LastName><ForeName>Cianna</ForeName><Initials>C</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-3066-9229</Identifier><AffiliationInfo><Affiliation>Department of Psychology, University of Oregon, Eugene, OR, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weston</LastName><ForeName>Sara J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-7782-6239</Identifier><AffiliationInfo><Affiliation>Department of Psychology, University of Oregon, Eugene, OR, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Diabetes</MedlineTA><NlmUniqueID>101719410</NlmUniqueID><ISSNLinking>2371-4379</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Latent Dirichlet Allocation</Keyword><Keyword MajorTopicYN="N">Twitter</Keyword><Keyword MajorTopicYN="N">data scraping</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">diabetes community</Keyword><Keyword MajorTopicYN="N">natural language processing</Keyword><Keyword MajorTopicYN="N">sentiment analysis</Keyword><Keyword MajorTopicYN="N">social media</Keyword><Keyword MajorTopicYN="N">social network analysis</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>05</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>08</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>08</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>15</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34652277</ArticleId><ArticleId IdType="pii">v6i4e30756</ArticleId><ArticleId IdType="doi">10.2196/30756</ArticleId><ArticleId IdType="pmc">PMC8556640</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Diabetes Sci Technol. 2019 Mar;13(2):187-197</Citation><ArticleIdList><ArticleId IdType="pubmed">30477335</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2017 Nov;12(6):1100-1122</Citation><ArticleIdList><ArticleId IdType="pubmed">28841086</ArticleId></ArticleIdList></Reference><Reference><Citation>Trauma Surg Acute Care Open. 2020 Aug 31;5(1):e000496</Citation><ArticleIdList><ArticleId IdType="pubmed">32923681</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Diabetes. 2018 Apr 24;3(2):e8</Citation><ArticleIdList><ArticleId IdType="pubmed">30291079</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Aging. 2018 Jun 22;1(1):e10176</Citation><ArticleIdList><ArticleId IdType="pubmed">31518231</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Educ. 2017 Jun;43(3):251-259</Citation><ArticleIdList><ArticleId IdType="pubmed">28520550</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Diab Rep. 2020 Feb 20;20(3):10</Citation><ArticleIdList><ArticleId IdType="pubmed">32080765</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Syndr Obes. 2013 Nov 06;6:421-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24232691</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2015 Aug 12;17(8):e196</Citation><ArticleIdList><ArticleId IdType="pubmed">26268425</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med. 2016 Aug 17;14(1):118</Citation><ArticleIdList><ArticleId IdType="pubmed">27530970</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Diabetes. 2016 Nov 07;1(2):e4</Citation><ArticleIdList><ArticleId IdType="pubmed">30291053</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Apr 6;101 Suppl 1:5228-35</Citation><ArticleIdList><ArticleId IdType="pubmed">14872004</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Diabetes. 2019 Apr 02;4(2):e13634</Citation><ArticleIdList><ArticleId IdType="pubmed">30938693</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2019 May;13(3):466-492</Citation><ArticleIdList><ArticleId IdType="pubmed">30854884</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Med Inform. 2020 Nov 27;8(11):e18666</Citation><ArticleIdList><ArticleId IdType="pubmed">33245281</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open Diabetes Res Care. 2020 Jun;8(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">32503810</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Mar 02;10(3):e0115545</Citation><ArticleIdList><ArticleId IdType="pubmed">25729900</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 May;12(3):712-718</Citation><ArticleIdList><ArticleId IdType="pubmed">29310448</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Med J. 2014 May;31(5):401-4</Citation><ArticleIdList><ArticleId IdType="pubmed">23423992</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Diabetes Rev. 2015;11(4):261-72</Citation><ArticleIdList><ArticleId IdType="pubmed">25901500</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">34635403</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-460X</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>12</Month></PubDate></JournalIssue><Title>Journal of diabetes and its complications</Title><ISOAbbreviation>J Diabetes Complications</ISOAbbreviation></Journal><ArticleTitle>Achievement of treatment targets predicts progression of vascular complications in type 1 diabetes.</ArticleTitle><Pagination><MedlinePgn>108072</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1056-8727(21)00291-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jdiacomp.2021.108072</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIM">To study the association between achievement of guideline-defined treatment targets on HbA1c, low-density lipoproteins (LDL-C), and blood pressure with the progression of diabetic complications in patients with type 1 diabetes (T1D).</AbstractText><AbstractText Label="METHODS">The study included 355 patients at baseline and 114 patients with follow-up data after 3-5..years. Outcome variables were the progression of diabetic kidney disease, retinopathy, or cardiovascular disease (CVD). We used logistic regression and other machine learning algorithms (MLA) to model the association of achievement of treatment targets and probability of progression of complications.</AbstractText><AbstractText Label="RESULTS">Achievement of the target blood pressure was associated with 96% lower odds of a new CVD event (0.04 (95% CI 0.00, 0.53), p..=..0.016), and 72% lower odds of progression of any complication (0.28 (95% CI 0.09, 0.89), p..=..0.027. Achievement of HbA1c target was associated with lower odds of composite complication progression by 82% (0.18 (95% CI 0.04, 0.88), p..=..0.034.) None of the patients who achieved HbA1c target progressed in CVD. MLA demonstrated good accuracy for the prediction of progression of CVD (AUC 0.824), and lower accuracy for other complications.</AbstractText><AbstractText Label="CONCLUSION">The achievement of blood pressure and HbA1c treatment targets is associated with lower odds of vascular complication of T1D in a real life study.</AbstractText><CopyrightInformation>Copyright .. 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salna</LastName><ForeName>Ilze</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University of Latvia, Faculty of Medicine, Jelgavas iela 3, LV 1004 Riga, Latvia; Pauls Stradi.... Clinical University Hospital, Endocrinology Department, Pilso..u iela 13, LV 1002 Riga, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salna</LastName><ForeName>Edgars</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Latvia, Faculty of Medicine, Jelgavas iela 3, LV 1004 Riga, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pahirko</LastName><ForeName>Leonora</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Latvia, Faculty of Physics, Mathematics and Optometry, Jelgavas iela 3, LV 1004 Riga, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skrebinska</LastName><ForeName>Sab..ne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Riga Stradi.... University, Faculty of Residency, Dzirciema iela 16, LV 1007 Riga, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krikova</LastName><ForeName>Reg..na</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Latvia, Faculty of Medicine, Jelgavas iela 3, LV 1004 Riga, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Folkmane</LastName><ForeName>Inese</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University of Latvia, Faculty of Medicine, Jelgavas iela 3, LV 1004 Riga, Latvia; Pauls Stradi.... Clinical University Hospital, Centre of Nephrology, Pilso..u iela 13, LV 1002 Riga, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P..r..gs</LastName><ForeName>Valdis</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of Latvia, Faculty of Medicine, Jelgavas iela 3, LV 1004 Riga, Latvia; Pauls Stradi.... Clinical University Hospital, Endocrinology Department, Pilso..u iela 13, LV 1002 Riga, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sokolovska</LastName><ForeName>Jelizaveta</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Latvia, Faculty of Medicine, Jelgavas iela 3, LV 1004 Riga, Latvia. Electronic address: jelizaveta.sokolovska@lu.lv.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Complications</MedlineTA><NlmUniqueID>9204583</NlmUniqueID><ISSNLinking>1056-8727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008078">Cholesterol, LDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008078" MajorTopicYN="N">Cholesterol, LDL</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048909" MajorTopicYN="Y">Diabetes Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003928" MajorTopicYN="Y">Diabetic Nephropathies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007844" MajorTopicYN="N" Type="Geographic">Latvia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Complication</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Treatment targets</Keyword><Keyword MajorTopicYN="Y">Type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>03</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>09</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>12</Day><Hour>5</Hour><Minute>48</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34635403</ArticleId><ArticleId IdType="pii">S1056-8727(21)00291-9</ArticleId><ArticleId IdType="doi">10.1016/j.jdiacomp.2021.108072</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">34543891</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0534</ISSN><JournalIssue CitedMedium="Internet"><Volume>138</Volume><PubDate><Year>2021</Year><Month>11</Month></PubDate></JournalIssue><Title>Computers in biology and medicine</Title><ISOAbbreviation>Comput Biol Med</ISOAbbreviation></Journal><ArticleTitle>Penalty weighted glucose prediction models could lead to better clinically usage.</ArticleTitle><Pagination><MedlinePgn>104865</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0010-4825(21)00659-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.compbiomed.2021.104865</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE">Numerous attempts to predict glucose value from continuous glucose monitors (CGM) have been published. However, there is a lack of proper analysis and modeling of penalty for errors in different glycemic ranges. The aim of this study was to investigate the potential for developing glucose prediction models with focus on the clinical aspects.</AbstractText><AbstractText Label="METHODS">We developed and compared six different models to test which approach were best suited for predicting glucose levels at different lead times between 10 and 60..min. The models were: last observation carried forward, linear extrapolation, ensemble methods using LSBoost and bagging, neural networks, one without error-weights and one with error-weights. The modeling and test were based on 225 type 1 diabetes patients with 315,000..h of CGM data.</AbstractText><AbstractText Label="RESULTS">Results show that it is possible to predict glucose levels based on CGM with a reasonable accuracy and precision with a 30-min prediction lead time. A comparison of different methods shows that there are improvements on performance gained from using more advanced machine learning algorithms (MARD 10.26-10.79 @ 30-min lead time) compared to a simple modeling (MARD 10.75-12.97 @ 30-min lead time). Moreover, the proposed use of error weights could lead to better clinical performance of these models, which is an important factor for real usage. E.g., the percentages in the C-zone of the consensus error grid without error-weights (0.57-0.68%) vs including error-weights (0.28%).</AbstractText><AbstractText Label="CONCLUSIONS">The results point toward that using error weighting in the training of the models could lead to better clinical performance.</AbstractText><CopyrightInformation>Copyright .. 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cichosz</LastName><ForeName>Simon Lebech</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Denmark. Electronic address: simcich@hst.aau.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kronborg</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Morten Hasselstr..m</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Denmark; Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hejlesen</LastName><ForeName>Ole</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Health Science and Technology, Aalborg University, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Biol Med</MedlineTA><NlmUniqueID>1250250</NlmUniqueID><ISSNLinking>0010-4825</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="Y">Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">CGM</Keyword><Keyword MajorTopicYN="Y">Continuous glucose monitoring</Keyword><Keyword MajorTopicYN="Y">Ensemble learning</Keyword><Keyword MajorTopicYN="Y">Glucose</Keyword><Keyword MajorTopicYN="Y">Neural network</Keyword><Keyword MajorTopicYN="Y">Prediction</Keyword><Keyword MajorTopicYN="Y">Type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>08</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>08</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>09</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>20</Day><Hour>20</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34543891</ArticleId><ArticleId IdType="pii">S0010-4825(21)00659-4</ArticleId><ArticleId IdType="doi">10.1016/j.compbiomed.2021.104865</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34521982</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3642</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>09</Month><Day>14</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>Identifying the lungs as a susceptible site for allele-specific regulatory changes associated with type 1 diabetes risk.</ArticleTitle><Pagination><MedlinePgn>1072</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42003-021-02594-0</ELocationID><Abstract><AbstractText>Type 1 diabetes (T1D) etiology is complex. We developed a machine learning approach that ranked the tissue-specific transcription regulatory effects for T1D SNPs and estimated their relative contributions to conversion to T1D by integrating case and control genotypes (Wellcome Trust Case Control Consortium and UK Biobank) with tissue-specific expression quantitative trait loci (eQTL) data. Here we show an eQTL (rs6679677) associated with changes to AP4B1-AS1 transcript levels in lung tissue makes the largest gene regulatory contribution to the risk of T1D development. Luciferase reporter assays confirmed allele-specific enhancer activity for the rs6679677 tagged locus in lung epithelial cells (i.e. A549 cells; C...&gt;...A reduces expression, p...=...0.005). Our results identify tissue-specific eQTLs for SNPs associated with T1D. The strongest tissue-specific eQTL effects were in the lung and may help explain associations between respiratory infections and risk of islet autoantibody seroconversion in young children.</AbstractText><CopyrightInformation>.. 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ho</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Liggins Institute, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Nyaga</LastName><ForeName>Denis M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Liggins Institute, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schierding</LastName><ForeName>William</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-5659-2701</Identifier><AffiliationInfo><Affiliation>Liggins Institute, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saffery</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9510-4181</Identifier><AffiliationInfo><Affiliation>Murdoch Children Research Institute, The University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Jo K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Liggins Institute, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>John A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>The Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biological Sciences, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vickers</LastName><ForeName>Mark H</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0003-4876-9356</Identifier><AffiliationInfo><Affiliation>Liggins Institute, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kempa-Liehr</LastName><ForeName>Andreas W</ForeName><Initials>AW</Initials><Identifier Source="ORCID">0000-0001-5558-0573</Identifier><AffiliationInfo><Affiliation>Department of Engineering Science, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Sullivan</LastName><ForeName>Justin M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0003-2927-450X</Identifier><AffiliationInfo><Affiliation>Liggins Institute, The University of Auckland, Auckland, New Zealand. justin.osullivan@auckland.ac.nz.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand. justin.osullivan@auckland.ac.nz.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biological Sciences, The University of Auckland, Auckland, New Zealand. justin.osullivan@auckland.ac.nz.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK. justin.osullivan@auckland.ac.nz.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UOAX1611</GrantID><Agency>Ministry of Business, Innovation and Employment (MBIE)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>07</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>08</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>15</Day><Hour>7</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34521982</ArticleId><ArticleId IdType="doi">10.1038/s42003-021-02594-0</ArticleId><ArticleId IdType="pii">10.1038/s42003-021-02594-0</ArticleId><ArticleId IdType="pmc">PMC8440780</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>N Engl J Med. 1986 May 22;314(21):1360-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3517648</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2019 Feb;20(2):232-242</Citation><ArticleIdList><ArticleId IdType="pubmed">30643266</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 1995 Oct;3(4):521-30</Citation><ArticleIdList><ArticleId IdType="pubmed">7584142</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Oct 11;550(7675):204-213</Citation><ArticleIdList><ArticleId IdType="pubmed">29022597</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Diab Rep. 2011 Dec;11(6):533-42</Citation><ArticleIdList><ArticleId IdType="pubmed">21912932</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1995 Aug 1;182(2):459-65</Citation><ArticleIdList><ArticleId IdType="pubmed">7543139</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Jun 7;447(7145):661-78</Citation><ArticleIdList><ArticleId IdType="pubmed">17554300</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2014 Aug;15(5):355-62</Citation><ArticleIdList><ArticleId IdType="pubmed">25075402</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vis Exp. 2014 Aug 17;(90):</Citation><ArticleIdList><ArticleId IdType="pubmed">25177895</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2017 Oct;60(10):1931-1940</Citation><ArticleIdList><ArticleId IdType="pubmed">28770319</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2016 Oct;48(10):1279-83</Citation><ArticleIdList><ArticleId IdType="pubmed">27548312</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics. 2015 Sep;106(3):159-164</Citation><ArticleIdList><ArticleId IdType="pubmed">26072433</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2011 Oct;60(10):2645-53</Citation><ArticleIdList><ArticleId IdType="pubmed">21873553</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19767-72</Citation><ArticleIdList><ArticleId IdType="pubmed">18056643</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2019 Jun;18(6):607-614</Citation><ArticleIdList><ArticleId IdType="pubmed">30959217</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2014 Feb 21;8:14</Citation><ArticleIdList><ArticleId IdType="pubmed">24600388</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2011 Dec;60(12):3300-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22110093</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2015 Apr;47(4):381-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25751624</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Feb;42(2):200-207</Citation><ArticleIdList><ArticleId IdType="pubmed">30655379</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2006 Apr;7(2):81-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16629713</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2016 Jul 15;214(2):248-57</Citation><ArticleIdList><ArticleId IdType="pubmed">27034343</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2016 Jan 1;25(1):180-90</Citation><ArticleIdList><ArticleId IdType="pubmed">26546613</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2003 Feb 12;19(3):368-75</Citation><ArticleIdList><ArticleId IdType="pubmed">12584122</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2015 Apr 14;6:158</Citation><ArticleIdList><ArticleId IdType="pubmed">25926831</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014 Apr;37(4):1069-75</Citation><ArticleIdList><ArticleId IdType="pubmed">24296850</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Genet. 2018 Nov 21;9:535</Citation><ArticleIdList><ArticleId IdType="pubmed">30524468</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Jun;45(6):664-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23603761</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Dev Immunol. 2013;2013:417657</Citation><ArticleIdList><ArticleId IdType="pubmed">24367383</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2018 Jul;50(7):956-967</Citation><ArticleIdList><ArticleId IdType="pubmed">29955180</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2018 Dec 5;9(1):5198</Citation><ArticleIdList><ArticleId IdType="pubmed">30518762</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Clin Nutr. 2011 Dec;94(6 Suppl):1821S-1823S</Citation><ArticleIdList><ArticleId IdType="pubmed">21633073</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Immunol. 2007 Apr;44(11):2806-12</Citation><ArticleIdList><ArticleId IdType="pubmed">17350686</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2016 Jul;17 Suppl 22:37-42</Citation><ArticleIdList><ArticleId IdType="pubmed">27411435</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Sep;40(9):1194-1202</Citation><ArticleIdList><ArticleId IdType="pubmed">28646072</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Pediatr. 2013 Sep;167(9):800-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23818010</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Mar;39(3):337-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26577414</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2018 Apr 3;15(4):e1002548</Citation><ArticleIdList><ArticleId IdType="pubmed">29614081</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2018 May;89:90-100</Citation><ArticleIdList><ArticleId IdType="pubmed">29310926</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 1996 Jul;39(7):807-12</Citation><ArticleIdList><ArticleId IdType="pubmed">8817105</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Psychol Gen. 2013 May;142(2):573-603</Citation><ArticleIdList><ArticleId IdType="pubmed">22774788</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2017 Aug 1;102(8):2873-2880</Citation><ArticleIdList><ArticleId IdType="pubmed">28520980</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34458264</PMID><DateRevised><Year>2021</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-634X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in cell and developmental biology</Title><ISOAbbreviation>Front Cell Dev Biol</ISOAbbreviation></Journal><ArticleTitle>3D <i>in vivo</i> Magnetic Particle Imaging of Human Stem Cell-Derived Islet Organoid Transplantation Using a Machine Learning Algorithm.</ArticleTitle><Pagination><MedlinePgn>704483</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcell.2021.704483</ELocationID><Abstract><AbstractText>Stem cell-derived islet organoids constitute a promising treatment of type 1 diabetes. A major hurdle in the field is the lack of appropriate <i>in vivo</i> method to determine graft outcome. Here, we investigate the feasibility of <i>in vivo</i> tracking of transplanted stem cell-derived islet organoids using magnetic particle imaging (MPI) in a mouse model. Human induced pluripotent stem cells-L1 were differentiated to islet organoids and labeled with superparamagnetic iron oxide nanoparticles. The phantoms comprising of different numbers of labeled islet organoids were imaged using an MPI system. Labeled islet organoids were transplanted into NOD/scid mice under the left kidney capsule and were then scanned using 3D MPI at 1, 7, and 28 days post transplantation. Quantitative assessment of the islet organoids was performed using the <i>K-means</i>++ algorithm analysis of 3D MPI. The left kidney was collected and processed for immunofluorescence staining of C-peptide and dextran. Islet organoids expressed islet cell markers including insulin and glucagon. Image analysis of labeled islet organoids phantoms revealed a direct linear correlation between the iron content and the number of islet organoids. The <i>K-means</i>++ algorithm showed that during the course of the study the signal from labeled islet organoids under the left kidney capsule decreased. Immunofluorescence staining of the kidney sections showed the presence of islet organoid grafts as confirmed by double staining for dextran and C-peptide. This study demonstrates that MPI with machine learning algorithm analysis can monitor islet organoids grafts labeled with super-paramagnetic iron oxide nanoparticles and provide quantitative information of their presence <i>in vivo</i>.</AbstractText><CopyrightInformation>Copyright .. 2021 Sun, Hayat, Liu, Tull, Bishop, Dwan, Gudi, Talebloo, Dizon, Li, Gaudet, Alessio, Aguirre and Wang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Aixia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Precision Health Program, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, College of Human Medicine, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayat</LastName><ForeName>Hasaan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Precision Health Program, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lyman Briggs College, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Sihai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Precision Health Program, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, College of Human Medicine, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedics, Beijing Charity Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tull</LastName><ForeName>Eliah</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Medgar Evers College, City University of New York, Brooklyn, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bishop</LastName><ForeName>Jack Owen</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Precision Health Program, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, College of Natural Science, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dwan</LastName><ForeName>Bennett Francis</ForeName><Initials>BF</Initials><AffiliationInfo><Affiliation>Precision Health Program, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Natural Science, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudi</LastName><ForeName>Mithil</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Precision Health Program, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lyman Briggs College, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talebloo</LastName><ForeName>Nazanin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Precision Health Program, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, College of Natural Science, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dizon</LastName><ForeName>James Raynard</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Radiology, UT Southwestern Medical Center, Dallas, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Electrical and Computer Engineering, College of Engineering, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Quantitative Health Science and Engineering (IQ), Department of Biomedical Engineering, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaudet</LastName><ForeName>Jeffery</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Quantitative Health Science and Engineering (IQ), Department of Biomedical Engineering, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Magnetic Insight Inc., Alameda, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alessio</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Quantitative Health Science and Engineering (IQ), Department of Biomedical Engineering, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computational Mathematics, Science and Engineering, College of Engineering, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguirre</LastName><ForeName>Aitor</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Quantitative Health Science and Engineering (IQ), Department of Biomedical Engineering, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Precision Health Program, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, College of Human Medicine, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R03 EB028349</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Dev Biol</MedlineTA><NlmUniqueID>101630250</NlmUniqueID><ISSNLinking>2296-634X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">magnetic particle imaging</Keyword><Keyword MajorTopicYN="N">stem cell tracking</Keyword><Keyword MajorTopicYN="N">unsupervised machine learning</Keyword></KeywordList><CoiStatement>JG was employed by company Magnetic Insight Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer RS declared a shared affiliation with the authors to the handling editor at the time of review.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>05</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>07</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34458264</ArticleId><ArticleId IdType="doi">10.3389/fcell.2021.704483</ArticleId><ArticleId IdType="pmc">PMC8397508</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cell Transplant. 2010;19(8):919-36</Citation><ArticleIdList><ArticleId IdType="pubmed">20350351</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hematol Oncol. 2014 Jul 19;7:50</Citation><ArticleIdList><ArticleId IdType="pubmed">25037625</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2018 Dec;289(3):604-615</Citation><ArticleIdList><ArticleId IdType="pubmed">30299232</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Adv Endocrinol Metab. 2011 Oct;2(5):197-210</Citation><ArticleIdList><ArticleId IdType="pubmed">23148185</ArticleId></ArticleIdList></Reference><Reference><Citation>Nano Lett. 2017 Mar 8;17(3):1648-1654</Citation><ArticleIdList><ArticleId IdType="pubmed">28206771</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmaceutics. 2019 Nov 06;11(11):</Citation><ArticleIdList><ArticleId IdType="pubmed">31698755</ArticleId></ArticleIdList></Reference><Reference><Citation>Stem Cells Int. 2017;2017:1783841</Citation><ArticleIdList><ArticleId IdType="pubmed">28115944</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Imaging Biol. 2020 Aug;22(4):958-968</Citation><ArticleIdList><ArticleId IdType="pubmed">31933022</ArticleId></ArticleIdList></Reference><Reference><Citation>ACS Appl Nano Mater. 2020 May 22;3(5):3991-3999</Citation><ArticleIdList><ArticleId IdType="pubmed">33163909</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2015 Jul 2;34(13):1759-72</Citation><ArticleIdList><ArticleId IdType="pubmed">25908839</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jun 11;9(2):e97631</Citation><ArticleIdList><ArticleId IdType="pubmed">24919061</ArticleId></ArticleIdList></Reference><Reference><Citation>Quant Imaging Med Surg. 2018 Mar;8(2):114-122</Citation><ArticleIdList><ArticleId IdType="pubmed">29675353</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Sep 11;5:14055</Citation><ArticleIdList><ArticleId IdType="pubmed">26358296</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1996 Sep;45(9):1161-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8772716</ArticleId></ArticleIdList></Reference><Reference><Citation>Stem Cells Int. 2018 Nov 15;2018:7315218</Citation><ArticleIdList><ArticleId IdType="pubmed">30581474</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Drug Deliv Rev. 2019 Jan 1;138:293-301</Citation><ArticleIdList><ArticleId IdType="pubmed">30552918</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2020 Mar 24;10(1):5302</Citation><ArticleIdList><ArticleId IdType="pubmed">32210316</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Pharm Des. 2012;18(28):4426-40</Citation><ArticleIdList><ArticleId IdType="pubmed">22788952</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 2017 Nov;78(5):1900-1910</Citation><ArticleIdList><ArticleId IdType="pubmed">28097749</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2019 Feb;40(2):206-212</Citation><ArticleIdList><ArticleId IdType="pubmed">30655254</ArticleId></ArticleIdList></Reference><Reference><Citation>Theranostics. 2016 Jan 01;6(3):291-301</Citation><ArticleIdList><ArticleId IdType="pubmed">26909106</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2012 Dec;61(12):3247-54</Citation><ArticleIdList><ArticleId IdType="pubmed">22923469</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2020 Apr 22;12(540):</Citation><ArticleIdList><ArticleId IdType="pubmed">32321868</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2020 Jun;51(6):1659-1668</Citation><ArticleIdList><ArticleId IdType="pubmed">31332868</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2020 Nov;69(11):2414-2422</Citation><ArticleIdList><ArticleId IdType="pubmed">32855170</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanoscale. 2017 Jan 19;9(3):1299-1306</Citation><ArticleIdList><ArticleId IdType="pubmed">28059427</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2011 Feb;60(2):565-71</Citation><ArticleIdList><ArticleId IdType="pubmed">21270267</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Imaging Biol. 2021 Feb;23(1):18-29</Citation><ArticleIdList><ArticleId IdType="pubmed">32833112</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc SPIE Int Soc Opt Eng. 2011;7965:79650z</Citation><ArticleIdList><ArticleId IdType="pubmed">22389573</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">34450712</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1424-8220</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>16</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>04</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>Using Absorption Models for Insulin and Carbohydrates and Deep Leaning to Improve Glucose Level Predictions.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5273</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/s21165273</ELocationID><Abstract><AbstractText>Diabetes is a chronic disease caused by the inability of the pancreas to produce insulin or problems in the body to use it efficiently. It is one of the fastest growing health challenges affecting more than 400 million people worldwide, according to the World Health Organization. Intensive research is being carried out on artificial intelligence methods to help people with diabetes to optimize the way in which they use insulin, carbohydrate intakes, or physical activity. By predicting upcoming levels of blood glucose concentrations, preventive actions can be taken. Previous research studies using machine learning methods for blood glucose level predictions have mainly focused on the machine learning model used. Little attention has been given to the pre-processing of insulin and carbohydrate signals in order to mimic the human absorption processes. In this manuscript, a recurrent neural network (RNN) based model for predicting upcoming blood glucose levels in people with type 1 diabetes is combined with several carbohydrate and insulin absorption curves in order to optimize the prediction results. The proposed method is applied to data from real patients suffering type 1 diabetes mellitus (T1DM). The achieved results are encouraging, obtaining accuracy levels around 0.510 mmol/L (9.2 mg/dl) in the best scenario.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mart..nez-Delgado</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Engineering, Universidad Carlos III de Madrid, 28911 Legan..s, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munoz-Organero</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4199-2002</Identifier><AffiliationInfo><Affiliation>Department of Telematic Engineering and UC3M-BS Institute of Financial Big Data, Universidad Carlos III de Madrid, 28911 Legan..s, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Queipo-Alvarez</LastName><ForeName>Paula</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6952-2972</Identifier><AffiliationInfo><Affiliation>Department of Telematic Engineering, Universidad Carlos III de Madrid, 28911 Legan..s, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PID2019-105221RB-C44</GrantID><Agency>Agencia Estatal de Investigaci..n</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="Y">Insulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">LSTM</Keyword><Keyword MajorTopicYN="N">carbohydrate absorption</Keyword><Keyword MajorTopicYN="N">data processing</Keyword><Keyword MajorTopicYN="N">deep learning</Keyword><Keyword MajorTopicYN="N">glucose level prediction</Keyword><Keyword MajorTopicYN="N">insulin absorption</Keyword><Keyword MajorTopicYN="N">machine learning models</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>06</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>07</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>07</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34450712</ArticleId><ArticleId IdType="pii">s21165273</ArticleId><ArticleId IdType="doi">10.3390/s21165273</ArticleId><ArticleId IdType="pmc">PMC8398465</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Math Biosci. 2007 Nov;210(1):17-33</Citation><ArticleIdList><ArticleId IdType="pubmed">17610909</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2015 Dec;53(12):1305-18</Citation><ArticleIdList><ArticleId IdType="pubmed">25773366</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2020 Jul 13;20(14):</Citation><ArticleIdList><ArticleId IdType="pubmed">32668724</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Meas. 2004 Aug;25(4):905-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15382830</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2018 Mar;20(3):235-246</Citation><ArticleIdList><ArticleId IdType="pubmed">29406789</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 Oct;54(10):1740-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17926672</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Endocrinol (Lausanne). 2021 Feb 15;11:583016</Citation><ArticleIdList><ArticleId IdType="pubmed">33658981</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2017 Jun;64(6):1412-1419</Citation><ArticleIdList><ArticleId IdType="pubmed">28113240</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Netw. 2012 Sep;33:181-93</Citation><ArticleIdList><ArticleId IdType="pubmed">22706092</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2005 Jan;52(1):3-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15651559</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Sep;2(5):792-801</Citation><ArticleIdList><ArticleId IdType="pubmed">19885262</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 May;12(3):639-649</Citation><ArticleIdList><ArticleId IdType="pubmed">29566547</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34326234</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>373</Volume><Issue>6554</Issue><PubDate><Year>2021</Year><Month>07</Month><Day>30</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation.</ArticleTitle><Pagination><MedlinePgn>522-527</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.abg4502</ELocationID><Abstract><AbstractText>Despite innovations in insulin therapy since its discovery, most patients living with type 1 diabetes do not achieve sufficient glycemic control to prevent complications, and they experience hypoglycemia, weight gain, and major self-care burden. Promising pharmacological advances in insulin therapy include the refinement of extremely rapid insulin analogs, alternate insulin-delivery routes, liver-selective insulins, add-on drugs that enhance insulin effect, and glucose-responsive insulin molecules. The greatest future impact will come from combining these pharmacological solutions with existing automated insulin delivery methods that integrate insulin pumps and glucose sensors. These systems will use algorithms enhanced by machine learning, supplemented by technologies that include activity monitors and sensors for other key metabolites such as ketones. The future challenges facing clinicians and researchers will be those of access and broad clinical implementation.</AbstractText><CopyrightInformation>Copyright .. 2021, American Association for the Advancement of Science.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perkins</LastName><ForeName>Bruce A</ForeName><Initials>BA</Initials><Identifier Source="ORCID">0000-0002-5885-0046</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology, Department of Medicine, University of Toronto, Toronto, ON, Canada. bruce.perkins@sinaihealthsystem.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sherr</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0001-9301-3043</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics (Endocrinology), Yale School of Medicine, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathieu</LastName><ForeName>Chantal</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4055-5233</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, UZ Gasthuisberg, Katholieke Universiteit Leuven (KULeuven), Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D061385">Insulins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D065567" MajorTopicYN="N">Absorption, Physiological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001331" MajorTopicYN="N">Automation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="Y">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085002" MajorTopicYN="Y">Glycemic Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061385" MajorTopicYN="N">Insulins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062407" MajorTopicYN="N">Meals</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>30</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34326234</ArticleId><ArticleId IdType="pii">373/6554/522</ArticleId><ArticleId IdType="doi">10.1126/science.abg4502</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">34300672</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1424-8220</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>14</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>20</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>Learning Carbohydrate Digestion and Insulin Absorption Curves Using Blood Glucose Level Prediction and Deep Learning Models.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4926</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/s21144926</ELocationID><Abstract><AbstractText>Type 1 diabetes is a chronic disease caused by the inability of the pancreas to produce insulin. Patients suffering type 1 diabetes depend on the appropriate estimation of the units of insulin they have to use in order to keep blood glucose levels in range (considering the calories taken and the physical exercise carried out). In recent years, machine learning models have been developed in order to help type 1 diabetes patients with their blood glucose control. These models tend to receive the insulin units used and the carbohydrate taken as inputs and generate optimal estimations for future blood glucose levels over a prediction horizon. The body glucose kinetics is a complex user-dependent process, and learning patient-specific blood glucose patterns from insulin units and carbohydrate content is a difficult task even for deep learning-based models. This paper proposes a novel mechanism to increase the accuracy of blood glucose predictions from deep learning models based on the estimation of carbohydrate digestion and insulin absorption curves for a particular patient. This manuscript proposes a method to estimate absorption curves by using a simplified model with two parameters which are fitted to each patient by using a genetic algorithm. Using simulated data, the results show the ability of the proposed model to estimate absorption curves with mean absolute errors below 0.1 for normalized fast insulin curves having a maximum value of 1 unit.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mu..oz-Organero</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4199-2002</Identifier><AffiliationInfo><Affiliation>Department of Telematic Engineering, Universidad Carlos III de Madrid, Legan..s, 28911 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UC3M-BS Institute of Financial Big Data, Universidad Carlos III de Madrid, Legan..s, 28911 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Queipo-..lvarez</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Telematic Engineering, Universidad Carlos III de Madrid, Legan..s, 28911 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc..a Guti..rrez</LastName><ForeName>Boni</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-1808-8410</Identifier><AffiliationInfo><Affiliation>Department of Telematic Engineering, Universidad Carlos III de Madrid, Legan..s, 28911 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PID2019-105221RB-C44</GrantID><Agency>Agencia Estatal de Investigaci..n</Agency><Country/></Grant><Grant><GrantID>EPUC3M21</GrantID><Agency>Direcci..n General de Universidades e Investigaci..n</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004063" MajorTopicYN="N">Digestion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">carbohydrate digestion</Keyword><Keyword MajorTopicYN="N">deep learning</Keyword><Keyword MajorTopicYN="N">glucose estimation</Keyword><Keyword MajorTopicYN="N">insulin absorption</Keyword><Keyword MajorTopicYN="N">long short-term memory (LSTM)</Keyword><Keyword MajorTopicYN="N">type 1 diabetics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>05</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>07</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>07</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>24</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34300672</ArticleId><ArticleId IdType="pii">s21144926</ArticleId><ArticleId IdType="doi">10.3390/s21144926</ArticleId><ArticleId IdType="pmc">PMC8309907</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>IEEE Trans Biomed Eng. 2017 Jun;64(6):1412-1419</Citation><ArticleIdList><ArticleId IdType="pubmed">28113240</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2020 Jul 13;20(14):</Citation><ArticleIdList><ArticleId IdType="pubmed">32668724</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Sci Monit. 2001 May-Jun;7(3):504-15</Citation><ArticleIdList><ArticleId IdType="pubmed">11386033</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Meas. 2004 Aug;25(4):905-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15382830</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1978 Oct;27(10):1027-42</Citation><ArticleIdList><ArticleId IdType="pubmed">700259</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 Oct;54(10):1740-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17926672</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Netw. 2012 Sep;33:181-93</Citation><ArticleIdList><ArticleId IdType="pubmed">22706092</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2005 Jan;52(1):3-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15651559</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Sep;2(5):792-801</Citation><ArticleIdList><ArticleId IdType="pubmed">19885262</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 May;12(3):639-649</Citation><ArticleIdList><ArticleId IdType="pubmed">29566547</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Endocrinol (Oxf). 1985 Jul;23(1):71-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2863015</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34280907</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1748-605X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>08</Month><Day>05</Day></PubDate></JournalIssue><Title>Biomedical materials (Bristol, England)</Title><ISOAbbreviation>Biomed Mater</ISOAbbreviation></Journal><ArticleTitle>A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1088/1748-605X/ac15b2</ELocationID><Abstract><AbstractText>Nanomedicine has recently experienced unprecedented growth and development. However, the complexity of operations at the nanoscale introduces a layer of difficulty in the clinical translation of nanodrugs and biomedical nanotechnology. This problem is further exacerbated when engineering and optimizing nanomaterials for biomedical purposes. To navigate this issue, artificial intelligence (AI) algorithms have been applied for data analysis and inference, allowing for a more applicable understanding of the complex interaction amongst the abundant variables in a system involving the synthesis or use of nanomedicine. Here, we report on the current relationship and implications of nanomedicine and AI. Particularly, we explore AI as a tool for enabling nanomedicine in the context of nanodrug screening and development, brain-machine interfaces and nanotoxicology. We also report on the current state and future direction of nanomedicine and AI in cancer, diabetes, and neurological disorder therapy.</AbstractText><CopyrightInformation>.. 2021 IOP Publishing Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hayat</LastName><ForeName>Hasaan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Precision Health Program,, Michigan State University, East Lansing, MI, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lyman Briggs College, Michigan State University, East Lansing, MI, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nukala</LastName><ForeName>Arijit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Precision Health Program,, Michigan State University, East Lansing, MI, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyamira</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lyman Briggs College, Michigan State University, East Lansing, MI, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Jinda</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3098-3397</Identifier><AffiliationInfo><Affiliation>Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ping</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6712-8939</Identifier><AffiliationInfo><Affiliation>Precision Health Program,, Michigan State University, East Lansing, MI, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, College of Human Medicine, Michigan State University, East Lansing, MI, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biomed Mater</MedlineTA><NlmUniqueID>101285195</NlmUniqueID><ISSNLinking>1748-6041</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001672">Biocompatible Materials</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001672" MajorTopicYN="Y">Biocompatible Materials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050997" MajorTopicYN="N">Nanomedicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049329" MajorTopicYN="Y">Nanostructures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068936" MajorTopicYN="Y">Theranostic Nanomedicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">artificial intelligence</Keyword><Keyword MajorTopicYN="Y">cancer</Keyword><Keyword MajorTopicYN="Y">deep learning</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">nanomedicine</Keyword><Keyword MajorTopicYN="Y">nanotechnology</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>07</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>19</Day><Hour>20</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34280907</ArticleId><ArticleId IdType="doi">10.1088/1748-605X/ac15b2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">34233382</PMID><DateRevised><Year>2022</Year><Month>01</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-7560</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Diabetes/metabolism research and reviews</Title><ISOAbbreviation>Diabetes Metab Res Rev</ISOAbbreviation></Journal><ArticleTitle>Machine learning based study of longitudinal HbA1c trends and their association with all-cause mortality: Analyses from a National Diabetes Registry.</ArticleTitle><Pagination><MedlinePgn>e3485</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/dmrr.3485</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The association of long-term HbA1c variability with mortality has been previously suggested. However, the significance of HbA1c variability and trends in different age and HbA1c categories is unclear.</AbstractText><AbstractText Label="RESEARCH DESIGN AND METHODS" NlmCategory="METHODS">Data on patients with diabetes listed in the Israeli National Diabetes Registry during years 2012-2016 (observation period) were collected. Patients with &gt;4 HbA1c measurements, type 1 diabetes, eGFR..&lt;..30mg/ml/min, persistent HbA1c..&lt;..6% or malignancy were excluded. Utilizing machine learning methods, patients were classified into clusters according to their HbA1c trend (increasing, stable, decreasing). Mortality risk during 2017-2019 was calculated in subgroups defined by age (35-54, 55-69, 70-89 years) and last HbA1c (...7% and &gt;7%) at end of observation period. Models were adjusted for demographic, clinical and laboratory measurements including HbA1c, standard deviation (SD) of HbA1c and HbA1c trend.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This historical cohort study included 293,314 patients. Increased HbA1c variability (high SD) during the observation period was an independent predictor of mortality in patients aged more than 55 years (p..&lt;..0.01). The HbA1c trend was another independent predictor of mortality. Patients with a decreasing versus stable HbA1c trend had a greater mortality risk; this association persisted in all age groups in patients with HbA1c..&gt;..7% at the end of the observation period (p..=..0.02 in age 35-54; p..&lt;..0.01 in aged &gt;55). Patients with an increasing versus stable HbA1c trend had a greater mortality risk only in the elderly group (&gt;70), yet in both HbA1c categories (p..&lt;..0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">HbA1c variability and trend are important determinants of mortality risk and should be considered when adjusting glycaemic targets.</AbstractText><CopyrightInformation>.. 2021 John Wiley..&amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cahn</LastName><ForeName>Avivit</ForeName><Initials>A</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-7830-9994</Identifier><AffiliationInfo><Affiliation>Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Hebrew University Hospital, Jerusalem, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuker</LastName><ForeName>Inbar</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Israel Center for Disease Control, Ministry of Health, Ramat Gan, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Preventive Medicine, Sackler Faculty of Medicine, School of Public Health, Tel Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eilenberg</LastName><ForeName>Roni</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>TIMNA-Israel Ministry of Health's Big Data Platform, Ministry of Health, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uziel</LastName><ForeName>Moshe</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>TIMNA-Israel Ministry of Health's Big Data Platform, Ministry of Health, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsadok</LastName><ForeName>Meytal Avgil</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>TIMNA-Israel Ministry of Health's Big Data Platform, Ministry of Health, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raz</LastName><ForeName>Itamar</ForeName><Initials>I</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-0209-4453</Identifier><AffiliationInfo><Affiliation>Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Hebrew University Hospital, Jerusalem, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lutski</LastName><ForeName>Miri</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Israel Center for Disease Control, Ministry of Health, Ramat Gan, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Preventive Medicine, Sackler Faculty of Medicine, School of Public Health, Tel Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>TIMNA, Ministry of Health, Israel</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Diabetes Metab Res Rev</MedlineTA><NlmUniqueID>100883450</NlmUniqueID><ISSNLinking>1520-7552</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HbA1c trend</Keyword><Keyword MajorTopicYN="N">National Diabetes Registry</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">type 2 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>06</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>02</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>06</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>7</Day><Hour>20</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34233382</ArticleId><ArticleId IdType="doi">10.1002/dmrr.3485</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Rogers DG. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. Clin Pediatr. 1994;33(6):378. https://doi.org/10.1097/00132586-199406000-00052</Citation></Reference><Reference><Citation>Turner R. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853. https://doi.org/10.1016/S0140-6736(98)07019-6</Citation></Reference><Reference><Citation>American Diabetes Association. Glycemic targets: standards of medical care in diabetes-2020. Diabetes Care. 2020;43:S66-S76. https://doi.org/10.2337/dc20-S006</Citation></Reference><Reference><Citation>Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes:..clinical and therapeutic implications. Lancet Diabetes Endocrinol...2019;7(3):221-230. https://doi.org/10.1016/S2213-8587(18)30136-0</Citation></Reference><Reference><Citation>Sun B, Luo Z, Zhou J. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Cardiovasc Diabetol. 2021;20(1):1-13. https://doi.org/10.1186/s12933-020-01200-7</Citation></Reference><Reference><Citation>Helleputte S, De Backer T, Lapauw B, et..al. The relationship between glycaemic variability and cardiovascular autonomic dysfunction in patients with type 1 diabetes: a systematic review. Diabetes Metab Res Rev. 2020;36(5):e3301. https://doi.org/10.1002/dmrr.3301</Citation></Reference><Reference><Citation>Gorst C, Kwok CS, Aslam S, et..al. Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis. Diabetes Care. 2015;38(12):2354-2369. https://doi.org/10.2337/dc15-1188</Citation></Reference><Reference><Citation>Luo M, Tan KHX, Tan CS, Lim WY, Tai ES, Venkataraman K. Longitudinal trends in HbA1c patterns and association with outcomes: a systematic review. Diabetes Metab Res Rev. 2018;34(6):e3015. https://doi.org/10.1002/dmrr.3015</Citation></Reference><Reference><Citation>Yu Z-B, Zhu Y, Li D, et..al. Association between visit-to-visit _variability of HbA1c and cognitive decline: a pooled analysis..of..two prospective population-based cohorts. Diabetologia. 2020;63(1):85-94. https://doi.org/10.1007/s00125-019-04986-8</Citation></Reference><Reference><Citation>Yang CY, Su PF, Hung JY, Ou HT, Kuo S. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes. Cardiovasc Diabetol. 2020;19(1). https://doi.org/10.1186/s12933-020-01082-9</Citation></Reference><Reference><Citation>Li CI, Cheng HM, Liu CS, et..al. Association between glucose variation and lower extremity amputation incidence in individuals with type 2 diabetes: a nationwide retrospective cohort study. Diabetologia. 2020;63(1):194-205. https://doi.org/10.1007/s00125-019-05012-7</Citation></Reference><Reference><Citation>Scott ES, Januszewski AS, O...Connell R, et..al. Long-term glycemic..variability and vascular complications in type 2 diabetes: post hoc analysis of the FIELD study. J Clin Endocrinol Metab...2020;105(10):e3638-e3649. https://doi.org/10.1210/clinem/dgaa361</Citation></Reference><Reference><Citation>Critchley JA, Carey IM, Harris T, DeWilde S, Cook DG. Variability in glycated hemoglobin and risk of poor outcomes among people with type 2 diabetes in a large primary care cohort study. Diabetes Care. 2019;42(12):2237-2246. https://doi.org/10.2337/dc19-0848</Citation></Reference><Reference><Citation>Wan EYF, Yu EYT, Chin WY, et..al. Age-specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: a 10- year cohort study. Diabetes Obes Metabol. 2020;22(8):1316-1327. https://doi.org/10.1111/dom.14034</Citation></Reference><Reference><Citation>Sheng CS, Tian J, Miao Y, et..al. Prognostic significance of long-term HbA1c variability for all-cause mortality in the ACCORD trial. Diabetes Care. 2020;43(6):1185-1190. https://doi.org/10.2337/dc19-2589</Citation></Reference><Reference><Citation>Gebregziabher M, Egede LE, Lynch CP, Echols C, Zhao Y. Effect of trajectories of glycemic control on mortality in type 2 diabetes: a semiparametric joint modeling approach. Am J Epidemiol. 2010;171(10):1090-1098. https://doi.org/10.1093/aje/kwq070</Citation></Reference><Reference><Citation>Laiteerapong N, Karter AJ, Moffet HH, et..al. Ten-year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: the Diabetes..&amp; Aging Study. J Diabet Complicat. 2017;31(1):94-100. https://doi.org/10.1016/j.jdiacomp.2016.07.023</Citation></Reference><Reference><Citation>Hemo B, Geva D, Shahar DR, Golan R, Heymann AD. Distinct trajectories in HbA1c are associated with different all-cause mortality and morbidity in newly diagnosed patients with type 2 diabetes. Prim Care Diabetes. 2020;14(5):413-419. https://doi.org/10.1016/j.pcd.2019.11.009</Citation></Reference><Reference><Citation>Lee S, Liu T, Zhou J, Zhang Q, Wong WT, Tse G. Predictions of diabetes complications and mortality using hba1c variability: a 10-year observational cohort study. Acta Diabetol 2020;58:171-180. https://doi.org/10.1007/s00592-020-01605-6</Citation></Reference><Reference><Citation>Leffondr.. K, Abrahamowicz M, Regeasse A, et..al. Statistical measures were proposed for identifying longitudinal patterns of..change in quantitative health indicators. J Clin Epidemiol. 2004;57(10):1049-1062. https://doi.org/10.1016/j.jclinepi.2004.02.012</Citation></Reference><Reference><Citation>Steinley D. K-means clustering: a half-century synthesis. Br J Math Stat Psychol. 2006;59(1):1-34. https://doi.org/10.1348/000711005X48266</Citation></Reference><Reference><Citation>Rousseeuw PJ. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J Comput Appl Math. 1987;20(C):53-65. https://doi.org/10.1016/0377-0427(87)90125-7</Citation></Reference><Reference><Citation>Kamen CS. The 2008 Israel Integrated Census of Population and Housing; 2005.</Citation></Reference><Reference><Citation>Ahlqvist E, Storm P, K..r..j..m..ki A, et..al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6(5):361-369. https://doi.org/10.1016/S2213-8587(18)30051-2</Citation></Reference><Reference><Citation>Karpati T, Leventer-Roberts M, Feldman B, Cohen-Stavi C, Raz I, Balicer R. Patient clusters based on HbA1c trajectories: a step toward individualized medicine in type 2 diabetes. PLoS One...2018;13(11):e0207096. https://doi.org/10.1371/journal.pone.0207096</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34166426</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>6</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Machine learning-based glucose prediction with use of continuous glucose and physical activity monitoring data: The Maastricht Study.</ArticleTitle><Pagination><MedlinePgn>e0253125</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0253125</ELocationID><Abstract><AbstractText Label="BACKGROUND">Closed-loop insulin delivery systems, which integrate continuous glucose monitoring (CGM) and algorithms that continuously guide insulin dosing, have been shown to improve glycaemic control. The ability to predict future glucose values can further optimize such devices. In this study, we used machine learning to train models in predicting future glucose levels based on prior CGM and accelerometry data.</AbstractText><AbstractText Label="METHODS">We used data from The Maastricht Study, an observational population-based cohort that comprises individuals with normal glucose metabolism, prediabetes, or type 2 diabetes. We included individuals who underwent &gt;48h of CGM (n = 851), most of whom (n = 540) simultaneously wore an accelerometer to assess physical activity. A random subset of individuals was used to train models in predicting glucose levels at 15- and 60-minute intervals based on either CGM data or both CGM and accelerometer data. In the remaining individuals, model performance was evaluated with root-mean-square error (RMSE), Spearman's correlation coefficient (rho) and surveillance error grid. For a proof-of-concept translation, CGM-based prediction models were optimized and validated with the use of data from individuals with type 1 diabetes (OhioT1DM Dataset, n = 6).</AbstractText><AbstractText Label="RESULTS">Models trained with CGM data were able to accurately predict glucose values at 15 (RMSE: 0.19mmol/L; rho: 0.96) and 60 minutes (RMSE: 0.59mmol/L, rho: 0.72). Model performance was comparable in individuals with type 2 diabetes. Incorporation of accelerometer data only slightly improved prediction. The error grid results indicated that model predictions were clinically safe (15 min: &gt;99%, 60 min &gt;98%). Our prediction models translated well to individuals with type 1 diabetes, which is reflected by high accuracy (RMSEs for 15 and 60 minutes of 0.43 and 1.73 mmol/L, respectively) and clinical safety (15 min: &gt;99%, 60 min: &gt;91%).</AbstractText><AbstractText Label="CONCLUSIONS">Machine learning-based models are able to accurately and safely predict glucose values at 15- and 60-minute intervals based on CGM data only. Future research should further optimize the models for implementation in closed-loop insulin delivery systems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Doorn</LastName><ForeName>William P T M</ForeName><Initials>WPTM</Initials><Identifier Source="ORCID">0000-0003-2676-7448</Identifier><AffiliationInfo><Affiliation>CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Chemistry, Central Diagnostic Laboratory, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foreman</LastName><ForeName>Yuri D</ForeName><Initials>YD</Initials><Identifier Source="ORCID">0000-0002-0035-1586</Identifier><AffiliationInfo><Affiliation>CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaper</LastName><ForeName>Nicolaas C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolic Disease, Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savelberg</LastName><ForeName>Hans H C M</ForeName><Initials>HHCM</Initials><AffiliationInfo><Affiliation>Department of Human Biology and Movement Science, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koster</LastName><ForeName>Annemarie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Social Medicine, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Kallen</LastName><ForeName>Carla J H</ForeName><Initials>CJH</Initials><AffiliationInfo><Affiliation>CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wesselius</LastName><ForeName>Anke</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Complex Genetics and Epidemiology, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schram</LastName><ForeName>Miranda T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Heart and Vascular Centre, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henry</LastName><ForeName>Ronald M A</ForeName><Initials>RMA</Initials><AffiliationInfo><Affiliation>CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Heart and Vascular Centre, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dagnelie</LastName><ForeName>Pieter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Galan</LastName><ForeName>Bastiaan E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolic Disease, Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bekers</LastName><ForeName>Otto</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Chemistry, Central Diagnostic Laboratory, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stehouwer</LastName><ForeName>Coen D A</ForeName><Initials>CDA</Initials><AffiliationInfo><Affiliation>CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meex</LastName><ForeName>Steven J R</ForeName><Initials>SJR</Initials><AffiliationInfo><Affiliation>CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Chemistry, Central Diagnostic Laboratory, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brouwers</LastName><ForeName>Martijn C G J</ForeName><Initials>MCGJ</Initials><AffiliationInfo><Affiliation>CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolic Disease, Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="Y">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018670" MajorTopicYN="N">Monitoring, Ambulatory</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011236" MajorTopicYN="N">Prediabetic State</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>This study received funding from Janssen-Cilag B.V, Novo Nordisk Farma B.V., Sanofi-Aventis Netherlands B.V and Medtronic. There are no patents, products in development or marketed products to declare. This does not alter the authors... adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors. N.C. Schaper, R.M.A. Henry, and M.C.G.J. Brouwers were supported by Medtronic (External Research Program). Medtronic did not direct design, conduct, or outcomes of this study. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>09</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>05</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>17</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34166426</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0253125</ArticleId><ArticleId IdType="pii">PONE-D-20-30681</ArticleId><ArticleId IdType="pmc">PMC8224858</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetologia. 2016 Apr;59(4):709-18</Citation><ArticleIdList><ArticleId IdType="pubmed">26831300</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Jan;42(Suppl 1):S61-S70</Citation><ArticleIdList><ArticleId IdType="pubmed">30559232</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Physiol Educ. 2014 Dec;38(4):308-14</Citation><ArticleIdList><ArticleId IdType="pubmed">25434013</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2020 May;22(5):395-403</Citation><ArticleIdList><ArticleId IdType="pubmed">31886732</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2019 Jul;98:109-134</Citation><ArticleIdList><ArticleId IdType="pubmed">31383477</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2016 Apr 9;387(10027):1513-1530</Citation><ArticleIdList><ArticleId IdType="pubmed">27061677</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2021 Mar;44(3):836-838</Citation><ArticleIdList><ArticleId IdType="pubmed">33397767</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Jul;8(4):658-72</Citation><ArticleIdList><ArticleId IdType="pubmed">25562886</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 Sep 01;7(5):1275-81</Citation><ArticleIdList><ArticleId IdType="pubmed">24124954</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Rev. 2013 Jan;93(1):137-88</Citation><ArticleIdList><ArticleId IdType="pubmed">23303908</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Mar 11;342:d556</Citation><ArticleIdList><ArticleId IdType="pubmed">21398359</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Biomed Eng. 2016 Nov;44(11):3158-3172</Citation><ArticleIdList><ArticleId IdType="pubmed">27352278</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1198-203</Citation><ArticleIdList><ArticleId IdType="pubmed">24026542</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2017 Apr 27;13(4):e1005232</Citation><ArticleIdList><ArticleId IdType="pubmed">28448498</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2011 Nov;60(11):2672-82</Citation><ArticleIdList><ArticleId IdType="pubmed">22025773</ArticleId></ArticleIdList></Reference><Reference><Citation>CEUR Workshop Proc. 2020 Sep;2675:71-74</Citation><ArticleIdList><ArticleId IdType="pubmed">33584164</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jan;9(1):86-90</Citation><ArticleIdList><ArticleId IdType="pubmed">25316712</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2012 Sep 15;176(6):473-81</Citation><ArticleIdList><ArticleId IdType="pubmed">22875755</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2020 Feb;24(2):414-423</Citation><ArticleIdList><ArticleId IdType="pubmed">31369390</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Mhealth Uhealth. 2019 Nov 1;7(11):e14452</Citation><ArticleIdList><ArticleId IdType="pubmed">31682586</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2016 Feb;18 Suppl 2:S3-S13</Citation><ArticleIdList><ArticleId IdType="pubmed">26784127</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Epidemiol. 2014 Jun;29(6):439-51</Citation><ArticleIdList><ArticleId IdType="pubmed">24756374</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Comput. 1997 Nov 15;9(8):1735-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9377276</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2019 May;7(5):385-396</Citation><ArticleIdList><ArticleId IdType="pubmed">30926258</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2017 Jul;5(7):501-512</Citation><ArticleIdList><ArticleId IdType="pubmed">28533136</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2019 Oct 31;381(18):1774-1775</Citation><ArticleIdList><ArticleId IdType="pubmed">31618534</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Diabetes. 2020 Sep 22;5(3):e18660</Citation><ArticleIdList><ArticleId IdType="pubmed">32960180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Jun 26;375(9733):2215-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20609967</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">34142425</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1463-1326</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>10</Month></PubDate></JournalIssue><Title>Diabetes, obesity &amp; metabolism</Title><ISOAbbreviation>Diabetes Obes Metab</ISOAbbreviation></Journal><ArticleTitle>Predictors of diabetes-related distress before and after FreeStyle Libre-1 use: Lessons from the Association of British Clinical Diabetologists nationwide study.</ArticleTitle><Pagination><MedlinePgn>2261-2268</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/dom.14467</ELocationID><Abstract><AbstractText Label="AIM">To identify the baseline demographic and clinical characteristics associated with diabetes-related distress (DRD) and factors associated with improvement in DRD after initiating use of the FreeStyle Libre (FSL) in people living with type 1 diabetes (T1D).</AbstractText><AbstractText Label="METHODS">The study was performed using baseline and follow-up data from the Association of British Clinical Diabetologists nationwide audit of people with diabetes who initiated use of the FSL in the United Kingdom. DRD was assessed using the two-item diabetes-related distress scale (DDS; defined as the average of the two-item score ...3). People living with T1D were categorized into two groups: those with high DRD, defined as an average DDS score ...3 and those with lower DRD, defined as a DDS score &lt;3. We used a gradient-boosting machine-learning (GBM) model to identify the relative influence (RI) of baseline variables on average DDS score.</AbstractText><AbstractText Label="RESULTS">The study population consisted of 9159 patients, 96.6% of whom had T1D. The median (interquartile range [IQR]) age was 45.1..(32-56) years, 50.1% were women, the median (IQR) baseline body mass index was 26.1 (23.2-29.6) kg/m<sup>2</sup> and the median (IQR) duration of diabetes was 20 (11-32) years. The two components of the DDS were significantly correlated (r<sup>2</sup> ..=..0.73; P...&lt;...0.0001). Higher DRD was prevalent in 53% (4879/9159) of people living with T1D at baseline. In the GBM model, the top baseline variables associated with average DDS score were baseline glycated haemoglobin (HbA1c; RI..=..51.1), baseline Gold score (RI..=..23.3), gender (RI..=..7.05) and fear of hypoglycaemia (RI..=..4.96). Follow-up data were available for 3312 participants. The top factors associated with improvement in DDS score following use of the FSL were change in Gold score (RI..=..28.2) and change in baseline HbA1c (RI..=..19.3).</AbstractText><AbstractText Label="CONCLUSIONS">In this large UK cohort of people living with T1D, diabetes distress was prevalent and associated with higher HbA1c, impaired awareness of hypoglycaemia and female gender. Improvement in glycaemic control and hypoglycaemia unawareness with the use of the FSL was associated with improvement in DRD in people living with T1D.</AbstractText><CopyrightInformation>.. 2021 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deshmukh</LastName><ForeName>Harshal</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-3859-3118</Identifier><AffiliationInfo><Affiliation>Hull University Teaching Hospitals NHS Trust and the University of Hull, Hull, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilmot</LastName><ForeName>Emma G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregory</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Leicester General Hospital, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnes</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Tunbridge Wells Hospital, Tunbridge Wells, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narendran</LastName><ForeName>Parth</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saunders</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Warrington and Halton Teaching Hospitals NHS Foundation Trust, Warrington, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furlong</LastName><ForeName>Niall</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley Teaching Hospitals NHS Trust, St Helens, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamaruddin</LastName><ForeName>Shafie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Darlington Memorial Hospital, Darlington, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banatwalla</LastName><ForeName>Rumaisa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>St Peter's Hospital, Chertsey, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herring</LastName><ForeName>Roselle</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Royal Surrey County Hospital, Guildford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kilvert</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Northampton General Hospital NHS Trust, Northampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patmore</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hull University Teaching Hospitals NHS Trust and the University of Hull, Hull, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walton</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hull University Teaching Hospitals NHS Trust and the University of Hull, Hull, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryder</LastName><ForeName>Robert E J</ForeName><Initials>REJ</Initials><AffiliationInfo><Affiliation>City Hospital, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sathyapalan</LastName><ForeName>Thozhukat</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3544-2231</Identifier></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Diabetes Obes Metab</MedlineTA><NlmUniqueID>100883645</NlmUniqueID><ISSNLinking>1462-8902</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048909" MajorTopicYN="Y">Diabetes Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="Y">Hypoglycemia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">FSL</Keyword><Keyword MajorTopicYN="Y">diabetes related distress</Keyword><Keyword MajorTopicYN="Y">glycaemic control</Keyword><Keyword MajorTopicYN="Y">observational study</Keyword><Keyword MajorTopicYN="Y">population study</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>06</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>03</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>06</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>18</Day><Hour>7</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34142425</ArticleId><ArticleId IdType="doi">10.1111/dom.14467</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Berry E, Lockhart S, Davies M, Lindsay JR, Dempster M. Diabetes distress: understanding the hidden struggles of living with diabetes and exploring intervention strategies. Postgrad Med J. 2015;91(1075):278-283.</Citation></Reference><Reference><Citation>Dennick K, Sturt J, Speight J. What is diabetes distress and how can we measure it? A narrative review and conceptual model. J Diabetes Complications. 2017;31(5):898-911.</Citation></Reference><Reference><Citation>Hagger V, Hendrieckx C, Cameron F, Pouwer F, Skinner TC, Speight J. Cut points for identifying clinically significant diabetes distress in adolescents with type 1 diabetes using the PAID-T: results from diabetes MILES Youth-Australia. Diabetes Care. 2017;40(11):1462-1468.</Citation></Reference><Reference><Citation>Hagger V, Hendrieckx C, Cameron F, Pouwer F, Skinner TC, Speight J. Diabetes distress is more strongly associated with HbA1c than depressive symptoms in adolescents with type 1 diabetes: results from diabetes MILES Youth-Australia. Pediatr Diabetes. 2018;19(4):840-847.</Citation></Reference><Reference><Citation>Hagger V, Hendrieckx C, Sturt J, Skinner TC, Speight J. Diabetes distress among adolescents with type 1 diabetes: a systematic review. Curr Diabetes Rep. 2016;16(1):9.</Citation></Reference><Reference><Citation>Powers MA, Richter SA, Ackard DM, Craft C. Diabetes distress among persons with type 1 diabetes. Diabetes Educ. 2017;43(1):105-113.</Citation></Reference><Reference><Citation>Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabetes Med. 2014;31(7):764-772.</Citation></Reference><Reference><Citation>Fisher L, Polonsky WH, Hessler D. Addressing diabetes distress in clinical care: a practical guide. Diabetes Med. 2019;36(7):803-812.</Citation></Reference><Reference><Citation>Fisher L, Polonsky WH, Hessler DM, et al. Understanding the sources of diabetes distress in adults with type 1 diabetes. J Diabetes Complications. 2015;29(4):572-577.</Citation></Reference><Reference><Citation>Boden MT, Gala S. Exploring correlates of diabetes-related stress among adults with type 1 diabetes in the T1D exchange clinic registry. Diabetes Res Clin Pract. 2018;138:211-219.</Citation></Reference><Reference><Citation>Eilander MMA, Snoek FJ, Rotteveel J, et al. Parental diabetes behaviors and distress are related to glycemic control in youth with type 1 diabetes: longitudinal data from the DINO study. J Diabetes Res. 2017;2017:1462064.</Citation></Reference><Reference><Citation>Hood KK, Iturralde E, Rausch J, Weissberg-Benchell J. Preventing diabetes distress in adolescents with type 1 diabetes: results 1 year after participation in the STePS program. Diabetes Care. 2018;41(8):1623-1630.</Citation></Reference><Reference><Citation>Todd PJ, Edwards F, Spratling L, et al. Evaluating the relationships of hypoglycaemia and HbA1c with screening-detected diabetes distress in type 1 diabetes. Endocrinol Diabetes Metab. 2018;1(1):e00003.</Citation></Reference><Reference><Citation>Deshmukh H, Wilmot EG, Gregory R, et al. Effect of flash glucose monitoring on glycemic control, hypoglycemia, diabetes-related distress, and resource utilization in the Association of British Clinical Diabetologists (ABCD) nationwide audit. Diabetes Care. 2020;43(9):2153-2160.</Citation></Reference><Reference><Citation>Nana M, Moore SL, Ang E, Lee ZX, Bondugulapati LNR. Flash glucose monitoring: impact on markers of glycaemic control and patient-reported outcomes in individuals with type 1 diabetes mellitus in the real-world setting. Diabetes Res Clin Pract. 2019;157:107893.</Citation></Reference><Reference><Citation>Pintus D, Ng SM. Freestyle libre flash glucose monitoring improves patient quality of life measures in children with type 1 diabetes mellitus (T1DM) with appropriate provision of education and support by healthcare professionals. Diabetes Metab Syndr. 2019;13(5):2923-2926.</Citation></Reference><Reference><Citation>Tyndall V, Stimson RH, Zammitt NN, et al. Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes. Diabetologia. 2019;62(8):1349-1356.</Citation></Reference><Reference><Citation>Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17(7):697-703.</Citation></Reference><Reference><Citation>Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH. Development of a brief diabetes distress screening instrument. Ann Fam Med. 2008;6(3):246-252.</Citation></Reference><Reference><Citation>Fukaya E, Flores AM, Lindholm D, et al. Clinical and genetic determinants of varicose veins. Circulation. 2018;138(25):2869-2880.</Citation></Reference><Reference><Citation>Natekin A, Knoll A. Gradient boosting machines, a tutorial. Front Neurorobot. 2013;7:21.</Citation></Reference><Reference><Citation>Altmann A, Tolosi L, Sander O, Lengauer T. Permutation importance: a corrected feature importance measure. Bioinformatics. 2010;26(10):1340-1347.</Citation></Reference><Reference><Citation>Hessler DM, Fisher L, Polonsky WH, et al. Diabetes distress is linked with worsening diabetes management over time in adults with type 1 diabetes. Diabetes Med. 2017;34(9):1228-1234.</Citation></Reference><Reference><Citation>Polonsky WH, Fisher L, Earles J, et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28(3):626-631.</Citation></Reference><Reference><Citation>Nicolucci A, Kovacs Burns K, Holt RI, et al. Diabetes attitudes, wishes and needs second study (DAWN2): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabetes Med. 2013;30(7):767-777.</Citation></Reference><Reference><Citation>Perrin NE, Davies MJ, Robertson N, Snoek FJ, Khunti K. The prevalence of diabetes-specific emotional distress in people with type 2 diabetes: a systematic review and meta-analysis. Diabetes Med. 2017;34(11):1508-1520.</Citation></Reference><Reference><Citation>Barata DS, Adan LF, Netto EM, Ramalho AC. The effect of the menstrual cycle on glucose control in women with type 1 diabetes evaluated using a continuous glucose monitoring system. Diabetes Care. 2013;36(5):e70.</Citation></Reference><Reference><Citation>Goldner WS, Kraus VL, Sivitz WI, Hunter SK, Dillon JS. Cyclic changes in glycemia assessed by continuous glucose monitoring system during multiple complete menstrual cycles in women with type 1 diabetes. Diabetes Technol Ther. 2004;6(4):473-480.</Citation></Reference><Reference><Citation>Phelan H, Foster NC, Schwandt A, et al. Longitudinal trajectories of BMI z-score: an international comparison of 11,513 Australian, American and German/Austrian/Luxembourgian youth with type 1 diabetes. Pediatr Obes. 2020;15(2):e12582.</Citation></Reference><Reference><Citation>Wardian JL, True MW, Folaron I, Colburn J, Tate JM, Beckman DJ. The choice should be yours: diabetes-related distress by insulin delivery method for people with type 1 diabetes. Diabetes Technol Ther. 2020;22(1):42-47.</Citation></Reference><Reference><Citation>Polonsky WH, Fortmann AL. The influence of time in range on daily mood in adults with type 1 diabetes. J Diabetes Complications. 2020;34(12):107746.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34127370</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-460X</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>08</Month></PubDate></JournalIssue><Title>Journal of diabetes and its complications</Title><ISOAbbreviation>J Diabetes Complications</ISOAbbreviation></Journal><ArticleTitle>Improved individual and population-level HbA1c estimation using CGM data and patient characteristics.</ArticleTitle><Pagination><MedlinePgn>107950</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1056-8727(21)00137-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jdiacomp.2021.107950</ELocationID><Abstract><AbstractText>Machine learning and linear regression models using CGM and participant data reduced HbA1c estimation error by up to 26% compared to the GMI formula, and exhibit superior performance in estimating the median of HbA1c at the cohort level, potentially of value for remote clinical trials interrupted by COVID-19.</AbstractText><CopyrightInformation>Copyright .. 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grossman</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Management Science and Engineering, Stanford School of Engineering, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Management Science and Engineering, Stanford School of Engineering, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crandell</LastName><ForeName>Jamie L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>School of Nursing, Department of Biostatistics, UNC Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prahalad</LastName><ForeName>Priya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Pediatric Endocrinology, Stanford School of Medicine, Stanford, CA, USA; Lucile Packard Children's Hospital, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maahs</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Division of Pediatric Endocrinology, Stanford School of Medicine, Stanford, CA, USA; Lucile Packard Children's Hospital, Stanford, CA, USA; Stanford Diabetes Research Center, Stanford School of Medicine, Stanford, CA, USA; Department of Health Research and Policy, Stanford School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheinker</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Management Science and Engineering, Stanford School of Engineering, Stanford, CA, USA; Division of Pediatric Endocrinology, Stanford School of Medicine, Stanford, CA, USA; Lucile Packard Children's Hospital, Stanford, CA, USA; Stanford Diabetes Research Center, Stanford School of Medicine, Stanford, CA, USA; Clinical Excellence Research Center, Stanford School of Medicine, Stanford, CA, USA. Electronic address: dscheink@stanford.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R18 DK122422</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Complications</MedlineTA><NlmUniqueID>9204583</NlmUniqueID><ISSNLinking>1056-8727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001800" MajorTopicYN="N">Blood Specimen Collection</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058998" MajorTopicYN="N">Remote Sensing Technology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="N">Statistics as Topic</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Continuous glucose monitoring</Keyword><Keyword MajorTopicYN="Y">HbA1c estimation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>05</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>05</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>08</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34127370</ArticleId><ArticleId IdType="pii">S1056-8727(21)00137-9</ArticleId><ArticleId IdType="doi">10.1016/j.jdiacomp.2021.107950</ArticleId><ArticleId IdType="pmc">PMC8316291</ArticleId><ArticleId IdType="mid">NIHMS1715764</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Intern Med. 2017 Jul 18;167(2):95-102</Citation><ArticleIdList><ArticleId IdType="pubmed">28605777</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2008 Aug;10(4):310-21</Citation><ArticleIdList><ArticleId IdType="pubmed">18828243</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Sep 14;10(9):e0137525</Citation><ArticleIdList><ArticleId IdType="pubmed">26367281</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Apr;40(4):538-545</Citation><ArticleIdList><ArticleId IdType="pubmed">28209654</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2008 Nov 15;112(10):4284-91</Citation><ArticleIdList><ArticleId IdType="pubmed">18694998</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Pract. 2015 Nov;21(11):1195-203</Citation><ArticleIdList><ArticleId IdType="pubmed">26214108</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Dec;40(12):1631-1640</Citation><ArticleIdList><ArticleId IdType="pubmed">29162583</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2020 Mar 1;105(3):</Citation><ArticleIdList><ArticleId IdType="pubmed">31650161</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Nov;41(11):2275-2280</Citation><ArticleIdList><ArticleId IdType="pubmed">30224348</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2020 Jul;22(7):501-508</Citation><ArticleIdList><ArticleId IdType="pubmed">32459124</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Child Adolesc Health. 2018 Sep;2(9):635-646</Citation><ArticleIdList><ArticleId IdType="pubmed">30119757</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34073433</PMID><DateRevised><Year>2021</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2306-5354</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>26</Day></PubDate></JournalIssue><Title>Bioengineering (Basel, Switzerland)</Title><ISOAbbreviation>Bioengineering (Basel)</ISOAbbreviation></Journal><ArticleTitle>Blood Glucose Level Forecasting on Type-1-Diabetes Subjects during Physical Activity: A Comparative Analysis of Different Learning Techniques.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">72</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/bioengineering8060072</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Type 1 Diabetes Mellitus (T1DM) is a widespread chronic disease in industrialized countries. Preventing blood glucose levels from exceeding the euglycaemic range would reduce the incidence of diabetes-related complications and improve the quality of life of subjects with T1DM. As a consequence, in the last decade, many Machine Learning algorithms aiming to forecast future blood glucose levels have been proposed. Despite the excellent performance they obtained, the prediction of abrupt changes in blood glucose values produced during physical activity (PA) is still one of the main challenges.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A Jump Neural Network was developed in order to overcome the issue of predicting blood glucose values during PA. Three learning configurations were developed and tested: offline training, online training, and online training with reinforcement. All configurations were tested on six subjects suffering from T1DM that held regular PA (three aerobic and three anaerobic) and exploited Continuous Glucose Monitoring (CGM).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The forecasting performance was evaluated in terms of the Root-Mean-Squared-Error (RMSE), according to a paradigm of Precision Medicine.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The online learning configurations performed better than the offline configuration in total days but not on the only CGM associated with the PA; thus, the results do not justify the increased computational burden because the improvement was not significant.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Paoli</LastName><ForeName>Benedetta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Unit of Computer Systems and Bioinformatics, Department of Engineering, Universit.. Campus Bio-Medico di Roma, 00128 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Antoni</LastName><ForeName>Federico</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-7377-5462</Identifier><AffiliationInfo><Affiliation>Unit of Computer Systems and Bioinformatics, Department of Engineering, Universit.. Campus Bio-Medico di Roma, 00128 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merone</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9406-2397</Identifier><AffiliationInfo><Affiliation>Unit of Computer Systems and Bioinformatics, Department of Engineering, Universit.. Campus Bio-Medico di Roma, 00128 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pieralice</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit of Diabetology and Endocrinology, Department of Medicine, Universit.. Campus Bio-Medico di Roma, 00128 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piemonte</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-2421-3938</Identifier><AffiliationInfo><Affiliation>Unit of Chemical Engineering, Department of Engineering, Universit.. Campus Bio-Medico di Roma, 00128 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pozzilli</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unit of Diabetology and Endocrinology, Department of Medicine, Universit.. Campus Bio-Medico di Roma, 00128 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Bioengineering (Basel)</MedlineTA><NlmUniqueID>101676056</NlmUniqueID><ISSNLinking>2306-5354</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">neural network</Keyword><Keyword MajorTopicYN="N">online learning</Keyword><Keyword MajorTopicYN="N">physical activity</Keyword><Keyword MajorTopicYN="N">precision medicine</Keyword><Keyword MajorTopicYN="N">time series forecasting</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>03</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>05</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>05</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>1</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34073433</ArticleId><ArticleId IdType="pii">bioengineering8060072</ArticleId><ArticleId IdType="doi">10.3390/bioengineering8060072</ArticleId><ArticleId IdType="pmc">PMC8229703</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pediatr Diabetes. 2014 Sep;15 Suppl 20:203-23</Citation><ArticleIdList><ArticleId IdType="pubmed">25182315</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2019 Jul;13(4):718-727</Citation><ArticleIdList><ArticleId IdType="pubmed">30654648</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Nov;39(11):2065-2079</Citation><ArticleIdList><ArticleId IdType="pubmed">27926890</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2019 Feb 1;104(2):604-612</Citation><ArticleIdList><ArticleId IdType="pubmed">30281094</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:2270-2273</Citation><ArticleIdList><ArticleId IdType="pubmed">28324962</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Clin Nutr Metab Care. 2015 Jul;18(4):428-33</Citation><ArticleIdList><ArticleId IdType="pubmed">26001653</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2019 Mar 20;11(484):</Citation><ArticleIdList><ArticleId IdType="pubmed">30894501</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2021 Jul;15(4):842-855</Citation><ArticleIdList><ArticleId IdType="pubmed">32476492</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Jan;3(1):56-67</Citation><ArticleIdList><ArticleId IdType="pubmed">20046650</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2014;113(1):144-52</Citation><ArticleIdList><ArticleId IdType="pubmed">24192453</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2017 May;5(5):377-390</Citation><ArticleIdList><ArticleId IdType="pubmed">28126459</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(1):9-16</Citation><ArticleIdList><ArticleId IdType="pubmed">24356592</ArticleId></ArticleIdList></Reference><Reference><Citation>J Sports Sci. 2021 May;39(10):1127-1135</Citation><ArticleIdList><ArticleId IdType="pubmed">33423600</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 Mar;23(2):650-659</Citation><ArticleIdList><ArticleId IdType="pubmed">29993992</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2019 Sep;13(5):919-927</Citation><ArticleIdList><ArticleId IdType="pubmed">30650997</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 May;15(5):386-400</Citation><ArticleIdList><ArticleId IdType="pubmed">23544672</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">34039433</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2046-4053</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>05</Month><Day>26</Day></PubDate></JournalIssue><Title>Systematic reviews</Title><ISOAbbreviation>Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Text mining to support abstract screening for knowledge syntheses: a semi-automated workflow.</ArticleTitle><Pagination><MedlinePgn>156</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13643-021-01700-x</ELocationID><Abstract><AbstractText Label="BACKGROUND">Current text mining tools supporting abstract screening in systematic reviews are not widely used, in part because they lack sensitivity and precision. We set out to develop an accessible, semi-automated "workflow" to conduct abstract screening for systematic reviews and other knowledge synthesis methods.</AbstractText><AbstractText Label="METHODS">We adopt widely recommended text-mining and machine-learning methods to (1) process title-abstracts into numerical training data; and (2) train a classification model to predict eligible abstracts. The predicted abstracts are screened by human reviewers for ("true") eligibility, and the newly eligible abstracts are..used to identify similar abstracts,..using near-neighbor methods, which are also screened. These abstracts, as well as their eligibility results, are used to update the classification model, and the above steps are iterated until no new eligible abstracts are identified. The workflow was implemented in R and evaluated using a systematic review of insulin formulations for type-1 diabetes (14,314 abstracts) and a scoping review of knowledge-synthesis methods (17,200 abstracts). Workflow performance was evaluated against the recommended practice of screening abstracts by 2 reviewers, independently. Standard measures were examined: sensitivity (inclusion of all truly eligible abstracts), specificity (exclusion of all truly ineligible abstracts), precision (inclusion of all truly eligible abstracts among all abstracts screened as eligible), F1-score (harmonic average of sensitivity and precision), and accuracy (correctly predicted eligible or ineligible abstracts). Workload reduction was measured as the hours the workflow saved, given only a subset of abstracts needed human screening.</AbstractText><AbstractText Label="RESULTS">With respect to the systematic and scoping reviews..respectively, the workflow attained 88%/89% sensitivity, 99%/99% specificity, 71%/72% precision, an F1-score of 79%/79%, 98%/97% accuracy, 63%/55% workload reduction, with 12%/11% fewer abstracts for full-text retrieval and screening, and 0%/1.5% missed studies in the completed reviews.</AbstractText><AbstractText Label="CONCLUSION">The workflow was a sensitive, precise, and efficient alternative to the recommended practice of screening abstracts with 2 reviewers. All eligible studies were identified in the first case, while 6 studies (1.5%) were missed in the second that would likely not impact the review's conclusions. We have described the workflow in language accessible to reviewers with limited exposure to natural language processing and machine learning, and have made the code available to reviewers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Ba'</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria St, Toronto, Ontario, M5B 1T8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jovanovic</LastName><ForeName>Jelena</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Software Engineering, University of Belgrade, Jove Ilica 154, Belgrade, 11000, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagheri</LastName><ForeName>Ebrahim</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Electrical and Computer Engineering, Ryerson University, 350 Victoria Street, Toronto, Ontario, M5B 2K3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antony</LastName><ForeName>Jesmin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria St, Toronto, Ontario, M5B 1T8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashoor</LastName><ForeName>Huda</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria St, Toronto, Ontario, M5B 1T8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Tam T</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Department of Electrical and Computer Engineering, Ryerson University, 350 Victoria Street, Toronto, Ontario, M5B 2K3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rios</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria St, Toronto, Ontario, M5B 1T8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robson</LastName><ForeName>Reid</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria St, Toronto, Ontario, M5B 1T8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Sonia M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria St, Toronto, Ontario, M5B 1T8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watt</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria St, Toronto, Ontario, M5B 1T8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Straus</LastName><ForeName>Sharon E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria St, Toronto, Ontario, M5B 1T8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tricco</LastName><ForeName>Andrea C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-4114-8971</Identifier><AffiliationInfo><Affiliation>Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria St, Toronto, Ontario, M5B 1T8, Canada. Andrea.Tricco@unityhealth.to.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Division and Institute for Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, 155 College St Room 500, Toronto, Ontario, M5T 3M7, Canada. Andrea.Tricco@unityhealth.to.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, School of Nursing, Queen's University, 99 University Ave, Kingston, Ontario, K7L 3N6, Canada. Andrea.Tricco@unityhealth.to.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Syst Rev</MedlineTA><NlmUniqueID>101580575</NlmUniqueID><ISSNLinking>2046-4053</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="Y">Data Mining</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="Y">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057188" MajorTopicYN="N">Workflow</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Abstract screening</Keyword><Keyword MajorTopicYN="Y">Automation</Keyword><Keyword MajorTopicYN="Y">Classification model</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Natural language processing</Keyword><Keyword MajorTopicYN="Y">Scoping review</Keyword><Keyword MajorTopicYN="Y">Systematic review</Keyword><Keyword MajorTopicYN="Y">Text mining</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>09</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>05</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34039433</ArticleId><ArticleId IdType="doi">10.1186/s13643-021-01700-x</ArticleId><ArticleId IdType="pii">10.1186/s13643-021-01700-x</ArticleId><ArticleId IdType="pmc">PMC8152711</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Public Health Nutr. 2006 Jun;9(4):494-500</Citation><ArticleIdList><ArticleId IdType="pubmed">16870022</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Rev. 2016 Aug 17;5(1):140</Citation><ArticleIdList><ArticleId IdType="pubmed">27535658</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Intern Med. 2021 Mar 19;:</Citation><ArticleIdList><ArticleId IdType="pubmed">33742305</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Rev. 2015 Jan 14;4:5</Citation><ArticleIdList><ArticleId IdType="pubmed">25588314</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2015 May 28;521(7553):436-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26017442</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2010 Jul-Aug;17(4):446-53</Citation><ArticleIdList><ArticleId IdType="pubmed">20595313</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Rev. 2019 Jan 15;8(1):23</Citation><ArticleIdList><ArticleId IdType="pubmed">30646959</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1999 Aug 18;282(7):634-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10517715</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2017 Feb 27;7(2):e012545</Citation><ArticleIdList><ArticleId IdType="pubmed">28242767</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2019 Feb;106:121-135</Citation><ArticleIdList><ArticleId IdType="pubmed">30312656</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Rev. 2018 Mar 12;7(1):45</Citation><ArticleIdList><ArticleId IdType="pubmed">29530097</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Rev. 2014 Oct 21;3:121</Citation><ArticleIdList><ArticleId IdType="pubmed">25335439</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2016 May;73:19-28</Citation><ArticleIdList><ArticleId IdType="pubmed">26891949</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2005 Mar;6(1):57-71</Citation><ArticleIdList><ArticleId IdType="pubmed">15826357</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2016 May 24;13(5):e1002028</Citation><ArticleIdList><ArticleId IdType="pubmed">27218655</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2016 May;73:36-42</Citation><ArticleIdList><ArticleId IdType="pubmed">26891951</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Rev. 2018 Jan 09;7(1):3</Citation><ArticleIdList><ArticleId IdType="pubmed">29316980</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011 Mar 17;6(3):e18029</Citation><ArticleIdList><ArticleId IdType="pubmed">21437291</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2002 Jun 15;21(11):1635-40</Citation><ArticleIdList><ArticleId IdType="pubmed">12111924</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Rev. 2015 Dec 22;4:183</Citation><ArticleIdList><ArticleId IdType="pubmed">26693720</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 2020;25:295-306</Citation><ArticleIdList><ArticleId IdType="pubmed">31797605</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2017 Jul;71:91-109</Citation><ArticleIdList><ArticleId IdType="pubmed">28552401</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Rev. 2016 Dec 5;5(1):210</Citation><ArticleIdList><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2018 Nov;103:101-111</Citation><ArticleIdList><ArticleId IdType="pubmed">30297037</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34034069</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1950-6007</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title><ISOAbbreviation>Biomed Pharmacother</ISOAbbreviation></Journal><ArticleTitle>Bifidobacterium reduction is associated with high blood pressure in children with type 1 diabetes mellitus.</ArticleTitle><Pagination><MedlinePgn>111736</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0753-3322(21)00518-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2021.111736</ELocationID><Abstract><AbstractText>Children with Type 1 diabetes mellitus (T1DM) have an elevated risk of abnormal blood pressure (BP) measurements and patterns. Both hypertension and T1DM are well-known risk factors for cardiovascular disease and kidney failure. The human microbiome has been linked to both diabetes and hypertension, but the relationship between the gut microbiome and BP in children with T1DM is not well-understood. In this cross-sectional study, we examined the relationship between resting office BP and gut microbiota composition, diversity, and richness in children with T1DM and healthy controls. We recruited 29 pediatric subjects and divided them into three groups: healthy controls (HC, n..=..5), T1DM with normal BP (T1DM-Normo, n..=..17), and T1DM with elevated BP (T1DM-HBP, n..=..7). We measured the BP, dietary and clinical parameters for each subject. We collected fecal samples to perform the 16s rDNA sequencing and to measure the short-chain fatty acids (SCFAs) level. The microbiome downstream analysis included the relative abundance of microbiota, alpha and beta diversity, microbial markers using Linear Discriminant effect size analysis (LEfSe), potential gut microbial metabolic pathways using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) and metabolic pathways validation using Statistical Inference of Associations between Microbial Communities And host phenotype (SIAMCAT) machine learning toolbox. Our study results showed that T1DM-HBP group had distinct gut microbial composition (at multiple taxonomic levels) and reduced diversity (richness and abundance) compared with T1DM-Normo and HC groups. Children with T1DM-HBP showed a significant reduction of Bifidobacterium levels (especially B. adolescentis, B. bifidum, and B. longum) compared to the T1DM-Normo group. We also observed unique gut-microbial metabolic pathways, such as elevated lipopolysaccharide synthesis and glutathione metabolism in children with T1DM-HBP compared to T1DM-Normo children. We can conclude that the reduction in the abundance of genus Bifidobacterium could play a significant role in elevating the BP in pediatric T1DM subjects. More studies are needed to corroborate our findings and further explore the potential contributing mechanisms we describe.</AbstractText><CopyrightInformation>Copyright .. 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lakshmanan</LastName><ForeName>Arun Prasath</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Research Department, Sidra Medicine, OPC, P.O. Box 26999, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shatat</LastName><ForeName>Ibrahim F</ForeName><Initials>IF</Initials><AffiliationInfo><Affiliation>Pediatric Nephrology and Hypertension, Sidra Medicine, HB. 7A. 106A, P.O. Box 26999, Doha, Qatar; Weill Cornell College of Medicine-Qatar, Ar-Rayyan, Doha, Qatar; Medical University of South Carolina, Charleston, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaidan</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Department, Sidra Medicine, OPC, P.O. Box 26999, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacob</LastName><ForeName>Shana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Department, Sidra Medicine, OPC, P.O. Box 26999, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bangarusamy</LastName><ForeName>Dhinoth Kumar</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Research Department, Sidra Medicine, OPC, P.O. Box 26999, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Abduljabbar</LastName><ForeName>Shaikha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Department, Sidra Medicine, OPC, P.O. Box 26999, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Khalaf</LastName><ForeName>Fawziya</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Pediatric Endocrinology, Sidra Medicine, OPC, P.O. Box 26999, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petroviski</LastName><ForeName>Goran</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pediatric Endocrinology, Sidra Medicine, OPC, P.O. Box 26999, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terranegra</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Department, Sidra Medicine, OPC, P.O. Box 26999, Doha, Qatar. Electronic address: aterranegra@sidra.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Biomed Pharmacother</MedlineTA><NlmUniqueID>8213295</NlmUniqueID><ISSNLinking>0753-3322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004269">DNA, Bacterial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004275">DNA, Ribosomal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005232">Fatty Acids, Volatile</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001644" MajorTopicYN="Y">Bifidobacterium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004269" MajorTopicYN="N">DNA, Bacterial</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004275" MajorTopicYN="N">DNA, Ribosomal</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005232" MajorTopicYN="N">Fatty Acids, Volatile</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood pressure</Keyword><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">Dysbiosis</Keyword><Keyword MajorTopicYN="N">Hypertension</Keyword><Keyword MajorTopicYN="N">Microbiota</Keyword><Keyword MajorTopicYN="N">Pediatric</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>03</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>05</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>05</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>25</Day><Hour>20</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34034069</ArticleId><ArticleId IdType="pii">S0753-3322(21)00518-7</ArticleId><ArticleId IdType="doi">10.1016/j.biopha.2021.111736</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33913816</PMID><DateRevised><Year>2021</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2371-4379</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>29</Day></PubDate></JournalIssue><Title>JMIR diabetes</Title><ISOAbbreviation>JMIR Diabetes</ISOAbbreviation></Journal><ArticleTitle>Improved Low-Glucose Predictive Alerts Based on Sustained Hypoglycemia: Model Development and Validation Study.</ArticleTitle><Pagination><MedlinePgn>e26909</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/26909</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Predictive alerts for impending hypoglycemic events enable persons with type 1 diabetes to take preventive actions and avoid serious consequences.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to develop a prediction model for hypoglycemic events with a low false alert rate, high sensitivity and specificity, and good generalizability to new patients and time periods.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Performance improvement by focusing on sustained hypoglycemic events, defined as glucose values less than 70 mg/dL for at least 15 minutes, was explored. Two different modeling approaches were considered: (1) a classification-based method to directly predict sustained hypoglycemic events, and (2) a regression-based prediction of glucose at multiple time points in the prediction horizon and subsequent inference of sustained hypoglycemia. To address the generalizability and robustness of the model, two different validation mechanisms were considered: (1) patient-based validation (model performance was evaluated on new patients), and (2) time-based validation (model performance was evaluated on new time periods).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This study utilized data from 110 patients over 30-90 days comprising 1.6 million continuous glucose monitoring values under normal living conditions. The model accurately predicted sustained events with &gt;97% sensitivity and specificity for both 30- and 60-minute prediction horizons. The false alert rate was kept to &lt;25%. The results were consistent across patient- and time-based validation strategies.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Providing alerts focused on sustained events instead of all hypoglycemic events reduces the false alert rate and improves sensitivity and specificity. It also results in models that have better generalizability to new patients and time periods.</AbstractText><CopyrightInformation>..Darpit Dave, Madhav Erraguntla, Mark Lawley, Daniel DeSalvo, Balakrishna Haridas, Siripoom McKay, Chester Koh. Originally published in JMIR Diabetes (https://diabetes.jmir.org), 29.04.2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dave</LastName><ForeName>Darpit</ForeName><Initials>D</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-2380-4549</Identifier><AffiliationInfo><Affiliation>Department of Industrial and Systems Engineering, Texas A&amp;M University, College Station, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erraguntla</LastName><ForeName>Madhav</ForeName><Initials>M</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-0017-5866</Identifier><AffiliationInfo><Affiliation>Department of Industrial and Systems Engineering, Texas A&amp;M University, College Station, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawley</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-3925-2806</Identifier><AffiliationInfo><Affiliation>Department of Industrial and Systems Engineering, Texas A&amp;M University, College Station, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeSalvo</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-0440-3339</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Baylor College of Medicine / Texas Children's Hospital, Houston, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haridas</LastName><ForeName>Balakrishna</ForeName><Initials>B</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-2008-6353</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Texas A&amp;M University, College Station, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKay</LastName><ForeName>Siripoom</ForeName><Initials>S</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-4387-0191</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Baylor College of Medicine / Texas Children's Hospital, Houston, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Chester</ForeName><Initials>C</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-8696-5193</Identifier><AffiliationInfo><Affiliation>Division of Pediatric Urology, Texas Children's Hospital, Houston, TX, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Scott Department of Urology, Baylor College of Medicine, Houston, TX, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P50 FD006428</GrantID><Acronym>FD</Acronym><Agency>FDA HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Diabetes</MedlineTA><NlmUniqueID>101719410</NlmUniqueID><ISSNLinking>2371-4379</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">continuous glucose monitoring</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">false alert rate</Keyword><Keyword MajorTopicYN="N">glucose monitoring</Keyword><Keyword MajorTopicYN="N">hypoglycemia</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">model generalizability</Keyword><Keyword MajorTopicYN="N">quantile regression forests</Keyword><Keyword MajorTopicYN="N">sustained hypoglycemia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>01</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>03</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>03</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>29</Day><Hour>12</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33913816</ArticleId><ArticleId IdType="pii">v6i2e26909</ArticleId><ArticleId IdType="doi">10.2196/26909</ArticleId><ArticleId IdType="pmc">PMC8120423</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Technol Ther. 2017 Jun;19(S3):S25-S37</Citation><ArticleIdList><ArticleId IdType="pubmed">28585879</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 May;23(3):1251-1260</Citation><ArticleIdList><ArticleId IdType="pubmed">29993728</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Jul;2(4):612-21</Citation><ArticleIdList><ArticleId IdType="pubmed">19885237</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Jul;15(7):538-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23631608</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Neural Syst Rehabil Eng. 2020 Apr;28(4):961-969</Citation><ArticleIdList><ArticleId IdType="pubmed">32054581</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2020 May 21;21(3):791-802</Citation><ArticleIdList><ArticleId IdType="pubmed">31220208</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Oct;15(10):792-801</Citation><ArticleIdList><ArticleId IdType="pubmed">23883406</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Oct;41(10):2155-2161</Citation><ArticleIdList><ArticleId IdType="pubmed">30089663</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Nurs Q. 2005 Oct-Dec;28(4):317-23</Citation><ArticleIdList><ArticleId IdType="pubmed">16239820</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2020 Jun 1;:1932296820922622</Citation><ArticleIdList><ArticleId IdType="pubmed">32476492</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2020 Nov;22(11):787-793</Citation><ArticleIdList><ArticleId IdType="pubmed">32267773</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Jan 1;8(1):117-122</Citation><ArticleIdList><ArticleId IdType="pubmed">24876547</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2012 Jun;59(6):1550-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22374344</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2018 Jun;20(S2):S250-S253</Citation><ArticleIdList><ArticleId IdType="pubmed">29873525</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2020 Dec;22(12):883-891</Citation><ArticleIdList><ArticleId IdType="pubmed">32324062</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Cybern. 2016 Jul;46(7):1704-14</Citation><ArticleIdList><ArticleId IdType="pubmed">27244754</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 Mar;23(2):650-659</Citation><ArticleIdList><ArticleId IdType="pubmed">29993992</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 Aug 22;10(5):1149-60</Citation><ArticleIdList><ArticleId IdType="pubmed">27381030</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2019 Sep;13(5):919-927</Citation><ArticleIdList><ArticleId IdType="pubmed">30650997</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2020 Jul 13;20(14):</Citation><ArticleIdList><ArticleId IdType="pubmed">32668724</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2009 Apr;11(4):243-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19344199</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Dis. 2019 Mar;11(Suppl 4):S574-S584</Citation><ArticleIdList><ArticleId IdType="pubmed">31032076</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Jan;11(1):138-147</Citation><ArticleIdList><ArticleId IdType="pubmed">27530720</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2020 Feb;24(2):414-423</Citation><ArticleIdList><ArticleId IdType="pubmed">31369390</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Jan;12(1):190-198</Citation><ArticleIdList><ArticleId IdType="pubmed">28741369</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Meas. 2004 Aug;25(4):905-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15382830</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Jan 01;4(1):25-33</Citation><ArticleIdList><ArticleId IdType="pubmed">20167164</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Mar 01;4(2):404-18</Citation><ArticleIdList><ArticleId IdType="pubmed">20307402</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2019 Feb;21(S1):S123-S137</Citation><ArticleIdList><ArticleId IdType="pubmed">30785328</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Apr 30;9(5):1126-37</Citation><ArticleIdList><ArticleId IdType="pubmed">25931581</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Informatics J. 2019 Dec;25(4):1170-1187</Citation><ArticleIdList><ArticleId IdType="pubmed">29278956</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2019 Dec 11;14(12):e0219636</Citation><ArticleIdList><ArticleId IdType="pubmed">31826018</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2013 Jan;17(1):71-81</Citation><ArticleIdList><ArticleId IdType="pubmed">23008265</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 May 01;7(3):789-94</Citation><ArticleIdList><ArticleId IdType="pubmed">23759412</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Jul;8(4):731-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24876412</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):634-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23848178</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2017 Aug;18(5):332-339</Citation><ArticleIdList><ArticleId IdType="pubmed">27125223</ArticleId></ArticleIdList></Reference><Reference><Citation>Ind Eng Chem Res. 2013 Sep 4;52(35):</Citation><ArticleIdList><ArticleId IdType="pubmed">24187436</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Inf Technol Biomed. 2010 Jan;14(1):157-65</Citation><ArticleIdList><ArticleId IdType="pubmed">19858035</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Nov 7;12(11):e0187754</Citation><ArticleIdList><ArticleId IdType="pubmed">29112978</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2019 May 21;14(5):e0217199</Citation><ArticleIdList><ArticleId IdType="pubmed">31112566</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Sep 01;4(5):1146-55</Citation><ArticleIdList><ArticleId IdType="pubmed">20920434</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Dec;40(12):1631-1640</Citation><ArticleIdList><ArticleId IdType="pubmed">29162583</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2007 Sep;1(5):624-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19885130</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2021 Jan 12;21(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">33445438</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2010 Jan;12(1):81-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20082589</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 Sep 01;6(5):1142-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23063041</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1999 Mar;48(3):445-51</Citation><ArticleIdList><ArticleId IdType="pubmed">10078542</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 Mar 7;13(3):e0194025</Citation><ArticleIdList><ArticleId IdType="pubmed">29513751</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2019 May 01;21(5):e11030</Citation><ArticleIdList><ArticleId IdType="pubmed">31042157</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 May;54(5):931-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17518291</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2020 Mar 19;20(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">32204318</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Mar;12(2):282-294</Citation><ArticleIdList><ArticleId IdType="pubmed">29493359</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2014;113(1):144-52</Citation><ArticleIdList><ArticleId IdType="pubmed">24192453</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2018 May 30;20(5):e10775</Citation><ArticleIdList><ArticleId IdType="pubmed">29848472</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Aug;42(8):1593-1603</Citation><ArticleIdList><ArticleId IdType="pubmed">31177185</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 Apr 17;:</Citation><ArticleIdList><ArticleId IdType="pubmed">30998484</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2005 Feb;7(1):3-14</Citation><ArticleIdList><ArticleId IdType="pubmed">15738700</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Mar;38(3):355-64</Citation><ArticleIdList><ArticleId IdType="pubmed">25205142</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Mar;12(2):265-272</Citation><ArticleIdList><ArticleId IdType="pubmed">29493356</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33726723</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>03</Month><Day>16</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>Stacked LSTM based deep recurrent neural network with kalman smoothing for blood glucose prediction.</ArticleTitle><Pagination><MedlinePgn>101</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-021-01462-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Blood glucose (BG) management is crucial for type-1 diabetes patients resulting in the necessity of reliable artificial pancreas or insulin infusion systems. In recent years, deep learning techniques have been utilized for a more accurate BG level prediction system. However, continuous glucose monitoring (CGM) readings are susceptible to sensor errors. As a result, inaccurate CGM readings would affect BG prediction and make it unreliable, even if the most optimal machine learning model is used.</AbstractText><AbstractText Label="METHODS">In this work, we propose a novel approach to predicting blood glucose level with a stacked Long short-term memory (LSTM) based deep recurrent neural network (RNN) model considering sensor fault. We use the Kalman smoothing technique for the correction of the inaccurate CGM readings due to sensor error.</AbstractText><AbstractText Label="RESULTS">For the OhioT1DM (2018) dataset, containing eight weeks' data from six different patients, we achieve an average RMSE of 6.45 and 17.24 mg/dl for 30..min and 60..min of prediction horizon (PH), respectively.</AbstractText><AbstractText Label="CONCLUSIONS">To the best of our knowledge, this is the leading average prediction accuracy for the ohioT1DM dataset. Different physiological information, e.g., Kalman smoothed CGM data, carbohydrates from the meal, bolus insulin, and cumulative step counts in a fixed time interval, are crafted to represent meaningful features used as input to the model. The goal of our approach is to lower the difference between the predicted CGM values and the fingerstick blood glucose readings-the ground truth. Our results indicate that the proposed approach is feasible for more reliable BG forecasting that might improve the performance of the artificial pancreas and insulin infusion system for T1D diabetes management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rabby</LastName><ForeName>Md Fazle</ForeName><Initials>MF</Initials><Identifier Source="ORCID">0000-0002-7857-5870</Identifier><AffiliationInfo><Affiliation>School of Computing and Informatics, The University of Louisiana at Lafayette, Lafayatte, LA, 70503, USA. md-fazle.rabby1@louisiana.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Yazhou</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Computing and Informatics, The University of Louisiana at Lafayette, Lafayatte, LA, 70503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hossen</LastName><ForeName>Md Imran</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>School of Computing and Informatics, The University of Louisiana at Lafayette, Lafayatte, LA, 70503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Insup</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Computer and Information Science, University of Pennsylvania, Philadelphia, PA, 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maida</LastName><ForeName>Anthony S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>School of Computing and Informatics, The University of Louisiana at Lafayette, Lafayatte, LA, 70503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hei</LastName><ForeName>Xiali</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Computing and Informatics, The University of Louisiana at Lafayette, Lafayatte, LA, 70503, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="Y">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Blood glucose level prediction</Keyword><Keyword MajorTopicYN="Y">Kalman smoothing</Keyword><Keyword MajorTopicYN="Y">Recurrent neural network</Keyword><Keyword MajorTopicYN="Y">Sensor fault correction</Keyword><Keyword MajorTopicYN="Y">Stacked long short-term memory</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>03</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>17</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33726723</ArticleId><ArticleId IdType="doi">10.1186/s12911-021-01462-5</ArticleId><ArticleId IdType="pii">10.1186/s12911-021-01462-5</ArticleId><ArticleId IdType="pmc">PMC7968367</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Horm Metab Res. 1981 Jul;13(7):365-7</Citation><ArticleIdList><ArticleId IdType="pubmed">7024077</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2012 Jun;59(6):1550-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22374344</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 May;23(3):1251-1260</Citation><ArticleIdList><ArticleId IdType="pubmed">29993728</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 May 01;7(3):689-98</Citation><ArticleIdList><ArticleId IdType="pubmed">23759402</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2016 Apr;18(4):264-72</Citation><ArticleIdList><ArticleId IdType="pubmed">26882463</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 Jan;23(1):218-226</Citation><ArticleIdList><ArticleId IdType="pubmed">29994742</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:4475-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25570985</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2013 Feb;60(2):406-16</Citation><ArticleIdList><ArticleId IdType="pubmed">23193300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ind Eng Chem Res. 2013 Sep 4;52(35):</Citation><ArticleIdList><ArticleId IdType="pubmed">24187436</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Neural Netw. 1994;5(2):157-66</Citation><ArticleIdList><ArticleId IdType="pubmed">18267787</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2010 Jan;12(1):81-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20082589</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2015 Jan;261(1):97-103</Citation><ArticleIdList><ArticleId IdType="pubmed">25133932</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2010 Jul 22;363(4):311-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20587585</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:706-712</Citation><ArticleIdList><ArticleId IdType="pubmed">31945995</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2011 Feb;13(2):135-41</Citation><ArticleIdList><ArticleId IdType="pubmed">21284480</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2015 Oct;62(10):2369-78</Citation><ArticleIdList><ArticleId IdType="pubmed">25935026</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Netw. 2015 Jan;61:85-117</Citation><ArticleIdList><ArticleId IdType="pubmed">25462637</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Jan;40(Suppl 1):S11-S24</Citation><ArticleIdList><ArticleId IdType="pubmed">27979889</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 Jan 01;7(1):206-14</Citation><ArticleIdList><ArticleId IdType="pubmed">23439179</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2003 Jun;26(6):1902-12</Citation><ArticleIdList><ArticleId IdType="pubmed">12766131</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Jul;2(4):612-21</Citation><ArticleIdList><ArticleId IdType="pubmed">19885237</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2018 Jun;65(6):1281-1290</Citation><ArticleIdList><ArticleId IdType="pubmed">28866479</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2011 Nov;60(11):2672-82</Citation><ArticleIdList><ArticleId IdType="pubmed">22025773</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2005 Jan;52(1):3-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15651559</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2003 Aug;26(8):2405-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12882870</ArticleId></ArticleIdList></Reference><Reference><Citation>CEUR Workshop Proc. 2020 Sep;2675:71-74</Citation><ArticleIdList><ArticleId IdType="pubmed">33584164</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Comput. 1997 Nov 15;9(8):1735-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9377276</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):722-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23650900</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Neural Netw. 1999;10(5):1204-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18252621</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2013 Jan;17(1):71-81</Citation><ArticleIdList><ArticleId IdType="pubmed">23008265</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 Jan;33 Suppl 1:S62-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20042775</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1979 Dec;28(12):1039-57</Citation><ArticleIdList><ArticleId IdType="pubmed">510803</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2020 Feb;24(2):603-613</Citation><ArticleIdList><ArticleId IdType="pubmed">30946685</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">33686873</PMID><DateRevised><Year>2021</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>Mar</Month><Day>09</Day></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>Machine Learning-Based Anomaly Detection Algorithms to Alert Patients Using Sensor Augmented Pump of Infusion Site Failures.</ArticleTitle><Pagination><MedlinePgn>1932296821997854</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1932296821997854</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Personal insulin pumps have shown to be effective in improving the quality of therapy for people with type 1 diabetes (T1D). However, the safety of this technology is limited by the possible infusion site failures, which are linked with hyperglycemia and ketoacidosis. Thanks to the large availability of collected data provided by modern therapeutic technologies, machine learning algorithms have the potential to provide new way to identify failures early and avert adverse events.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A clinical dataset (<i>N</i>...=...20) is used to evaluate a novel method for detecting real-time infusion site failures using unsupervised anomaly detection algorithms, previously proposed and developed on in-silico data. An adapted feature engineering procedure is introduced to make the method able to operate in the absence of a closed-loop (CL) system and meal announcements.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In the optimal configuration, we obtained a performance of 0.75 Sensitivity (15 out of 20 total failures detected) and 0.08...FP/day, outperforming previously proposed literature algorithms. The algorithm was able to anticipate the replacement of the malfunctioning infusion sets by ~2...h on average.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">On the considered dataset, the proposed algorithm showed the potential to improve the safety of patients treated with sensor-augmented pump systems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meneghetti</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dassau</LastName><ForeName>Eyal</ForeName><Initials>E</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-5333-6892</Identifier><AffiliationInfo><Affiliation>Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doyle</LastName><ForeName>Francis J</ForeName><Initials>FJ</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Favero</LastName><ForeName>Simone</ForeName><Initials>S</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-8214-2752</Identifier><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SAP</Keyword><Keyword MajorTopicYN="N">anomaly detection</Keyword><Keyword MajorTopicYN="N">fault detection</Keyword><Keyword MajorTopicYN="N">infusion site failures</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>9</Day><Hour>8</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33686873</ArticleId><ArticleId IdType="doi">10.1177/1932296821997854</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">33673415</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1424-8220</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>Forecasting of Glucose Levels and Hypoglycemic Events: Head-to-Head Comparison of Linear and Nonlinear Data-Driven Algorithms Based on Continuous Glucose Monitoring Data Only.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1647</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/s21051647</ELocationID><Abstract><AbstractText>In type 1 diabetes management, the availability of algorithms capable of accurately forecasting future blood glucose (BG) concentrations and hypoglycemic episodes could enable proactive therapeutic actions, e.g., the consumption of carbohydrates to mitigate, or even avoid, an impending critical event. The only input of this kind of algorithm is often continuous glucose monitoring (CGM) sensor data, because other signals (such as injected insulin, ingested carbs, and physical activity) are frequently unavailable. Several predictive algorithms fed by CGM data only have been proposed in the literature, but they were assessed using datasets originated by different experimental protocols, making a comparison of their relative merits difficult. The aim of the present work was to perform a head-to-head comparison of thirty different linear and nonlinear predictive algorithms using the same dataset, given by 124 CGM traces collected over 10 days with the newest Dexcom G6 sensor available on the market and considering a 30-min prediction horizon. We considered the state-of-the art methods, investigating, in particular, linear black-box methods (autoregressive; autoregressive moving-average; and autoregressive integrated moving-average, ARIMA) and nonlinear machine-learning methods (support vector regression, SVR; regression random forest; feed-forward neural network, fNN; and long short-term memory neural network). For each method, the prediction accuracy and hypoglycemia detection capabilities were assessed using either population or individualized model parameters. As far as prediction accuracy is concerned, the results show that the best linear algorithm (individualized ARIMA) provides accuracy comparable to that of the best nonlinear algorithm (individualized fNN), with root mean square errors of 22.15 and 21.52 mg/dL, respectively. As far as hypoglycemia detection is concerned, the best linear algorithm (individualized ARIMA) provided precision = 64%, recall = 82%, and one false alarm/day, comparable to the best nonlinear technique (population SVR): precision = 63%, recall = 69%, and 0.5 false alarms/day. In general, the head-to-head comparison of the thirty algorithms fed by CGM data only made using a wide dataset shows that individualized linear models are more effective than population ones, while no significant advantages seem to emerge when employing nonlinear methodologies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prendin</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, 35131 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Favero</LastName><ForeName>Simone</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8214-2752</Identifier><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, 35131 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vettoretti</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, 35131 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sparacino</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-3248-1393</Identifier><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, 35131 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Facchinetti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8041-2280</Identifier><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, 35131 Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RBSI14JYM2</GrantID><Agency>Ministero dell'Istruzione, dell'Universit.. e della Ricerca</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="Y">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="Y">Hypoglycemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">data-driven modeling</Keyword><Keyword MajorTopicYN="N">glucose sensor</Keyword><Keyword MajorTopicYN="N">signal processing</Keyword><Keyword MajorTopicYN="N">time series</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>02</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>02</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>6</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33673415</ArticleId><ArticleId IdType="pii">s21051647</ArticleId><ArticleId IdType="doi">10.3390/s21051647</ArticleId><ArticleId IdType="pmc">PMC7956406</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Med Biol Eng Comput. 2015 Dec;53(12):1333-43</Citation><ArticleIdList><ArticleId IdType="pubmed">26049412</ArticleId></ArticleIdList></Reference><Reference><Citation>J Chem Inf Comput Sci. 2003 Nov-Dec;43(6):1947-58</Citation><ArticleIdList><ArticleId IdType="pubmed">14632445</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 May;23(3):1251-1260</Citation><ArticleIdList><ArticleId IdType="pubmed">29993728</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2015 Dec;62(12):2735-49</Citation><ArticleIdList><ArticleId IdType="pubmed">26292334</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 Jun;33(6):1249-54</Citation><ArticleIdList><ArticleId IdType="pubmed">20508231</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Dev Ind Pharm. 2003 Mar;29(3):349-55</Citation><ArticleIdList><ArticleId IdType="pubmed">12741616</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Syst. 2017 Aug 8;41(9):142</Citation><ArticleIdList><ArticleId IdType="pubmed">28791547</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2019 Nov;21(11):644-655</Citation><ArticleIdList><ArticleId IdType="pubmed">31335191</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2020 Dec 04;20(23):</Citation><ArticleIdList><ArticleId IdType="pubmed">33291519</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):634-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23848178</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2020 Feb;24(2):603-613</Citation><ArticleIdList><ArticleId IdType="pubmed">30946685</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2007 Sep;1(5):624-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19885130</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2014;113(1):144-52</Citation><ArticleIdList><ArticleId IdType="pubmed">24192453</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2005 Feb;7(1):3-14</Citation><ArticleIdList><ArticleId IdType="pubmed">15738700</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 May 01;7(3):689-98</Citation><ArticleIdList><ArticleId IdType="pubmed">23759402</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosens Bioelectron. 2018 Jul 1;110:175-179</Citation><ArticleIdList><ArticleId IdType="pubmed">29609166</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2018 Jun;20(6):395-402</Citation><ArticleIdList><ArticleId IdType="pubmed">29901421</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnostics (Basel). 2019 Mar 15;9(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">30875898</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 Mar;23(2):650-659</Citation><ArticleIdList><ArticleId IdType="pubmed">29993992</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 Aug 22;10(5):1149-60</Citation><ArticleIdList><ArticleId IdType="pubmed">27381030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2019 Oct 16;19(20):</Citation><ArticleIdList><ArticleId IdType="pubmed">31623111</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocrinol Metab Clin North Am. 2020 Mar;49(1):37-55</Citation><ArticleIdList><ArticleId IdType="pubmed">31980120</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 Nov;23(6):2633-2641</Citation><ArticleIdList><ArticleId IdType="pubmed">30571648</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2013 Apr;36(4):793-800</Citation><ArticleIdList><ArticleId IdType="pubmed">23172973</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 May 01;7(3):789-94</Citation><ArticleIdList><ArticleId IdType="pubmed">23759412</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Jan 01;4(1):41-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20167166</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Inf Technol Biomed. 2010 Jan;14(1):157-65</Citation><ArticleIdList><ArticleId IdType="pubmed">19858035</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Jul 24;7(1):6232</Citation><ArticleIdList><ArticleId IdType="pubmed">28740090</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2010 Jan;12(1):81-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20082589</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2019 Feb 15;19(4):</Citation><ArticleIdList><ArticleId IdType="pubmed">30781431</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 Sep 01;6(5):1142-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23063041</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2017 Nov;133:178-192</Citation><ArticleIdList><ArticleId IdType="pubmed">28965029</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Mar 04;10(3):e0118432</Citation><ArticleIdList><ArticleId IdType="pubmed">25738806</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 May;54(5):931-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17518291</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 May;33(5):1013-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20200307</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:706-712</Citation><ArticleIdList><ArticleId IdType="pubmed">31945995</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2016;228:577-81</Citation><ArticleIdList><ArticleId IdType="pubmed">27577449</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab J. 2019 Aug;43(4):383-397</Citation><ArticleIdList><ArticleId IdType="pubmed">31441246</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2011 Feb;13(2):111-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21284477</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocrinol Metab Clin North Am. 2020 Mar;49(1):1-18</Citation><ArticleIdList><ArticleId IdType="pubmed">31980111</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33651704</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2168-2208</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>10</Month></PubDate></JournalIssue><Title>IEEE journal of biomedical and health informatics</Title><ISOAbbreviation>IEEE J Biomed Health Inform</ISOAbbreviation></Journal><ArticleTitle>TrMAps: Trust Management in Specification-Based Misbehavior Detection System for IMD-Enabled Artificial Pancreas System.</ArticleTitle><Pagination><MedlinePgn>3763-3775</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/JBHI.2021.3063173</ELocationID><Abstract><AbstractText>Advances of implantable medical devices (IMD) are transforming the traditional method of providing medical treatment, especially those patients under the most challenging condition. Accordingly, the IMD-enabled artificial pancreas system (APS) has now reached global market. It helped many patients suffering from chronic disease, called diabetes mellitus, in monitoring and maintaining blood glucose level conveniently. However, this advancement is accompanied by various security threats that place the life of patients at risk. Hence, protective measures, especially against yet unknown threats, are of paramount importance. This paper proposes a specification-based misbehavior detection system (SMDS) as an alternative solution to effectively mitigate security threats. Moreover, an outlier detection algorithm is also introduced to validate integrity of unprotected data transmitted by the different components. The monitor agent applies a smoothened-trust-based scheme to assess the trustworthiness of the APS. To demonstrate effectiveness of the proposed method, we first extend the UVA/Padova simulator for glucose-insulin data collection and subsequently simulate scenario with well-behave and malicious APS in MATLAB. The results show that there exists an optimal trust threshold that can achieve high specificity and sensitivity rate. Moreover, the proposed technique was compared to contemporary machine learning classifier including decision tree, support vector machine, k-nearest neighbor, and the SMDS called SMDAps. It is shown that our approach can dominate detection performance, especially to malicious behavior that manifests habitually (hidden mode).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Astillo</LastName><ForeName>Philip Virgil</ForeName><Initials>PV</Initials></Author><Author ValidYN="Y"><LastName>Choudhary</LastName><ForeName>Gaurav</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Duguma</LastName><ForeName>Daniel Gerbi</ForeName><Initials>DG</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jiyoon</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Ilsun</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE J Biomed Health Inform</MedlineTA><NlmUniqueID>101604520</NlmUniqueID><ISSNLinking>2168-2194</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019397" MajorTopicYN="Y">Pancreas, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019736" MajorTopicYN="N">Prostheses and Implants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035502" MajorTopicYN="N">Trust</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>2</Day><Hour>17</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33651704</ArticleId><ArticleId IdType="doi">10.1109/JBHI.2021.3063173</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33573645</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>02</Month><Day>11</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>Performance evaluation of case definitions of type 1 diabetes for health insurance claims data in Japan.</ArticleTitle><Pagination><MedlinePgn>52</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-021-01422-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">No case definition of Type 1 diabetes (T1D) for the claims data has been proposed in Japan yet. This study aimed to evaluate the performance of candidate case definitions for T1D using Electronic health care records (EHR) and claims data in a University Hospital in Japan.</AbstractText><AbstractText Label="METHODS">The EHR and claims data for all the visiting patients in a University Hospital were used. As the candidate case definitions for claims data, we constructed 11 definitions by combinations of International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. (ICD 10) code of T1D, the claims code of insulin needles for T1D patients, basal insulin, and syringe pump for continuous subcutaneous insulin infusion (CSII). We constructed a predictive model for T1D patients using disease names, medical practices, and medications as explanatory variables. The predictive model was applied to patients of test group (validation data), and performances of candidate case definitions were evaluated.</AbstractText><AbstractText Label="RESULTS">As a result of performance evaluation, the sensitivity of the confirmed disease name of T1D was 32.9 (95% CI: 28.4, 37.2), and positive predictive value (PPV) was 33.3 (95% CI: 38.0, 38.4). By using the case definition of both the confirmed diagnosis of T1D and either of the claims code of the two insulin treatment methods (i.e., syringe pump for CSII and insulin needles), PPV improved to 90.2 (95% CI: 85.2, 94.4).</AbstractText><AbstractText Label="CONCLUSIONS">We have established a case definition with high PPV, and the case definition can be used for precisely detecting T1D patients from claims data in Japan.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Okui</LastName><ForeName>Tasuku</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Medical Information Center, Kyushu University Hospital, Maidashi 3-1-1 Higashi-ku, Fukuoka City, Fukuoka Prefecture, 812-8582, Japan. task10300@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nojiri</LastName><ForeName>Chinatsu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Information Center, Kyushu University Hospital, Maidashi 3-1-1 Higashi-ku, Fukuoka City, Fukuoka Prefecture, 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Shinichiro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Metabolism, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>Kentaro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Hospital Organization Kokura Medical Center, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maeno</LastName><ForeName>Sayaka</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sasaki Diabetes Clinic, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minami</LastName><ForeName>Masae</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinic Masae Minami, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maeda</LastName><ForeName>Yasutaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinic Masae Minami, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tajima</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Jikei University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawamura</LastName><ForeName>Tomoyuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Departmentof Pediatrics, Osaka City University, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakashima</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medical Information Center, Kyushu University Hospital, Maidashi 3-1-1 Higashi-ku, Fukuoka City, Fukuoka Prefecture, 812-8582, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007348" MajorTopicYN="N">Insurance, Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038801" MajorTopicYN="N">International Classification of Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Predictive model</Keyword><Keyword MajorTopicYN="Y">Type 1 diabetes</Keyword><Keyword MajorTopicYN="Y">Validation study</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>01</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>12</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33573645</ArticleId><ArticleId IdType="doi">10.1186/s12911-021-01422-z</ArticleId><ArticleId IdType="pii">10.1186/s12911-021-01422-z</ArticleId><ArticleId IdType="pmc">PMC7879626</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adv Med. 2018 Jun 5;2018:1473160</Citation><ArticleIdList><ArticleId IdType="pubmed">29974056</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypertension. 2009 Dec;54(6):1423-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19858407</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Diabetes. 2016 Dec;40(6):586-593</Citation><ArticleIdList><ArticleId IdType="pubmed">27545597</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Ther. 2020 Feb;11(2):387-409</Citation><ArticleIdList><ArticleId IdType="pubmed">31902063</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2010 Aug;89(2):189-95</Citation><ArticleIdList><ArticleId IdType="pubmed">20363043</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2013 Apr;36(4):914-21</Citation><ArticleIdList><ArticleId IdType="pubmed">23193215</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2006 May;49(5):828-36</Citation><ArticleIdList><ArticleId IdType="pubmed">16568259</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Jul;11(4):791-799</Citation><ArticleIdList><ArticleId IdType="pubmed">27932531</ArticleId></ArticleIdList></Reference><Reference><Citation>J Paediatr Child Health. 2019 Jun;55(6):718-722</Citation><ArticleIdList><ArticleId IdType="pubmed">31155794</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2015 Aug 27;5(8):e008424</Citation><ArticleIdList><ArticleId IdType="pubmed">26316651</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2016 Aug 05;6(8):e009952</Citation><ArticleIdList><ArticleId IdType="pubmed">27496226</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2017 Jul;34(7):909-915</Citation><ArticleIdList><ArticleId IdType="pubmed">27925270</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2014 Jan 4;383(9911):69-82</Citation><ArticleIdList><ArticleId IdType="pubmed">23890997</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Inform Insights. 2017 Feb 10;9:1178222616685880</Citation><ArticleIdList><ArticleId IdType="pubmed">28469428</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastroenterol Hepatol. 2020 May;35(5):760-768</Citation><ArticleIdList><ArticleId IdType="pubmed">31498502</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2017 Dec;152:53-70</Citation><ArticleIdList><ArticleId IdType="pubmed">29054261</ArticleId></ArticleIdList></Reference><Reference><Citation>Drugs Real World Outcomes. 2018 Mar;5(1):35-43</Citation><ArticleIdList><ArticleId IdType="pubmed">29185233</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Sep;11(5):1055-1056</Citation><ArticleIdList><ArticleId IdType="pubmed">28859515</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2019 Mar 1;9(3):e025806</Citation><ArticleIdList><ArticleId IdType="pubmed">30826768</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Ther. 2019 Nov;41(11):2239-2251</Citation><ArticleIdList><ArticleId IdType="pubmed">31629532</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Med Inform. 2017 Jan;97:120-127</Citation><ArticleIdList><ArticleId IdType="pubmed">27919371</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2013 Dec;20(e2):e319-26</Citation><ArticleIdList><ArticleId IdType="pubmed">24026307</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2019 Sep;97:103258</Citation><ArticleIdList><ArticleId IdType="pubmed">31369862</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Heart Assoc. 2018 Jan 12;7(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">29330259</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33504254</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1741-2811</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><MedlineDate>2021 Jan-Mar</MedlineDate></PubDate></JournalIssue><Title>Health informatics journal</Title><ISOAbbreviation>Health Informatics J</ISOAbbreviation></Journal><ArticleTitle>The challenge of predicting blood glucose concentration changes in patients with type I diabetes.</ArticleTitle><Pagination><MedlinePgn>1460458220977584</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1460458220977584</ELocationID><Abstract><AbstractText>Patients with Type I Diabetes (T1D) must take insulin injections to prevent the serious long term effects of hyperglycemia. They must also be careful not to inject too much insulin because this could induce (potentially fatal) hypoglycemia. Patients therefore follow a "regimen" that determines how much insulin to inject at each time, based on various measurements. We can produce an effective regimen if we can accurately predict a patient's future blood glucose (BG) values from his/her current features. This study explores the challenges of predicting future BG by applying a number of machine learning algorithms, as well as various data preprocessing variations (corresponding to 312 [learner, preprocessed-dataset] combinations), to a new T1D dataset that contains 29,601 entries from 47 different patients. Our most accurate predictor, a weighted ensemble of two Gaussian Process Regression models, achieved a (cross-validation) <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math> loss of 2.7...mmol/L (48.65...mg/dl). This result was unexpectedly poor given that one can obtain an <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math> of 2.9...mmol/L (52.43...mg/dl) using the naive approach of simply predicting the patient's average BG. These results suggest that the diabetes diary data that is typically collected may be insufficient to produce accurate BG prediction models; additional data may be necessary to build accurate BG prediction models over hours.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borle</LastName><ForeName>Neil C</ForeName><Initials>NC</Initials><Identifier Source="ORCID">0000-0002-5960-1236</Identifier><AffiliationInfo><Affiliation>University of Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Edmond A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>University of Alberta, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alberta Diabetes Institute, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greiner</LastName><ForeName>Russell</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Alberta, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alberta Machine Intelligence Institute, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Informatics J</MedlineTA><NlmUniqueID>100883604</NlmUniqueID><ISSNLinking>1460-4582</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="Y">Hypoglycemia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">blood glucose prediction</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>28</Day><Hour>5</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33504254</ArticleId><ArticleId IdType="doi">10.1177/1460458220977584</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33480091</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>05</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Performance assessment of different machine learning approaches in predicting diabetic ketoacidosis in adults with type 1 diabetes using electronic health records data.</ArticleTitle><Pagination><MedlinePgn>610-618</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.5199</ELocationID><Abstract><AbstractText Label="PURPOSE">To assess the performance of different machine learning (ML) approaches in identifying risk factors for diabetic ketoacidosis (DKA) and predicting DKA.</AbstractText><AbstractText Label="METHODS">This study applied flexible ML (XGBoost, distributed random forest [DRF] and feedforward network) and conventional ML approaches (logistic regression and least absolute shrinkage and selection operator [LASSO]) to 3400 DKA cases and 11...780 controls nested in adults with type 1 diabetes identified from Optum.. de-identified Electronic Health Record dataset (2007-2018). Area under the curve (AUC), accuracy, sensitivity and specificity were computed using fivefold cross validation, and their 95% confidence intervals (CI) were established using 1000 bootstrap samples. The importance of predictors was compared across these models.</AbstractText><AbstractText Label="RESULTS">In the training set, XGBoost and feedforward network yielded higher AUC values (0.89 and 0.86, respectively) than logistic regression (0.83), LASSO (0.83) and DRF (0.81). However, the AUC values were similar (0.82) among these approaches in the test set (95% CI range, 0.80-0.84). While the accuracy values &gt;0.8 and the specificity values &gt;0.9 for all models, the sensitivity values were only 0.4. The differences in these metrics across these models were minimal in the test set. All approaches selected some known risk factors for DKA as the top 10 features. XGBoost and DRF included more laboratory measurements or vital signs compared with conventional ML approaches, while feedforward network included more social demographics.</AbstractText><AbstractText Label="CONCLUSIONS">In our empirical study, all ML approaches demonstrated similar performance, and identified overlapping, but different, top 10 predictors. The difference in selected top predictors needs further research.</AbstractText><CopyrightInformation>.. 2021 Sanofi. Pharmacoepidemiology and Drug Safety published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Lin</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3972-735X</Identifier><AffiliationInfo><Affiliation>Sanofi U.S. LLC, Bridgewater, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chuang-Chung</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Sanofi U.S. LLC, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Fang Liz</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Sanofi U.S. LLC, Bridgewater, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molony</LastName><ForeName>Cliona</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sanofi U.S. LLC, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doder</LastName><ForeName>Zoran</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Sanofi U.S. LLC, Bridgewater, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zalmover</LastName><ForeName>Evgeny</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Sanofi U.S. LLC, Bridgewater, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Kristen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Sanofi U.S. LLC, Bridgewater, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juhaeri</LastName><ForeName>Juhaeri</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sanofi U.S. LLC, Bridgewater, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chuntao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sanofi U.S. LLC, Bridgewater, New Jersey, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016883" MajorTopicYN="Y">Diabetic Ketoacidosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">AUC</Keyword><Keyword MajorTopicYN="Y">diabetic ketoacidosis</Keyword><Keyword MajorTopicYN="Y">least absolute shrinkage and selection operator</Keyword><Keyword MajorTopicYN="Y">logistic regression</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">prediction model</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>01</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>08</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33480091</ArticleId><ArticleId IdType="doi">10.1002/pds.5199</ArticleId><ArticleId IdType="pmc">PMC8049019</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pharmacoepidemiol Drug Saf. 2021 May;30(5):610-618</Citation><ArticleIdList><ArticleId IdType="pubmed">33480091</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2019 Jun;110:12-22</Citation><ArticleIdList><ArticleId IdType="pubmed">30763612</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Res Methodol. 2008 Jul 21;8:48</Citation><ArticleIdList><ArticleId IdType="pubmed">18644127</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neural Syst. 1997 Apr;8(2):209-18</Citation><ArticleIdList><ArticleId IdType="pubmed">9327276</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2013 Apr;36(4):914-21</Citation><ArticleIdList><ArticleId IdType="pubmed">23193215</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2012 Jul;16(5):933-51</Citation><ArticleIdList><ArticleId IdType="pubmed">22465077</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2011 Mar 17;12:77</Citation><ArticleIdList><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2019 Jun 26;9(1):9277</Citation><ArticleIdList><ArticleId IdType="pubmed">31243311</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Res Methodol. 2011 Nov 23;11:157</Citation><ArticleIdList><ArticleId IdType="pubmed">22112194</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2012 Apr 1;175(7):715-24</Citation><ArticleIdList><ArticleId IdType="pubmed">22396388</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2015 Oct 28;351:h5660</Citation><ArticleIdList><ArticleId IdType="pubmed">26510442</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2018 Apr 3;319(13):1317-1318</Citation><ArticleIdList><ArticleId IdType="pubmed">29532063</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):362-365</Citation><ArticleIdList><ArticleId IdType="pubmed">29596400</ArticleId></ArticleIdList></Reference><Reference><Citation>EGEMS (Wash DC). 2013 Dec 17;1(3):1035</Citation><ArticleIdList><ArticleId IdType="pubmed">25848578</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Jun;42(6):1147-1154</Citation><ArticleIdList><ArticleId IdType="pubmed">30728224</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1053-1059</Citation><ArticleIdList><ArticleId IdType="pubmed">29292555</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2020 Jan 3;3(1):e1918962</Citation><ArticleIdList><ArticleId IdType="pubmed">31922560</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Pharmacol. 2020 Jul 16;11:1028</Citation><ArticleIdList><ArticleId IdType="pubmed">32765261</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Emerg Hosp Med Rep. 2013 Mar 1;1(1):1-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23997994</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">33466659</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1424-8220</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>14</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>Machine Learning Techniques for Hypoglycemia Prediction: Trends and Challenges.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E546</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/s21020546</ELocationID><Abstract><AbstractText>(1) Background: the use of machine learning techniques for the purpose of anticipating hypoglycemia has increased considerably in the past few years. Hypoglycemia is the drop in blood glucose below critical levels in diabetic patients. This may cause loss of cognitive ability, seizures, and in extreme cases, death. In almost half of all the severe cases, hypoglycemia arrives unannounced and is essentially asymptomatic. The inability of a diabetic patient to anticipate and intervene the occurrence of a hypoglycemic event often results in crisis. Hence, the prediction of hypoglycemia is a vital step in improving the life quality of a diabetic patient. The objective of this paper is to review work performed in the domain of hypoglycemia prediction by using machine learning and also to explore the latest trends and challenges that the researchers face in this area; (2) Methods: literature obtained from PubMed and Google Scholar was reviewed. Manuscripts from the last five years were searched for this purpose. A total of 903 papers were initially selected of which 57 papers were eventually shortlisted for detailed review; (3) Results: a thorough dissection of the shortlisted manuscripts provided an interesting split between the works based on two categories: hypoglycemia prediction and hypoglycemia detection. The entire review was carried out keeping this categorical distinction in perspective while providing a thorough overview of the machine learning approaches used to anticipate hypoglycemia, the type of training data, and the prediction horizon.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mujahid</LastName><ForeName>Omer</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-9694-9621</Identifier><AffiliationInfo><Affiliation>Model Identification and Control Laboratory, Institut d'Informatica i Applicacions, Universitat de Girona, 17003 Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Model Identification and Control Laboratory, Institut d'Informatica i Applicacions, Universitat de Girona, 17003 Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vehi</LastName><ForeName>Josep</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6884-9789</Identifier><AffiliationInfo><Affiliation>Model Identification and Control Laboratory, Institut d'Informatica i Applicacions, Universitat de Girona, 17003 Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), 17003 Girona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="Y">Hypoglycemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">decision support system (DSS)</Keyword><Keyword MajorTopicYN="N">detection</Keyword><Keyword MajorTopicYN="N">hypoglycemia</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">prediction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>01</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>01</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>20</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33466659</ArticleId><ArticleId IdType="pii">s21020546</ArticleId><ArticleId IdType="doi">10.3390/s21020546</ArticleId><ArticleId IdType="pmc">PMC7828835</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>ISA Trans. 2016 Sep;64:440-446</Citation><ArticleIdList><ArticleId IdType="pubmed">27311357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2019 May;20(5):e262-e273</Citation><ArticleIdList><ArticleId IdType="pubmed">31044724</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Syst. 2017 Aug 8;41(9):142</Citation><ArticleIdList><ArticleId IdType="pubmed">28791547</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 2018 Dec;39(12):1457-1462</Citation><ArticleIdList><ArticleId IdType="pubmed">30394238</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Med Inform. 2019 Nov 8;7(4):e14340</Citation><ArticleIdList><ArticleId IdType="pubmed">31702562</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2017 Jul;5(7):501-512</Citation><ArticleIdList><ArticleId IdType="pubmed">28533136</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2017 Nov;133:30-39</Citation><ArticleIdList><ArticleId IdType="pubmed">28888993</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 Nov 1;10(6):1245-1250</Citation><ArticleIdList><ArticleId IdType="pubmed">27660190</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2020 Mar;14(2):250-256</Citation><ArticleIdList><ArticleId IdType="pubmed">31390891</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Diab Rep. 2018 Aug 18;18(10):83</Citation><ArticleIdList><ArticleId IdType="pubmed">30121746</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Med Inform. 2019 Jun;126:1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">31029250</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Mar;12(2):243-250</Citation><ArticleIdList><ArticleId IdType="pubmed">29493361</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Metab. 2020 Jul;2(7):612-619</Citation><ArticleIdList><ArticleId IdType="pubmed">32694787</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Chim Acta. 2019 Apr 4;1052:37-48</Citation><ArticleIdList><ArticleId IdType="pubmed">30685040</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2020 Nov;22(11):801-811</Citation><ArticleIdList><ArticleId IdType="pubmed">32297795</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2020 Sep 06;20(18):</Citation><ArticleIdList><ArticleId IdType="pubmed">32899979</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Endocrinol Diabetes Metab. 2018;2018(3):126-134</Citation><ArticleIdList><ArticleId IdType="pubmed">30786677</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2019 Dec 2;14(12):e0225613</Citation><ArticleIdList><ArticleId IdType="pubmed">31790464</ArticleId></ArticleIdList></Reference><Reference><Citation>J Breath Res. 2017 Jun 01;11(2):026007</Citation><ArticleIdList><ArticleId IdType="pubmed">28569238</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:1680-1683</Citation><ArticleIdList><ArticleId IdType="pubmed">29060208</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2015 Nov 17;132(20):1920-30</Citation><ArticleIdList><ArticleId IdType="pubmed">26572668</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2016 Jul 21;11(7):e0158722</Citation><ArticleIdList><ArticleId IdType="pubmed">27441367</ArticleId></ArticleIdList></Reference><Reference><Citation>Home Healthc Now. 2017 Sep;35(8):414-419</Citation><ArticleIdList><ArticleId IdType="pubmed">28857864</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 2020 Apr 20;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32311079</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:3503-3506</Citation><ArticleIdList><ArticleId IdType="pubmed">28269053</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2019 Sep;13(5):919-927</Citation><ArticleIdList><ArticleId IdType="pubmed">30650997</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2019 Oct 16;19(20):</Citation><ArticleIdList><ArticleId IdType="pubmed">31623111</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:5502-5505</Citation><ArticleIdList><ArticleId IdType="pubmed">33019225</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2020 May;24(5):1439-1446</Citation><ArticleIdList><ArticleId IdType="pubmed">31536025</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Diabetes. 2018 Apr;42 Suppl 1:S104-S108</Citation><ArticleIdList><ArticleId IdType="pubmed">29650081</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2020 Feb;24(2):414-423</Citation><ArticleIdList><ArticleId IdType="pubmed">31369390</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Jun;38(6):971-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25998289</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2019 Jul 18;19(14):</Citation><ArticleIdList><ArticleId IdType="pubmed">31323886</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Endocrinol. 2017 Jul;177(1):R37-R47</Citation><ArticleIdList><ArticleId IdType="pubmed">28381450</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2020 Jul;107:101917</Citation><ArticleIdList><ArticleId IdType="pubmed">32828456</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2020 Aug 05;PP:</Citation><ArticleIdList><ArticleId IdType="pubmed">32755873</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2021 Jan;68(1):247-255</Citation><ArticleIdList><ArticleId IdType="pubmed">32746033</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocrinol Metab Clin North Am. 2013 Dec;42(4):657-76</Citation><ArticleIdList><ArticleId IdType="pubmed">24286945</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Informatics J. 2020 Mar;26(1):703-718</Citation><ArticleIdList><ArticleId IdType="pubmed">31195880</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Med Inform. 2019 Sep;129:374-380</Citation><ArticleIdList><ArticleId IdType="pubmed">31445280</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2017 Jan 19;17(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">28106820</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Pract. 2014 Apr;20(4):331-40</Citation><ArticleIdList><ArticleId IdType="pubmed">24246338</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2020 Jul;43(7):1504-1511</Citation><ArticleIdList><ArticleId IdType="pubmed">32350021</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Inform Decis Mak. 2019 Nov 6;19(1):210</Citation><ArticleIdList><ArticleId IdType="pubmed">31694629</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2020 Feb;24(2):603-613</Citation><ArticleIdList><ArticleId IdType="pubmed">30946685</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2018 Jan 6;66(1):149-153</Citation><ArticleIdList><ArticleId IdType="pubmed">29020316</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocrinol Metab Clin North Am. 1999 Sep;28(3):495-500, v-vi</Citation><ArticleIdList><ArticleId IdType="pubmed">10500927</ArticleId></ArticleIdList></Reference><Reference><Citation>Pol Arch Med Wewn. 2016 Oct 11;126(11):870-878</Citation><ArticleIdList><ArticleId IdType="pubmed">27906880</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2020 Aug;22(8):562-569</Citation><ArticleIdList><ArticleId IdType="pubmed">31928415</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Annu Symp Proc. 2020 Mar 04;2019:874-882</Citation><ArticleIdList><ArticleId IdType="pubmed">32308884</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2020 Jun 1;:1932296820922622</Citation><ArticleIdList><ArticleId IdType="pubmed">32476492</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Diabetol. 2015 Jun;52(3):581-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25528005</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Res Rev. 2020 Nov;36(8):e3348</Citation><ArticleIdList><ArticleId IdType="pubmed">32445286</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Deliv. 2017 Jun;8(6):411-423</Citation><ArticleIdList><ArticleId IdType="pubmed">28530149</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab J. 2019 Aug;43(4):383-397</Citation><ArticleIdList><ArticleId IdType="pubmed">31441246</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2019 Sep;178:175-180</Citation><ArticleIdList><ArticleId IdType="pubmed">31416546</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2020 Mar 19;20(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">32204318</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2018 May 30;20(5):e10775</Citation><ArticleIdList><ArticleId IdType="pubmed">29848472</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 Apr 17;:</Citation><ArticleIdList><ArticleId IdType="pubmed">30998484</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2016 Oct;134:179-86</Citation><ArticleIdList><ArticleId IdType="pubmed">27480742</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2019 Mar 11;21(3):e11990</Citation><ArticleIdList><ArticleId IdType="pubmed">30855231</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocrinol Metab Clin North Am. 1999 Sep;28(3):555-77</Citation><ArticleIdList><ArticleId IdType="pubmed">10500931</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2019 Oct 18;19(20):</Citation><ArticleIdList><ArticleId IdType="pubmed">31635378</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33400644</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>07</Month></PubDate></JournalIssue><Title>IEEE transactions on bio-medical engineering</Title><ISOAbbreviation>IEEE Trans Biomed Eng</ISOAbbreviation></Journal><ArticleTitle>Physical Activity and Psychological Stress Detection and Assessment of Their Effects on Glucose Concentration Predictions in Diabetes Management.</ArticleTitle><Pagination><MedlinePgn>2251-2260</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/TBME.2020.3049109</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Continuous glucose monitoring (CGM) enables prediction of the future glucose concentration (GC) trajectory for making informed diabetes management decisions. The glucose concentration values are affected by various physiological and metabolic variations, such as physical activity (PA) and acute psychological stress (APS), in addition to meals and insulin. In this work, we extend our adaptive glucose modeling framework to incorporate the effects of PA and APS on the GC predictions.</AbstractText><AbstractText Label="METHODS">A wristband conducive of use by free-living ambulatory people is used. The measured physiological variables are analyzed to generate new quantifiable input features for PA and APS. Machine learning techniques estimate the type and intensity of the PA and APS when they occur individually and concurrently. Variables quantifying the characteristics of both PA and APS are integrated as exogenous inputs in an adaptive system identification technique for enhancing the accuracy of GC predictions. Data from clinical experiments illustrate the improvement in GC prediction accuracy.</AbstractText><AbstractText Label="RESULTS">The average mean absolute error (MAE) of one-hour-ahead GC predictions with testing data decreases from 35.1 to 31.9..mg/dL (p-value = 0.01) with the inclusion of PA information, and it decreases from 16.9 to 14.2..mg/dL (p-value = 0.006) with the inclusion of PA and APS information.</AbstractText><AbstractText Label="CONCLUSION">The first-ever glucose prediction model is developed that incorporates measures of physical activity and acute psychological stress to improve GC prediction accuracy.</AbstractText><AbstractText Label="SIGNIFICANCE">Modeling the effects of physical activity and acute psychological stress on glucose concentration values will improve diabetes management and enable informed meal, activity and insulin dosing decisions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sevil</LastName><ForeName>Mert</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rashid</LastName><ForeName>Mudassir</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hajizadeh</LastName><ForeName>Iman</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Minsun</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Laurie</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Cinar</LastName><ForeName>Ali</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP3 DK101075</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP3 DK101077</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE Trans Biomed Eng</MedlineTA><NlmUniqueID>0012737</NlmUniqueID><ISSNLinking>0018-9294</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="Y">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>07</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>5</Day><Hour>17</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33400644</ArticleId><ArticleId IdType="doi">10.1109/TBME.2020.3049109</ArticleId><ArticleId IdType="pmc">PMC8265613</ArticleId><ArticleId IdType="mid">NIHMS1716298</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Diabetes Sci Technol. 2018 Sep;12(5):953-966</Citation><ArticleIdList><ArticleId IdType="pubmed">30060699</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Sens J. 2020 Nov;20(21):12859-12870</Citation><ArticleIdList><ArticleId IdType="pubmed">33100923</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2016 Dec;59(12):2561-2571</Citation><ArticleIdList><ArticleId IdType="pubmed">27704167</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Physiol. 2018 Dec 21;9:1764</Citation><ArticleIdList><ArticleId IdType="pubmed">30622475</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2012 Jun;59(6):1658-69</Citation><ArticleIdList><ArticleId IdType="pubmed">22481799</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 Aug 22;10(5):1169-73</Citation><ArticleIdList><ArticleId IdType="pubmed">26880390</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2017 Mar 07;17(3):</Citation><ArticleIdList><ArticleId IdType="pubmed">28272368</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2006 Jan;23(1):1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">16409558</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2012 Sep;61(9):2230-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22688340</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2014 Aug;16(8):506-11</Citation><ArticleIdList><ArticleId IdType="pubmed">24702135</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Oct 05;9(6):1175-84</Citation><ArticleIdList><ArticleId IdType="pubmed">26438720</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1191-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24757226</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Oct 01;9(6):1217-26</Citation><ArticleIdList><ArticleId IdType="pubmed">26428933</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Aug;40(8):1096-1102</Citation><ArticleIdList><ArticleId IdType="pubmed">28584075</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Psychol. 1990;9(5):516-28</Citation><ArticleIdList><ArticleId IdType="pubmed">2226382</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1184-90</Citation><ArticleIdList><ArticleId IdType="pubmed">24757225</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Mar 01;4(2):391-403</Citation><ArticleIdList><ArticleId IdType="pubmed">20307401</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 Jun;33(6):1249-54</Citation><ArticleIdList><ArticleId IdType="pubmed">20508231</ArticleId></ArticleIdList></Reference><Reference><Citation>J Toxicol Sci. 2007 May;32(2):121-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17538236</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2014 Jan;38:94-124</Citation><ArticleIdList><ArticleId IdType="pubmed">24239854</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Psychol. 1990;9(5):503-15</Citation><ArticleIdList><ArticleId IdType="pubmed">2226381</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Meas. 2004 Aug;25(4):905-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15382830</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1952 Sep-Oct;1(5):383-92</Citation><ArticleIdList><ArticleId IdType="pubmed">12979986</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychoneuroendocrinology. 2005 Jul;30(6):599-610</Citation><ArticleIdList><ArticleId IdType="pubmed">15808930</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vis Exp. 2011 Oct 19;(56):</Citation><ArticleIdList><ArticleId IdType="pubmed">22042290</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2012 Nov;59(11):2986-99</Citation><ArticleIdList><ArticleId IdType="pubmed">22481809</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 May;12(3):639-649</Citation><ArticleIdList><ArticleId IdType="pubmed">29566547</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2017 May;21(3):619-627</Citation><ArticleIdList><ArticleId IdType="pubmed">28278487</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1992 Oct;15(10):1413-22</Citation><ArticleIdList><ArticleId IdType="pubmed">1425110</ArticleId></ArticleIdList></Reference><Reference><Citation>Ind Eng Chem Res. 2013 Sep 4;52(35):</Citation><ArticleIdList><ArticleId IdType="pubmed">24187436</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Jan;3(1):56-67</Citation><ArticleIdList><ArticleId IdType="pubmed">20046650</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2005 Dec;7(6):849-62</Citation><ArticleIdList><ArticleId IdType="pubmed">16386091</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 May;54(5):931-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17518291</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2008 Feb;31(2):295-300</Citation><ArticleIdList><ArticleId IdType="pubmed">17977934</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Oct 18;9(6):1208-16</Citation><ArticleIdList><ArticleId IdType="pubmed">26481641</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Oct 06;9(6):1200-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26443291</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2005 Dec;101(6):1873-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16301277</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 1999 Dec;138(6 Pt 1):1033-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10577432</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2014 Mar;61(3):883-91</Citation><ArticleIdList><ArticleId IdType="pubmed">24557689</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Aug;42(8):1593-1603</Citation><ArticleIdList><ArticleId IdType="pubmed">31177185</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 1984 Jul;108(1):56-63</Citation><ArticleIdList><ArticleId IdType="pubmed">6731283</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2017 May;5(5):377-390</Citation><ArticleIdList><ArticleId IdType="pubmed">28126459</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33334280</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-4286</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>24</Issue><PubDate><MedlineDate>2021</MedlineDate></PubDate></JournalIssue><Title>Current pharmaceutical design</Title><ISOAbbreviation>Curr Pharm Des</ISOAbbreviation></Journal><ArticleTitle>A Three-gene-based Type 1 Diabetes Diagnostic Signature.</ArticleTitle><Pagination><MedlinePgn>2827-2833</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1381612826666201217143403</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Type 1 diabetes is a chronic autoimmune disease featured by insulin deprivation caused by pancreatic ..-cell loss, followed by hyperglycaemia.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Currently, there is no cure for this disease in clinical treatment, and patients have to accept a lifelong injection of insulin. The exploration of potential diagnosis biomarkers through analysis of mass data by bioinformatics tools and machine learning is important for type 1 diabetes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We collected two mRNA expression datasets of type 1 diabetes peripheral blood samples from GEO, screened differentially expressed genes (DEGs) by R software, and conducted GO and KEGG pathway enrichment using the DEGs. Moreover, the STRING database and Cytoscape were used to build PPI network and predict hub genes. We constructed a logistic regression model by using the hub genes to assess sample type.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Bioinformatic analysis of the GEO dataset revealed 92 and 75 DEGs in GSE50098 and GSE9006 datasets, separately, and 10 overlapping DEGs. PPI network of these 10 DEGs showed 7 hub genes, namely EGR1, LTF, CXCL1, TNFAIP6, PGLYRP1, CHI3L1 and CAMP. We built a logistic regression model based on these hub genes and optimized the model to 3 genes (LTF, CAMP and PGLYRP1) based logistic model. The values of the area under the curve (AUC) of training set GSE50098 and testing set GSE9006 were 0.8452 and 0.8083, indicating the efficacy of this model.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Integrated bioinformatic analysis of gene expression in type 1 diabetes and the effective logistic regression model built in our study may provide promising diagnostic methods for type 1 diabetes.</AbstractText><CopyrightInformation>Copyright.. Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Rongrong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Endocrine Diabetes Department, Cangzhou Central Hospital, Cangzhou, Hebei, 061000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yanan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Endocrine Diabetes Department, Cangzhou Central Hospital, Cangzhou, Hebei, 061000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Endocrine Diabetes Department, Cangzhou Central Hospital, Cangzhou, Hebei, 061000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shaoqing</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Endocrine Diabetes Department, Cangzhou Central Hospital, Cangzhou, Hebei, 061000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Runzhou</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Endocrine Diabetes Department, Cangzhou Central Hospital, Cangzhou, Hebei, 061000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yongcai</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Endocrine Diabetes Department, Cangzhou Central Hospital, Cangzhou, Hebei, 061000, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Pharm Des</MedlineTA><NlmUniqueID>9602487</NlmUniqueID><ISSNLinking>1381-6128</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">GO</Keyword><Keyword MajorTopicYN="N">KEGG.</Keyword><Keyword MajorTopicYN="N">Type 1 diabetes</Keyword><Keyword MajorTopicYN="N">bioinformatic analysis</Keyword><Keyword MajorTopicYN="N">diagnosis</Keyword><Keyword MajorTopicYN="N">logistic regression model</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>07</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>18</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33334280</ArticleId><ArticleId IdType="pii">CPD-EPUB-112505</ArticleId><ArticleId IdType="doi">10.2174/1381612826666201217143403</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">33332927</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1752-2978</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>02</Month><Day>01</Day></PubDate></JournalIssue><Title>Current opinion in endocrinology, diabetes, and obesity</Title><ISOAbbreviation>Curr Opin Endocrinol Diabetes Obes</ISOAbbreviation></Journal><ArticleTitle>Telehealth in type 1 diabetes.</ArticleTitle><Pagination><MedlinePgn>21-29</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MED.0000000000000600</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">The role of telehealth in the care of people with type 1 diabetes (T1D) has expanded dramatically during the coronavirus pandemic, and is expected to remain a major care delivery modality going forward. This review explores the landscape of recent evidence for telehealth in T1D care.</AbstractText><AbstractText Label="RECENT FINDINGS">Telemedicine for routine T1D care has shown equivalence to standard in-person care, with respect to glycemic control, while also increasing access, convenience, and satisfaction. Telehealth use promotes increased engagement of adolescents with T1D. Telehealth platforms have successfully been used in the care of microvascular complications and to support mental health related to diabetes. Machine learning and advanced decision support will increasingly be used to augment T1D care, as recent evidence suggests increasing capabilities to improve glycemic control. A spectrum of digital connected care services are emerging to support people with diabetes with daily management of diabetes. Finally, policy and systems are required that promote data interoperability, telemedicine provision, and reimbursement to support the ongoing growth of telehealth in T1D.</AbstractText><AbstractText Label="SUMMARY">A developing field of evidence supports use of telehealth in T1D. As this care modality scales, it has the potential to increase access to high-quality diabetes care for many people with T1D.</AbstractText><CopyrightInformation>Copyright .. 2020 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kompala</LastName><ForeName>Tejaswi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neinstein</LastName><ForeName>Aaron B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Digital Health Innovation, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 DK007418</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Opin Endocrinol Diabetes Obes</MedlineTA><NlmUniqueID>101308636</NlmUniqueID><ISSNLinking>1752-296X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>17</Day><Hour>17</Hour><Minute>55</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33332927</ArticleId><ArticleId IdType="doi">10.1097/MED.0000000000000600</ArticleId><ArticleId IdType="pii">01266029-202102000-00005</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mehrotra A, Chernew ME, Linetsky D et al. The impact of the COVID-19 pandemic on outpatient visits: changing patterns of care in the newest COVID-19 hot spots. https://www.commonwealthfund.org/publications/2020/aug/impact-covid-19-pandemic-outpatient-visits-changing-patterns-care-newest. [Last accessed 19 October 2020].</Citation></Reference><Reference><Citation>Vigersky RA, Fish L, Hogan P, et al. The clinical endocrinology workforce: current status and future projections of supply and demand. J Clin Endocrinol Metab 2014; 99:3112...3121.</Citation></Reference><Reference><Citation>Lal RA, Cuttriss N, Haller MJ, et al. Primary care providers in California and Florida report low confidence in providing type 1 diabetes care. Clin Diabetes 2020; 38:159...165.</Citation></Reference><Reference><Citation>Cuttriss N, Bouchonville MF, Maahs DM, et al. Tele-rounds and case-based training project ECHO telementoring model applied to complex diabetes care. Pediatr Clin N Am 2020; 67:759...772.</Citation></Reference><Reference><Citation>Secrest AM, Costacou T, Gutelius B, et al. Associations between socioeconomic status and major complications in type 1 diabetes: the Pittsburgh epidemiology of diabetes complication (EDC) Study. Ann Epidemiol 2011; 21:374...381.</Citation></Reference><Reference><Citation>Agarwal S, Kanapka LG, Raymond JK, et al. Racial-ethnic inequity in young adults with type 1 diabetes. J Clin Endocrinol Metab 2020; 105:e2960...e2969.</Citation></Reference><Reference><Citation>Walker AF, Hu H, Cuttriss N, et al. The neighborhood deprivation index and provider geocoding identify critical catchment areas for diabetes outreach. J Clin Endocrinol Metabolism 2020; 105:3069...3075.</Citation></Reference><Reference><Citation>N..rgaard K. Telemedicine consultations and diabetes technology during COVID-19. J Diabetes Sci Technol 2020; 14:767...768.</Citation></Reference><Reference><Citation>Dover AR, Ritchie SA, McKnight JA, et al. Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring. Diabetic Med 2020; e14374https://doi.org/10.1111/dme.14374</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.14374</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonora BM, Boscari F, Avogaro A, et al. Glycaemic control among people with type 1 diabetes during lockdown for the SARS-CoV-2 outbreak in Italy. Diabetes Ther 2020; 11:1369...1379.</Citation></Reference><Reference><Citation>Garg SK, Rodbard D, Hirsch IB, et al. Managing new-onset type 1 diabetes during the COVID-19 pandemic: challenges and opportunities. Diabetes Technol Ther 2020; 22:431...439.</Citation></Reference><Reference><Citation>Scott SN, Fontana FY, Z..ger T, et al. Use and perception of telemedicine in people with type 1 diabetes during the COVID-19 pandemic ... results of a global survey. Endocrinol Diabetes Metab 2020; 168:108393.</Citation></Reference><Reference><Citation>de Adana MSR, Alhambra-Exp..sito MR, Mu..oz-Garach A, et al. Randomized study to evaluate the impact of telemedicine care in patients with type 1 diabetes with multiple doses of insulin and suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study. Diabetes Care 2020; 43:337...342.</Citation></Reference><Reference><Citation>Yaron M, Sher B, Sorek D, et al. A randomized controlled trial comparing a telemedicine therapeutic intervention with routine care in adults with type 1 diabetes mellitus treated by insulin pumps. Acta Diabetol 2019; 56:667...673.</Citation></Reference><Reference><Citation>Bertuzzi F, Stefani I, Rivolta B, et al. Teleconsultation in type 1 diabetes mellitus (TELEDIABE). Acta Diabetol 2018; 55:185...192.</Citation></Reference><Reference><Citation>Sood A, Watts SA, Johnson JK, et al. Telemedicine consultation for patients with diabetes mellitus: a cluster randomised controlled trial. J Telemed Telecare 2018; 24:385...391.</Citation></Reference><Reference><Citation>Xu T, Pujara S, Sutton S, et al. Telemedicine in the management of type 1 diabetes. Prev Chronic Dis 2018; 15:E13.</Citation></Reference><Reference><Citation>Crossen S, Raymond J, Neinstein AB. Top ten tips for successfully implementing a diabetes telehealth program. Diabetes Technol Ther 2020; 22: 8. DOI: 10.1089/dia.2020.0042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2020.0042</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid MW, Krishnan S, Berget C, et al. CoYoT1 clinic: home telemedicine increases young adult engagement in diabetes care. Diabetes Technol Ther 2018; 20:370...379.</Citation></Reference><Reference><Citation>Miller KM, Foster NC, Beck RW, et al. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D exchange clinic registry. Diabetes Care 2015; 38:971...978.</Citation></Reference><Reference><Citation>Guzman KRD, Snoswell CL, Taylor ML, et al. A systematic review of pediatric telediabetes service models. Diabetes Technol The 2020; 22:623...638.</Citation></Reference><Reference><Citation>Raymond JK, Reid MW, Fox S, et al. Adapting home telehealth group appointment model (CoYoT1 clinic) for a low SES, publicly insured, minority young adult population with type 1 diabetes. Contemp Clin Trials 2020; 88:105896.</Citation></Reference><Reference><Citation>Wood CL, Clements SA, McFann K, et al. Use of telemedicine to improve adherence to american diabetes association standards in pediatric type 1 diabetes. Diabetes Technol Ther 2016; 18:7...14.</Citation></Reference><Reference><Citation>Crossen S, Glaser N, Sauers-Ford H, et al. Home-based video visits for pediatric patients with poorly controlled type 1 diabetes. J Telemed Telecare 2018; 26:349...355.</Citation></Reference><Reference><Citation>Crossen SS, Marcin JP, Qi L, et al. Home visits for children and adolescents with uncontrolled type 1 diabetes. Diabetes Technol The 2020; 22:34...41.</Citation></Reference><Reference><Citation>Klee P, Bussien C, Castellsague M, et al. An intervention by a patient-designed do-it-yourself mobile device app reduces HbA1c in children and adolescents with type 1 diabetes: a randomized double-crossover study. Diabetes Technol Ther 2018; 20:797...805.</Citation></Reference><Reference><Citation>Gandrud L, Altan A, Buzinec P, et al. Intensive remote monitoring versus conventional care in type 1 diabetes: a randomized controlled trial. Pediatr Diabetes 2018.</Citation></Reference><Reference><Citation>D....er E, Bozbulut R, Soysal Acar A.., et al. Effect of telehealth system on glycemic control in children and adolescents with type 1 diabetes. J Clin Res Pediatr Endocrinol 2019; 11:70...75.</Citation></Reference><Reference><Citation>von Sengbusch S, Doerdelmann J, Lemke S, et al. Parental expectations before and after 12-month experience with video consultations combined with regular outpatient care for children with type 1 diabetes: a qualitative study. Diabet Med 2020; e14410.</Citation></Reference><Reference><Citation>Prahalad P, Zaharieva DP, Addala A, et al. Improving clinical outcomes in newly diagnosed pediatric type 1 diabetes: teamwork, targets, technology, and tight control ... the 4T study. Front Endocrinol (Lausanne) 2020; 11:360.</Citation></Reference><Reference><Citation>Lee JY, Lee SWH. Telemedicine cost-effectiveness for diabetes management: a systematic review. Diabetes Technol Ther 2018; 20:492...500.</Citation></Reference><Reference><Citation>Strul S, Zheng Y, Gangaputra S, et al. Pediatric diabetic retinopathy telescreening. J Am Assoc Pediatric Ophthalmol Strabismus 2020; 24:10.e1...10.e5.</Citation></Reference><Reference><Citation>Jani PD, Forbes L, Choudhury A, et al. Evaluation of diabetic retinal screening and factors for ophthalmology referral in a telemedicine network. JAMA Ophthalmol 2017; 135:706.</Citation></Reference><Reference><Citation>Smith-Str..m H, Igland J, ..stbye T, et al. The effect of telemedicine follow-up care on diabetes-related foot ulcers: a cluster randomized controlled noninferiority trial. Diabetes Care 2017; 41:dc171025.</Citation></Reference><Reference><Citation>Hazenberg CEVB, Stegge WB, Baal SGV, et al. Telehealth and telemedicine applications for the diabetic foot: a systematic review. Diabetes Metabolism Res Rev 2020; 36:e3247.</Citation></Reference><Reference><Citation>Shin L, Bowling FL, Armstrong DG, et al. Saving the diabetic foot during the COVID-19 pandemic: a tale of two cities. Diabetes Care 2020; 43:1704...1709.</Citation></Reference><Reference><Citation>Agiostratidou G, Anhalt H, Ball D, et al. Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care 2017; 40:1622...1630.</Citation></Reference><Reference><Citation>Nobis S, Lehr D, Ebert DD, et al. Efficacy of a web-based intervention with mobile phone support in treating depressive symptoms in adults with type 1 and type 2 diabetes: a randomized controlled trial. Diabetes Care 2015; 38:776...783.</Citation></Reference><Reference><Citation>Nobis S, Ebert DD, Lehr D, et al. Web-based intervention for depressive symptoms in adults with types 1 and 2 diabetes mellitus: a health economic evaluation. Br J Psychiatry 2018; 212:199...206.</Citation></Reference><Reference><Citation>Bakhach M, Reid MW, Pyatak EA, et al. Home telemedicine (CoYoT1 Clinic): a novel approach to improve psychosocial outcomes in young adults with diabetes. Diabetes Educ 2019; 45:420...430.</Citation></Reference><Reference><Citation>Marker AM, Monzon AD, Nelson E-L, et al. An intervention to reduce hypoglycemia fear in parents of young kids with type 1 diabetes through video-based telemedicine (REDCHiP): trial design, feasibility, and acceptability. Diabetes Technol Ther 2019; 22:25...33.</Citation></Reference><Reference><Citation>Ramchandani N. Virtual coaching to enhance diabetes care. Diabetes Technol Ther 2019; 21:S248...S251.</Citation></Reference><Reference><Citation>Levine BJ, Close KL, Gabbay RA. A care team-based classification and population management schema for connected diabetes care. NPJ Digit Med 2020; 3:104.</Citation></Reference><Reference><Citation>Tenderich A. Virtual nation: telemedicine's breakout moment. J Diabetes Sci Technol 2020; 14:799...800.</Citation></Reference><Reference><Citation>Debong F, Mayer H, Kober J. Real-world assessments of mySugr Mobile Health App. Diabetes Technol Ther 2019; 21:S235...S240.</Citation></Reference><Reference><Citation>Derozier V, Arnavielhe S, Renard E, et al. How knowledge emerges from artificial intelligence algorithm and data visualization for diabetes management. J Diabetes Sci Technol 2019; 13:698...707.</Citation></Reference><Reference><Citation>Lemelin A, Godbout A, Par.. G, et al. Improved glycemic control through the use of a telehomecare program in diabetic patients treated with insulin. Diabetes Technol Ther 2019; 22:243...248.</Citation></Reference><Reference><Citation>Nimri R, Battelino T, Laffel LM, et al. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes. Nat Med 2020; 26:1380...1384.</Citation></Reference><Reference><Citation>Joubert M, Benhamou P-Y, Schaepelynck P, et al. Remote monitoring of diabetes: a cloud-connected digital system for individuals with diabetes and their healthcare providers. J Diabetes Sci Technol 2019; 13:1161...1168.</Citation></Reference><Reference><Citation>Barnard-Kelly K. Utilizing eHealth and telemedicine technologies to enhance access and quality of consultations: it's not what you say, it's the way you say it. Diabetes Technol Ther 2019; 21 (S2):S241...S247.</Citation></Reference><Reference><Citation>Cafazzo JA. A digital-first model of diabetes care. Diabetes Technol Ther 2019; 21:S2...52.</Citation></Reference><Reference><Citation>Phillip M, Bergenstal RM, Close KL, et al. The digital/virtual diabetes clinic ... the future is now. Recommendations from an international panel on diabetes digital technologies introduction. Diabetes Technol Ther 2020; dia.2020.0375.</Citation></Reference><Reference><Citation>Chandrashekar P, Jain SH. Eliminating barriers to virtual care: implementing portable medical licensure. Am J Managed Care 2019; 26:20...22.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33318626</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2042-0226</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>03</Month></PubDate></JournalIssue><Title>Cellular &amp; molecular immunology</Title><ISOAbbreviation>Cell Mol Immunol</ISOAbbreviation></Journal><ArticleTitle>A machine learning approach to predict response to immunotherapy in type 1 diabetes.</ArticleTitle><Pagination><MedlinePgn>515-517</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41423-020-00594-4</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fousteri</LastName><ForeName>Georgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Regulation of Adaptive immunity Unit, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Ely Montee</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Experimental Diabetes Unit, Division of Immunology, Transplantation and Infectious Diseases, Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giamporcaro</LastName><ForeName>Gian Maria</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Experimental Diabetes Unit, Division of Immunology, Transplantation and Infectious Diseases, Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falcone</LastName><ForeName>Marika</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-6080-5351</Identifier><AffiliationInfo><Affiliation>Experimental Diabetes Unit, Division of Immunology, Transplantation and Infectious Diseases, Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy. falcone.marika@hsr.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Cell Mol Immunol</MedlineTA><NlmUniqueID>101242872</NlmUniqueID><ISSNLinking>1672-7681</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Nat Immunol. 2020 Oct;21(10):1244-1255</RefSource><PMID Version="1">32747817</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007167" MajorTopicYN="N">Immunotherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33318626</ArticleId><ArticleId IdType="doi">10.1038/s41423-020-00594-4</ArticleId><ArticleId IdType="pii">10.1038/s41423-020-00594-4</ArticleId><ArticleId IdType="pmc">PMC8027390</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Edner, N. M. et al. Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes. Nat. Immunol. 21, 1244...1255 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0744-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd, J. A. Etiology of type 1 diabetes. Immunity 32, 457...467 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.04.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Fousteri, G., Ippolito, E., Ahmed, R. &amp; Hamad, A. R. A. Beta-cell specific autoantibodies: are they just an indicator of type 1 diabetes? Curr. Diabet. Rev. 13, 322...329 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573399812666160427104157</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamberlain, N. et al. Rituximab does not reset defective early B cell tolerance checkpoints. J. Clin. Invest. 126, 282...287 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI83840</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty, S. T follicular helper cell biology: a decade of discovery and diseases. Immunity 50, 1132...1148 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.04.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherry, N. et al. Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial. Lancet 378, 487...497 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60931-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Keymeulen, B. et al. Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia 53, 614...623 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-009-1644-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Orban, T. et al. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet 378, 412...419 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60886-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, J. et al. Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma. Nat. Med. 25, 462...469 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0349-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Rachid, O., Osman, A., Abdi, R. &amp; Haik, Y. CTLA4-Ig (abatacept): a promising investigational drug for use in type 1 diabetes. Expert Opin. Investig. Drugs 29, 221...236 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543784.2020.1727885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira, R. C. et al. IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients. Diabetologia 58, 781...790 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-015-3509-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Vecchione, A. et al. Reduced PD-1 expression on circulating follicular and conventional FOXP3(+) Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children. Clin. Immunol. 211, 108319 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2019.108319</ArticleId></ArticleIdList></Reference><Reference><Citation>McAdam, A. J. et al. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J. Immunol. 165, 5035...5040 (2000).</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.165.9.5035</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, H. et al. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature 496, 523...527 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12058</ArticleId></ArticleIdList></Reference><Reference><Citation>Linsley, P. S., Greenbaum, C. J., Speake, C., Long, S. A. &amp; Dufort, M. J. B lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetes. JCI Insight 4, e126136 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.126136</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33307036</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-2191</ISSN><JournalIssue CitedMedium="Internet"><Volume>191</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>03</Month></PubDate></JournalIssue><Title>The American journal of pathology</Title><ISOAbbreviation>Am J Pathol</ISOAbbreviation></Journal><ArticleTitle>Image-Based Machine Learning Algorithms for Disease Characterization in the Human Type 1 Diabetes Pancreas.</ArticleTitle><Pagination><MedlinePgn>454-462</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0002-9440(20)30551-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajpath.2020.11.010</ELocationID><Abstract><AbstractText>Emerging data suggest that type 1 diabetes affects not only the ..-cell-containing islets of Langerhans, but also the surrounding exocrine compartment. Using digital pathology, machine learning algorithms were applied to high-resolution, whole-slide images of human pancreata to determine whether the tissue composition in individuals with or at risk for type 1 diabetes differs from those without diabetes. Transplant-grade pancreata from organ donors were evaluated from 16 nondiabetic autoantibody-negative controls, 8 nondiabetic autoantibody-positive subjects with increased type 1 diabetes risk, and 19 persons with type 1 diabetes (0 to 12 years' duration). HALO image analysis algorithms were implemented to compare architecture of the main pancreatic duct as well as cell size, density, and area of acinar, endocrine, ductal, and other nonendocrine, nonexocrine tissues. Type 1 diabetes was found to affect exocrine area, acinar cell density, and size, whereas the type of difference correlated with the presence or absence of insulin-positive cells remaining in the pancreas. These changes were not observed before disease onset, as indicated by modeling cross-sectional data from pancreata of autoantibody-positive subjects and those diagnosed with type 1 diabetes. These data provide novel insights into anatomic differences in type 1 diabetes pancreata and demonstrate that machine learning can be adapted for the evaluation of disease processes from cross-sectional data sets.</AbstractText><CopyrightInformation>Copyright .. 2021 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Xiaohan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, Florida; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusmartseva</LastName><ForeName>Irina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kulkarni</LastName><ForeName>Shweta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posgai</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Speier</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Paul Langerhans Institute Dresden of the Helmholtz Zentrum M..nchen at the University Clinic Carl Gustav Carus of Technische Universit..t Dresden, Helmholtz Zentrum M..nchen, Neuherberg, Germany; Institute of Physiology, Faculty of Medicine, Technische Universit..t Dresden, Dresden, Germany; German Center for Diabetes Research, M..nchen-Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schatz</LastName><ForeName>Desmond A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, College of Medicine, University of Florida Diabetes Institute, Gainesville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haller</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, College of Medicine, University of Florida Diabetes Institute, Gainesville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell-Thompson</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, Florida; J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wasserfall</LastName><ForeName>Clive H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roep</LastName><ForeName>Bart O</ForeName><Initials>BO</Initials><AffiliationInfo><Affiliation>Department of Diabetes Immunology, Diabetes and Metabolism Research Institute, City of Hope/Beckman Research Institute, Duarte, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaddis</LastName><ForeName>John S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Diabetes Immunology, Diabetes and Metabolism Research Institute, City of Hope/Beckman Research Institute, Duarte, California; Department of Diabetes and Cancer Discovery Science, Diabetes and Metabolism Research Institute, City of Hope/Beckman Research Institute, Duarte, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atkinson</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, Florida; Department of Pediatrics, College of Medicine, University of Florida Diabetes Institute, Gainesville, Florida. Electronic address: atkinson@ufl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AI042288</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK102429</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD023861</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 DK104162</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK122160</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK123292</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK108132</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Pathol</MedlineTA><NlmUniqueID>0370502</NlmUniqueID><ISSNLinking>0002-9440</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014019" MajorTopicYN="N">Tissue Donors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>07</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>11</Day><Hour>20</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33307036</ArticleId><ArticleId IdType="pii">S0002-9440(20)30551-4</ArticleId><ArticleId IdType="doi">10.1016/j.ajpath.2020.11.010</ArticleId><ArticleId IdType="pmc">PMC7919855</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Restor Dent Endod. 2013 Feb;38(1):52-4</Citation><ArticleIdList><ArticleId IdType="pubmed">23495371</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 1984 Jun;26(6):456-61</Citation><ArticleIdList><ArticleId IdType="pubmed">6381192</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Feb;42(2):248-257</Citation><ArticleIdList><ArticleId IdType="pubmed">30552135</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiographics. 2006 May-Jun;26(3):715-31</Citation><ArticleIdList><ArticleId IdType="pubmed">16702450</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2005 Dec;54 Suppl 2:S52-61</Citation><ArticleIdList><ArticleId IdType="pubmed">16306341</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Feb;42(2):281-287</Citation><ArticleIdList><ArticleId IdType="pubmed">30552130</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Cell. 2018 Jun 18;45(6):726-737.e3</Citation><ArticleIdList><ArticleId IdType="pubmed">29920277</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2016 Jan;59(1):217-221</Citation><ArticleIdList><ArticleId IdType="pubmed">26358584</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1965 Oct;14(10):619-33</Citation><ArticleIdList><ArticleId IdType="pubmed">5318831</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2012 Sep;97(9):3197-206</Citation><ArticleIdList><ArticleId IdType="pubmed">22745242</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2012 Dec 12;308(22):2337-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23232891</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Transplant. 2010 Mar-Apr;24(2):236-42</Citation><ArticleIdList><ArticleId IdType="pubmed">19719726</ArticleId></ArticleIdList></Reference><Reference><Citation>Ups J Med Sci. 2016 May;121(2):133-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26899404</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Res Rev. 2012 Oct;28(7):608-17</Citation><ArticleIdList><ArticleId IdType="pubmed">22585677</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2013 Jun 19;309(23):2473-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23780460</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Exp Med Biol. 2009;639:1-13</Citation><ArticleIdList><ArticleId IdType="pubmed">19227530</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Anthropol. 1999;28:109-53</Citation><ArticleIdList><ArticleId IdType="pubmed">12295621</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem. 2011 Feb;57(2):168-75</Citation><ArticleIdList><ArticleId IdType="pubmed">21127152</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2014 Nov;63(11):3880-90</Citation><ArticleIdList><ArticleId IdType="pubmed">24947367</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 May 23;6:26286</Citation><ArticleIdList><ArticleId IdType="pubmed">27212078</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Endocrinol. 2015;2015:595649</Citation><ArticleIdList><ArticleId IdType="pubmed">25892991</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Endocr Metab Disord. 2019 Jun;20(2):129-149</Citation><ArticleIdList><ArticleId IdType="pubmed">31077020</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Physiol. 1986 Oct;251(4 Pt 1):G487-94</Citation><ArticleIdList><ArticleId IdType="pubmed">3020992</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2014 Feb;15(1):1-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24325575</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2020 Jul;63(7):1418-1423</Citation><ArticleIdList><ArticleId IdType="pubmed">32388592</ArticleId></ArticleIdList></Reference><Reference><Citation>Cold Spring Harb Perspect Biol. 2016 Apr 01;8(4):a019083</Citation><ArticleIdList><ArticleId IdType="pubmed">26254313</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2013 Nov;36(11):3815-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24041678</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Jun;38(6):979-88</Citation><ArticleIdList><ArticleId IdType="pubmed">25998290</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Physiol Biochem Pharmacol. 2013;165:1-30</Citation><ArticleIdList><ArticleId IdType="pubmed">23881310</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Cell Res. 2019 Feb 15;375(2):28-35</Citation><ArticleIdList><ArticleId IdType="pubmed">30625303</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2016 May 17;164(10):649-55</Citation><ArticleIdList><ArticleId IdType="pubmed">26999810</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2020 Jan;69(1):60-66</Citation><ArticleIdList><ArticleId IdType="pubmed">31597639</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Gastroenterol. 1994 May;89(5):762-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8172153</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 1997 Sep;53(3):983-97</Citation><ArticleIdList><ArticleId IdType="pubmed">9333350</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Apr;40(4):577-582</Citation><ArticleIdList><ArticleId IdType="pubmed">28115475</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pathol Inform. 2019 Mar 08;10:9</Citation><ArticleIdList><ArticleId IdType="pubmed">30984469</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2012 Nov;97(11):E2109-13</Citation><ArticleIdList><ArticleId IdType="pubmed">22879632</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Oct;38(10):1964-74</Citation><ArticleIdList><ArticleId IdType="pubmed">26404926</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2019 May 3;2(5):e193963</Citation><ArticleIdList><ArticleId IdType="pubmed">31099869</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">33203629</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>11</Month><Day>17</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>New Diabetes Questionnaire to add patients' perspectives to diabetes care for adults with type 1 and type 2 diabetes: nationwide cross-sectional study of construct validity assessing associations with generic health-related quality of life and clinical variables.</ArticleTitle><Pagination><MedlinePgn>e038966</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2020-038966</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To study evidence for construct validity, the aim was to describe the outcome from the recently developed Diabetes Questionnaire, assess the associations of that outcome with clinical variables and generic health-related quality of life, and study the sensitivity to differences between clinically relevant groups of glycaemic control in adults with type 1 and type 2 diabetes in a nation-wide setting.</AbstractText><AbstractText Label="DESIGN">Cross-sectional survey.</AbstractText><AbstractText Label="SETTING">Swedish diabetes care clinics connected to the National Diabetes Register (NDR).</AbstractText><AbstractText Label="PARTICIPANTS">Among 2479 adults with type 1 diabetes and 2469 with type 2 diabetes selected at random from the NDR, 1373 (55.4%) with type 1 and 1353 (54.8%) with type 2 diabetes chose to participate.</AbstractText><AbstractText Label="OUTCOME MEASURES">The Diabetes Questionnaire, the generic 36-item Short Form version 2 (SF-36v2) health survey and clinical variables.</AbstractText><AbstractText Label="RESULTS">Related to the prespecified assumptions, supporting evidence for construct validity for the Diabetes Questionnaire was found. Supporting divergent validity, the statistically significant correlations with the clinical variables were few and weak. In relation to the SF-36v2 and in support of convergent validity, the strongest correlations were seen in the Diabetes Questionnaire scales General Well-being and Mood and Energy. In those scales, machine learning analyses showed that about 40%-45% of the variance was explained by the SF-36v2 results and clinical variables. In multiple regression analyses among three groups with differing levels of glycated haemoglobin adjusted for demographics, other risk factors, and diabetes complications, the high-risk group had, in support of sensitivity to clinically relevant groups, statistically significant lower scores than the well-controlled group in most Diabetes Questionnaire scales.</AbstractText><AbstractText Label="CONCLUSIONS">This nation-wide study shows that the Diabetes Questionnaire captures some generic health-related quality-of-life dimensions, in addition to adding diabetes-specific information not covered by the SF-36v2 and clinical variables. The Diabetes Questionnaire is also sensitive to differences between clinically relevant groups of glycaemic control.</AbstractText><CopyrightInformation>.. Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Svedbo Engstr..m</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8267-592X</Identifier><AffiliationInfo><Affiliation>School of Education, Health and Social Studies, Dalarna University, Falun, Sweden msd@du.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leksell</LastName><ForeName>Janeth</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8682-2045</Identifier><AffiliationInfo><Affiliation>School of Education, Health and Social Studies, Dalarna University, Falun, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Diabetology and Metabolism, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansson</LastName><ForeName>Unn-Britt</ForeName><Initials>UB</Initials><Identifier Source="ORCID">0000-0003-3309-136X</Identifier><AffiliationInfo><Affiliation>Department of Health Promotion Science, Sophiahemmet University, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences and Education, S..dersjukhuset, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borg</LastName><ForeName>Sixten</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6292-7002</Identifier><AffiliationInfo><Affiliation>Department of Clinical Sciences in Malm.., Health Economics Unit, Medicon Village, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palaszewski</LastName><ForeName>Bo</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-4854-2701</Identifier><AffiliationInfo><Affiliation>Department of Data Management and Analysis, V..stra G..talandsregionen, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franz..n</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Register Center V..stra G..taland, V..stra G..talandsregionen, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudbj..rnsdottir</LastName><ForeName>Soffia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Register Center V..stra G..taland, V..stra G..talandsregionen, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eeg-Olofsson</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3376-4707</Identifier><AffiliationInfo><Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">clinical audit</Keyword><Keyword MajorTopicYN="Y">general diabetes</Keyword><Keyword MajorTopicYN="Y">quality in health care</Keyword></KeywordList><CoiStatement>Competing interests: KE-O reports grants from the ALF agreement (ALFGBG 698991), during the conduct of the study; personal fees from Abbott, personal fees from Lilly, personal fees from Novo Nordisk, personal fees from Bayer, outside the submitted work; SG reports grants from the ALF-agreement (ALFGBG 725311), during the conduct of the study; grants and personal fees from AstraZeneca, grants and personal fees from Boehringer Ingelheim, grants and personal fees from Eli Lilly, grants and personal fees from Merck Sharp &amp; Dohme, grants and personal fees from Novo Nordisk, grants and personal fees from Sanofi, outside the submitted work; the other authors declare that they have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>18</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33203629</ArticleId><ArticleId IdType="pii">bmjopen-2020-038966</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2020-038966</ArticleId><ArticleId IdType="pmc">PMC7674110</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMJ Open. 2019 Jan 4;9(1):e025033</Citation><ArticleIdList><ArticleId IdType="pubmed">30612113</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Life Res. 2012 Oct;21(8):1305-14</Citation><ArticleIdList><ArticleId IdType="pubmed">22048932</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2010 Jul;63(7):737-45</Citation><ArticleIdList><ArticleId IdType="pubmed">20494804</ArticleId></ArticleIdList></Reference><Reference><Citation>Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11124729</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Qual Life Outcomes. 2019 Aug 14;17(1):141</Citation><ArticleIdList><ArticleId IdType="pubmed">31412881</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2008 May;31(5):1046-50</Citation><ArticleIdList><ArticleId IdType="pubmed">18445728</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2006 Jun;23(6):579-93</Citation><ArticleIdList><ArticleId IdType="pubmed">16759299</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2020 Jan;43(Suppl 1):S66-S76</Citation><ArticleIdList><ArticleId IdType="pubmed">31862749</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Dec;39(12):2126-2140</Citation><ArticleIdList><ArticleId IdType="pubmed">27879358</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2016 Mar 24;6(3):e010249</Citation><ArticleIdList><ArticleId IdType="pubmed">27013595</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2014 May 10;32(14):1480-501</Citation><ArticleIdList><ArticleId IdType="pubmed">24711559</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2016 Jul;97(7):1051-2</Citation><ArticleIdList><ArticleId IdType="pubmed">27095143</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2003 Apr;26(4):1270-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12663609</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2014 Dec;106 Suppl 2:S291-4</Citation><ArticleIdList><ArticleId IdType="pubmed">25550056</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2011 Apr;64(4):358-65</Citation><ArticleIdList><ArticleId IdType="pubmed">20800442</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurs Times. 2010 Feb 23-Mar 1;106(7):12-4</Citation><ArticleIdList><ArticleId IdType="pubmed">20334016</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiovasc Nurs. 2011 Dec;10(4):248-51</Citation><ArticleIdList><ArticleId IdType="pubmed">21764386</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2009 Apr;26(4):315-27</Citation><ArticleIdList><ArticleId IdType="pubmed">19388959</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2020 Jan;43(Suppl 1):S37-S47</Citation><ArticleIdList><ArticleId IdType="pubmed">31862747</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Environ Res Public Health. 2014 Nov 26;11(12):12223-46</Citation><ArticleIdList><ArticleId IdType="pubmed">25431875</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Diab Rep. 2002 Apr;2(2):153-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12643134</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient Educ Couns. 2018 Jan;101(1):139-146</Citation><ArticleIdList><ArticleId IdType="pubmed">28736071</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2015 Feb;32(2):155-63</Citation><ArticleIdList><ArticleId IdType="pubmed">25354315</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2020 Jan;43(Suppl 1):S48-S65</Citation><ArticleIdList><ArticleId IdType="pubmed">31862748</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33124145</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1753-0407</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of diabetes</Title><ISOAbbreviation>J Diabetes</ISOAbbreviation></Journal><ArticleTitle>Prediction of the development of islet autoantibodies through integration of environmental, genetic, and metabolic markers.</ArticleTitle><Pagination><MedlinePgn>143-153</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/1753-0407.13093</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Environmental Determinants of the Diabetes in the Young (TEDDY) study has prospectively followed, from birth, children at increased genetic risk of type 1 diabetes. TEDDY has collected heterogenous data longitudinally to gain insights into the environmental and biological mechanisms driving the progression to persistent islet autoantibodies.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We developed a machine learning model to predict imminent transition to the development of persistent islet autoantibodies based on time-varying metabolomics data integrated with time-invariant risk factors (eg, gestational age). The machine learning was initiated with 221 potential features (85 genetic, 5 environmental, 131 metabolomic) and an ensemble-based feature evaluation was utilized to identify a small set of predictive features that can be interrogated to better understand the pathogenesis leading up to persistent islet autoimmunity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The final integrative machine learning model included 42 disparate features, returning a cross-validated receiver operating characteristic area under the curve (AUC) of 0.74 and an AUC of ~0.65 on an independent validation dataset. The model identified a principal set of 20 time-invariant markers, including 18 genetic markers (16 single nucleotide polymorphisms [SNPs] and two HLA-DR genotypes) and two demographic markers (gestational age and exposure to a prebiotic formula). Integration with the metabolome identified 22 supplemental metabolites and lipids, including adipic acid and ceramide d42:0, that predicted development of islet autoantibodies.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The majority (86%) of metabolites that predicted development of islet autoantibodies belonged to three pathways: lipid oxidation, phospholipase A2 signaling, and pentose phosphate, suggesting that these metabolic processes may play a role in triggering islet autoimmunity.</AbstractText><CopyrightInformation>.. 2020 The Authors. Journal of Diabetes published by Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Webb-Robertson</LastName><ForeName>Bobbie-Jo M</ForeName><Initials>BM</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-4744-2397</Identifier><AffiliationInfo><Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bramer</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-8384-1926</Identifier><AffiliationInfo><Affiliation>Computing and Analytics Division, Pacific Northwest National Laboratory, Richland, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanfill</LastName><ForeName>Bryan A</ForeName><Initials>BA</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-0612-5333</Identifier><AffiliationInfo><Affiliation>Computing and Analytics Division, Pacific Northwest National Laboratory, Richland, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reehl</LastName><ForeName>Sarah M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Computing and Analytics Division, Pacific Northwest National Laboratory, Richland, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakayasu</LastName><ForeName>Ernesto S</ForeName><Initials>ES</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-4056-2695</Identifier><AffiliationInfo><Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metz</LastName><ForeName>Thomas O</ForeName><Initials>TO</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-6049-3968</Identifier><AffiliationInfo><Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frohnert</LastName><ForeName>Brigitte I</ForeName><Initials>BI</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-6636-4048</Identifier><AffiliationInfo><Affiliation>Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norris</LastName><ForeName>Jill M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-8674-2598</Identifier><AffiliationInfo><Affiliation>Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Randi K</ForeName><Initials>RK</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-9345-4439</Identifier><AffiliationInfo><Affiliation>Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rich</LastName><ForeName>Stephen S</ForeName><Initials>SS</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-3872-7793</Identifier><AffiliationInfo><Affiliation>Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rewers</LastName><ForeName>Marian J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-3829-9207</Identifier><AffiliationInfo><Affiliation>Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 DK063821</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK116073</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001082</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK063865</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK100238</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000064</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK127786</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK063865</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>J Diabetes</MedlineTA><NlmUniqueID>101504326</NlmUniqueID><ISSNLinking>1753-0407</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="Y">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007515" MajorTopicYN="N">Islets of Langerhans</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText>......: .......................................(TEDDY).....................1..................................................................... TEDDY......................................................................................................... ......: ...............................................................(............)............................................................................................................221...............(......85..................5..................131.....................)........................................................................................................................................................................ ......: .......................................42........................................................................(AUC)...0.74.................................AUC......0.65....................................20...........................18...............(16........................[SNPs].........HLA-DR.........)...2........................(........................)....................................22...............................................................d42:0...................................................... ......: ..........................................(86%)..............................:..............................A2.............................................................................................................</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">............</Keyword><Keyword MajorTopicYN="N">............</Keyword><Keyword MajorTopicYN="N">............</Keyword><Keyword MajorTopicYN="N">......</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>03</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>06</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>07</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33124145</ArticleId><ArticleId IdType="doi">10.1111/1753-0407.13093</ArticleId><ArticleId IdType="pmc">PMC7818425</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bioinformatics. 2010 Jan 15;26(2):280-2</Citation><ArticleIdList><ArticleId IdType="pubmed">19933164</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Oct;38 Suppl 2:S1-3</Citation><ArticleIdList><ArticleId IdType="pubmed">26405066</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2017 May;60(5):766-768</Citation><ArticleIdList><ArticleId IdType="pubmed">28303304</ArticleId></ArticleIdList></Reference><Reference><Citation>NPJ Syst Biol Appl. 2018 Jun 1;4:20</Citation><ArticleIdList><ArticleId IdType="pubmed">29872543</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2013 Nov;98(11):E1845-51</Citation><ArticleIdList><ArticleId IdType="pubmed">23979957</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2019 May;19(5):337-348</Citation><ArticleIdList><ArticleId IdType="pubmed">30890785</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes. 2021 Feb;13(2):143-153</Citation><ArticleIdList><ArticleId IdType="pubmed">33124145</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2019 Apr 18;9(1):6250</Citation><ArticleIdList><ArticleId IdType="pubmed">31000755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2016 Jul;15(7):473-84</Citation><ArticleIdList><ArticleId IdType="pubmed">26965202</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Mar;41(3):522-530</Citation><ArticleIdList><ArticleId IdType="pubmed">29343517</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2017 Dec;66(12):3122-3129</Citation><ArticleIdList><ArticleId IdType="pubmed">28903990</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Diab Rep. 2018 Oct 23;18(12):136</Citation><ArticleIdList><ArticleId IdType="pubmed">30353256</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Res Rev. 2009 Oct;25(7):665-70</Citation><ArticleIdList><ArticleId IdType="pubmed">19768733</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2009 Nov 13;284(46):31936-44</Citation><ArticleIdList><ArticleId IdType="pubmed">19776010</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Chem. 2009 Dec 15;81(24):10038-48</Citation><ArticleIdList><ArticleId IdType="pubmed">19928838</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Eng Comput Biol. 2019 Jul 15;10:1179597219858954</Citation><ArticleIdList><ArticleId IdType="pubmed">31320812</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Protoc. 2011 Jun 30;6(7):1060-83</Citation><ArticleIdList><ArticleId IdType="pubmed">21720319</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2012 Jan;40(Database issue):D1308-12</Citation><ArticleIdList><ArticleId IdType="pubmed">22140107</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2017 Aug;60(8):1370-1381</Citation><ArticleIdList><ArticleId IdType="pubmed">28550517</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2013 Aug;10(8):755-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23817071</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2019 May 21;20(3):952-975</Citation><ArticleIdList><ArticleId IdType="pubmed">29194464</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 2009;:451-63</Citation><ArticleIdList><ArticleId IdType="pubmed">19209722</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Princ Pract. 2019;28(1):1-9</Citation><ArticleIdList><ArticleId IdType="pubmed">30685765</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Protoc Mol Biol. 2016 Apr 01;114:30.4.1-30.4.32</Citation><ArticleIdList><ArticleId IdType="pubmed">27038389</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Dec;38(12):2308-15</Citation><ArticleIdList><ArticleId IdType="pubmed">26519334</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2017 Jun;60(6):998-1006</Citation><ArticleIdList><ArticleId IdType="pubmed">28314946</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2012 Jan 1;28(1):112-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22039212</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2019 Apr 18;14(4):e0214121</Citation><ArticleIdList><ArticleId IdType="pubmed">30998683</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Chem. 2019 Mar 5;91(5):3590-3596</Citation><ArticleIdList><ArticleId IdType="pubmed">30758187</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Pediatr. 2013 Sep;167(9):808-15</Citation><ArticleIdList><ArticleId IdType="pubmed">23836309</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2018 Oct;562(7728):589-594</Citation><ArticleIdList><ArticleId IdType="pubmed">30356183</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2018 Oct;562(7728):583-588</Citation><ArticleIdList><ArticleId IdType="pubmed">30356187</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2015 May;64(5):1818-29</Citation><ArticleIdList><ArticleId IdType="pubmed">25422107</ArticleId></ArticleIdList></Reference><Reference><Citation>Microorganisms. 2019 Mar 02;7(3):</Citation><ArticleIdList><ArticleId IdType="pubmed">30832381</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Res Rev. 2014 Jul;30(5):424-34</Citation><ArticleIdList><ArticleId IdType="pubmed">24339168</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2020 Feb;69(2):238-248</Citation><ArticleIdList><ArticleId IdType="pubmed">31740441</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2019 May;20(3):263-270</Citation><ArticleIdList><ArticleId IdType="pubmed">30628751</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Treat Options Oncol. 2018 Feb 8;19(2):8</Citation><ArticleIdList><ArticleId IdType="pubmed">29423762</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Chem. 2017 Nov 21;89(22):12360-12368</Citation><ArticleIdList><ArticleId IdType="pubmed">29064229</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Res Rev. 2020 Jan;36(1):e3204</Citation><ArticleIdList><ArticleId IdType="pubmed">31322810</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Sep;40(9):1194-1202</Citation><ArticleIdList><ArticleId IdType="pubmed">28646072</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocrinology. 2014 Sep;155(9):3352-64</Citation><ArticleIdList><ArticleId IdType="pubmed">25004092</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2018 Apr 3;15(4):e1002548</Citation><ArticleIdList><ArticleId IdType="pubmed">29614081</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 1996 Jul;39(7):807-12</Citation><ArticleIdList><ArticleId IdType="pubmed">8817105</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2007;8(9):R183</Citation><ArticleIdList><ArticleId IdType="pubmed">17784955</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2013 Oct;123(10):4309-17</Citation><ArticleIdList><ArticleId IdType="pubmed">24091325</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2020 May 21;21(3):1047-1057</Citation><ArticleIdList><ArticleId IdType="pubmed">31067315</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Physiol Endocrinol Metab. 2012 Dec 1;303(11):E1386-95</Citation><ArticleIdList><ArticleId IdType="pubmed">23074238</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33112249</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2291-5222</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>10</Month><Day>28</Day></PubDate></JournalIssue><Title>JMIR mHealth and uHealth</Title><ISOAbbreviation>JMIR Mhealth Uhealth</ISOAbbreviation></Journal><ArticleTitle>Carbohydrate Counting App Using Image Recognition for Youth With Type 1 Diabetes: Pilot Randomized Control Trial.</ArticleTitle><Pagination><MedlinePgn>e22074</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/22074</ELocationID><Abstract><AbstractText Label="BACKGROUND">Carbohydrate counting is an important component of diabetes management, but it is challenging, often performed inaccurately, and can be a barrier to optimal diabetes management. iSpy is a novel mobile app that leverages machine learning to allow food identification through images and that was designed to assist youth with type 1 diabetes in counting carbohydrates.</AbstractText><AbstractText Label="OBJECTIVE">Our objective was to test the app's usability and potential impact on carbohydrate counting accuracy.</AbstractText><AbstractText Label="METHODS">Iterative usability testing (3 cycles) was conducted involving a total of 16 individuals aged 8.5-17.0 years with type 1 diabetes. Participants were provided a mobile device and asked to complete tasks using iSpy app features while thinking aloud. Errors were noted, acceptability was assessed, and refinement and retesting were performed across cycles. Subsequently, iSpy was evaluated in a pilot randomized controlled trial with 22 iSpy users and 22 usual care controls aged 10-17 years. Primary outcome was change in carbohydrate counting ability over 3 months. Secondary outcomes included levels of engagement and acceptability. Change in HbA<sub>1c</sub> level was also assessed.</AbstractText><AbstractText Label="RESULTS">Use of iSpy was associated with improved carbohydrate counting accuracy (total grams per meal, P=.008), reduced frequency of individual counting errors greater than 10 g (P=.047), and lower HbA<sub>1c</sub> levels (P=.03). Qualitative interviews and acceptability scale scores were positive. No major technical challenges were identified. Moreover, 43% (9/21) of iSpy participants were still engaged, with usage at least once every 2 weeks, at the end of the study.</AbstractText><AbstractText Label="CONCLUSIONS">Our results provide evidence of efficacy and high acceptability of a novel carbohydrate counting app, supporting the advancement of digital health apps for diabetes care among youth with type 1 diabetes. Further testing is needed, but iSpy may be a useful adjunct to traditional diabetes management.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ClinicalTrials.gov NCT04354142; https://clinicaltrials.gov/ct2/show/NCT04354142.</AbstractText><CopyrightInformation>..Jeffrey E Alfonsi, Elizabeth E Y Choi, Taha Arshad, Stacie-Ann S Sammott, Vanita Pais, Cynthia Nguyen, Bryan R Maguire, Jennifer N Stinson, Mark R Palmert. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 28.10.2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alfonsi</LastName><ForeName>Jeffrey E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0002-6305-9195</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Schulich School of Medicine &amp; Dentistry, Western University, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inner Analytics Inc, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Elizabeth E Y</ForeName><Initials>EEY</Initials><Identifier Source="ORCID">0000-0003-0531-8133</Identifier><AffiliationInfo><Affiliation>Inner Analytics Inc, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arshad</LastName><ForeName>Taha</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-1673-301X</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology, Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sammott</LastName><ForeName>Stacie-Ann S</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0001-9092-5231</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology, Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pais</LastName><ForeName>Vanita</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-7142-0972</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology, Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9741-2463</Identifier><AffiliationInfo><Affiliation>Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maguire</LastName><ForeName>Bryan R</ForeName><Initials>BR</Initials><Identifier Source="ORCID">0000-0003-2855-2563</Identifier><AffiliationInfo><Affiliation>Biostatistics Design and Analysis Unit, SickKids Research Institute, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stinson</LastName><ForeName>Jennifer N</ForeName><Initials>JN</Initials><Identifier Source="ORCID">0000-0002-9969-8052</Identifier><AffiliationInfo><Affiliation>Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lawrence S Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmert</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0002-4096-0685</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology, Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Pediatrics and Physiology, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04354142</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Mhealth Uhealth</MedlineTA><NlmUniqueID>101624439</NlmUniqueID><ISSNLinking>2291-5222</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002241">Carbohydrates</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002241" MajorTopicYN="N">Carbohydrates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063731" MajorTopicYN="Y">Mobile Applications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044623" MajorTopicYN="Y">Nutrition Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">carbohydrate counting</Keyword><Keyword MajorTopicYN="Y">digital health applications (apps)</Keyword><Keyword MajorTopicYN="Y">image recognition</Keyword><Keyword MajorTopicYN="Y">mHealth</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword><Keyword MajorTopicYN="Y">youth</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>07</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>09</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>09</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33112249</ArticleId><ArticleId IdType="pii">v8i10e22074</ArticleId><ArticleId IdType="doi">10.2196/22074</ArticleId><ArticleId IdType="pmc">PMC7657721</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pediatr Diabetes. 2013 Jun;14(4):231-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23627878</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2009 Mar;26(3):279-85</Citation><ArticleIdList><ArticleId IdType="pubmed">19317823</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2006 Apr;49(4):621-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16525844</ArticleId></ArticleIdList></Reference><Reference><Citation>J Health Commun. 2015;20(10):1224-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26042660</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 May;9(3):516-24</Citation><ArticleIdList><ArticleId IdType="pubmed">25883165</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2016 May 11;18(5):e101</Citation><ArticleIdList><ArticleId IdType="pubmed">27170498</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2018 Mar 8;360:k698</Citation><ArticleIdList><ArticleId IdType="pubmed">29519932</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Mhealth Uhealth. 2016 Sep 09;4(3):e107</Citation><ArticleIdList><ArticleId IdType="pubmed">27613084</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Spectr. 2010 Oct 2;23(4):238-243</Citation><ArticleIdList><ArticleId IdType="pubmed">21297890</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2009 Jun;32(6):1014-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19244089</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Behav Med. 2009 Aug;38(1):28-39</Citation><ArticleIdList><ArticleId IdType="pubmed">19806416</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutrients. 2018 Jan 22;10(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">29361766</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2015 Jul;17(7):482-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25751133</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2014 Feb;2(2):133-40</Citation><ArticleIdList><ArticleId IdType="pubmed">24622717</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetol Metab Syndr. 2019 Oct 16;11:84</Citation><ArticleIdList><ArticleId IdType="pubmed">31636719</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Mhealth Uhealth. 2019 Feb 20;7(2):e9838</Citation><ArticleIdList><ArticleId IdType="pubmed">30785409</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Psychol. 2009 Oct;34(9):999-1007</Citation><ArticleIdList><ArticleId IdType="pubmed">19423660</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2012 Jul;29(7):e21-4</Citation><ArticleIdList><ArticleId IdType="pubmed">22268422</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):670-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23844569</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Educ. 1991 Mar-Apr;17(2):114-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1995281</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Nurs. 2011 Nov-Dec;34(6):479-86</Citation><ArticleIdList><ArticleId IdType="pubmed">21372703</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2012 May 08;14(3):e70</Citation><ArticleIdList><ArticleId IdType="pubmed">22564332</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Diabetes. 2013 Apr;37 Suppl 1:S1-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24070926</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 Mar;33(3):457-62</Citation><ArticleIdList><ArticleId IdType="pubmed">20007940</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Investig. 2017 Jul;8(4):496-500</Citation><ArticleIdList><ArticleId IdType="pubmed">27896954</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2010 Dec;90(3):243-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21035226</ArticleId></ArticleIdList></Reference><Reference><Citation>Prev Med. 1997 Nov-Dec;26(6):808-16</Citation><ArticleIdList><ArticleId IdType="pubmed">9388792</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Mhealth Uhealth. 2016 Aug 01;4(3):e85</Citation><ArticleIdList><ArticleId IdType="pubmed">27480144</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Res Pediatr Endocrinol. 2014;6(2):74-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24932599</ArticleId></ArticleIdList></Reference><Reference><Citation>Open Access Maced J Med Sci. 2018 Aug 19;6(8):1431-1434</Citation><ArticleIdList><ArticleId IdType="pubmed">30159070</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Mhealth Uhealth. 2017 Jun 19;5(6):e82</Citation><ArticleIdList><ArticleId IdType="pubmed">28630037</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2000 Sep 16;321(7262):694-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10987780</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutrients. 2015 Jun 17;7(6):4897-910</Citation><ArticleIdList><ArticleId IdType="pubmed">26091234</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2013 Jan;99(1):19-23</Citation><ArticleIdList><ArticleId IdType="pubmed">23146371</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes. 2010 Sep;2(3):194-202</Citation><ArticleIdList><ArticleId IdType="pubmed">20923484</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33019225</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2694-0604</ISSN><JournalIssue CitedMedium="Internet"><Volume>2020</Volume><PubDate><Year>2020</Year><Month>07</Month></PubDate></JournalIssue><Title>Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference</Title><ISOAbbreviation>Annu Int Conf IEEE Eng Med Biol Soc</ISOAbbreviation></Journal><ArticleTitle>Nonlinear Machine Learning Models for Insulin Bolus Estimation in Type 1 Diabetes Therapy.</ArticleTitle><Pagination><MedlinePgn>5502-5505</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/EMBC44109.2020.9176021</ELocationID><Abstract><AbstractText>Type 1 diabetes (T1D) therapy requires multiple daily insulin injections to compensate the lack of endogenous insulin production due to ..-cells destruction. An empirical standard formula (SF) is commonly used for such a task. Unfortunately, SF does not include information on glucose dynamics, e.g. the glucose rate-of-change (ROC) provided by continuous glucose monitoring (CGM) sensor. Hence, SF can sometimes lead to under/overestimations that can cause critical hypo/hyperglycemic episodes during/after the meal. Recently, to overcome this limitation, we proposed new linear regression models, integrating ROC information and personalized features. Despite the first encouraging results, the nonlinear nature of the problem calls for the application of nonlinear models. In this work, random forest (RF) and gradient boosting tree (GBT), nonlinear machine learning methodologies, were investigated. A dataset of 100 virtual subjects, opportunely divided into training and testing sets, was used. For each individual, a single-meal scenario with different meal conditions (preprandial ROC, BG and meal amounts) was simulated. The assessment was performed both in terms of accuracy in estimating the optimal bolus and glycemic control. Results were compared to the best performing linear model previously developed. The two tree-based models proposed lead to a statistically significant improvement of glycemic control compared to the linear approach, reducing the time spent in hypoglycemia (from 32.49% to 27.57-25.20% for RF and GBT, respectively). These results represent a preliminary step to prove that nonlinear machine learning techniques can improve the estimation of insulin bolus in T1D therapy. Particularly, RF and GBT were shown to outperform the previously linear models proposed.Clinical Relevance- Insulin bolus estimation with nonlinear machine learning techniques reduces the risk of adverse events in T1D therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Noaro</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Cappon</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Sparacino</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Del Favero</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Facchinetti</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Int Conf IEEE Eng Med Biol Soc</MedlineTA><NlmUniqueID>101763872</NlmUniqueID><ISSNLinking>2375-7477</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="Y">Insulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017711" MajorTopicYN="N">Nonlinear Dynamics</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>6</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33019225</ArticleId><ArticleId IdType="doi">10.1109/EMBC44109.2020.9176021</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32960180</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2371-4379</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>22</Day></PubDate></JournalIssue><Title>JMIR diabetes</Title><ISOAbbreviation>JMIR Diabetes</ISOAbbreviation></Journal><ArticleTitle>The Diabits App for Smartphone-Assisted Predictive Monitoring of Glycemia in Patients With Diabetes: Retrospective Observational Study.</ArticleTitle><Pagination><MedlinePgn>e18660</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/18660</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Diabetes mellitus, which causes dysregulation of blood glucose in humans, is a major public health challenge. Patients with diabetes must monitor their glycemic levels to keep them in a healthy range. This task is made easier by using continuous glucose monitoring (CGM) devices and relaying their output to smartphone apps, thus providing users with real-time information on their glycemic fluctuations and possibly predicting future trends.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to discuss various challenges of predictive monitoring of glycemia and examines the accuracy and blood glucose control effects of Diabits, a smartphone app that helps patients with diabetes monitor and manage their blood glucose levels in real time.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using data from CGM devices and user input, Diabits applies machine learning techniques to create personalized patient models and predict blood glucose fluctuations up to 60 min in advance. These predictions give patients an opportunity to take pre-emptive action to maintain their blood glucose values within the reference range. In this retrospective observational cohort study, the predictive accuracy of Diabits and the correlation between daily use of the app and blood glucose control metrics were examined based on real app users' data. Moreover, the accuracy of predictions on the 2018 Ohio T1DM (type 1 diabetes mellitus) data set was calculated and compared against other published results.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">On the basis of more than 6.8 million data points, 30-min Diabits predictions evaluated using Parkes Error Grid were found to be 86.89% (5,963,930/6,864,130) clinically accurate (zone A) and 99.56% (6,833,625/6,864,130) clinically acceptable (zones A and B), whereas 60-min predictions were 70.56% (4,843,605/6,864,130) clinically accurate and 97.49% (6,692,165/6,864,130) clinically acceptable. By analyzing daily use statistics and CGM data for the 280 most long-standing users of Diabits, it was established that under free-living conditions, many common blood glucose control metrics improved with increased frequency of app use. For instance, the average blood glucose for the days these users did not interact with the app was 154.0 (SD 47.2) mg/dL, with 67.52% of the time spent in the healthy 70 to 180 mg/dL range. For days with 10 or more Diabits sessions, the average blood glucose decreased to 141.6 (SD 42.0) mg/dL (P&lt;.001), whereas the time in euglycemic range increased to 74.28% (P&lt;.001). On the Ohio T1DM data set of 6 patients with type 1 diabetes, 30-min predictions of the base Diabits model had an average root mean square error of 18.68 (SD 2.19) mg/dL, which is an improvement over the published state-of-the-art results for this data set.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Diabits accurately predicts future glycemic fluctuations, potentially making it easier for patients with diabetes to maintain their blood glucose in the reference range. Furthermore, an improvement in glucose control was observed on days with more frequent Diabits use.</AbstractText><CopyrightInformation>..Stan Kriventsov, Alexander Lindsey, Amir Hayeri. Originally published in JMIR Diabetes (http://diabetes.jmir.org), 22.09.2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kriventsov</LastName><ForeName>Stan</ForeName><Initials>S</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-3612-3681</Identifier><AffiliationInfo><Affiliation>Bio Conscious Technologies Inc, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindsey</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-4750-7533</Identifier><AffiliationInfo><Affiliation>Bio Conscious Technologies Inc, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayeri</LastName><ForeName>Amir</ForeName><Initials>A</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-0302-9813</Identifier><AffiliationInfo><Affiliation>Bio Conscious Technologies Inc, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Diabetes</MedlineTA><NlmUniqueID>101719410</NlmUniqueID><ISSNLinking>2371-4379</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">blood glucose predictions</Keyword><Keyword MajorTopicYN="N">digital health</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">mobile phone</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>03</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>07</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>06</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>22</Day><Hour>12</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32960180</ArticleId><ArticleId IdType="pii">v5i3e18660</ArticleId><ArticleId IdType="doi">10.2196/18660</ArticleId><ArticleId IdType="pmc">PMC7539161</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Care. 2000 Aug;23(8):1143-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10937512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Biomed Eng. 2003 Jan;31(1):91-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12572659</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2009 Apr;11(4):243-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19344199</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2011 Nov;60(11):2672-82</Citation><ArticleIdList><ArticleId IdType="pubmed">22025773</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2016 Feb;18 Suppl 2:S3-S13</Citation><ArticleIdList><ArticleId IdType="pubmed">26784127</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2013 Jan;17(1):71-81</Citation><ArticleIdList><ArticleId IdType="pubmed">23008265</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2020 Feb;24(2):603-613</Citation><ArticleIdList><ArticleId IdType="pubmed">30946685</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2011 Feb;13(2):111-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21284477</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2011 Aug;13(8):787-96</Citation><ArticleIdList><ArticleId IdType="pubmed">21612393</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2012 Jun;59(6):1550-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22374344</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1987 Sep-Oct;10(5):622-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3677983</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2004 Aug;27(8):1922-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15277418</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2019 Nov;13(6):1008-1016</Citation><ArticleIdList><ArticleId IdType="pubmed">31645119</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Sep 01;3(5):1207-14</Citation><ArticleIdList><ArticleId IdType="pubmed">20144438</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2006;2006:3545-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17947036</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Control. 2012 Dec;36(2):255-266</Citation><ArticleIdList><ArticleId IdType="pubmed">23175620</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Jan 1;8(1):26-34</Citation><ArticleIdList><ArticleId IdType="pubmed">24876534</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2007 Jul;1(4):478-86</Citation><ArticleIdList><ArticleId IdType="pubmed">19885110</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2012;2012:2889-92</Citation><ArticleIdList><ArticleId IdType="pubmed">23366528</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Mar 24;8(2):331-345</Citation><ArticleIdList><ArticleId IdType="pubmed">24876585</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosystems. 2011 Jan;103(1):67-72</Citation><ArticleIdList><ArticleId IdType="pubmed">20934485</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jan;9(1):63-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25305282</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Sep;2(5):792-801</Citation><ArticleIdList><ArticleId IdType="pubmed">19885262</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Jan;11(1):59-67</Citation><ArticleIdList><ArticleId IdType="pubmed">27566735</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 1981 Dec;68(6):1456-67</Citation><ArticleIdList><ArticleId IdType="pubmed">7033284</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:2887-2891</Citation><ArticleIdList><ArticleId IdType="pubmed">29060501</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2010 Jan;12(1):81-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20082589</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Sep 01;4(5):1087-98</Citation><ArticleIdList><ArticleId IdType="pubmed">20920428</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:7945-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22256183</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2005 May;28(5):1245-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15855602</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2006 Aug;29(8):1805-11</Citation><ArticleIdList><ArticleId IdType="pubmed">16873784</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Nov;41(11):2275-2280</Citation><ArticleIdList><ArticleId IdType="pubmed">30224348</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2016 Aug;18(8):505-11</Citation><ArticleIdList><ArticleId IdType="pubmed">27253751</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 May;54(5):931-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17518291</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 Sep 01;7(5):1275-81</Citation><ArticleIdList><ArticleId IdType="pubmed">24124954</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2017 Dec;18(8):903-910</Citation><ArticleIdList><ArticleId IdType="pubmed">28165180</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 Oct;54(10):1740-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17926672</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Diabetes Rev. 2008 Aug;4(3):193-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18690900</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2003;5(5):817-28</Citation><ArticleIdList><ArticleId IdType="pubmed">14633347</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Aug;42(8):1593-1603</Citation><ArticleIdList><ArticleId IdType="pubmed">31177185</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1995 Feb;18(2):258-68</Citation><ArticleIdList><ArticleId IdType="pubmed">7729308</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32940087</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>03</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>Mathematical Models of Meal Amount and Timing Variability With Implementation in the Type-1 Diabetes Patient Decision Simulator.</ArticleTitle><Pagination><MedlinePgn>346-359</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1932296820952123</ELocationID><Abstract><AbstractText Label="BACKGROUND">In type 1 diabetes (T1D) research, in-silico clinical trials (ISCTs) have proven effective in accelerating the development of new therapies. However, published simulators lack a realistic description of some aspects of patient lifestyle which can remarkably affect glucose control. In this paper, we develop a mathematical description of meal carbohydrates (CHO) amount and timing, with the aim to improve the meal generation module in the T1D Patient Decision Simulator (T1D-PDS) published in Vettoretti et al.</AbstractText><AbstractText Label="METHODS">Data of 32 T1D subjects under free-living conditions for 4874...days were used. Univariate probability density function (PDF) parametric models with different candidate shapes were fitted, individually, against sample distributions of: CHO amounts of breakfast (CHO<sub>B</sub>), lunch (CHO<sub>L</sub>), dinner (CHO<sub>D</sub>), and snack (CHO<sub>S</sub>); breakfast timing (T<sub>B</sub>); and time between breakfast-lunch (T<sub>BL</sub>) and between lunch-dinner (T<sub>LD</sub>). Furthermore, a support vector machine (SVM) classifier was developed to predict the occurrence of a snack in future fixed-length time windows. Once embedded inside the T1D-PDS, an ISCT was performed.</AbstractText><AbstractText Label="RESULTS">Resulting PDF models were: gamma (CHO<sub>B</sub>, CHO<sub>S</sub>), lognormal (CHO<sub>L</sub>, T<sub>B</sub>), loglogistic (CHO<sub>D</sub>), and generalized-extreme-values (T<sub>BL</sub>, T<sub>LD</sub>). The SVM showed a classification accuracy of 0.8 over the test set. The distributions of simulated meal data were not statistically different from the distributions of the real data used to develop the models (.....=...0.05).</AbstractText><AbstractText Label="CONCLUSIONS">The models of meal amount and timing variability developed are suitable for describing real data. Their inclusion in modules that describe patient behavior in the T1D-PDS can permit investigators to perform more realistic, reliable, and insightful ISCTs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Camerlingo</LastName><ForeName>Nunzio</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-3222-2479</Identifier><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vettoretti</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Favero</LastName><ForeName>Simone</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8214-2752</Identifier><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Facchinetti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sparacino</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-3248-1393</Identifier><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>J Diabetes Sci Technol. 2021 Feb 20;:1932296821996137</RefSource><PMID Version="1">33615837</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062408" MajorTopicYN="N">Breakfast</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062407" MajorTopicYN="N">Meals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">in-silico clinical trials</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">maximum absolute difference</Keyword><Keyword MajorTopicYN="Y">parametric modelling</Keyword><Keyword MajorTopicYN="Y">support vector machine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>17</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32940087</ArticleId><ArticleId IdType="doi">10.1177/1932296820952123</ArticleId><ArticleId IdType="pmc">PMC7925444</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Diabetes Sci Technol. 2010 Jan 01;4(1):132-44</Citation><ArticleIdList><ArticleId IdType="pubmed">20167177</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Inf Technol Biomed. 2008 Mar;12(2):247-56</Citation><ArticleIdList><ArticleId IdType="pubmed">18348954</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2017 Jul;146:125-131</Citation><ArticleIdList><ArticleId IdType="pubmed">28688482</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2020 Jan 13;15(1):e0227637</Citation><ArticleIdList><ArticleId IdType="pubmed">31929574</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Jan;3(1):44-55</Citation><ArticleIdList><ArticleId IdType="pubmed">19444330</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2018 Feb;20(2):98-105</Citation><ArticleIdList><ArticleId IdType="pubmed">29355438</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 May;11(3):545-552</Citation><ArticleIdList><ArticleId IdType="pubmed">28745098</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Jul;39(7):1151-60</Citation><ArticleIdList><ArticleId IdType="pubmed">27208331</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2019 Nov;13(6):1065-1076</Citation><ArticleIdList><ArticleId IdType="pubmed">31608660</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2008 Jan 15;24(2):258-64</Citation><ArticleIdList><ArticleId IdType="pubmed">18024475</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Struct Biotechnol J. 2020 Feb 22;18:464-481</Citation><ArticleIdList><ArticleId IdType="pubmed">32180905</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2020 Jun;37(6):1066-1073</Citation><ArticleIdList><ArticleId IdType="pubmed">31970814</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2018 Mar;65(3):479-488</Citation><ArticleIdList><ArticleId IdType="pubmed">28092515</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Chem Eng. 2019 Nov 2;130:</Citation><ArticleIdList><ArticleId IdType="pubmed">32863472</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2018 Jun;65(6):1281-1290</Citation><ArticleIdList><ArticleId IdType="pubmed">28866479</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Mar;12(2):273-281</Citation><ArticleIdList><ArticleId IdType="pubmed">29451021</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 Nov 01;7(6):1416-26</Citation><ArticleIdList><ArticleId IdType="pubmed">24351168</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Physiol Endocrinol Metab. 2002 May;282(5):E992-1007</Citation><ArticleIdList><ArticleId IdType="pubmed">11934663</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2019 Nov;21(11):644-655</Citation><ArticleIdList><ArticleId IdType="pubmed">31335191</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Pract. 2008 Dec;14(9):1095-101</Citation><ArticleIdList><ArticleId IdType="pubmed">19158048</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2016 Jan;69:125-36</Citation><ArticleIdList><ArticleId IdType="pubmed">26186899</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Sep;12(5):937-952</Citation><ArticleIdList><ArticleId IdType="pubmed">30095007</ArticleId></ArticleIdList></Reference><Reference><Citation>J Acad Nutr Diet. 2015 Jan;115(1):50-63</Citation><ArticleIdList><ArticleId IdType="pubmed">25088521</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2020 Oct;22(10):749-759</Citation><ArticleIdList><ArticleId IdType="pubmed">32223551</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2000 May;16(5):412-24</Citation><ArticleIdList><ArticleId IdType="pubmed">10871264</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Direct. 2018 Apr 3;13(1):5</Citation><ArticleIdList><ArticleId IdType="pubmed">29615097</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab J. 2019 Aug;43(4):383-397</Citation><ArticleIdList><ArticleId IdType="pubmed">31441246</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2006 Mar;44(1-2):69-78</Citation><ArticleIdList><ArticleId IdType="pubmed">16929923</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2015 Dec;3(12):939-47</Citation><ArticleIdList><ArticleId IdType="pubmed">26432775</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2020 Aug;22(8):553-561</Citation><ArticleIdList><ArticleId IdType="pubmed">32125178</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32784179</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>08</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>A Novel Approach for Continuous Health Status Monitoring and Automatic Detection of Infection Incidences in People With Type 1 Diabetes Using Machine Learning Algorithms (Part 2): A Personalized Digital Infectious Disease Detection Mechanism.</ArticleTitle><Pagination><MedlinePgn>e18912</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/18912</ELocationID><Abstract><AbstractText Label="BACKGROUND">Semisupervised and unsupervised anomaly detection methods have been widely used in various applications to detect anomalous objects from a given data set. Specifically, these methods are popular in the medical domain because of their suitability for applications where there is a lack of a sufficient data set for the other classes. Infection incidence often brings prolonged hyperglycemia and frequent insulin injections in people with type 1 diabetes, which are significant anomalies. Despite these potentials, there have been very few studies that focused on detecting infection incidences in individuals with type 1 diabetes using a dedicated personalized health model.</AbstractText><AbstractText Label="OBJECTIVE">This study aims to develop a personalized health model that can automatically detect the incidence of infection in people with type 1 diabetes using blood glucose levels and insulin-to-carbohydrate ratio as input variables. The model is expected to detect deviations from the norm because of infection incidences considering elevated blood glucose levels coupled with unusual changes in the insulin-to-carbohydrate ratio.</AbstractText><AbstractText Label="METHODS">Three groups of one-class classifiers were trained on target data sets (regular days) and tested on a data set containing both the target and the nontarget (infection days). For comparison, two unsupervised models were also tested. The data set consists of high-precision self-recorded data collected from three real subjects with type 1 diabetes incorporating blood glucose, insulin, diet, and events of infection. The models were evaluated on two groups of data: raw and filtered data and compared based on their performance, computational time, and number of samples required.</AbstractText><AbstractText Label="RESULTS">The one-class classifiers achieved excellent performance. In comparison, the unsupervised models suffered from performance degradation mainly because of the atypical nature of the data. Among the one-class classifiers, the boundary and domain-based method produced a better description of the data. Regarding the computational time, nearest neighbor, support vector data description, and self-organizing map took considerable training time, which typically increased as the sample size increased, and only local outlier factor and connectivity-based outlier factor took considerable testing time.</AbstractText><AbstractText Label="CONCLUSIONS">We demonstrated the applicability of one-class classifiers and unsupervised models for the detection of infection incidence in people with type 1 diabetes. In this patient group, detecting infection can provide an opportunity to devise tailored services and also to detect potential public health threats. The proposed approaches achieved excellent performance; in particular, the boundary and domain-based method performed better. Among the respective groups, particular models such as one-class support vector machine, K-nearest neighbor, and K-means achieved excellent performance in all the sample sizes and infection cases. Overall, we foresee that the results could encourage researchers to examine beyond the presented features into other additional features of the self-recorded data, for example, continuous glucose monitoring features and physical activity data, on a large scale.</AbstractText><CopyrightInformation>..Ashenafi Zebene Woldaregay, Ilkka Kalervo Launonen, David Albers, Jorge Igual, Eirik ..rsand, Gunnar Hartvigsen. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 12.08.2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Woldaregay</LastName><ForeName>Ashenafi Zebene</ForeName><Initials>AZ</Initials><Identifier Source="ORCID">0000-0002-9464-3407</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, University of Troms.. - The Arctic University of Norway, Troms.., Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Launonen</LastName><ForeName>Ilkka Kalervo</ForeName><Initials>IK</Initials><Identifier Source="ORCID">0000-0002-0565-800X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Research, University Hospital of North Norway, Troms.., Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albers</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-5369-526X</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Informatics and Data Science, University of Colorado, Aurora, CO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Igual</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3408-4014</Identifier><AffiliationInfo><Affiliation>Universitat Polit..cnica de Val..ncia, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>..rsand</LastName><ForeName>Eirik</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9520-1408</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, University of Troms.. - The Arctic University of Norway, Troms.., Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartvigsen</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8771-9867</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, University of Troms.. - The Arctic University of Norway, Troms.., Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048909" MajorTopicYN="N">Diabetes Complications</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">decision support techniques</Keyword><Keyword MajorTopicYN="Y">infection detection</Keyword><Keyword MajorTopicYN="Y">outbreak detection system</Keyword><Keyword MajorTopicYN="Y">self-recorded health data</Keyword><Keyword MajorTopicYN="Y">syndromic surveillance</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>03</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>06</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>06</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32784179</ArticleId><ArticleId IdType="pii">v22i8e18912</ArticleId><ArticleId IdType="doi">10.2196/18912</ArticleId><ArticleId IdType="pmc">PMC7450372</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Med Internet Res. 2020 Aug 12;22(8):e18912</Citation><ArticleIdList><ArticleId IdType="pubmed">32784179</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2008;136:21-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18487702</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Informatics J. 2012 Mar;18(1):26-35</Citation><ArticleIdList><ArticleId IdType="pubmed">22447875</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2006 May;37(1):7-18</Citation><ArticleIdList><ArticleId IdType="pubmed">16233974</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Syst Man Cybern B Cybern. 2006 Dec;36(6):1283-95</Citation><ArticleIdList><ArticleId IdType="pubmed">17186805</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Nutr. 2005;25:9-35</Citation><ArticleIdList><ArticleId IdType="pubmed">16011457</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2017 Jun;128:40-50</Citation><ArticleIdList><ArticleId IdType="pubmed">28437734</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Mol Res. 2005 Sep 30;4(3):608-15</Citation><ArticleIdList><ArticleId IdType="pubmed">16342046</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Signal. 2012 Oct 23;5(247):pt10</Citation><ArticleIdList><ArticleId IdType="pubmed">23092890</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 1989 Aug;69(2):317-23</Citation><ArticleIdList><ArticleId IdType="pubmed">2666428</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2003 Sep-Oct;10(5):399-408</Citation><ArticleIdList><ArticleId IdType="pubmed">12807803</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2019 May 01;21(5):e11030</Citation><ArticleIdList><ArticleId IdType="pubmed">31042157</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2016 Apr 19;11(4):e0152173</Citation><ArticleIdList><ArticleId IdType="pubmed">27093601</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1973 Sep 20;289(12):618-21</Citation><ArticleIdList><ArticleId IdType="pubmed">4198822</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2004;107(Pt 1):716-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15360906</ArticleId></ArticleIdList></Reference><Reference><Citation>ScientificWorldJournal. 2014 Mar 20;2014:730712</Citation><ArticleIdList><ArticleId IdType="pubmed">24778600</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>Best Pract Res Clin Endocrinol Metab. 2001 Dec;15(4):533-51</Citation><ArticleIdList><ArticleId IdType="pubmed">11800522</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 1995 Jan;98(1):75-84</Citation><ArticleIdList><ArticleId IdType="pubmed">7825623</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Surg. 2013;47:287-97</Citation><ArticleIdList><ArticleId IdType="pubmed">24298857</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Nov 01;3(6):1250-60</Citation><ArticleIdList><ArticleId IdType="pubmed">20144378</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 1982 Mar;72(3):439-50</Citation><ArticleIdList><ArticleId IdType="pubmed">7036735</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Public Health Surveill. 2020 May 26;6(2):e11512</Citation><ArticleIdList><ArticleId IdType="pubmed">32357126</ArticleId></ArticleIdList></Reference><Reference><Citation>Life Sci Soc Policy. 2018 Jun 14;14(1):13</Citation><ArticleIdList><ArticleId IdType="pubmed">29900518</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32746033</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>01</Month></PubDate></JournalIssue><Title>IEEE transactions on bio-medical engineering</Title><ISOAbbreviation>IEEE Trans Biomed Eng</ISOAbbreviation></Journal><ArticleTitle>Machine-Learning Based Model to Improve Insulin Bolus Calculation in Type 1 Diabetes Therapy.</ArticleTitle><Pagination><MedlinePgn>247-255</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/TBME.2020.3004031</ELocationID><Abstract><AbstractText Label="OBJECTIVE">This paper aims at proposing a new machine-learning based model to improve the calculation of mealtime insulin boluses (MIB) in type 1 diabetes (T1D) therapy using continuous glucose monitoring (CGM) data. Indeed, MIB is still often computed through the standard formula (SF), which does not account for glucose rate-of-change ( ...G), causing critical hypo/hyperglycemic episodes.</AbstractText><AbstractText Label="METHODS">Four candidate models for MIB calculation, based on multiple linear regression (MLR) and least absolute shrinkage and selection operator (LASSO) are developed. The proposed models are assessed in silico, using the UVa/Padova T1D simulator, in different mealtime scenarios and compared to the SF and three ...G-accounting variants proposed in the literature. An assessment on real data, by retrospectively analyzing 218 glycemic traces, is also performed.</AbstractText><AbstractText Label="RESULTS">All four tested models performed better than the existing techniques. LASSO regression with extended feature-set including quadratic terms (LASSO <sub>Q</sub>) produced the best results. In silico, LASSO <sub>Q</sub> reduced the error in estimating the optimal bolus to only 0.86..U (1.45..U of SF and 1.36-1.44..U of literature methods), as well as hypoglycemia incidence (from 44.41% of SF and 44.60-45.01% of literature methods, to 35.93%). Results are confirmed by the retrospective application to real data.</AbstractText><AbstractText Label="CONCLUSION">New models to improve MIB calculation accounting for CGM- ...G and easy-to-measure features can be developed within a machine learning framework. Particularly, in this paper, a new LASSO <sub>Q</sub> model was developed, which ensures better glycemic control than SF and other literature methods.</AbstractText><AbstractText Label="SIGNIFICANCE">MIB dosage with the proposed LASSO <sub>Q</sub> model can potentially reduce the risk of adverse events in T1D therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Noaro</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Cappon</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Vettoretti</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Sparacino</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Favero</LastName><ForeName>Simone Del</ForeName><Initials>SD</Initials></Author><Author ValidYN="Y"><LastName>Facchinetti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE Trans Biomed Eng</MedlineTA><NlmUniqueID>0012737</NlmUniqueID><ISSNLinking>0018-9294</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32746033</ArticleId><ArticleId IdType="doi">10.1109/TBME.2020.3004031</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35072085</PMID><DateRevised><Year>2022</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2640-3498</ISSN><JournalIssue CitedMedium="Internet"><Volume>126</Volume><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Proceedings of machine learning research</Title><ISOAbbreviation>Proc Mach Learn Res</ISOAbbreviation></Journal><ArticleTitle>Comparing Machine Learning Techniques for Blood Glucose Forecasting Using Free-living and Patient Generated Data.</ArticleTitle><Pagination><MedlinePgn>871-894</MedlinePgn></Pagination><Abstract><AbstractText>Managing a chronic disease like Type 1 diabetes (T1D) is both challenging and time consuming, but new technologies that allow continuous measurement of glucose and delivery of insulin have led to significant improvements. The development of an artificial pancreas (AP), which algorithmically determines insulin dosing and delivers insulin in a fully automated way, may transform T1D care but it is not yet widely available. Patient-led alternatives, like the Open Artificial Pancreas (OpenAPS), are being used by hundreds of individuals and have also led to a dramatic increase in the availability of patient generated health data (PGHD). All APs require an accurate forecast of blood glucose (BG). While there have been efforts to develop better forecasts and apply new ML techniques like deep learning to this problem, methods are often tested on small controlled datasets that do not indicate how they may perform in reality - and the most advanced methods have not always outperformed the simplest. We introduce a rigorous comparison of BG forecasting using both a small controlled research dataset and large heterogeneous PGHD. Our comparison advances the state of the art in BG forecasting by providing insight into how methods may fare when moving beyond small controlled studies to real-world use.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hameed</LastName><ForeName>Hadia</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Electrical and Computer Engineering, Stevens Institute of Technology, Hoboken, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleinberg</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Computer Science, Stevens Institute of Technology, Hoboken, NJ, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM011826</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Mach Learn Res</MedlineTA><NlmUniqueID>101735789</NlmUniqueID></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>24</Day><Hour>8</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35072085</ArticleId><ArticleId IdType="pmc">PMC8782424</ArticleId><ArticleId IdType="mid">NIHMS1770799</ArticleId></ArticleIdList><?nihms ?><ReferenceList><Reference><Citation>Math Biosci. 2009 Feb;217(2):101-17</Citation><ArticleIdList><ArticleId IdType="pubmed">19022264</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2016 Jan 26;133(4):e38-360</Citation><ArticleIdList><ArticleId IdType="pubmed">26673558</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2005 Oct;7(5):776-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16241881</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2002 Feb;25(2):347-52</Citation><ArticleIdList><ArticleId IdType="pubmed">11815508</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Comput. 1997 Nov 15;9(8):1735-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9377276</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:4843-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25571076</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2013 Jan;17(1):71-81</Citation><ArticleIdList><ArticleId IdType="pubmed">23008265</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Oct;15(10):792-801</Citation><ArticleIdList><ArticleId IdType="pubmed">23883406</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Oct;38(10):e158-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26269199</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2019 Jul;13(4):790-793</Citation><ArticleIdList><ArticleId IdType="pubmed">30348013</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:706-712</Citation><ArticleIdList><ArticleId IdType="pubmed">31945995</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:5140-5145</Citation><ArticleIdList><ArticleId IdType="pubmed">33019143</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2019 Oct;21(10):2333-2337</Citation><ArticleIdList><ArticleId IdType="pubmed">31183929</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2010 Apr 14;2(27):27ra27</Citation><ArticleIdList><ArticleId IdType="pubmed">20393188</ArticleId></ArticleIdList></Reference><Reference><Citation>CEUR Workshop Proc. 2020 Sep;2675:71-74</Citation><ArticleIdList><ArticleId IdType="pubmed">33584164</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):634-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23848178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2003 Jul 15;139(2):137-47</Citation><ArticleIdList><ArticleId IdType="pubmed">12859163</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2017 May;21(3):619-627</Citation><ArticleIdList><ArticleId IdType="pubmed">28278487</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2020 Feb;24(2):603-613</Citation><ArticleIdList><ArticleId IdType="pubmed">30946685</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2009 Feb;56(2):246-54</Citation><ArticleIdList><ArticleId IdType="pubmed">19272928</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2020 Nov;67(11):3101-3124</Citation><ArticleIdList><ArticleId IdType="pubmed">32091990</ArticleId></ArticleIdList></Reference><Reference><Citation>Automatica (Oxf). 2012 Aug;48(8):1892-1897</Citation><ArticleIdList><ArticleId IdType="pubmed">22865931</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32694787</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2522-5812</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>07</Month></PubDate></JournalIssue><Title>Nature metabolism</Title><ISOAbbreviation>Nat Metab</ISOAbbreviation></Journal><ArticleTitle>An artificial intelligence decision support system for the management of type 1 diabetes.</ArticleTitle><Pagination><MedlinePgn>612-619</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42255-020-0212-y</ELocationID><Abstract><AbstractText>Type 1 diabetes (T1D) is characterized by pancreatic beta cell dysfunction and insulin depletion. Over 40% of people with T1D manage their glucose through multiple injections of long-acting basal and short-acting bolus insulin, so-called multiple daily injections (MDI)<sup>1,2</sup>. Errors in dosing can lead to life-threatening hypoglycaemia events (&lt;70...mg...dl<sup>-1</sup>) and hyperglycaemia (&gt;180...mg...dl<sup>-1</sup>), increasing the risk of retinopathy, neuropathy, and nephropathy. Machine learning (artificial intelligence) approaches are being harnessed to incorporate decision support into many medical specialties. Here, we report an algorithm that provides weekly insulin dosage recommendations to adults with T1D using MDI therapy. We employ a unique virtual platform<sup>3</sup> to generate over 50,000 glucose observations to train a k-nearest neighbours<sup>4</sup> decision support system (KNN-DSS) to identify causes of hyperglycaemia or hypoglycaemia and determine necessary insulin adjustments from a set of 12 potential recommendations. The KNN-DSS algorithm achieves an overall agreement with board-certified endocrinologists of 67.9% when validated on real-world human data, and delivers safe recommendations, per endocrinologist review. A comparison of inter-physician-recommended adjustments to insulin pump therapy indicates full agreement of 41.2% among endocrinologists, which is consistent with previous measures of inter-physician agreement (41-45%)<sup>5</sup>. In silico<sup>3,6</sup> benchmarking using a platform accepted by the United States Food and Drug Administration for evaluation of artificial pancreas technologies indicates substantial improvement in glycaemic outcomes after 12 weeks of KNN-DSS use. Our data indicate that the KNN-DSS allows for early identification of dangerous insulin regimens and may be used to improve glycaemic outcomes and prevent life-threatening complications in people with T1D.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tyler</LastName><ForeName>Nichole S</ForeName><Initials>NS</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3293-9680</Identifier><AffiliationInfo><Affiliation>Artificial Intelligence for Medical Systems (AIMS) Lab, Oregon Health &amp; Science University, Portland, OR, USA. tylern@ohsu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosquera-Lopez</LastName><ForeName>Clara M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Artificial Intelligence for Medical Systems (AIMS) Lab, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Leah M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3634-481X</Identifier><AffiliationInfo><Affiliation>Harold Schnitzer Diabetes Health Center, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dodier</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Artificial Intelligence for Medical Systems (AIMS) Lab, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Branigan</LastName><ForeName>Deborah L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Harold Schnitzer Diabetes Health Center, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabo</LastName><ForeName>Virginia B</ForeName><Initials>VB</Initials><AffiliationInfo><Affiliation>Harold Schnitzer Diabetes Health Center, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guillot</LastName><ForeName>Florian H</ForeName><Initials>FH</Initials><AffiliationInfo><Affiliation>Harold Schnitzer Diabetes Health Center, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilts</LastName><ForeName>Wade W</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>Artificial Intelligence for Medical Systems (AIMS) Lab, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Youssef</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Harold Schnitzer Diabetes Health Center, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castle</LastName><ForeName>Jessica R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Harold Schnitzer Diabetes Health Center, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Peter G</ForeName><Initials>PG</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-9897-4783</Identifier><AffiliationInfo><Affiliation>Artificial Intelligence for Medical Systems (AIMS) Lab, Oregon Health &amp; Science University, Portland, OR, USA. jacobsp@ohsu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03443713</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK120367</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Nat Metab</MedlineTA><NlmUniqueID>101736592</NlmUniqueID><ISSNLinking>2522-5812</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085002" MajorTopicYN="N">Glycemic Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006943" MajorTopicYN="N">Hyperglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>09</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32694787</ArticleId><ArticleId IdType="doi">10.1038/s42255-020-0212-y</ArticleId><ArticleId IdType="pii">10.1038/s42255-020-0212-y</ArticleId><ArticleId IdType="pmc">PMC7384292</ArticleId><ArticleId IdType="mid">NIHMS1587540</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Paris, C. A. et al. Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for diabetes in youth study. J. Pediatr. 155, 183...189.e1 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2009.01.063</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, K. M. et al. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care 38, 971...978 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc15-0078</ArticleId></ArticleIdList></Reference><Reference><Citation>Resalat, N., El Youssef, J., Tyler, N., Castle, J. &amp; Jacobs, P. G. A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise model. PLoS One 14, e0217301 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0217301</ArticleId></ArticleIdList></Reference><Reference><Citation>Cover, T. &amp; Hart, P. Nearest neighbor pattern classification. IEEE Trans. Inf. Theor. 13, 21...27 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TIT.1967.1053964</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimri, R. et al. Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians. Diabetes Obes. Metab. 20, 2458...2466 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.13408</ArticleId></ArticleIdList></Reference><Reference><Citation>Man, C. D. et al. The UVA/PADOVA type 1 diabetes simulator: new features. J. Diabetes Sci. Technol. 8, 26...34 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1932296813514502</ArticleId></ArticleIdList></Reference><Reference><Citation>The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT/EDIC study 30-year follow-up. Diabetes Care 39, 686...693 (2016).</Citation></Reference><Reference><Citation>Schwartz, F. L., Guo, A., Marling, C. R. &amp; Shubrook, J. H. Analysis of use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in type 1 diabetes mellitus patients treated with multiple daily insulin injections. J. Diabetes Sci. Technol. 6, 150...152 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/193229681200600118</ArticleId></ArticleIdList></Reference><Reference><Citation>Roze, S. et al. Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in type 1 diabetes: a systematic review. Diabet. Med. 32, 1415...1424 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.12792</ArticleId></ArticleIdList></Reference><Reference><Citation>McNally, K., Rohan, J., Pendley, J. S., Delamater, A. &amp; Drotar, D. Executive functioning, treatment adherence, and glycemic control in children with type 1 diabetes. Diabetes Care 33, 1159...1162 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc09-2116</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarbacker, G. B. &amp; Urteaga, E. M. Adherence to insulin therapy. Diabetes Spectr. 29, 166...170 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diaspect.29.3.166</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirwan, M., Vandelanotte, C., Fenning, A. &amp; Duncan, J. M. Diabetes self-management smartphone application for adults with type 1 diabetes: randomized controlled trial. J. Med. Internet Res. 15, e235 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.2588</ArticleId></ArticleIdList></Reference><Reference><Citation>Charpentier, G. et al. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care 34, 533...539 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc10-1259</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Y. et al. Mobile app-based interventions to support diabetes self-management: a systematic review of randomized controlled trials to identify functions associated with glycemic efficacy. JMIR Mhealth Uhealth 5, e35 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/mhealth.6522</ArticleId></ArticleIdList></Reference><Reference><Citation>Veazie, S et al. Rapid evidence review of mobile applications for self-management of diabetes. J. Gen. Intern. Med. 33, 1167...1176 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-018-4410-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck, R. W. et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 317, 371...378 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.19975</ArticleId></ArticleIdList></Reference><Reference><Citation>Steil, G. M. et al. Use of automated clinical decision support (CDS) to effect glycemic control in elderly patients with T1D. Diabetes 67, 921-P (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db18-921-P</ArticleId></ArticleIdList></Reference><Reference><Citation>Palerm, C. C., Zisser, H., Jovanovic, L. &amp; Doyle, F. J. 3rd A run-to-run control strategy to adjust basal insulin infusion rates in type 1 diabetes. J. Process Control 18, 258...265 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprocont.2007.07.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero, P., Bondia, J., Gimenez, M., Oliver, N. &amp; Georgiou, P. Automatic adaptation of basal insulin using sensor-augmented pump therapy. J. Diabetes Sci. Technol. 12, 282...294 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1932296818761752</ArticleId></ArticleIdList></Reference><Reference><Citation>Toffanin, C., Messori, M., Cobelli, C. &amp; Magni, L. Automatic adaptation of basal therapy for type 1 diabetic patients: a run-to-run approach. Biomed. Signal Process. Control 31, 539...549 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bspc.2016.09.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisser, H., Palerm, C. C., Bevier, W. C., Doyle, F. J. 3rd &amp; Jovanovic, L. Clinical update on optimal prandial insulin dosing using a refined run-to-run control algorithm. J. Diabetes Sci. Technol. 3, 487...491 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/193229680900300312</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero, P. et al. Advanced insulin bolus advisor based on run-to-run control and case-based reasoning. IEEE J. Biomed. Health Inform. 19, 1087...1096 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">24956470</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Gandia, C. et al. Decision support in diabetes care: the challenge of supporting patients in their daily living using a mobile glucose predictor. J. Diabetes Sci. Technol. 12, 243...250 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1932296818761457</ArticleId></ArticleIdList></Reference><Reference><Citation>Breton, M. D. et al. Continuous glucose monitoring and insulin informed advisory system with automated titration and dosing of insulin reduces glucose variability in type 1 diabetes mellitus. Diabetes Technol. Ther. 20, 531...540 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2018.0079</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy, M. et al. Clinical safety and feasibility of the advanced bolus calculator for type 1 diabetes based on case-based reasoning: a 6-week nonrandomized single-arm pilot study. Diabetes Technol. Ther. 18, 487...493 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2015.0413</ArticleId></ArticleIdList></Reference><Reference><Citation>Resalat, N., El Youssef, J., Reddy, R., Castle, J. &amp; Jacobs, P. G. Adaptive tuning of basal and bolus insulin to reduce postprandial hypoglycemia in a hybrid artificial pancreas. J. Process Control 80, 247...254 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprocont.2019.05.018</ArticleId></ArticleIdList></Reference><Reference><Citation>S..rensen, T. J A Method of Establishing Groups of Equal Amplitude in Plant Sociology Based on Similarity of Species Content and its Application to Analyses of the Vegetation on Danish Commons (I kommission hos E. Munksgaard, 1948).</Citation></Reference><Reference><Citation>Davidson, M. B., Duran, P., Davidson, S. J. &amp; Lee, M. Comparison of insulin dose adjustments by primary care physicians and endocrinologists. Clin. Diabetes 36, 39...43 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/cd17-0021</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashan, E. &amp; Hodish, I. Frequent insulin dosage adjustments based on glucose readings alone are sufficient for a safe and effective therapy. J. Diabetes Complicat. 26, 230...236 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2012.03.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy, R. et al. The effect of exercise on sleep in adults with type 1 diabetes. Diabetes Obes. Metab. 20, 443...447 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.13065</ArticleId></ArticleIdList></Reference><Reference><Citation>Castle, J. R. et al. Randomized outpatient trial of single- and dual-hormone closed-loop systems that adapt to exercise using wearable sensors. Diabetes Care 41, 1471...1477 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc18-0228</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettus, J. &amp; Edelman, S. V. Recommendations for using real-time continuous glucose monitoring (rtCGM) data for insulin adjustments in type 1 diabetes. J. Diabetes Sci. Technol. 11, 138...147 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1932296816663747</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitney, A. W. A direct method of nonparametric measurement selection. IEEE Trans. Comput. 20, 1100...1103 (1971).</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/T-C.1971.223410</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheiner, G. Practical CGM: Improving Patient Outcomes Through Continuous Glucose Monitoring (American Diabetes Association, 2015).</Citation></Reference><Reference><Citation>White, J. W., Rassweiler, A., Samhouri, J. F., Stier, A. C. &amp; White, C. Ecologists should not use statistical significance tests to interpret simulation model results. Oikos 123, 385...388 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0706.2013.01073.x</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32692360</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1945-7197</ISSN><JournalIssue CitedMedium="Internet"><Volume>105</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>09</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of clinical endocrinology and metabolism</Title><ISOAbbreviation>J Clin Endocrinol Metab</ISOAbbreviation></Journal><ArticleTitle>Gut Microbiota in T1DM-Onset Pediatric Patients: Machine-Learning Algorithms to Classify Microorganisms as Disease Linked.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">dgaa407</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1210/clinem/dgaa407</ELocationID><Abstract><AbstractText Label="AIMS">The purpose of this work is to find the gut microbial fingerprinting of pediatric patients with type 1 diabetes.</AbstractText><AbstractText Label="METHODS">The microbiome of 31 children with type 1 diabetes at onset and of 25 healthy children was determined using multiple polymorphic regions of the 16S ribosomal RNA. We performed machine-learning analyses and metagenome functional analysis to identify significant taxa and their metabolic pathways content.</AbstractText><AbstractText Label="RESULTS">Compared with healthy controls, patients showed a significantly higher relative abundance of the following most important taxa: Bacteroides stercoris, Bacteroides fragilis, Bacteroides intestinalis, Bifidobacterium bifidum, Gammaproteobacteria and its descendants, Holdemania, and Synergistetes and its descendants. On the contrary, the relative abundance of Bacteroides vulgatus, Deltaproteobacteria and its descendants, Parasutterella and the Lactobacillus, Turicibacter genera were significantly lower in patients with respect to healthy controls. The predicted metabolic pathway more associated with type 1 diabetes patients concerns "carbon metabolism," sugar and iron metabolisms in particular. Among the clinical variables considered, standardized body mass index, anti-insulin autoantibodies, glycemia, hemoglobin A1c, Tanner stage, and age at onset emerged as most significant positively or negatively correlated with specific clusters of taxa.</AbstractText><AbstractText Label="CONCLUSIONS">The relative abundance and supervised analyses confirmed the importance of B stercoris in type 1 diabetes patients at onset and showed a relevant role of Synergistetes and its descendants in patients with respect to healthy controls. In general the robustness and coherence of the showed results underline the relevance of studying the microbioma using multiple polymorphic regions, different types of analysis, and different approaches within each analysis.</AbstractText><CopyrightInformation>.. Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Biassoni</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Molecular Diagnostics, Analysis Laboratory, IRCCS Istituto Giannina Gaslini, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Marco</LastName><ForeName>Eddi</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Molecular Diagnostics, Analysis Laboratory, IRCCS Istituto Giannina Gaslini, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Squillario</LastName><ForeName>Margherita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>DIBRIS University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barla</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>DIBRIS University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piccolo</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pediatric Clinic Regional Center for Pediatric Diabetes, IRCCS Istituto Giannina Gaslini, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ugolotti</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Molecular Diagnostics, Analysis Laboratory, IRCCS Istituto Giannina Gaslini, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gatti</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Molecular Diagnostics, Analysis Laboratory, IRCCS Istituto Giannina Gaslini, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minuto</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pediatric Clinic Regional Center for Pediatric Diabetes, IRCCS Istituto Giannina Gaslini, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patti</LastName><ForeName>Giuseppa</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, IRCCS Istituto Giannina Gaslini, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University Of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maghnie</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Clinic Regional Center for Pediatric Diabetes, IRCCS Istituto Giannina Gaslini, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, IRCCS Istituto Giannina Gaslini, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University Of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>d'Annunzio</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pediatric Clinic Regional Center for Pediatric Diabetes, IRCCS Istituto Giannina Gaslini, Genoa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Endocrinol Metab</MedlineTA><NlmUniqueID>0375362</NlmUniqueID><ISSNLinking>0021-972X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054892" MajorTopicYN="N">Metagenome</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">adolescent</Keyword><Keyword MajorTopicYN="Y">autoimmunity</Keyword><Keyword MajorTopicYN="Y">children</Keyword><Keyword MajorTopicYN="Y">gut</Keyword><Keyword MajorTopicYN="Y">machine learning algorithms</Keyword><Keyword MajorTopicYN="Y">microbiota</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes mellitus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>07</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32692360</ArticleId><ArticleId IdType="pii">5871462</ArticleId><ArticleId IdType="doi">10.1210/clinem/dgaa407</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32668724</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1424-8220</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>14</Issue><PubDate><Year>2020</Year><Month>Jul</Month><Day>13</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>Deep Physiological Model for Blood Glucose Prediction in T1DM Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E3896</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/s20143896</ELocationID><Abstract><AbstractText>Accurate estimations for the near future levels of blood glucose are crucial for Type 1 Diabetes Mellitus (T1DM) patients in order to be able to react on time and avoid hypo and hyper-glycemic episodes. Accurate predictions for blood glucose are the base for control algorithms in glucose regulating systems such as the artificial pancreas. Numerous research studies have already been conducted in order to provide predictions for blood glucose levels with particularities in the input signals and underlying models used. These models can be categorized into two major families: those based on tuning glucose physiological-metabolic models and those based on learning glucose evolution patterns based on machine learning techniques. This paper reviews the state of the art in blood glucose predictions for T1DM patients and proposes, implements, validates and compares a new hybrid model that decomposes a deep machine learning model in order to mimic the metabolic behavior of physiological blood glucose methods. The differential equations for carbohydrate and insulin absorption in physiological models are modeled using a Recurrent Neural Network (RNN) implemented using Long Short-Term Memory (LSTM) cells. The results show Root Mean Square Error (RMSE) values under 5 mg/dL for simulated patients and under 10 mg/dL for real patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Munoz-Organero</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4199-2002</Identifier><AffiliationInfo><Affiliation>Telematic Engineering Department and UC3M-BS Institute of Financial Big Data, Universidad Carlos III de Madrid, Leganes, 28911 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>TIN2016-77158-C4-1-R</GrantID><Agency>Ministerio de Econom..a, Industria y Competitividad, Gobierno de Espa..a</Agency><Country/></Grant><Grant><GrantID>TIN2016-77158-C4-1-R</GrantID><Agency>European Regional Development Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">blood glucose prediction</Keyword><Keyword MajorTopicYN="N">deep machine learning</Keyword><Keyword MajorTopicYN="N">physiological models</Keyword><Keyword MajorTopicYN="N">type 1 diabetes mellitus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>06</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>07</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>07</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32668724</ArticleId><ArticleId IdType="pii">s20143896</ArticleId><ArticleId IdType="doi">10.3390/s20143896</ArticleId><ArticleId IdType="pmc">PMC7412558</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Med Biol Eng Comput. 2015 Dec;53(12):1305-18</Citation><ArticleIdList><ArticleId IdType="pubmed">25773366</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Netw. 2012 Sep;33:181-93</Citation><ArticleIdList><ArticleId IdType="pubmed">22706092</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2019 Jul;13(4):718-727</Citation><ArticleIdList><ArticleId IdType="pubmed">30654648</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Meas. 2004 Aug;25(4):905-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15382830</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:2887-2891</Citation><ArticleIdList><ArticleId IdType="pubmed">29060501</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2019 Jul;98:109-134</Citation><ArticleIdList><ArticleId IdType="pubmed">31383477</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2020 Jan;43(1):19-21</Citation><ArticleIdList><ArticleId IdType="pubmed">31862822</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Sep;2(5):792-801</Citation><ArticleIdList><ArticleId IdType="pubmed">19885262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ind Eng Chem Res. 2013 Sep 4;52(35):</Citation><ArticleIdList><ArticleId IdType="pubmed">24187436</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2020 Feb;24(2):603-613</Citation><ArticleIdList><ArticleId IdType="pubmed">30946685</ArticleId></ArticleIdList></Reference><Reference><Citation>Popul Health Manag. 2019 Jun;22(3):229-242</Citation><ArticleIdList><ArticleId IdType="pubmed">30256722</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2010 Jan;12(1):81-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20082589</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2020 Aug;22(8):562-569</Citation><ArticleIdList><ArticleId IdType="pubmed">31928415</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 Oct;54(10):1740-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17926672</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2020 Mar 19;20(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">32204318</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2012 Jun;59(6):1550-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22374344</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2003;5(3):425-38</Citation><ArticleIdList><ArticleId IdType="pubmed">12828827</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1987 Sep-Oct;10(5):622-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3677983</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Genet. 2018 Nov 06;9:515</Citation><ArticleIdList><ArticleId IdType="pubmed">30459809</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:3503-3506</Citation><ArticleIdList><ArticleId IdType="pubmed">28269053</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 May;54(5):931-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17518291</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Struct Biotechnol J. 2017 Jan 08;15:104-116</Citation><ArticleIdList><ArticleId IdType="pubmed">28138367</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2003;5(4):641-51</Citation><ArticleIdList><ArticleId IdType="pubmed">14511419</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 Apr 17;:</Citation><ArticleIdList><ArticleId IdType="pubmed">30998484</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32634869</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1598-866X</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Genomics &amp; informatics</Title><ISOAbbreviation>Genomics Inform</ISOAbbreviation></Journal><ArticleTitle>Extending TextAE for annotation of non-contiguous entities.</ArticleTitle><Pagination><MedlinePgn>e15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5808/GI.2020.18.2.e15</ELocationID><Abstract><AbstractText>Named entity recognition tools are used to identify mentions of biomedical entities in free text and are essential components of high-quality information retrieval and extraction systems. Without good entity recognition, methods will mislabel searched text and will miss important information or identify spurious text that will frustrate users. Most tools do not capture non-contiguous entities which are separate spans of text that together refer to an entity, e.g., the entity "type 1 diabetes" in the phrase "type 1 and type 2 diabetes." This type is commonly found in biomedical texts, especially in lists, where multiple biomedical entities are named in shortened form to avoid repeating words. Most text annotation systems, that enable users to view and edit entity annotations, do not support non-contiguous entities. Therefore, experts cannot even visualize non-contiguous entities, let alone annotate them to build valuable datasets for machine learning methods. To combat this problem and as part of the BLAH6 hackathon, we extended the TextAE platform to allow visualization and annotation of non-contiguous entities. This enables users to add new subspans to existing entities by selecting additional text. We integrate this new functionality with TextAE's existing editing functionality to allow easy changes to entity annotation and editing of relation annotations involving non-contiguous entities, with importing and exporting to the PubAnnotation format. Finally, we roughly quantify the problem across the entire accessible biomedical literature to highlight that there are a substantial number of non-contiguous entities that appear in lists that would be missed by most text mining systems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lever</LastName><ForeName>Jake</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, Stanford University, Stanford, CA, 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altman</LastName><ForeName>Russ</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, Stanford University, Stanford, CA, 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jin-Dong</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Database Center for Life Science, Research Organization of Information and Systems, Kashiwa 277-0871, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Genomics Inform</MedlineTA><NlmUniqueID>101223836</NlmUniqueID><ISSNLinking>1598-866X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">editor</Keyword><Keyword MajorTopicYN="N">text annotation</Keyword><Keyword MajorTopicYN="N">text mining</Keyword><Keyword MajorTopicYN="N">visualization</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>03</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32634869</ArticleId><ArticleId IdType="pii">GI.2020.18.2.e15</ArticleId><ArticleId IdType="doi">10.5808/GI.2020.18.2.e15</ArticleId><ArticleId IdType="pmc">PMC7362949</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nat Methods. 2019 Jun;16(6):505-507</Citation><ArticleIdList><ArticleId IdType="pubmed">31110280</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cheminform. 2015 Jan 19;7(Suppl 1 Text mining for chemistry and the CHEMDNER track):S3</Citation><ArticleIdList><ArticleId IdType="pubmed">25810774</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 2008;:652-63</Citation><ArticleIdList><ArticleId IdType="pubmed">18229723</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2013 Nov 15;29(22):2909-17</Citation><ArticleIdList><ArticleId IdType="pubmed">23969135</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2019 Dec 15;:</Citation><ArticleIdList><ArticleId IdType="pubmed">31838514</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 2020;25:611-622</Citation><ArticleIdList><ArticleId IdType="pubmed">31797632</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613</Citation><ArticleIdList><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2019 Jul 2;47(W1):W587-W593</Citation><ArticleIdList><ArticleId IdType="pubmed">31114887</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32607451</PMID><DateRevised><Year>2021</Year><Month>01</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2397-7523</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Diagnostic and prognostic research</Title><ISOAbbreviation>Diagn Progn Res</ISOAbbreviation></Journal><ArticleTitle>Logistic regression has similar performance to optimised machine learning algorithms in a clinical setting: application to the discrimination between type 1 and type 2 diabetes in young adults.</ArticleTitle><Pagination><MedlinePgn>6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s41512-020-00075-2</ELocationID><Abstract><AbstractText Label="Background" NlmCategory="UNASSIGNED">There is much interest in the use of prognostic and diagnostic prediction models in all areas of clinical medicine. The use of machine learning to improve prognostic and diagnostic accuracy in this area has been increasing at the expense of classic statistical models. Previous studies have compared performance between these two approaches but their findings are inconsistent and many have limitations. We aimed to compare the discrimination and calibration of seven models built using logistic regression and optimised machine learning algorithms in a clinical setting, where the number of potential predictors is often limited, and externally validate the models.</AbstractText><AbstractText Label="Methods" NlmCategory="UNASSIGNED">We trained models using logistic regression and six commonly used machine learning algorithms to predict if a patient diagnosed with diabetes has type 1 diabetes (versus type 2 diabetes). We used seven predictor variables (age, BMI, GADA islet-autoantibodies, sex, total cholesterol, HDL cholesterol and triglyceride) using a UK cohort of adult participants (aged 18-50...years) with clinically diagnosed diabetes recruited from primary and secondary care (<i>n</i> = 960, 14% with type 1 diabetes). Discrimination performance (ROC AUC), calibration and decision curve analysis of each approach was compared in a separate external validation dataset (<i>n</i> = 504, 21% with type 1 diabetes).</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">Average performance obtained in internal validation was similar in all models (ROC AUC ... 0.94). In external validation, there were very modest reductions in discrimination with AUC ROC remaining ... 0.93 for all methods. Logistic regression had the numerically highest value in external validation (ROC AUC 0.95). Logistic regression had good performance in terms of calibration and decision curve analysis. Neural network and gradient boosting machine had the best calibration performance. Both logistic regression and support vector machine had good decision curve analysis for clinical useful threshold probabilities.</AbstractText><AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Logistic regression performed as well as optimised machine algorithms to classify patients with type 1 and type 2 diabetes. This study highlights the utility of comparing traditional regression modelling to machine learning, particularly when using a small number of well understood, strong predictor variables.</AbstractText><CopyrightInformation>.. The Author(s) 2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lynam</LastName><ForeName>Anita L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, EX2 5DW UK.</Affiliation><Identifier Source="GRID">grid.8391.3</Identifier><Identifier Source="ISNI">0000 0004 1936 8024</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dennis</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, EX2 5DW UK.</Affiliation><Identifier Source="GRID">grid.8391.3</Identifier><Identifier Source="ISNI">0000 0004 1936 8024</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owen</LastName><ForeName>Katharine R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, OX3 7LE UK.</Affiliation><Identifier Source="GRID">grid.4991.5</Identifier><Identifier Source="ISNI">0000 0004 1936 8948</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Foundation Trust, John Radcliffe Hospital, Oxford, UK.</Affiliation><Identifier Source="GRID">grid.8348.7</Identifier><Identifier Source="ISNI">0000 0001 2306 7492</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oram</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, EX2 5DW UK.</Affiliation><Identifier Source="GRID">grid.8391.3</Identifier><Identifier Source="ISNI">0000 0004 1936 8024</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Angus G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, EX2 5DW UK.</Affiliation><Identifier Source="GRID">grid.8391.3</Identifier><Identifier Source="ISNI">0000 0004 1936 8024</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shields</LastName><ForeName>Beverley M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, EX2 5DW UK.</Affiliation><Identifier Source="GRID">grid.8391.3</Identifier><Identifier Source="ISNI">0000 0004 1936 8024</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrat</LastName><ForeName>Lauric A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, EX2 5DW UK.</Affiliation><Identifier Source="GRID">grid.8391.3</Identifier><Identifier Source="ISNI">0000 0004 1936 8024</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DRF-2010-03-72</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Diagn Progn Res</MedlineTA><NlmUniqueID>101718985</NlmUniqueID><ISSNLinking>2397-7523</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Logistic regression</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Model selection</Keyword></KeywordList><CoiStatement>Competing interestsThe authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>08</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>03</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32607451</ArticleId><ArticleId IdType="doi">10.1186/s41512-020-00075-2</ArticleId><ArticleId IdType="pii">75</ArticleId><ArticleId IdType="pmc">PMC7318367</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Health Informatics J. 2020 Mar;26(1):34-44</Citation><ArticleIdList><ArticleId IdType="pubmed">30488755</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Manag Res. 2018 Nov 26;10:6317-6324</Citation><ArticleIdList><ArticleId IdType="pubmed">30568493</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2019 Jun;110:12-22</Citation><ArticleIdList><ArticleId IdType="pubmed">30763612</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2001 Feb;34(1):28-36</Citation><ArticleIdList><ArticleId IdType="pubmed">11376540</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2016 Oct 11;11(10):e0163942</Citation><ArticleIdList><ArticleId IdType="pubmed">27727289</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1645-56</Citation><ArticleIdList><ArticleId IdType="pubmed">23956026</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Neural Netw. 1995;6(1):273-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18263309</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2015 Mar 17;5(3):e007825</Citation><ArticleIdList><ArticleId IdType="pubmed">25783428</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2012 May;55(5):1265-72</Citation><ArticleIdList><ArticleId IdType="pubmed">22218698</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2018 Jul 3;320(1):27-28</Citation><ArticleIdList><ArticleId IdType="pubmed">29813156</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann R Coll Surg Engl. 2015 Mar;97(2):137-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25723691</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2006 Nov 25;333(7578):1091</Citation><ArticleIdList><ArticleId IdType="pubmed">17032691</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Emerg Med. 2005 Nov;46(5):431-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16271675</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 2010 May 19;102(10):680-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20427433</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2010 Dec 09;341:c6624</Citation><ArticleIdList><ArticleId IdType="pubmed">21148212</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jun 18;9(6):e98587</Citation><ArticleIdList><ArticleId IdType="pubmed">24940623</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2008 Feb 12;117(6):743-53</Citation><ArticleIdList><ArticleId IdType="pubmed">18212285</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Nov 28;343:d7163</Citation><ArticleIdList><ArticleId IdType="pubmed">22123912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2007 Jan 27;369(9558):283-92</Citation><ArticleIdList><ArticleId IdType="pubmed">17258668</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2018 Apr 3;319(13):1317-1318</Citation><ArticleIdList><ArticleId IdType="pubmed">29532063</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2010 Aug;27(8):887-95</Citation><ArticleIdList><ArticleId IdType="pubmed">20653746</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2016 May 16;353:i2416</Citation><ArticleIdList><ArticleId IdType="pubmed">27184143</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Decis Making. 2006 Nov-Dec;26(6):565-74</Citation><ArticleIdList><ArticleId IdType="pubmed">17099194</ArticleId></ArticleIdList></Reference><Reference><Citation>Ultrasound Obstet Gynecol. 2017 Sep;50(3):342-346</Citation><ArticleIdList><ArticleId IdType="pubmed">28436125</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2019 Aug 22;23(1):284</Citation><ArticleIdList><ArticleId IdType="pubmed">31439010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Transl Med. 2018 Aug;6(15):308</Citation><ArticleIdList><ArticleId IdType="pubmed">30211196</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2012 Jun;35(6):1206-12</Citation><ArticleIdList><ArticleId IdType="pubmed">22432108</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2008 Dec 1;113(11):3075-99</Citation><ArticleIdList><ArticleId IdType="pubmed">18823041</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Struct Biotechnol J. 2014 Nov 15;13:8-17</Citation><ArticleIdList><ArticleId IdType="pubmed">25750696</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 1998 Nov 15;17(21):2501-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9819841</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Med Inform. 2018 Nov;119:22-38</Citation><ArticleIdList><ArticleId IdType="pubmed">30342683</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Res Methodol. 2011 Oct 25;11:143</Citation><ArticleIdList><ArticleId IdType="pubmed">22026551</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):368-75</Citation><ArticleIdList><ArticleId IdType="pubmed">26152680</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Decis Making. 2001 Jan-Feb;21(1):45-56</Citation><ArticleIdList><ArticleId IdType="pubmed">11206946</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2019 Mar 1;2(3):e190968</Citation><ArticleIdList><ArticleId IdType="pubmed">30901048</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Res Methodol. 2014 Dec 22;14:137</Citation><ArticleIdList><ArticleId IdType="pubmed">25532820</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2010 Feb;137(2):263-72</Citation><ArticleIdList><ArticleId IdType="pubmed">19762550</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2018 Aug 3;1(4):e181018</Citation><ArticleIdList><ArticleId IdType="pubmed">30646095</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Cardiol. 2017 Feb 1;2(2):204-209</Citation><ArticleIdList><ArticleId IdType="pubmed">27784047</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2012 Sep 18;345:e5900</Citation><ArticleIdList><ArticleId IdType="pubmed">22990994</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Struct Biotechnol J. 2017 Jan 08;15:104-116</Citation><ArticleIdList><ArticleId IdType="pubmed">28138367</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32499887</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2037-7452</ISSN><JournalIssue CitedMedium="Print"><Volume>30</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>07</Day></PubDate></JournalIssue><Title>European journal of translational myology</Title><ISOAbbreviation>Eur J Transl Myol</ISOAbbreviation></Journal><ArticleTitle>Thirty years of translational research in Mobility Medicine: Collection of abstracts of the 2020 Padua Muscle Days.</ArticleTitle><Pagination><MedlinePgn>8826</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4081/ejtm.2019.8826</ELocationID><Abstract><AbstractText>More than half a century of skeletal muscle research is continuing at Padua University (Italy) under the auspices of the Interdepartmental Research Centre of Myology (CIR-Myo), the European Journal of Translational Myology (EJTM) and recently also with the support of the A&amp;CM-C Foundation for Translational Myology, Padova, Italy. The Volume 30(1), 2020 of the EJTM opens with the collection of abstracts for the conference "2020 Padua Muscle Days: Mobility Medicine 30 years of Translational Research". This is an international conference that will be held between March 18-21, 2020 in Euganei Hills and Padova in Italy. The abstracts are excellent examples of translational research and of the multidimensional approaches that are needed to classify and manage (in both the acute and chronic phases) diseases of Mobility that span from neurologic, metabolic and traumatic syndromes to the biological process of aging. One of the typical aim of Physical Medicine and Rehabilitation is indeed to reduce pain and increase mobility enough to enable impaired persons to walk freely, garden, and drive again. The excellent contents of this Collection of Abstracts reflect the high scientific caliber of researchers and clinicians who are eager to present their results at the PaduaMuscleDays. A series of EJTM Communications will also add to this preliminary evidence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carraro</LastName><ForeName>Ugo</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Interdepartmental Research Centre of Myology (CIR-Myo), Department of Biomedical Sciences, University of Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>A&amp;C M-C Foundation for Translational Myology, Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Eur J Transl Myol</MedlineTA><NlmUniqueID>101576208</NlmUniqueID><ISSNLinking>2037-7452</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">%MVC</Keyword><Keyword MajorTopicYN="N">2020 Padua Muscle Days</Keyword><Keyword MajorTopicYN="N">3D strain imaging</Keyword><Keyword MajorTopicYN="N">Aging</Keyword><Keyword MajorTopicYN="N">Aging Muscle</Keyword><Keyword MajorTopicYN="N">Aging muscle</Keyword><Keyword MajorTopicYN="N">Amyotrophic Lateral Sclerosis</Keyword><Keyword MajorTopicYN="N">Anti-oxidant</Keyword><Keyword MajorTopicYN="N">BME</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">C. elegans</Keyword><Keyword MajorTopicYN="N">C2C12 Myotubes</Keyword><Keyword MajorTopicYN="N">CTX</Keyword><Keyword MajorTopicYN="N">Ca2+ entry unit (CEU)</Keyword><Keyword MajorTopicYN="N">Central Core Disease (CCD)</Keyword><Keyword MajorTopicYN="N">Color Computed Tomography</Keyword><Keyword MajorTopicYN="N">Computed Tomography</Keyword><Keyword MajorTopicYN="N">EDA</Keyword><Keyword MajorTopicYN="N">ETFDH</Keyword><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Electrostimulation</Keyword><Keyword MajorTopicYN="N">Extra-cellular matrix</Keyword><Keyword MajorTopicYN="N">FBXL4</Keyword><Keyword MajorTopicYN="N">FES</Keyword><Keyword MajorTopicYN="N">FPP..</Keyword><Keyword MajorTopicYN="N">Fermented Papaya</Keyword><Keyword MajorTopicYN="N">Fermented papaya product</Keyword><Keyword MajorTopicYN="N">Functional Electrical Stimulation (FES)</Keyword><Keyword MajorTopicYN="N">Gymnastic</Keyword><Keyword MajorTopicYN="N">HERG Expression</Keyword><Keyword MajorTopicYN="N">IL-10</Keyword><Keyword MajorTopicYN="N">IL-17</Keyword><Keyword MajorTopicYN="N">IL-4</Keyword><Keyword MajorTopicYN="N">IMMUNAGE</Keyword><Keyword MajorTopicYN="N">Interferon gamma</Keyword><Keyword MajorTopicYN="N">M. Zygomaticus</Keyword><Keyword MajorTopicYN="N">Masters World records</Keyword><Keyword MajorTopicYN="N">Mitochondria</Keyword><Keyword MajorTopicYN="N">Mitochondrial disease</Keyword><Keyword MajorTopicYN="N">Mobility Medicine</Keyword><Keyword MajorTopicYN="N">Multiple Sclerosis</Keyword><Keyword MajorTopicYN="N">Multiple acyl-CoA dehydrogenase deficiency</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword><Keyword MajorTopicYN="N">Muscle architecture</Keyword><Keyword MajorTopicYN="N">Muscle spindle</Keyword><Keyword MajorTopicYN="N">Neuromuscular diseases</Keyword><Keyword MajorTopicYN="N">Neurotrophins</Keyword><Keyword MajorTopicYN="N">Neutral lipid storage disease with myopathy</Keyword><Keyword MajorTopicYN="N">Nutrition</Keyword><Keyword MajorTopicYN="N">P300</Keyword><Keyword MajorTopicYN="N">P50</Keyword><Keyword MajorTopicYN="N">PABPN1</Keyword><Keyword MajorTopicYN="N">Padova Anatomy School</Keyword><Keyword MajorTopicYN="N">Performance</Keyword><Keyword MajorTopicYN="N">Physical Activity</Keyword><Keyword MajorTopicYN="N">Preventive Medicine</Keyword><Keyword MajorTopicYN="N">QOL for seniors</Keyword><Keyword MajorTopicYN="N">Ryanodine Receptor type-1 (RYR1)</Keyword><Keyword MajorTopicYN="N">SCL</Keyword><Keyword MajorTopicYN="N">SCR</Keyword><Keyword MajorTopicYN="N">Spinal Cord Injury</Keyword><Keyword MajorTopicYN="N">Telomeres</Keyword><Keyword MajorTopicYN="N">Transcranial direct current stimulation (tDCS)</Keyword><Keyword MajorTopicYN="N">Transcutaneous vagus nerve stimulation (tANS)</Keyword><Keyword MajorTopicYN="N">UPP</Keyword><Keyword MajorTopicYN="N">VO2max</Keyword><Keyword MajorTopicYN="N">Vitamin C</Keyword><Keyword MajorTopicYN="N">Wartenberg pendulum test</Keyword><Keyword MajorTopicYN="N">acetylcholine receptors</Keyword><Keyword MajorTopicYN="N">adipose content</Keyword><Keyword MajorTopicYN="N">adipose triglyceride lipase</Keyword><Keyword MajorTopicYN="N">age</Keyword><Keyword MajorTopicYN="N">ageing</Keyword><Keyword MajorTopicYN="N">aging</Keyword><Keyword MajorTopicYN="N">aging muscle</Keyword><Keyword MajorTopicYN="N">agonist</Keyword><Keyword MajorTopicYN="N">arousal</Keyword><Keyword MajorTopicYN="N">atrophy</Keyword><Keyword MajorTopicYN="N">atrophy and flattening</Keyword><Keyword MajorTopicYN="N">auricular nerve</Keyword><Keyword MajorTopicYN="N">bed rest</Keyword><Keyword MajorTopicYN="N">biology of aging</Keyword><Keyword MajorTopicYN="N">blood contamination</Keyword><Keyword MajorTopicYN="N">brain aging</Keyword><Keyword MajorTopicYN="N">calcium</Keyword><Keyword MajorTopicYN="N">cancer cachexia</Keyword><Keyword MajorTopicYN="N">cancer prevention</Keyword><Keyword MajorTopicYN="N">capsule</Keyword><Keyword MajorTopicYN="N">cardiovascular conditions</Keyword><Keyword MajorTopicYN="N">circulating myokines</Keyword><Keyword MajorTopicYN="N">clinical outcomes</Keyword><Keyword MajorTopicYN="N">cochlea</Keyword><Keyword MajorTopicYN="N">cochlear implant</Keyword><Keyword MajorTopicYN="N">cognitive aging</Keyword><Keyword MajorTopicYN="N">comorbidities</Keyword><Keyword MajorTopicYN="N">compressed sensing</Keyword><Keyword MajorTopicYN="N">connective tissue</Keyword><Keyword MajorTopicYN="N">connective tissue content</Keyword><Keyword MajorTopicYN="N">control of energy metabolism</Keyword><Keyword MajorTopicYN="N">cortisol</Keyword><Keyword MajorTopicYN="N">cvxEDA</Keyword><Keyword MajorTopicYN="N">cymba conchae</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">denervated degenerating muscle</Keyword><Keyword MajorTopicYN="N">denervation</Keyword><Keyword MajorTopicYN="N">dietary phosphorus overload</Keyword><Keyword MajorTopicYN="N">diffusion MRI</Keyword><Keyword MajorTopicYN="N">diffusion modeling</Keyword><Keyword MajorTopicYN="N">dynamic MRI</Keyword><Keyword MajorTopicYN="N">early aging</Keyword><Keyword MajorTopicYN="N">electric stimulation</Keyword><Keyword MajorTopicYN="N">electromyography</Keyword><Keyword MajorTopicYN="N">endocannabinoid</Keyword><Keyword MajorTopicYN="N">endoplasmic reticulum stress</Keyword><Keyword MajorTopicYN="N">endurance</Keyword><Keyword MajorTopicYN="N">endurance exercise</Keyword><Keyword MajorTopicYN="N">energy metabolism</Keyword><Keyword MajorTopicYN="N">epicatechins</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">excitation contraction (EC) coupling</Keyword><Keyword MajorTopicYN="N">excitation-contraction (EC) coupling</Keyword><Keyword MajorTopicYN="N">exercise</Keyword><Keyword MajorTopicYN="N">fascia</Keyword><Keyword MajorTopicYN="N">fasciae</Keyword><Keyword MajorTopicYN="N">fatty acid oxidation</Keyword><Keyword MajorTopicYN="N">fermented papaya preparation</Keyword><Keyword MajorTopicYN="N">fibrinogen</Keyword><Keyword MajorTopicYN="N">finite element model</Keyword><Keyword MajorTopicYN="N">functional recovery</Keyword><Keyword MajorTopicYN="N">gender differences</Keyword><Keyword MajorTopicYN="N">gene upregulation</Keyword><Keyword MajorTopicYN="N">growth factors</Keyword><Keyword MajorTopicYN="N">health</Keyword><Keyword MajorTopicYN="N">high density EEG</Keyword><Keyword MajorTopicYN="N">home Functional Electrical Stimulation</Keyword><Keyword MajorTopicYN="N">home-based full-body in-bed gym</Keyword><Keyword MajorTopicYN="N">hyaluronan</Keyword><Keyword MajorTopicYN="N">hypogonadism</Keyword><Keyword MajorTopicYN="N">imaging flow cytometry</Keyword><Keyword MajorTopicYN="N">immobilization</Keyword><Keyword MajorTopicYN="N">label-free microscopy</Keyword><Keyword MajorTopicYN="N">lipid droplets</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">mdx mouse</Keyword><Keyword MajorTopicYN="N">mechanics</Keyword><Keyword MajorTopicYN="N">microRNAs</Keyword><Keyword MajorTopicYN="N">mitObesity</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">mitochondrial Ca2+ signalling</Keyword><Keyword MajorTopicYN="N">mitochondrial database</Keyword><Keyword MajorTopicYN="N">mitochondrial fusion and fission</Keyword><Keyword MajorTopicYN="N">mitochondrial metabolism</Keyword><Keyword MajorTopicYN="N">mitochondrial permeability transition pore</Keyword><Keyword MajorTopicYN="N">mitochondrial respiration</Keyword><Keyword MajorTopicYN="N">mitochondrial respiratory capacity</Keyword><Keyword MajorTopicYN="N">mitochondrial transplantation</Keyword><Keyword MajorTopicYN="N">mouse models</Keyword><Keyword MajorTopicYN="N">mouth fluids</Keyword><Keyword MajorTopicYN="N">multi arrays electrodes</Keyword><Keyword MajorTopicYN="N">muscle</Keyword><Keyword MajorTopicYN="N">muscle and neural fatigue</Keyword><Keyword MajorTopicYN="N">muscle atrophy</Keyword><Keyword MajorTopicYN="N">muscle co-activation</Keyword><Keyword MajorTopicYN="N">muscle fiber conduction velocity</Keyword><Keyword MajorTopicYN="N">muscle regeneration</Keyword><Keyword MajorTopicYN="N">muscle tendon-unit</Keyword><Keyword MajorTopicYN="N">muscle trophism</Keyword><Keyword MajorTopicYN="N">muscle ultrasound</Keyword><Keyword MajorTopicYN="N">muscle wasting</Keyword><Keyword MajorTopicYN="N">muscles</Keyword><Keyword MajorTopicYN="N">myomiRs</Keyword><Keyword MajorTopicYN="N">nanotechno- logical devices</Keyword><Keyword MajorTopicYN="N">natural products</Keyword><Keyword MajorTopicYN="N">neuromuscular activity</Keyword><Keyword MajorTopicYN="N">neuromuscular junction</Keyword><Keyword MajorTopicYN="N">neuromuscular maladaptation</Keyword><Keyword MajorTopicYN="N">non-coding RNAs</Keyword><Keyword MajorTopicYN="N">non-invasive analyses</Keyword><Keyword MajorTopicYN="N">nucelar aggregates</Keyword><Keyword MajorTopicYN="N">numerical model</Keyword><Keyword MajorTopicYN="N">oculopharyngeal muscular dystrophy</Keyword><Keyword MajorTopicYN="N">older adults</Keyword><Keyword MajorTopicYN="N">older and oldest persons</Keyword><Keyword MajorTopicYN="N">oxytocin</Keyword><Keyword MajorTopicYN="N">pain</Keyword><Keyword MajorTopicYN="N">peripheral effect</Keyword><Keyword MajorTopicYN="N">permeabilized muscle fibers</Keyword><Keyword MajorTopicYN="N">platinum electrodes</Keyword><Keyword MajorTopicYN="N">postural exercise program</Keyword><Keyword MajorTopicYN="N">power</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">radiodensity</Keyword><Keyword MajorTopicYN="N">rate of performance decay</Keyword><Keyword MajorTopicYN="N">reactive oxygen species</Keyword><Keyword MajorTopicYN="N">reference values</Keyword><Keyword MajorTopicYN="N">rehabilitation</Keyword><Keyword MajorTopicYN="N">rejuvenation</Keyword><Keyword MajorTopicYN="N">reliability</Keyword><Keyword MajorTopicYN="N">reproducibility crisis</Keyword><Keyword MajorTopicYN="N">riboflavin</Keyword><Keyword MajorTopicYN="N">sarcomere</Keyword><Keyword MajorTopicYN="N">sarcopenia</Keyword><Keyword MajorTopicYN="N">sarcoplasmic reticulum (SR)</Keyword><Keyword MajorTopicYN="N">schizophrenia</Keyword><Keyword MajorTopicYN="N">seniors</Keyword><Keyword MajorTopicYN="N">serological biomarkers</Keyword><Keyword MajorTopicYN="N">serum proteins</Keyword><Keyword MajorTopicYN="N">shear wave elastography</Keyword><Keyword MajorTopicYN="N">single myofiber</Keyword><Keyword MajorTopicYN="N">skeletal muscle</Keyword><Keyword MajorTopicYN="N">skeletal muscle atrophy</Keyword><Keyword MajorTopicYN="N">skin</Keyword><Keyword MajorTopicYN="N">spasticity</Keyword><Keyword MajorTopicYN="N">spinal cord injury</Keyword><Keyword MajorTopicYN="N">spinal muscular atrophy</Keyword><Keyword MajorTopicYN="N">stem cells</Keyword><Keyword MajorTopicYN="N">store-operated Ca2+ entry (SOCE)</Keyword><Keyword MajorTopicYN="N">strategies</Keyword><Keyword MajorTopicYN="N">strength</Keyword><Keyword MajorTopicYN="N">strength and resistance training</Keyword><Keyword MajorTopicYN="N">stress</Keyword><Keyword MajorTopicYN="N">stroke</Keyword><Keyword MajorTopicYN="N">super-aging society</Keyword><Keyword MajorTopicYN="N">survival motor neuron 1</Keyword><Keyword MajorTopicYN="N">testosterone</Keyword><Keyword MajorTopicYN="N">training</Keyword><Keyword MajorTopicYN="N">transcranial magnetic stimulation</Keyword><Keyword MajorTopicYN="N">translational research</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword><Keyword MajorTopicYN="N">ultrasound</Keyword><Keyword MajorTopicYN="N">unilateral facial paralysis</Keyword><Keyword MajorTopicYN="N">variability</Keyword><Keyword MajorTopicYN="N">vasopressin</Keyword><Keyword MajorTopicYN="N">vesicles</Keyword><Keyword MajorTopicYN="N">young people...s education</Keyword><Keyword MajorTopicYN="N">zebrafish</Keyword><Keyword MajorTopicYN="N">...anti-aging...</Keyword></KeywordList><CoiStatement>Author confirms that he have read the Journal...s position on issues involved in ethical publication and affirms that this report is consistent with those guidelines.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32499887</ArticleId><ArticleId IdType="doi">10.4081/ejtm.2019.8826</ArticleId><ArticleId IdType="pmc">PMC7254447</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aging Cell. 2019 Jun;18(3):e12953</Citation><ArticleIdList><ArticleId IdType="pubmed">30916479</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2015 Jan 15;31(2):166-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25260700</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Protein Pept Sci. 2018;19(7):673-680</Citation><ArticleIdList><ArticleId IdType="pubmed">27875962</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2014;2014:121254</Citation><ArticleIdList><ArticleId IdType="pubmed">25197630</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2004 Oct 1;70(2-3):315-29</Citation><ArticleIdList><ArticleId IdType="pubmed">15329307</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Cancer Biol. 2017 Apr;43:111-118</Citation><ArticleIdList><ArticleId IdType="pubmed">28088584</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 May 08;9(5):e96440</Citation><ArticleIdList><ArticleId IdType="pubmed">24810991</ArticleId></ArticleIdList></Reference><Reference><Citation>Cells. 2019 Mar 11;8(3):</Citation><ArticleIdList><ArticleId IdType="pubmed">30862132</ArticleId></ArticleIdList></Reference><Reference><Citation>J Electromyogr Kinesiol. 2008 Dec;18(6):879-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19004645</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Med Sci Sports. 2015 Dec;25 Suppl 4:126-34</Citation><ArticleIdList><ArticleId IdType="pubmed">26589126</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Exp Med Biol. 2018;1088:585-591</Citation><ArticleIdList><ArticleId IdType="pubmed">30390271</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2018 Nov 16;28(4):7905</Citation><ArticleIdList><ArticleId IdType="pubmed">30662701</ArticleId></ArticleIdList></Reference><Reference><Citation>J Enzyme Inhib Med Chem. 2017 Dec;32(1):363-368</Citation><ArticleIdList><ArticleId IdType="pubmed">28095711</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2016 Aug 05;26(3):6221</Citation><ArticleIdList><ArticleId IdType="pubmed">27990246</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2019 Jun 12;10(1):2576</Citation><ArticleIdList><ArticleId IdType="pubmed">31189900</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2019 Dec 19;17(12):e3000553</Citation><ArticleIdList><ArticleId IdType="pubmed">31856161</ArticleId></ArticleIdList></Reference><Reference><Citation>Ultrasound Med Biol. 2018 Dec;44(12):2492-2504</Citation><ArticleIdList><ArticleId IdType="pubmed">30185385</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Physiol. 1994;56:509-34</Citation><ArticleIdList><ArticleId IdType="pubmed">8010750</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2018 Feb 15;378(7):625-635</Citation><ArticleIdList><ArticleId IdType="pubmed">29443664</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurorehabil Neural Repair. 2010 Oct;24(8):709-21</Citation><ArticleIdList><ArticleId IdType="pubmed">20460493</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 2015 May;73(5):1852-63</Citation><ArticleIdList><ArticleId IdType="pubmed">25046255</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Bull. 2007 Jul 12;73(4-6):155-202</Citation><ArticleIdList><ArticleId IdType="pubmed">17562384</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Behav. 2012 May 15;106(2):298-304</Citation><ArticleIdList><ArticleId IdType="pubmed">22330325</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2014 May 21;24(3):2221</Citation><ArticleIdList><ArticleId IdType="pubmed">26913133</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Dev. 2011 Sep 15;25(18):1915-27</Citation><ArticleIdList><ArticleId IdType="pubmed">21890647</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2018;1782:31-70</Citation><ArticleIdList><ArticleId IdType="pubmed">29850993</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2015 Sep 23;25(4):253-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26913165</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neurosci. 2017 Jan 20;10:609</Citation><ArticleIdList><ArticleId IdType="pubmed">28163670</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 2007 Dec;58(6):1182-95</Citation><ArticleIdList><ArticleId IdType="pubmed">17969013</ArticleId></ArticleIdList></Reference><Reference><Citation>JIMD Rep. 2018;38:33-40</Citation><ArticleIdList><ArticleId IdType="pubmed">28456887</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Metastasis Rev. 2019 Jun;38(1-2):205-222</Citation><ArticleIdList><ArticleId IdType="pubmed">30911978</ArticleId></ArticleIdList></Reference><Reference><Citation>Histochem Cell Biol. 1998 Aug;110(2):179-82</Citation><ArticleIdList><ArticleId IdType="pubmed">9720990</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Physiol (1985). 2018 Sep 13;:</Citation><ArticleIdList><ArticleId IdType="pubmed">30212307</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 2014 Nov;184(11):3094-104</Citation><ArticleIdList><ArticleId IdType="pubmed">25174878</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2019 Dec 10;29(4):8713</Citation><ArticleIdList><ArticleId IdType="pubmed">31908751</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2016 Jun 22;26(2):6015</Citation><ArticleIdList><ArticleId IdType="pubmed">27478562</ArticleId></ArticleIdList></Reference><Reference><Citation>Histochem J. 1990 Dec;22(12):677-82</Citation><ArticleIdList><ArticleId IdType="pubmed">1706695</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Med Child Neurol. 2000 Mar;42(3):182-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10755458</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurol Res. 2018 Apr;40(4):277-282</Citation><ArticleIdList><ArticleId IdType="pubmed">29447083</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Aging Neurosci. 2014 Jul 24;6:189</Citation><ArticleIdList><ArticleId IdType="pubmed">25104935</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2014 Sep 22;24(3):3790</Citation><ArticleIdList><ArticleId IdType="pubmed">26913138</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Appl Physiol. 2011 Mar;111(3):403-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20617334</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Mol Sci. 2019 Aug 27;20(17):</Citation><ArticleIdList><ArticleId IdType="pubmed">31461843</ArticleId></ArticleIdList></Reference><Reference><Citation>J Physiol. 2017 May 1;595(9):2931-2939</Citation><ArticleIdList><ArticleId IdType="pubmed">27234805</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuropathol Exp Neurol. 2004 Sep;63(9):919-31</Citation><ArticleIdList><ArticleId IdType="pubmed">15453091</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2013 Sep 5;93(3):471-81</Citation><ArticleIdList><ArticleId IdType="pubmed">23993193</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Histochem. 2016 Jun 28;60(2):2643</Citation><ArticleIdList><ArticleId IdType="pubmed">27349320</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Biochem Cell Biol. 2009 Oct;41(10):1837-45</Citation><ArticleIdList><ArticleId IdType="pubmed">19467914</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Physiol. 1983 Mar;114(3):346-64</Citation><ArticleIdList><ArticleId IdType="pubmed">6601109</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Imaging. 2015 Jul;33(6):709-17</Citation><ArticleIdList><ArticleId IdType="pubmed">25839394</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Res. 2020 Feb 28;126(5):589-599</Citation><ArticleIdList><ArticleId IdType="pubmed">32078436</ArticleId></ArticleIdList></Reference><Reference><Citation>Mech Ageing Dev. 2017 Jun;164:61-66</Citation><ArticleIdList><ArticleId IdType="pubmed">28431907</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2016 Apr 14;17:67</Citation><ArticleIdList><ArticleId IdType="pubmed">27081004</ArticleId></ArticleIdList></Reference><Reference><Citation>Future Med Chem. 2009 Oct;1(7):1333-49</Citation><ArticleIdList><ArticleId IdType="pubmed">20191092</ArticleId></ArticleIdList></Reference><Reference><Citation>Colloids Surf B Biointerfaces. 2019 Jan 1;173:400-406</Citation><ArticleIdList><ArticleId IdType="pubmed">30321797</ArticleId></ArticleIdList></Reference><Reference><Citation>Aging Cell. 2019 Jun;18(3):e12954</Citation><ArticleIdList><ArticleId IdType="pubmed">30953403</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Musculoskelet Disord. 2014 Jun 17;15:209</Citation><ArticleIdList><ArticleId IdType="pubmed">24939372</ArticleId></ArticleIdList></Reference><Reference><Citation>Orphanet J Rare Dis. 2017 May 12;12(1):90</Citation><ArticleIdList><ArticleId IdType="pubmed">28499397</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscles Ligaments Tendons J. 2018 Apr 16;7(4):573-581</Citation><ArticleIdList><ArticleId IdType="pubmed">29721459</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychoneuroendocrinology. 2019 Jul;105:164-171</Citation><ArticleIdList><ArticleId IdType="pubmed">30826163</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 May 31;6:26991</Citation><ArticleIdList><ArticleId IdType="pubmed">27244599</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Anat. 2019 Oct;32(7):948-960</Citation><ArticleIdList><ArticleId IdType="pubmed">31301253</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Physiol Cell Physiol. 2011 Nov;301(5):C1128-39</Citation><ArticleIdList><ArticleId IdType="pubmed">21849670</ArticleId></ArticleIdList></Reference><Reference><Citation>Obes Rev. 2018 Apr;19(4):557-575</Citation><ArticleIdList><ArticleId IdType="pubmed">29356299</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2016 Sep 24;388(10051):1255-6</Citation><ArticleIdList><ArticleId IdType="pubmed">27475275</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2013 May;98(5):1891-900</Citation><ArticleIdList><ArticleId IdType="pubmed">23533227</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1994 Jun 1;35(11):850-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8054407</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2013;4:2805</Citation><ArticleIdList><ArticleId IdType="pubmed">24241282</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rehabil Med. 2012 Nov;44(11):991-2</Citation><ArticleIdList><ArticleId IdType="pubmed">23069862</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutrients. 2019 Jun 30;11(7):</Citation><ArticleIdList><ArticleId IdType="pubmed">31262054</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancers (Basel). 2019 Jan 20;11(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">30669508</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Metab. 2017 Nov;35(6):598-607</Citation><ArticleIdList><ArticleId IdType="pubmed">27838794</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Struct Funct. 2009;34(2):77-88</Citation><ArticleIdList><ArticleId IdType="pubmed">19622873</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mutat. 2003 Jul;22(1):12-23</Citation><ArticleIdList><ArticleId IdType="pubmed">12815589</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 2018 Nov;80(5):2094-2108</Citation><ArticleIdList><ArticleId IdType="pubmed">29577406</ArticleId></ArticleIdList></Reference><Reference><Citation>Skelet Muscle. 2020 Jan 16;10(1):1</Citation><ArticleIdList><ArticleId IdType="pubmed">31948476</ArticleId></ArticleIdList></Reference><Reference><Citation>Contemp Clin Trials. 2018 Feb;65:19-32</Citation><ArticleIdList><ArticleId IdType="pubmed">29313802</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Jun 19;476(7360):336-40</Citation><ArticleIdList><ArticleId IdType="pubmed">21685888</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Nov 2;377(18):1713-1722</Citation><ArticleIdList><ArticleId IdType="pubmed">29091557</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2013 Sep 5;93(3):482-95</Citation><ArticleIdList><ArticleId IdType="pubmed">23993194</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2017 Sep 23;390(10101):1489-1498</Citation><ArticleIdList><ArticleId IdType="pubmed">28728956</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cachexia Sarcopenia Muscle. 2014 Mar;5(1):1-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24595459</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 Aug 13;13(8):e0201764</Citation><ArticleIdList><ArticleId IdType="pubmed">30102724</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychophysiology. 2012 Aug;49(8):1017-34</Citation><ArticleIdList><ArticleId IdType="pubmed">22680988</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2016 Nov 25;26(4):6125</Citation><ArticleIdList><ArticleId IdType="pubmed">28078070</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Pharmacol. 2015 Jun;22:100-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25974750</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Dis. 2011 Aug 18;2:e193</Citation><ArticleIdList><ArticleId IdType="pubmed">21850047</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2014 Mar 27;24(1):3298</Citation><ArticleIdList><ArticleId IdType="pubmed">26913129</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurol Res. 2017 Jul;39(7):660-666</Citation><ArticleIdList><ArticleId IdType="pubmed">28403681</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neuropathol. 2016 Jan-Feb;35(1):22-30</Citation><ArticleIdList><ArticleId IdType="pubmed">26588026</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Mater Res B Appl Biomater. 2015 Jul;103(5):1013-22</Citation><ArticleIdList><ArticleId IdType="pubmed">25220821</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2016 Nov 25;26(4):5972</Citation><ArticleIdList><ArticleId IdType="pubmed">28078066</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2011 Jun;12(4 Pt 1):345-64</Citation><ArticleIdList><ArticleId IdType="pubmed">20860561</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neurosci. 2019 Dec 10;13:1279</Citation><ArticleIdList><ArticleId IdType="pubmed">31920475</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2018 Nov 07;28(4):7732</Citation><ArticleIdList><ArticleId IdType="pubmed">30662695</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Physiol (1985). 2014 Aug 15;117(4):363-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24994884</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Physiol (1985). 1999 Sep;87(3):1003-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10484570</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2017 Mar 27;27(1):6483</Citation><ArticleIdList><ArticleId IdType="pubmed">28458808</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2006 May 26;312(5777):1220-3</Citation><ArticleIdList><ArticleId IdType="pubmed">16645049</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 May 25;533(7604):452-4</Citation><ArticleIdList><ArticleId IdType="pubmed">27225100</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Gerontol. 2013 Jan;48(1):69-75</Citation><ArticleIdList><ArticleId IdType="pubmed">22433628</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2016 Jun 22;26(2):6008</Citation><ArticleIdList><ArticleId IdType="pubmed">27478561</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res Cogn. 2015 Sep 09;2(3):166-169</Citation><ArticleIdList><ArticleId IdType="pubmed">29379766</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Rehabil. 2000 Aug;14(4):402-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10945424</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2014 Oct 24;453(3):368-74</Citation><ArticleIdList><ArticleId IdType="pubmed">25264200</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2018 Sep;24(10):1356-1365</Citation><ArticleIdList><ArticleId IdType="pubmed">28752800</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2015 Mar 11;25(2):4910</Citation><ArticleIdList><ArticleId IdType="pubmed">26913151</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Genet Metab. 2015 Jun-Jul;115(2-3):110-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25956450</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2016 Sep 24;388(10051):1254-5</Citation><ArticleIdList><ArticleId IdType="pubmed">27475269</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2016 Apr;63(4):797-804</Citation><ArticleIdList><ArticleId IdType="pubmed">26336110</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2009 Nov;1787(11):1309-16</Citation><ArticleIdList><ArticleId IdType="pubmed">19413950</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Sports Physiol Perform. 2019 Sep 1;14(8):1015-1021</Citation><ArticleIdList><ArticleId IdType="pubmed">31172832</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2015 Aug 24;25(3):5184</Citation><ArticleIdList><ArticleId IdType="pubmed">26913156</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Differ. 2019 Jan;26(2):362-381</Citation><ArticleIdList><ArticleId IdType="pubmed">30232375</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2014;2014:168407</Citation><ArticleIdList><ArticleId IdType="pubmed">24877061</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2006 Apr 8;332(7545):808</Citation><ArticleIdList><ArticleId IdType="pubmed">16601021</ArticleId></ArticleIdList></Reference><Reference><Citation>Antioxid Redox Signal. 2011 Nov 1;15(9):2529-41</Citation><ArticleIdList><ArticleId IdType="pubmed">21539480</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Organs. 2005 Mar;29(3):203-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15725217</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytotherapy. 2018 Feb;20(2):189-203</Citation><ArticleIdList><ArticleId IdType="pubmed">29246648</ArticleId></ArticleIdList></Reference><Reference><Citation>J Physiol. 2017 Jul 1;595(13):4301-4315</Citation><ArticleIdList><ArticleId IdType="pubmed">28326563</ArticleId></ArticleIdList></Reference><Reference><Citation>Plast Reconstr Surg Glob Open. 2014 Jul 09;2(6):e173</Citation><ArticleIdList><ArticleId IdType="pubmed">25289366</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):273-280</Citation><ArticleIdList><ArticleId IdType="pubmed">30708040</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2018 Apr 24;28(2):7380</Citation><ArticleIdList><ArticleId IdType="pubmed">29991986</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscle Nerve. 2014 Mar;49(3):378-88</Citation><ArticleIdList><ArticleId IdType="pubmed">23761265</ArticleId></ArticleIdList></Reference><Reference><Citation>Exerc Sport Sci Rev. 2015 Jul;43(3):125-33</Citation><ArticleIdList><ArticleId IdType="pubmed">25906424</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mutat. 2006 Oct;27(10):977-89</Citation><ArticleIdList><ArticleId IdType="pubmed">16917943</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2006 Jul;24(1):182-90</Citation><ArticleIdList><ArticleId IdType="pubmed">16729262</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 2020 Jul;84(1):142-156</Citation><ArticleIdList><ArticleId IdType="pubmed">31828833</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicine (Baltimore). 2019 Dec;98(52):e18509</Citation><ArticleIdList><ArticleId IdType="pubmed">31876739</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Cell. 2009 Feb;20(3):1058-67</Citation><ArticleIdList><ArticleId IdType="pubmed">19037102</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Exp Med Biol. 2018;1088:549-560</Citation><ArticleIdList><ArticleId IdType="pubmed">30390269</ArticleId></ArticleIdList></Reference><Reference><Citation>Cells. 2019 Feb 21;8(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">30795549</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Rev. 2012 Jun;33(3):314-77</Citation><ArticleIdList><ArticleId IdType="pubmed">22433122</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2011 Dec;25(12):4312-25</Citation><ArticleIdList><ArticleId IdType="pubmed">21885651</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscle Nerve. 2017 May;55(5):676-684</Citation><ArticleIdList><ArticleId IdType="pubmed">27576772</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Stimul. 2018 Jul - Aug;11(4):947-948</Citation><ArticleIdList><ArticleId IdType="pubmed">29895444</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19339-44</Citation><ArticleIdList><ArticleId IdType="pubmed">18042706</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Neurol. 2016 Aug;61:70-5</Citation><ArticleIdList><ArticleId IdType="pubmed">27353697</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Physiol Cell Physiol. 2004 Oct;287(4):C817-33</Citation><ArticleIdList><ArticleId IdType="pubmed">15355853</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2015 Jan 12;25(1):4836</Citation><ArticleIdList><ArticleId IdType="pubmed">26913146</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2016 Nov 17;26(4):6033</Citation><ArticleIdList><ArticleId IdType="pubmed">28078067</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Biol. 2005 May 9;169(3):435-45</Citation><ArticleIdList><ArticleId IdType="pubmed">15866891</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Biochem Biophys. 2019 Mar 15;663:22-33</Citation><ArticleIdList><ArticleId IdType="pubmed">30578752</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscle Nerve. 2014 Sep;50(3):348-57</Citation><ArticleIdList><ArticleId IdType="pubmed">24519557</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Growth Differ. 1995 Jan;6(1):81-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7718487</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Metab. 2017 Jun 6;25(6):1374-1389.e6</Citation><ArticleIdList><ArticleId IdType="pubmed">28552492</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Genet. 2018 Nov 16;9:548</Citation><ArticleIdList><ArticleId IdType="pubmed">30505320</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipids Health Dis. 2018 Nov 13;17(1):254</Citation><ArticleIdList><ArticleId IdType="pubmed">30424791</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Physiol. 2019 Jan 08;9:1885</Citation><ArticleIdList><ArticleId IdType="pubmed">30670984</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem Lab Med. 2019 Jul 26;57(8):1115-1124</Citation><ArticleIdList><ArticleId IdType="pubmed">30511922</ArticleId></ArticleIdList></Reference><Reference><Citation>Rejuvenation Res. 2010 Apr-Jun;13(2-3):175-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20370494</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 2018 Feb;79(2):912-922</Citation><ArticleIdList><ArticleId IdType="pubmed">28560822</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Otolaryngol. 2020 Mar - Apr;41(2):102366</Citation><ArticleIdList><ArticleId IdType="pubmed">31837837</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Mhealth Uhealth. 2019 Jan 16;7(1):e11098</Citation><ArticleIdList><ArticleId IdType="pubmed">30664474</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2019 Jan;33(1):181-194</Citation><ArticleIdList><ArticleId IdType="pubmed">29932867</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2014 Jun 10;5:4082</Citation><ArticleIdList><ArticleId IdType="pubmed">24915299</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Aging Res. 2003 Jan-Mar;29(1):47-65</Citation><ArticleIdList><ArticleId IdType="pubmed">12735081</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Aging Neurosci. 2019 Mar 15;11:51</Citation><ArticleIdList><ArticleId IdType="pubmed">30930766</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Dev Neurosci. 2000 Apr-Jun;18(2-3):193-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10715574</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Miner Res. 2014 Jan;29(1):182-91</Citation><ArticleIdList><ArticleId IdType="pubmed">23775701</ArticleId></ArticleIdList></Reference><Reference><Citation>Antioxid Redox Signal. 2015 Feb 1;22(4):339-45</Citation><ArticleIdList><ArticleId IdType="pubmed">25268638</ArticleId></ArticleIdList></Reference><Reference><Citation>J Frailty Aging. 2018;7(2):142-146</Citation><ArticleIdList><ArticleId IdType="pubmed">29741201</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2013 Jan 1;29(1):15-21</Citation><ArticleIdList><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Biopharm. 2017;6:</Citation><ArticleIdList><ArticleId IdType="pubmed">31007971</ArticleId></ArticleIdList></Reference><Reference><Citation>Orphanet J Rare Dis. 2007 May 15;2:25</Citation><ArticleIdList><ArticleId IdType="pubmed">17504518</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2004 Dec;20(6):1008-19</Citation><ArticleIdList><ArticleId IdType="pubmed">15558560</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Physiol (1985). 2016 Apr 15;120(8):965-75</Citation><ArticleIdList><ArticleId IdType="pubmed">26796754</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Aging Neurosci. 2019 Dec 16;11:340</Citation><ArticleIdList><ArticleId IdType="pubmed">31998111</ArticleId></ArticleIdList></Reference><Reference><Citation>J Anim Physiol Anim Nutr (Berl). 2019 May;103(3):786-790</Citation><ArticleIdList><ArticleId IdType="pubmed">30900779</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2019 Jun;49(6):1655-1664</Citation><ArticleIdList><ArticleId IdType="pubmed">30569482</ArticleId></ArticleIdList></Reference><Reference><Citation>Cells. 2019 Nov 27;8(12):</Citation><ArticleIdList><ArticleId IdType="pubmed">31783583</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2017 Mar 24;27(1):6597</Citation><ArticleIdList><ArticleId IdType="pubmed">28458809</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Radiol Anat. 2018 Dec;40(12):1329-1341</Citation><ArticleIdList><ArticleId IdType="pubmed">30167822</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Med Sci Sports. 2014 Feb;24(1):1-10</Citation><ArticleIdList><ArticleId IdType="pubmed">23600729</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neural Eng. 2019 Apr;16(2):026037</Citation><ArticleIdList><ArticleId IdType="pubmed">30754028</ArticleId></ArticleIdList></Reference><Reference><Citation>Theranostics. 2019 May 26;9(12):3595-3607</Citation><ArticleIdList><ArticleId IdType="pubmed">31281500</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2019 Oct 28;8:</Citation><ArticleIdList><ArticleId IdType="pubmed">31657717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Adv Neurol Disord. 2019 Apr 22;12:1756286419843359</Citation><ArticleIdList><ArticleId IdType="pubmed">31040882</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2017 Aug 4;292(31):12885-12894</Citation><ArticleIdList><ArticleId IdType="pubmed">28607151</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2014 Apr;28(4):1621-33</Citation><ArticleIdList><ArticleId IdType="pubmed">24371120</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2017 Jan 24;88(4):359-365</Citation><ArticleIdList><ArticleId IdType="pubmed">28011929</ArticleId></ArticleIdList></Reference><Reference><Citation>Invest Ophthalmol Vis Sci. 1999 Mar;40(3):547-54</Citation><ArticleIdList><ArticleId IdType="pubmed">10067956</ArticleId></ArticleIdList></Reference><Reference><Citation>Aging Clin Exp Res. 2017 Aug;29(4):579-590</Citation><ArticleIdList><ArticleId IdType="pubmed">27592133</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2019 Aug 02;29(3):8327</Citation><ArticleIdList><ArticleId IdType="pubmed">31579476</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2019 May 15;28(10):1694-1708</Citation><ArticleIdList><ArticleId IdType="pubmed">30649389</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Carbohydr Chem Biochem. 2017;74:1-59</Citation><ArticleIdList><ArticleId IdType="pubmed">29173725</ArticleId></ArticleIdList></Reference><Reference><Citation>Pflugers Arch. 2018 Aug;470(8):1165-1179</Citation><ArticleIdList><ArticleId IdType="pubmed">29541860</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2016 Jun 13;26(2):5873</Citation><ArticleIdList><ArticleId IdType="pubmed">27478558</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Gerontol. 2010 May;45(5):389-93</Citation><ArticleIdList><ArticleId IdType="pubmed">20226849</ArticleId></ArticleIdList></Reference><Reference><Citation>J Physiol. 2008 Oct 15;586(20):4815-24</Citation><ArticleIdList><ArticleId IdType="pubmed">18772199</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1951 Jan-Feb;1(1):18-24</Citation><ArticleIdList><ArticleId IdType="pubmed">14785753</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci Methods. 2009 Apr 15;178(2):340-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19183563</ArticleId></ArticleIdList></Reference><Reference><Citation>J Physiol. 2016 Aug 15;594(16):4499-512</Citation><ArticleIdList><ArticleId IdType="pubmed">26921061</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Otorhinolaryngol Ital. 2020 Feb;40(1):64-71</Citation><ArticleIdList><ArticleId IdType="pubmed">31570903</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):20-27</Citation><ArticleIdList><ArticleId IdType="pubmed">29193905</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Rep. 2016 Dec;4(24):</Citation><ArticleIdList><ArticleId IdType="pubmed">28039397</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2016 May;195:172-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26896810</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2015 Aug 25;25(4):231-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26913161</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 Mar 7;13(3):e0193241</Citation><ArticleIdList><ArticleId IdType="pubmed">29513690</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcif Tissue Int. 2012 May;90(5):354-64</Citation><ArticleIdList><ArticleId IdType="pubmed">22451219</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2018 Sep 27;379(13):1244-1250</Citation><ArticleIdList><ArticleId IdType="pubmed">30247091</ArticleId></ArticleIdList></Reference><Reference><Citation>Anim Sci J. 2019 Feb;90(2):255-263</Citation><ArticleIdList><ArticleId IdType="pubmed">30523660</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Cell Res. 2011 Feb 1;317(3):356-66</Citation><ArticleIdList><ArticleId IdType="pubmed">21070767</ArticleId></ArticleIdList></Reference><Reference><Citation>Vet Pathol. 2014 Jul;51(4):759-74</Citation><ArticleIdList><ArticleId IdType="pubmed">24045890</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gerontol A Biol Sci Med Sci. 2015 Feb;70(2):163-73</Citation><ArticleIdList><ArticleId IdType="pubmed">24550352</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Gerontol. 2013 Nov;48(11):1343-50</Citation><ArticleIdList><ArticleId IdType="pubmed">23994518</ArticleId></ArticleIdList></Reference><Reference><Citation>J Sports Med Phys Fitness. 2018 Oct;58(10):1418-1422</Citation><ArticleIdList><ArticleId IdType="pubmed">28880050</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomech Model Mechanobiol. 2017 Dec;16(6):1833-1843</Citation><ArticleIdList><ArticleId IdType="pubmed">28584973</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Genomics. 2018 Aug;19(5):356-369</Citation><ArticleIdList><ArticleId IdType="pubmed">30065611</ArticleId></ArticleIdList></Reference><Reference><Citation>JIMD Rep. 2016;27:1-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26404457</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Stimul. 2018 Jul - Aug;11(4):699-708</Citation><ArticleIdList><ArticleId IdType="pubmed">29716843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ind Psychiatry J. 2009 Jan;18(1):70-3</Citation><ArticleIdList><ArticleId IdType="pubmed">21234168</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Neurol. 2017 Oct;30(5):545-552</Citation><ArticleIdList><ArticleId IdType="pubmed">28665810</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2016 Sep 15;26(4):6105</Citation><ArticleIdList><ArticleId IdType="pubmed">28078069</ArticleId></ArticleIdList></Reference><Reference><Citation>Sports Med. 2016 Sep;46(9):1311-32</Citation><ArticleIdList><ArticleId IdType="pubmed">26893098</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2015 Nov 3;6(34):35358-71</Citation><ArticleIdList><ArticleId IdType="pubmed">26485763</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1995 Mar 10;80(5):795-803</Citation><ArticleIdList><ArticleId IdType="pubmed">7889573</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2019 Nov 5;14(11):e0224232</Citation><ArticleIdList><ArticleId IdType="pubmed">31689322</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2015 Mar 11;25(2):5014</Citation><ArticleIdList><ArticleId IdType="pubmed">26913153</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Genomics. 2016 Mar;48(3):210-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26787216</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gerontol A Biol Sci Med Sci. 2019 Sep 15;74(10):1612-1619</Citation><ArticleIdList><ArticleId IdType="pubmed">30541065</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2016 Feb 23;26(1):5830</Citation><ArticleIdList><ArticleId IdType="pubmed">27054019</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2019;1925:103-109</Citation><ArticleIdList><ArticleId IdType="pubmed">30674020</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Anat. 2002 Jan;15(1):35-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11835542</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Transl Myol. 2018 Nov 30;28(4):7957</Citation><ArticleIdList><ArticleId IdType="pubmed">30662705</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Oct 27;7(1):14286</Citation><ArticleIdList><ArticleId IdType="pubmed">29079778</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2019 Sep 26;14(9):e0223195</Citation><ArticleIdList><ArticleId IdType="pubmed">31557257</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Aging Res. 2015;41(2):115-35</Citation><ArticleIdList><ArticleId IdType="pubmed">25724012</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxid Med Cell Longev. 2017;2017:1987218</Citation><ArticleIdList><ArticleId IdType="pubmed">28845212</ArticleId></ArticleIdList></Reference><Reference><Citation>F1000Res. 2015 Aug 25;4:622</Citation><ArticleIdList><ArticleId IdType="pubmed">26594344</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Pharmacol Physiol. 2007 Aug;34(8):760-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17600553</ArticleId></ArticleIdList></Reference><Reference><Citation>Mediators Inflamm. 2015;2015:624801</Citation><ArticleIdList><ArticleId IdType="pubmed">25944987</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2006 Jul;20(9):1531-3</Citation><ArticleIdList><ArticleId IdType="pubmed">16723379</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32476492</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>07</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>Feature-Based Machine Learning Model for Real-Time Hypoglycemia Prediction.</ArticleTitle><Pagination><MedlinePgn>842-855</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1932296820922622</ELocationID><Abstract><AbstractText Label="BACKGROUND">Hypoglycemia is a serious health concern in youth with type 1 diabetes (T1D). Real-time data from continuous glucose monitoring (CGM) can be used to predict hypoglycemic risk, allowing patients to take timely intervention measures.</AbstractText><AbstractText Label="METHODS">A machine learning model is developed for probabilistic prediction of hypoglycemia (&lt;70 mg/dL) in 30- and 60-minute time horizons based on CGM datasets obtained from 112 patients over a range of 90 days consisting of over 1.6 million CGM values under normal living conditions. A comprehensive set of features relevant for hypoglycemia are developed and a parsimonious subset with most influence on predicting hypoglycemic risk is identified. Model performance is evaluated both with and without contextual information on insulin and carbohydrate intake.</AbstractText><AbstractText Label="RESULTS">The model predicted hypoglycemia with &gt;91% sensitivity for 30- and 60-minute prediction horizons while maintaining specificity &gt;90%. Inclusion of insulin and carbohydrate data yielded performance improvement for 60-minute but not for 30-minute predictions. Model performance was highest for nocturnal hypoglycemia (~95% sensitivity). Shortterm (less than one hour) and medium-term (one to four hours) features for good prediction performance are identified.</AbstractText><AbstractText Label="CONCLUSIONS">Innovative feature identification facilitated high performance for hypoglycemia risk prediction in pediatric youth with T1D. Timely alerts of impending hypoglycemia may enable proactive measures to avoid severe hypoglycemia and achieve optimal glycemic control. The model will be deployed on a patient-facing smartphone application in an upcoming pilot study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dave</LastName><ForeName>Darpit</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Industrial and Systems Engineering, Texas A&amp;M University, College Station, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeSalvo</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Texas Children's Hospital, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haridas</LastName><ForeName>Balakrishna</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Texas A&amp;M University, College Station, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKay</LastName><ForeName>Siripoom</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Texas Children's Hospital, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shenoy</LastName><ForeName>Akhil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Chester J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Texas Children's Hospital, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawley</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Industrial and Systems Engineering, Texas A&amp;M University, College Station, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erraguntla</LastName><ForeName>Madhav</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0017-5866</Identifier><AffiliationInfo><Affiliation>Department of Industrial and Systems Engineering, Texas A&amp;M University, College Station, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P50 FD006428</GrantID><Acronym>FD</Acronym><Agency>FDA HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>J Diabetes Sci Technol. 2021 Jun 16;:19322968211027985</RefSource><PMID Version="1">34132137</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>J Diabetes Sci Technol. 2021 Nov 19;:19322968211059154</RefSource><PMID Version="1">34796727</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="Y">Hypoglycemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">carbohydrate intake</Keyword><Keyword MajorTopicYN="Y">continuous glucose monitoring</Keyword><Keyword MajorTopicYN="Y">feature extraction</Keyword><Keyword MajorTopicYN="Y">hypoglycemia prediction</Keyword><Keyword MajorTopicYN="Y">insulin pump data</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32476492</ArticleId><ArticleId IdType="doi">10.1177/1932296820922622</ArticleId><ArticleId IdType="pmc">PMC8258517</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Technol Ther. 2017 Jun;19(S3):S25-S37</Citation><ArticleIdList><ArticleId IdType="pubmed">28585879</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2014 Oct;16(10):667-78</Citation><ArticleIdList><ArticleId IdType="pubmed">24918271</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 May;23(3):1251-1260</Citation><ArticleIdList><ArticleId IdType="pubmed">29993728</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2018 Feb;19(1):114-120</Citation><ArticleIdList><ArticleId IdType="pubmed">28429581</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Cybern. 2016 Jul;46(7):1704-14</Citation><ArticleIdList><ArticleId IdType="pubmed">27244754</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Mar 01;4(2):404-18</Citation><ArticleIdList><ArticleId IdType="pubmed">20307402</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Oct;15(10):792-801</Citation><ArticleIdList><ArticleId IdType="pubmed">23883406</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Oct;41(10):2155-2161</Citation><ArticleIdList><ArticleId IdType="pubmed">30089663</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Nov 7;12(11):e0187754</Citation><ArticleIdList><ArticleId IdType="pubmed">29112978</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1987 Sep-Oct;10(5):617-21</Citation><ArticleIdList><ArticleId IdType="pubmed">3677982</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 May;54(5):931-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17518291</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2020 Mar;14(2):250-256</Citation><ArticleIdList><ArticleId IdType="pubmed">31390891</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Jan 1;8(1):117-122</Citation><ArticleIdList><ArticleId IdType="pubmed">24876547</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2012 Jun;59(6):1550-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22374344</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2018 Jun;20(S2):S250-S253</Citation><ArticleIdList><ArticleId IdType="pubmed">29873525</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2019 Oct 31;381(18):1707-1717</Citation><ArticleIdList><ArticleId IdType="pubmed">31618560</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Jul;2(4):612-21</Citation><ArticleIdList><ArticleId IdType="pubmed">19885237</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2018 Jun;20(6):395-402</Citation><ArticleIdList><ArticleId IdType="pubmed">29901421</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2008 Dec;10(6):441-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19049372</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2010 Jan;27(1):72-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20121892</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Jul;15(7):538-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23631608</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 Mar;23(2):650-659</Citation><ArticleIdList><ArticleId IdType="pubmed">29993992</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 Aug 22;10(5):1149-60</Citation><ArticleIdList><ArticleId IdType="pubmed">27381030</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2019 Sep;13(5):919-927</Citation><ArticleIdList><ArticleId IdType="pubmed">30650997</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2009 Apr;11(4):243-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19344199</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 Jun;33(6):1249-54</Citation><ArticleIdList><ArticleId IdType="pubmed">20508231</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Jan;11(1):138-147</Citation><ArticleIdList><ArticleId IdType="pubmed">27530720</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Jan;2(1):158-63</Citation><ArticleIdList><ArticleId IdType="pubmed">19578532</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Endocrinol Metab. 1998 Mar;11 Suppl 1:189-94</Citation><ArticleIdList><ArticleId IdType="pubmed">9642659</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2020 Jul;24(7):2064-2072</Citation><ArticleIdList><ArticleId IdType="pubmed">31796419</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2020 Feb;24(2):414-423</Citation><ArticleIdList><ArticleId IdType="pubmed">31369390</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Jan;12(1):190-198</Citation><ArticleIdList><ArticleId IdType="pubmed">28741369</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Inform Decis Mak. 2019 Nov 14;19(1):223</Citation><ArticleIdList><ArticleId IdType="pubmed">31727058</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Meas. 2004 Aug;25(4):905-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15382830</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Jan 01;4(1):25-33</Citation><ArticleIdList><ArticleId IdType="pubmed">20167164</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Apr 30;9(5):1126-37</Citation><ArticleIdList><ArticleId IdType="pubmed">25931581</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Informatics J. 2019 Dec;25(4):1170-1187</Citation><ArticleIdList><ArticleId IdType="pubmed">29278956</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2019 Dec 11;14(12):e0219636</Citation><ArticleIdList><ArticleId IdType="pubmed">31826018</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2013 Jan;17(1):71-81</Citation><ArticleIdList><ArticleId IdType="pubmed">23008265</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Jul;8(4):731-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24876412</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):634-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23848178</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2017 Aug;18(5):332-339</Citation><ArticleIdList><ArticleId IdType="pubmed">27125223</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Behav Med. 2014;21(5):804-10</Citation><ArticleIdList><ArticleId IdType="pubmed">24190791</ArticleId></ArticleIdList></Reference><Reference><Citation>Ind Eng Chem Res. 2013 Sep 4;52(35):</Citation><ArticleIdList><ArticleId IdType="pubmed">24187436</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Inf Technol Biomed. 2010 Jan;14(1):157-65</Citation><ArticleIdList><ArticleId IdType="pubmed">19858035</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Sep 01;4(5):1146-55</Citation><ArticleIdList><ArticleId IdType="pubmed">20920434</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2007 Sep;1(5):624-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19885130</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2020 Nov;14(6):1081-1087</Citation><ArticleIdList><ArticleId IdType="pubmed">31441336</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2010 Jan;12(1):81-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20082589</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 Sep 01;6(5):1142-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23063041</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1999 Mar;48(3):445-51</Citation><ArticleIdList><ArticleId IdType="pubmed">10078542</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Mar;12(2):282-294</Citation><ArticleIdList><ArticleId IdType="pubmed">29493359</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychol Med Settings. 2008 Sep;15(3):252-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19104970</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2014;113(1):144-52</Citation><ArticleIdList><ArticleId IdType="pubmed">24192453</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 Apr 17;:</Citation><ArticleIdList><ArticleId IdType="pubmed">30998484</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2005 Feb;7(1):3-14</Citation><ArticleIdList><ArticleId IdType="pubmed">15738700</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Mar;38(3):355-64</Citation><ArticleIdList><ArticleId IdType="pubmed">25205142</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Mar;12(2):265-272</Citation><ArticleIdList><ArticleId IdType="pubmed">29493356</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32445286</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-7560</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>11</Month></PubDate></JournalIssue><Title>Diabetes/metabolism research and reviews</Title><ISOAbbreviation>Diabetes Metab Res Rev</ISOAbbreviation></Journal><ArticleTitle>Improving blood glucose level predictability using machine learning.</ArticleTitle><Pagination><MedlinePgn>e3348</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/dmrr.3348</ELocationID><Abstract><AbstractText>This study was designed to improve blood glucose level predictability and future hypoglycemic and hyperglycemic event alerts through a novel patient-specific supervised-machine-learning (SML) analysis of glucose level based on a continuous-glucose-monitoring system (CGM) that needs no human intervention, and minimises false-positive alerts. The CGM data over 7 to 50 non-consecutive days from 11 type-1 diabetic patients aged 18 to 39 with a mean HbA1C of 7.5%........1.2% were analysed using four SML models. The algorithm was constructed to choose the best-fit model for each patient. Several statistical parameters were calculated to aggregate the magnitudes of the prediction errors. The personalised solutions provided by the algorithm were effective in predicting glucose levels 30...minutes after the last measurement. The average root-mean-square-error was 20.48...mg/dL and the average absolute-mean-error was 15.36...mg/dL when the best-fit model was selected for each patient. Using the best-fit-model, the true-positive-hypoglycemia-prediction-rate was 64%, whereas the false-positive- rate was 4.0%, and the false-negative-rate was 0.015%. Similar results were found even when only CGM samples below 70 were considered. The true-positive-hyperglycemia-prediction-rate was 61%. State-of-the-art SML tools are effective in predicting the glucose level values of patients with type-1diabetes and notifying these patients of future hypoglycemic and hyperglycemic events, thus improving glycemic control. The algorithm can be used to improve the calculation of the basal insulin rate and bolus insulin, and suitable for a closed loop "artificial pancreas" system. The algorithm provides a personalised medical solution that can successfully identify the best-fit method for each patient.</AbstractText><CopyrightInformation>.. 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marcus</LastName><ForeName>Yonit</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Institute of Endocrinology, Metabolism and Hypertension, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eldor</LastName><ForeName>Roy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Institute of Endocrinology, Metabolism and Hypertension, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yaron</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Institute of Endocrinology, Metabolism and Hypertension, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaklai</LastName><ForeName>Sigal</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Institute of Endocrinology, Metabolism and Hypertension, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ish-Shalom</LastName><ForeName>Maya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Institute of Endocrinology, Metabolism and Hypertension, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shefer</LastName><ForeName>Gabi</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The Institute of Endocrinology, Metabolism and Hypertension, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stern</LastName><ForeName>Naftali</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The Institute of Endocrinology, Metabolism and Hypertension, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golan</LastName><ForeName>Nehor</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The Department of Computer Science, Ariel University, Ariel, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ariel Cyber Innovation Centre, Ariel University, Ariel, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dvir</LastName><ForeName>Amit Z</ForeName><Initials>AZ</Initials><AffiliationInfo><Affiliation>The Department of Computer Science, Ariel University, Ariel, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ariel Cyber Innovation Centre, Ariel University, Ariel, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pele</LastName><ForeName>Ofir</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>The Department of Computer Science, Ariel University, Ariel, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonen</LastName><ForeName>Mira</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1566-979X</Identifier><AffiliationInfo><Affiliation>The Department of Computer Science, Ariel University, Ariel, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Diabetes Metab Res Rev</MedlineTA><NlmUniqueID>100883450</NlmUniqueID><ISSNLinking>1520-7552</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007557" MajorTopicYN="N" Type="Geographic">Israel</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">blood glucose predictability</Keyword><Keyword MajorTopicYN="Y">supervised machine learning</Keyword><Keyword MajorTopicYN="Y">type-1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>09</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>05</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32445286</ArticleId><ArticleId IdType="doi">10.1002/dmrr.3348</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Colberg SR, Laan R, Dassau E, Kerr D. Physical activity and type 1 diabetes: time for a rewire? J Diabetes Sci Technol. 2015;9:609-618.</Citation></Reference><Reference><Citation>P..rez-Gand..a C, Facchinetti A, Sparacino G, et al. A dynamic risk measure from continuous glucose monitoring data. Diabetes Technol Ther. 2011;13:843-852.</Citation></Reference><Reference><Citation>Magni P, Bellazzi R. A stochastic model to assess the variability of blood glucose time series in diabetic patients self-monitoring. IEEE Trans Biomed Eng. 2006;53:977-985.</Citation></Reference><Reference><Citation>Briegel T, Tresp V. A nonlinear state space model for the blood glucose metabolism of a diabetic (Ein Nichtlineares Zustandsraummodell F..r Den Blutglukosemetabolismus Eines Diabetikers). At-Automatisierungstechnik Methoden Und Anwendungen Der Steuerungs-, Regelungs-Und Informationstechnik. 2002;50:228.</Citation></Reference><Reference><Citation>Gani A, Gribok AV, Lu Y, Ward WK, Vigersky RA, Reifman J. Universal glucose models for predicting subcutaneous glucose concentration in humans. IEEE Trans Inf Technol Biomed. 2010;14:157-165.</Citation></Reference><Reference><Citation>Gani A, Gribok AV, Rajaraman S, Ward WK, Reifman J. Predicting subcutaneous glucose concentration in humans: data-driven glucose modelling. IEEE Trans Biomed Eng. 2009;56:246-254.</Citation></Reference><Reference><Citation>Mhaskar HN, Pereverzyev SV, der Walt V, Maria D. A deep learning approach to diabetic blood glucose prediction. Front Appl Math Stat. 2017;3:14.</Citation></Reference><Reference><Citation>Lynch SM, Bequette BW, Estimation-based model predictive control of blood glucose in type I diabetics: a simulation study. Paper presented at: Proceedings of the IEEE 27th Annual Northeast Bioengineering Conference (Cat. No.01CH37201), 2001</Citation></Reference><Reference><Citation>Ozyetkin MM, Nath N, Tatlicioglu E, Dawson DM, A new robust nonlinear control algorithm for the regulation of blood glucose in diabetic patients. Paper presented at: IEEE International Conference on Control Applications, 2012</Citation></Reference><Reference><Citation>Wang Q, Molenaar P, Harsh S, et al. Personalised state-space modelling of glucose dynamics for type 1 diabetes using continuously monitored glucose, insulin dose, and meal intake: an extended Kalman filter approach. J Diabetes Sci Technol. 2014;8:2.</Citation></Reference><Reference><Citation>De Nicolao G, Magni L, Dalla Man C, Cobelli C, Modelling and Control of Diabetes: Towards the Artificial Pancreas. Paper presented at: Proceedings of the 18th World Congress of the International Federation of Automatic Control, 2011</Citation></Reference><Reference><Citation>Del Favero S, Place J, Kropff J, et al. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes. Diabetes Obes Metab. 2015;17:468-476.</Citation></Reference><Reference><Citation>Cobelli C, Dalla Man C, Sparacino G, Magni L, De Nicolao G, Kovatchev B. Diabetes: models, signals, and control. IEEE Rev Biomed Eng. 2009;2:54-96.</Citation></Reference><Reference><Citation>Lunze K, Singh T, Walter M, Brendel MD, Leonhardt S. Blood glucose control algorithms for type 1 diabetic patients: a methodological review. Biomed Signal Process Control. 2013;8(2):107-119.</Citation></Reference><Reference><Citation>Patek SD, Breton MD, Chen Y, Solomon C, Kovatchev B. Linear quadratic Gaussian-based closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2007;1:6.</Citation></Reference><Reference><Citation>Turksoy K, Bayrak ES, Quinn L, Littlejohn E, Rollins D, Cinar A. Hypoglycemia early alarm systems based on multivariable models. Ind Eng Chem Res. 2013;52(35):12329-12336.</Citation></Reference><Reference><Citation>Yu X, Turksoy K, Rashid M, et al. Model-fusion-based online glucose concentration predictions in people with type 1 diabetes. Control Eng Pract. 2018;71:129-141.</Citation></Reference><Reference><Citation>Turksoy K, Quinn L, Littlejohn E, Cinar A. Multivariable adaptive identification and control for artificial pancreas systems. IEEE Trans Biomed Eng. 2014;6(3):883-891.</Citation></Reference><Reference><Citation>Pappada SM, Cameron BD, Rosman PM, et al. Neural network-based real-time prediction of glucose in patients with insulin-dependent diabetes. Diabetes Technol Ther. 2011;13(2):135-141.</Citation></Reference><Reference><Citation>P..rez-Gand..a C, Facchinetti A, Sparacino G, et al. Artificial neural network algorithm for online glucose prediction from continuous glucose monitoring. Diabetes Technol Ther. 2010;12(1):81-88.</Citation></Reference><Reference><Citation>Bunescu R, Struble N, Marling C, Shubrook J, Schwartz F. Blood glucose level prediction using physiological models and support vector regression. Paper presented at: Machine learning and applications (ICMLA), 12th international conference on IEEE, 2013, pp. 135-140</Citation></Reference><Reference><Citation>Reymann MP, Dorschky E, Groh BH, Martindale C, Blank P, Eskofier BM. Blood glucose level prediction based on support vector regression using mobile platforms. Paper presented at: Engineering in medicine and biology society (EMBC), 2016 IEEE 38th Annual International Conference of the IEEE, 2016, pp. 2990-2993</Citation></Reference><Reference><Citation>Plis K, Bunescu RC, Marling C, Shubrook J, Schwartz F. A machine learning approach to predicting blood glucose levels for diabetes management. Paper presented at: AAAI Workshop: Modern Artificial Intelligence for Health Analytics, 2014, pp. 35-39</Citation></Reference><Reference><Citation>Kotsiantis SB, Zaharakis I, Pintelas P. Supervised machine learning: a review of classification techniques. Emerging Artif Intell Appl Comput Eng. 2007;160:3-24.</Citation></Reference><Reference><Citation>Vovk V. Kernel Ridge Regression. Empirical Inference. Springer; 2013:105-116.</Citation></Reference><Reference><Citation>Getoor L, Taskar B. Introduction to Statistical Relational Learning. Cambridge, Massachusetts: MIT Press; 2007.</Citation></Reference><Reference><Citation>Vapnik V. The Nature of Statistical Learning Theory. Springer Science &amp; Business Media; 2013.</Citation></Reference><Reference><Citation>Clarke WL, Cox D, Gonder-Frederick AL, Carter W, Pohl SLA. Evaluating clinical accuracy of Systems for Self-Monitoring of blood glucose. Diabetes Care. 1987;10:662-668.</Citation></Reference><Reference><Citation>Paul SK, Samanta M. Predicting upcoming glucose levels in patients with type 1 diabetes using a generalised autoregressive conditional heteroscedasticity modelling approach. Int J Stat Med Res. 2015;4:188-198.</Citation></Reference><Reference><Citation>Patton AJ. Volatility forecast comparison using imperfect volatility proxies. J Econ. 2011;160:246-256.</Citation></Reference><Reference><Citation>Hyndman RJ, Koehler AB. Another look at measures of forecast accuracy. Int J Forecast. 2006;22:679-688.</Citation></Reference><Reference><Citation>Zisser H, Dassau E, Lee JJ, Harvey RA, Bevier W, Doyle FJ III. Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion. J Diabetes Sci Technol. 2015;9:564-572.</Citation></Reference><Reference><Citation>Zisser H, Renard E, Kovatchev B, et al. Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. Diabetes Technol Ther. 2014;16:613-622.</Citation></Reference><Reference><Citation>Oron T, Farfel A, Muller I, et al. A remote monitoring system for artificial pancreas support is safe, reliable, and user friendly. Diabetes Technol Ther. 2014;16:699-705.</Citation></Reference><Reference><Citation>Dassau E, Cameron F, Lee H, et al. Real-time hypoglycemia prediction suite using continuous monitoring a safety net for the artificial pancreas. Diabetes Care. 2010;33:1249-1254.</Citation></Reference><Reference><Citation>Georga EI, Principe JC, Rizos EC, Fotiadis DI, Kernel-based adaptive learning improves accuracy of glucose predictive modelling in type 1 diabetes: a proof-of-concept study. Paper presented at: Conference Proceedings of IEEE Eng Med Biol Soc 2017; pp. 2765-2768</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32324658</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-6500</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Current opinion in anaesthesiology</Title><ISOAbbreviation>Curr Opin Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>Augmented intelligence in pediatric anesthesia and pediatric critical care.</ArticleTitle><Pagination><MedlinePgn>404-410</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ACO.0000000000000845</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">Acute care technologies, including novel monitoring devices, big data, increased computing capabilities, machine-learning algorithms and automation, are converging. This enables the application of augmented intelligence for improved outcome predictions, clinical decision-making, and offers unprecedented opportunities to improve patient outcomes, reduce costs, and improve clinician workflow. This article briefly explores recent work in the areas of automation, artificial intelligence and outcome prediction models in pediatric anesthesia and pediatric critical care.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Recent years have yielded little published research into pediatric physiological closed loop control (a type of automation) beyond studies focused on glycemic control for type 1 diabetes. However, there has been a greater range of research in augmented decision-making, leveraging artificial intelligence and machine-learning techniques, in particular, for pediatric ICU outcome prediction.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">Most studies focusing on artificial intelligence demonstrate good performance on prediction or classification, whether they use traditional statistical tools or novel machine-learning approaches. Yet the challenges of implementation, user acceptance, ethics and regulation cannot be underestimated. Areas in which there is easy access to routinely labeled data and robust outcomes, such as those collected through national networks and quality improvement programs, are likely to be at the forefront of the adoption of these advances.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>G..rges</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Pharmacology &amp; Therapeutics, University of British Columbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute, BC Children's Hospital, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ansermino</LastName><ForeName>J Mark</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Pharmacology &amp; Therapeutics, University of British Columbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute, BC Children's Hospital, Vancouver, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Opin Anaesthesiol</MedlineTA><NlmUniqueID>8813436</NlmUniqueID><ISSNLinking>0952-7907</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="Y">Anesthesia</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="Y">Critical Care</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007360" MajorTopicYN="N">Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32324658</ArticleId><ArticleId IdType="doi">10.1097/ACO.0000000000000845</ArticleId><ArticleId IdType="pii">00001503-202006000-00023</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Matheny M, Israni ST, Ahmed M, et al. Artificial intelligence in healthcare: the hope, the hype, the promise, the peril. Washington, DC: National Academy of Medicine; 2019. https://nam.edu/artificial-intelligence-special-publication.</Citation></Reference><Reference><Citation>Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med 2019; 25:44...56.</Citation></Reference><Reference><Citation>Heldt T, Long B, Verghese GC, et al. Integrating data, models, and reasoning in critical care. Conf Proc IEEE Eng Med Biol Soc Annu Conf 2006; 1:350...353.</Citation></Reference><Reference><Citation>Johnson AEW, Ghassemi MM, Nemati S, et al. Machine learning and decision support in critical care. Proc IEEE Inst Electr Electron Eng 2016; 104:444...466.</Citation></Reference><Reference><Citation>Mallett S, Halligan S, Matthew Thompson GP, et al. Interpreting diagnostic accuracy studies for patient care. BMJ 2012; 345:e3999.</Citation></Reference><Reference><Citation>Dumont GA, Ansermino JM. Closed-loop control of anesthesia: a primer for anesthesiologists. Anesth Analg 2013; 117:1130...1138.</Citation></Reference><Reference><Citation>Ekhlaspour L, Forlenza GP, Chernavvsky D, et al. Closed loop control in adolescents and children during winter sports: use of the tandem control-IQ AP system. Pediatr Diabetes 2019; 20:759...768.</Citation></Reference><Reference><Citation>Musolino G, Dovc K, Boughton CK, et al. Kidsap ConsortiumReduced burden of diabetes and improved quality of life: experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes. Pediatr Diabetes 2019; 20:794...799.</Citation></Reference><Reference><Citation>Berget C, Messer LH, Vigers T, et al. Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system. Pediatr Diabetes 2019; 21:310...318.</Citation></Reference><Reference><Citation>Lal RA, Basina M, Maahs DM, et al. One year clinical experience of the first commercial hybrid closed-loop. Diabetes Care 2019; 42:2190...2196.</Citation></Reference><Reference><Citation>Partridge H, Perkins B, Mathieu S, et al. Clinical recommendations in the management of the patient with type 1 diabetes on insulin pump therapy in the perioperative period: a primer for the anaesthetist. Br J Anaesth 2016; 116:18...26.</Citation></Reference><Reference><Citation>van den Heuvel MEN, van Zanten HA, Bachman TE, et al. Optimal target range of closed-loop inspired oxygen support in preterm infants: a randomized cross-over study. J Pediatr 2018; 197:36...41.</Citation></Reference><Reference><Citation>Gajdos M, Waitz M, Mendler MR, et al. Effects of a new device for automated closed loop control of inspired oxygen concentration on fluctuations of arterial and different regional organ tissue oxygen saturations in preterm infants. Arch Dis Child Fetal Neonatal Ed 2019; 104:F360...F365.</Citation></Reference><Reference><Citation>Ghazal S, Sauthier M, Brossier D, et al. Using machine learning models to predict oxygen saturation following ventilator support adjustment in critically ill children: a single center pilot study. PLoS One 2019; 14:e0198921.</Citation></Reference><Reference><Citation>Rose L, Schultz MJ, Cardwell CR, et al. Automated versus nonautomated weaning for reducing the duration of mechanical ventilation for critically ill adults and children: a cochrane systematic review and meta-analysis. Crit Care 2015; 19:48.</Citation></Reference><Reference><Citation>Beck J, Emeriaud G, Liu Y, et al. Neurally-adjusted ventilatory assist (NAVA) in children: a systematic review. Minerva Anestesiol 2016; 82:874...883.</Citation></Reference><Reference><Citation>Hartmann SM, Farris RW, Yanay O, et al. Interaction of critical care practitioners with a decision support tool for weaning mechanical ventilation in children. Respir Care 2020; 65:333...340.</Citation></Reference><Reference><Citation>van Heusden K, Soltesz K, Cooke E, et al. Optimizing robust PID control of propofol anesthesia for children: design and clinical evaluation. IEEE Trans Biomed Eng 2019; 66:2918...2923.</Citation></Reference><Reference><Citation>West N, Dumont GA, Van Heusden K, et al. Robust closed-loop control of induction and maintenance of propofol anesthesia in children. Paediatr Anaesth 2013; 23:712...719.</Citation></Reference><Reference><Citation>Christodoulou E, Ma J, Collins GS, et al. A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. J Clin Epidemiol 2019; 110:12...22.</Citation></Reference><Reference><Citation>Shah ND, Steyerberg EW, Kent DM. Big data and predictive analytics: recalibrating expectations. JAMA 2018; 320:27...28.</Citation></Reference><Reference><Citation>Basic Books, Topol EJ. Deep medicine: how artificial intelligence can make healthcare human again. 2019.</Citation></Reference><Reference><Citation>Wiens J, Fackler J. Striking the right balance...applying machine learning to pediatric critical care data. Pediatr Crit Care Med 2018; 19:672...673.</Citation></Reference><Reference><Citation>Chang A. Artificial intelligence in pediatric critical care medicine: are we (finally) ready? Pediatr Crit Care Med 2018; 19:997...998.</Citation></Reference><Reference><Citation>Olive MK, Owens GE. Current monitoring and innovative predictive modeling to improve care in the pediatric cardiac intensive care unit. Transl Pediatr 2018; 7:120...128.</Citation></Reference><Reference><Citation>Correa M, Zimic M, Barrientos F, et al. Automatic classification of pediatric pneumonia based on lung ultrasound pattern recognition. PLoS One 2018; 13:1...13.</Citation></Reference><Reference><Citation>Reyna MA, Josef CS, Jeter R, et al. Early prediction of sepsis from clinical data: the PhysioNet/Computing in Cardiology Challenge 2019. Crit Care Med 2020; 48:210...217.</Citation></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315:801...810.</Citation></Reference><Reference><Citation>Kamaleswaran R, Akbilgic O, Hallman MA, et al. Applying artificial intelligence to identify physiomarkers predicting severe sepsis in the PICU. Pediatr Crit Care Med 2018; 19:E495...E503.</Citation></Reference><Reference><Citation>Le S, Hoffman J, Barton C, et al. Pediatric severe sepsis prediction using machine learning. Front Pediatr 2019; 7:413.</Citation></Reference><Reference><Citation>Masino AJ, Harris MC, Forsyth D, et al. Machine learning models for early sepsis recognition in the neonatal intensive care unit using readily available electronic health record data. PLoS One 2019; 14:e0212665.</Citation></Reference><Reference><Citation>Williams JB, Ghosh D, Wetzel RC. Applying machine learning to pediatric critical care data. Pediatr Crit Care Med 2018; 19:599...608.</Citation></Reference><Reference><Citation>Carlin CS, Ho LV, Ledbetter DR, et al. Predicting individual physiologically acceptable states at discharge from a pediatric intensive care unit. J Am Med Informatics Assoc 2018; 25:1600...1607.</Citation></Reference><Reference><Citation>Grogan KL, Goldsmith MP, Masino AJ, et al. A narrative review of analytics in pediatric cardiac anesthesia and critical care medicine. J Cardiothorac Vasc Anesth 2019; 000:1...4.</Citation></Reference><Reference><Citation>Michelet D, Julien-Marsollier F, Hilly J, et al. Predictive factors of intraoperative cell salvage during pediatric scoliosis surgery. Cell saver during scoliosis surgery in children. Anaesth Crit Care Pain Med 2018; 37:141...146.</Citation></Reference><Reference><Citation>Nafiu OO, Thompson A, Chiravuri SD, et al. Factors associated with recovery room intravenous opiate requirement after pediatric outpatient operations. Anesth Analg 2019; 128:1225...1233.</Citation></Reference><Reference><Citation>Vo D, Zurakowski D, Faraoni D. Incidence and predictors of 30-day postoperative readmission in children. Paediatr Anaesth 2018; 28:63...70.</Citation></Reference><Reference><Citation>Alexander PMA, DiOrio M, Andren K, et al. Accurate prediction of congenital heart surgical length of stay incorporating a procedure-based categorical variable. Pediatr Crit Care Med 2018; 19:949...956.</Citation></Reference><Reference><Citation>Matava C, Pankiv E, Ahumada L, et al. Artificial intelligence, machine learning and the pediatric airway. Paediatr Anaesth 2019; doi: 10.1111/pan.13792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.13792</ArticleId></ArticleIdList></Reference><Reference><Citation>Matava C, Pankiv E, Raisbeck S, et al. A convolutional neural network for real time classification, identification, and labelling of vocal cord and tracheal using laryngoscopy and bronchoscopy video. J Med Syst 2020; 44:44.</Citation></Reference><Reference><Citation>Cuendet GL, Schoettker P, Y..ce A, et al. Facial image analysis for fully automatic prediction of difficult endotracheal intubation. IEEE Trans Biomed Eng 2016; 63:328...329.</Citation></Reference><Reference><Citation>Liu L, Ni Y, Zhang N, Nick Pratap J. Mining patient-specific and contextual data with machine learning technologies to predict cancellation of children's surgery. Int J Med Inform 2019; 129:234...241.</Citation></Reference><Reference><Citation>Bartek MA, Saxena RC, Solomon S, et al. Improving operating room efficiency: machine learning approach to predict case-time duration. J Am Coll Surg 2019; 229:346.e3...354.e3.</Citation></Reference><Reference><Citation>Wall J, Krummel T. The digital surgeon: how big data, automation, and artificial intelligence will change surgical practice. J Pediatr Surg 2019; 55:47...50.</Citation></Reference><Reference><Citation>Loftus TJ, Tighe PJ, Filiberto AC, et al. Artificial intelligence and surgical decision-making. JAMA Surg 2020; 155:148...158.</Citation></Reference><Reference><Citation>Stead WW. Clinical implications and challenges of artificial intelligence and deep learning. JAMA 2018; 320:1107...1108.</Citation></Reference><Reference><Citation>Hofer IS, Halperin E, Cannesson M. Opening the black box: understanding the science behind big data and predictive analytics. Anesth Analg 2018; 127:1139...1143.</Citation></Reference><Reference><Citation>Beam AL, Manrai AK, Ghassemi M. Challenges to the reproducibility of machine learning models in healthcare. JAMA 2020; 323:305...306.</Citation></Reference><Reference><Citation>Hinton G. Deep learning-a technology with the potential to transform healthcare. JAMA 2018; 320:1101...1102.</Citation></Reference><Reference><Citation>Valdes G, Luna JM, Eaton E, et al. MediBoost: a patient stratification tool for interpretable decision making in the era of precision medicine. Sci Rep 2016; 6:37854.</Citation></Reference><Reference><Citation>Adadi A, Berrada M. Peeking inside the black-box: a survey on explainable artificial intelligence (XAI). IEEE Access 2018; 6:52138...52160.</Citation></Reference><Reference><Citation>Lundberg SM, Nair B, Vavilala MS, et al. Explainable machine-learning predictions for the prevention of hypoxaemia during surgery. Nat Biomed Eng 2018; 2:749...760.</Citation></Reference><Reference><Citation>US Food and Drug Administration: Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD). 2019. Available at: https://www.fda.gov/media/122535/download. Accessed 2020-01-30.</Citation></Reference><Reference><Citation>G..rges M, Afshar K, West N, et al. Integrating intraoperative physiology data into outcome analysis for the ACS Pediatric National Surgical Quality Improvement Program. Paediatr Anaesth 2019; 29:27...37.</Citation></Reference><Reference><Citation>Hoorweg A-LJ, Pasma W, van Wolfswinkel L, et al. Incidence of artifacts and deviating values in research data obtained from an anesthesia information management system in children. Anesthesiology 2018; 128:293...304.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32315515</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5448</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>08</Month></PubDate></JournalIssue><Title>Pediatric diabetes</Title><ISOAbbreviation>Pediatr Diabetes</ISOAbbreviation></Journal><ArticleTitle>Continuous glucose monitoring for hypoglycaemia in children: Perspectives in 2020.</ArticleTitle><Pagination><MedlinePgn>697-706</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pedi.13029</ELocationID><Abstract><AbstractText>Hypoglycaemia in children is a major risk factor for adverse neurodevelopment with rates as high as 50% in hyperinsulinaemic hypoglycaemia (HH). A key part of management relies upon timely identification and treatment of hypoglycaemia. The current standard of care for glucose monitoring is by infrequent fingerprick plasma glucose testing but this carries a high risk of missed hypoglycaemia identification. High-frequency Continuous Glucose Monitoring (CGM) offers an attractive alternative for glucose trend monitoring and glycaemic phenotyping but its utility remains largely unestablished in disorders of hypoglycaemia. Attempts to determine accuracy through correlation with plasma glucose measurements using conventional methods such as Mean Absolute Relative Difference (MARD) overestimate accuracy at hypoglycaemia. The inaccuracy of CGM in true hypoglycaemia is amplified by calibration algorithms that prioritize hyperglycaemia over hypoglycaemia with minimal objective evidence of efficacy in HH. Conversely, alternative algorithm design has significant potential for predicting hypoglycaemia to prevent neuroglycopaenia and consequent brain dysfunction in childhood disorders. Delays in the detection of hypoglycaemia, alarm fatigue, device calibration and current high cost are all barriers to the wider adoption of CGM in disorders of hypoglycaemia. However, machine learning, artificial intelligence and other computer-generated algorithms now offer significant potential for further improvement in CGM device technology and widespread application in childhood hypoglycaemia.</AbstractText><CopyrightInformation>.. 2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Worth</LastName><ForeName>Chris</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6609-2735</Identifier><AffiliationInfo><Affiliation>Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunne</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Arunabha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Inherited Metabolic Disease, St Mary's Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harper</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Computer Engineering, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Indraneel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_18056</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016456">Historical Article</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Pediatr Diabetes</MedlineTA><NlmUniqueID>100939345</NlmUniqueID><ISSNLinking>1399-543X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004704" MajorTopicYN="N">Endocrinology</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049674" MajorTopicYN="N">History, 21st Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065886" MajorTopicYN="N">Neurodevelopmental Disorders</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">children</Keyword><Keyword MajorTopicYN="Y">continuous glucose monitoring</Keyword><Keyword MajorTopicYN="Y">hyperinsulinism</Keyword><Keyword MajorTopicYN="Y">hypoglycaemia</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>03</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>04</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32315515</ArticleId><ArticleId IdType="doi">10.1111/pedi.13029</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Olczuk D, Priefer R. A history of continuous glucose monitors (CGMs) in self-monitoring of diabetes mellitus. Diabetes Metab Syndr Clin Res Rev. 2018;12(2):181-187. https://doi.org/10.1016/j.dsx.2017.09.005.</Citation></Reference><Reference><Citation>Karam JH, Lorenzi M, Young CW, et al. Feedback-controlled dextrose infusion during surgical management of insulinomas. Am J Med. 1979;66(4):675-680. https://doi.org/10.1016/0002-9343(79)91183-5.</Citation></Reference><Reference><Citation>Ginsberg BH. The FDA panel advises approval of the first continuous glucose sensor. Diabetes Technol Ther. 1999;1(2):203-204. https://doi.org/10.1089/152091599317431.</Citation></Reference><Reference><Citation>Garg SK, Akturk HK. A new era in continuous glucose monitoring: food and drug administration creates a new category of factory-calibrated nonadjunctive, interoperable class ii medical devices. Diabetes Technol Ther. 2018;20(6):391-394. https://doi.org/10.1089/dia.2018.0142.</Citation></Reference><Reference><Citation>Klonoff DC, Ahn D, Drincic A. Continuous glucose monitoring: a review of the technology and clinical use. Diabetes Res Clin Pract. 2017;133:178-192. https://doi.org/10.1016/j.diabres.2017.08.005.</Citation></Reference><Reference><Citation>Shah R, McKinlay CJD, Harding JE. Neonatal hypoglycemia: continuous glucose monitoring. Curr Opin Pediatr. 2018;30(2):204-208. https://doi.org/10.1097/MOP.0000000000000592.</Citation></Reference><Reference><Citation>Kanaka-Gantenbein C. Hypoglycemia in childhood: long-term effects. Pediatr Endocrinol Rev. 2004;1:530-536.</Citation></Reference><Reference><Citation>Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. Br Med J. 1988;297:1304-1308.</Citation></Reference><Reference><Citation>Duvanel CB, Fawer CL, Colling J, Hohlfeld P, Matthieu JM. Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants. J Pediatr. 1999;134(4):492-498. https://doi.org/10.1016/S0022-3476(99)70209-X.</Citation></Reference><Reference><Citation>Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics. 2008;122(1):65-74. https://doi.org/10.1542/peds.2007-2822.</Citation></Reference><Reference><Citation>Lord K, Radcliffe J, Gallagher PR, Adzick NS, Stanley CA, De Le..n DD. High risk of diabetes and neurobehavioral deficits in individuals with surgically treated hyperinsulinism. J Clin Endocrinol Metab. 2015;100(11):4133-4139. https://doi.org/10.1210/jc.2015-2539.</Citation></Reference><Reference><Citation>Avatapalle HB, Banerjee I, Shah S, et al. Abnormal neurodevelopmental outcomes are common in children with transient congenital hyperinsulinism. Front Endocrinol (Lausanne). 2013;4(May). https://doi.org/10.3389/fendo.2013.00060.</Citation></Reference><Reference><Citation>Christesen HT, Brusgaard K, Hussain K. Recurrent spontaneous hypoglycaemia causes loss of neurogenic and neuroglycopaenic signs in infants with congenital hyperinsulinism. Clin Endocrinol (Oxf). 2012;76(4):548-554. https://doi.org/10.1111/j.1365-2265.2011.04250.x.</Citation></Reference><Reference><Citation>Gill GV, Woodward A, Casson IF, Weston PJ. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes-the ...dead in bed... syndrome revisited. Diabetologia. 2009;52(1):42-45.</Citation></Reference><Reference><Citation>Kovatchev BP. Hypoglycemia reduction and accuracy of continuous glucose monitoring. Diabetes Technol Ther. 2015;17(8):530-533. https://doi.org/10.1089/dia.2015.0144.</Citation></Reference><Reference><Citation>Rodbard D. Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes. Diabetes Technol Ther. 2017;19(S3):S25-S37. https://doi.org/10.1089/dia.2017.0035.</Citation></Reference><Reference><Citation>Van Beers CAJ, Devries JH. Continuous glucose monitoring: impact on hypoglycemia. J Diabetes Sci Technol. 2016;10(6):1251-1258. https://doi.org/10.1177/1932296816653411.</Citation></Reference><Reference><Citation>Tomotaki S, Toyoshima K, Shimokaze T, Kawai M. Reliability of real-time continuous glucose monitoring in infants. Pediatr Int. 2019;61:1001-1006. https://doi.org/10.1111/ped.13961.</Citation></Reference><Reference><Citation>Perri A, Giordano L, Corsello M, et al. Continuous glucose monitoring (CGM) in very low birth weight newborns needing parenteral nutrition: validation and glycemic percentiles. Ital J Pediatr. 2018;44(1). https://doi.org/10.1186/s13052-018-0542-5.</Citation></Reference><Reference><Citation>Dexcom G6 CGM System User Guide, 2018.</Citation></Reference><Reference><Citation>Data on File, Abbott Diabetes Care Inc. Clinical Report: Evaluation of the Accuracy of the Abbott Sensor-Based Interstitial Glucose Monitoring System 2014.</Citation></Reference><Reference><Citation>Monsod TP, Flanagan DE, Rife F, et al. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care. 2002;25(5):889-893. https://doi.org/10.2337/diacare.25.5.889.</Citation></Reference><Reference><Citation>Reiterer F, Polterauer P, Schoemaker M, et al. Significance and reliability of MARD for the accuracy of CGM systems. J Diabetes Sci Technol. 2017;11(1):59-67. https://doi.org/10.1177/1932296816662047.</Citation></Reference><Reference><Citation>Pardo S, Simmons DA. The quantitative relationship between ISO 15197 accuracy criteria and mean absolute relative difference (MARD) in the evaluation of analytical performance of self-monitoring of blood glucose (SMBG) systems. J Diabetes Sci Technol. 2016;10(5):1182-1187. https://doi.org/10.1177/1932296816644468.</Citation></Reference><Reference><Citation>Noujaim SE, Horwitz D, Sharma M, Marhoul J. Accuracy requirements for a hypoglycemia detector: an analytical model to evaluate the effects of bias, precision, and rate of glucose change. J Diabetes Sci Technol. 2007;1(5):652-668. https://doi.org/10.1177/193229680700100509.</Citation></Reference><Reference><Citation>Conrad SC, Mastrototaro JJ, Gitelman SE. The use of a continuous glucose monitoring system in hypoglycemic disorders. J Pediatr Endocrinol Metab. 2004;17(3):281-288. https://doi.org/10.1515/JPEM.2004.17.3.281.</Citation></Reference><Reference><Citation>Signal M, Le Compte A, Harris DL, Weston PJ, Harding JE, Chase JG. Impact of retrospective calibration algorithms on hypoglycemia detection in newborn infants using continuous glucose monitoring. Diabetes Technol Ther. 2012;14(10):883-890. https://doi.org/10.1089/dia.2012.0111.</Citation></Reference><Reference><Citation>King C, Anderson SM, Breton M, Clarke WL, Kovatchev BP. Modeling of calibration effectiveness and blood-to-interstitial glucose dynamics as potential confounders of the accuracy of continuous glucose sensors during Hyperinsulinemic clamp. J Diabetes Sci Technol. 2007;1(3):317-322. https://doi.org/10.1177/193229680700100302.</Citation></Reference><Reference><Citation>Guerra S, Facchinetti A, Sparacino G, De Nicolao G, Cobelli C. Enhancing the accuracy of subcutaneous glucose sensors: a real-time deconvolution-based approach. IEEE Trans Biomed Eng. 2012;59(6):1658-1669. https://doi.org/10.1109/TBME.2012.2191782.</Citation></Reference><Reference><Citation>Zavitsanou S, Lee JB, Pinsker JE, Church MM, Doyle FJ, Dassau E. A Personalized Week-to-Week Updating Algorithm to Improve Continuous Glucose Monitoring Performance. J Diabetes Sci Technol. 2017;11:1070-1079. https://doi.org/10.1177/1932296817734367.</Citation></Reference><Reference><Citation>Acciaroli G, Vettoretti M, Facchinetti A, Sparacino G. Toward calibration-free continuous glucose monitoring sensors: Bayesian calibration approach applied to next-generation Dexcom technology. Diabetes Technol Ther. 2018;20(1):59-67. https://doi.org/10.1089/dia.2017.0297.</Citation></Reference><Reference><Citation>De Block C, Manuel-Y-keenoy B, Van Gaal L. A review of current evidence with continuous glucose monitoring in patients with diabetes. J Diabetes Sci Technol. 2008;2:718-727. https://doi.org/10.1177/193229680800200426.</Citation></Reference><Reference><Citation>Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311-320. https://doi.org/10.1056/NEJMoa1002853.</Citation></Reference><Reference><Citation>Wentholt IME, Hoekstra JBL, Devries JH. Continuous glucose monitors: the long-awaited watch dogs? Diabetes Technol Ther. 2007;9(5):399-409. https://doi.org/10.1089/dia.2007.0215.</Citation></Reference><Reference><Citation>Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJPM. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2012;2017(12). https://doi.org/10.1002/14651858.CD008101.pub2.</Citation></Reference><Reference><Citation>vanBeers CAJ, DeVries JH, Kleijer SJ, et al. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. Lancet Diabetes Endocrinol. 2016;4(11):893-902. https://doi.org/10.1016/S2213-8587(16)30193-0.</Citation></Reference><Reference><Citation>Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011;34(4):795-800. https://doi.org/10.2337/dc10-1989.</Citation></Reference><Reference><Citation>Puhr S, Derdzinski M, Welsh JB, Parker AS, Walker T, Price DA. Real-world hypoglycemia avoidance with a continuous glucose monitoring System's predictive Low glucose alert. Diabetes Technol Ther. 2019;21(4):155-158. https://doi.org/10.1089/dia.2018.0359.</Citation></Reference><Reference><Citation>Beardsall K, Ogilvy-Stuart AL, Ahluwalia J, Thompson M, Dunger DB. The continuous glucose monitoring sensor in neonatal intensive care. Arch Dis Child Fetal Neonatal Ed. 2005;90(4):307-310. https://doi.org/10.1136/adc.2004.051979.</Citation></Reference><Reference><Citation>Grunau RE, Whitfield MF, Petrie-Thomas J, et al. Neonatal pain, parenting stress and interaction, in relation to cognitive and motor development at 8 and 18 months in preterm infants. Pain. 2009;143(1-2):138-146. https://doi.org/10.1016/j.pain.2009.02.014.</Citation></Reference><Reference><Citation>Harris DL, Battin MR, Weston PJ, Harding JE. Continuous glucose monitoring in newborn babies at risk of hypoglycemia. J Pediatr. 2010;157(2):198.e1-202.e1. https://doi.org/10.1016/j.jpeds.2010.02.003.</Citation></Reference><Reference><Citation>Uettwiller F, Chemin A, Bonnemaison E, Favrais G, Saliba E, Labarthe F. Real-time continuous glucose monitoring reduces the duration of hypoglycemia episodes: a randomized trial in very low birth weight neonates. PLoS One. 2015;10(1). https://doi.org/10.1371/journal.pone.0116255.</Citation></Reference><Reference><Citation>Thomson L, Elleri D, Bond S, Howlett J, Dunger DB, Beardsall K. Targeting glucose control in preterm infants: pilot studies of continuous glucose monitoring. Arch Dis Child Fetal Neonatal Ed. 2019;104(4):F353-F359. https://doi.org/10.1136/archdischild-2018-314814.</Citation></Reference><Reference><Citation>McKinlay CJD, Alsweiler JM, Ansell JM, et al. Neonatal glycemia and neurodevelopmental outcomes at 2...years. N Engl J Med. 2015;373(16):1507-1518. https://doi.org/10.1056/NEJMoa1504909.</Citation></Reference><Reference><Citation>Kishnani PS, Austin SL, Abdenur JE, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014;16(11):1-29. https://doi.org/10.1038/gim.2014.128.</Citation></Reference><Reference><Citation>Hershkovitz E, Rachmel A, Ben-Zaken H, Phillip M. Continuous glucose monitoring in children with glycogen storage disease type I. J Inherit Metab Dis. 2001;24(8):863-869. https://doi.org/10.1023/A:1013996325720.</Citation></Reference><Reference><Citation>Maran A, Crepaldi C, Avogaro A, et al. Continuous glucose monitoring in conditions other than diabetes. Diabetes Metab Res Rev. 2004;20(SUPPL. 2):50-55. https://doi.org/10.1002/dmrr.518.</Citation></Reference><Reference><Citation>Kasapkara CS, Cinasal Demir G, Hasano..lu A, T..mer L. Continuous glucose monitoring in children with glycogen storage disease type i. Eur J Clin Nutr. 2014;68(1):101-105. https://doi.org/10.1038/ejcn.2013.186.</Citation></Reference><Reference><Citation>Herbert M, Pendyal S, Rairikar M, Halaby C, Benjamin RW, Kishnani PS. Role of continuous glucose monitoring in the management of glycogen storage disorders. J Inherit Metab Dis. 2018;41(6):917-927. https://doi.org/10.1007/s10545-018-0200-5.</Citation></Reference><Reference><Citation>White FJ, Jones SA. The use of continuous glucose monitoring in the practical management of glycogen storage disorders. J Inherit Metab Dis. 2011;34(3):631-642. https://doi.org/10.1007/s10545-011-9335-3.</Citation></Reference><Reference><Citation>Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364-389. https://doi.org/10.1210/jc.2015-1710.</Citation></Reference><Reference><Citation>Watanabe T, Ozawa A, Ishii S, et al. Usage of continuous glucose monitoring (CGM) for detecting an unrecognized hypoglycemia and management of glucocorticoid replacement therapy in adult patients with central hypoadrenalism. Endocr J. 2018;65(5):547-556. https://doi.org/10.1507/endocrj.EJ16-0387.</Citation></Reference><Reference><Citation>Cambiaso P, Schiaffini R, Pontrelli G, et al. Nocturnal hypoglycaemia in ACTH and GH deficient children: role of continuous glucose monitoring. Clin Endocrinol (Oxf). 2013;79(2):232-237. https://doi.org/10.1111/cen.12123.</Citation></Reference><Reference><Citation>Menni F, De Lonlay P, Sevin C, et al. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics. 2001;107:476-479.</Citation></Reference><Reference><Citation>Saif M, Kapoor A, Kochar I, Jindal R. Continuous glucose monitoring system for congenital hyperinsulinemia. Indian Pediatr. 2013;50(4):421-422. https://doi.org/10.1007/s13312-013-0103-3.</Citation></Reference><Reference><Citation>Philippon M, S..jil S, Mugnier M, et al. Use of the continuous glucose monitoring system to treat insulin autoimmune syndrome: quantification of glucose excursions and evaluation of treatment efficacy. Diabet Med. 2014;31(7):e20-e24. https://doi.org/10.1111/dme.12418.</Citation></Reference><Reference><Citation>Alsaffar H, Turner L, Yung Z, Didi M, Senniappan S. Continuous flash glucose monitoring in children with congenital Hyperinsulinism; first report on accuracy and patient experience. Int J Pediatr Endocrinol. 2018;2018(1). https://doi.org/10.1186/s13633-018-0057-2.</Citation></Reference><Reference><Citation>Vezzosi D, Guillaume E, Bennet A, Mouly C, Hanaire H, Caron P. Medical therapy in patients with endogenous hypoglycaemia: is euglycaemia achievable? Clin Endocrinol (Oxf). 2019;90(6):798-804. https://doi.org/10.1111/cen.13961.</Citation></Reference><Reference><Citation>Munir A, Choudhary P, Harrison B, Heller S, Newell-Price J. Continuous glucose monitoring in patients with insulinoma. Clin Endocrinol (Oxf). 2008;68(6):912-918. https://doi.org/10.1111/j.1365-2265.2007.03161.x.</Citation></Reference><Reference><Citation>Sawyer AM, Schade DS. Use of a continuous glucose monitor in the management of inoperable meta static insulinoma: a case report. Endocr Pract. 2008;14(7):880-883. https://doi.org/10.4158/EP.14.7.880.</Citation></Reference><Reference><Citation>Okabayashi T, Shima Y, Sumiyoshi T, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19(6):829-837. https://doi.org/10.3748/wjg.v19.i6.829.</Citation></Reference><Reference><Citation>Manabe M, Morimatsu H, Egi M, et al. Anesthetic management of pediatric patients with insulinoma using continuous glucose monitoring. Masui. 2009;58(6):757-759. http://www.ncbi.nlm.nih.gov/pubmed/19522271.</Citation></Reference><Reference><Citation>Rodr..guez Flores M, Cruz Soto RC, V..zquez Vel..zquez V, Soriano Cort..s RR, Aguilar Salinas C, Garc..a EG. Continuous glucose monitoring in the management of patients after gastric bypass. Endocrinol Diabetes Metab Case Rep. 2019;2019. https://doi.org/10.1530/edm-18-0155.</Citation></Reference><Reference><Citation>Nielsen JB, Abild CB, Pedersen AM, Pedersen SB, Richelsen B. Continuous glucose monitoring after gastric bypass to evaluate the glucose variability after a Low-carbohydrate diet and to determine hypoglycemia. Obes Surg. 2016;26(9):2111-2118. https://doi.org/10.1007/s11695-016-2058-7.</Citation></Reference><Reference><Citation>Bila R, Varo R, Madrid L, Sitoe A, Bassat Q. Continuous glucose monitoring in resource-constrained settings for hypoglycaemia detection: looking at the problem from the other side of the coin. Biosensors. 2018;8(2):2-7. https://doi.org/10.3390/bios8020043.</Citation></Reference><Reference><Citation>Osier FHA, Berkley JA, Ross A, Sanderson F, Mohammed S, Newton CRJC. Abnormal blood glucose concentrations on admission to a rural Kenyan district hospital: prevalence and outcome. Arch Dis Child. 2003;88(7):621-625. https://doi.org/10.1136/adc.88.7.621.</Citation></Reference><Reference><Citation>Jallow M, Casals-Pascual C, Ackerman H, et al. Clinical features of severe malaria associated with death: a 13-year observational study in The Gambia. PLoS One. 2012;7(9). https://doi.org/10.1371/journal.pone.0045645.</Citation></Reference><Reference><Citation>Willcox ML, Forster M, Dicko MI, Graz B, Mayon-White R, Barennes H. Blood glucose and prognosis in children with presumed severe malaria: is there a threshold for ...hypoglycaemia...? Trop Med Int Heal. 2010;15(2):232-240. https://doi.org/10.1111/j.1365-3156.2009.02444.x.</Citation></Reference><Reference><Citation>Chen C, Zhao XL, Li ZH, Zhu ZG, Qian SH, Flewitt AJ. Current and emerging technology for continuous glucose monitoring. Sensors (Switzerland). 2017;17(1). https://doi.org/10.3390/s17010182.</Citation></Reference><Reference><Citation>Davey RJ, Low C, Jones TW, Fournier PA. Contribution of an intrinsic lag of continuous glucose monitoring systems to differences in measured and actual glucose concentrations changing at variable rates in vitro. J Diabetes Sci Technol. 2010;4(6):1393-1399. https://doi.org/10.1177/193229681000400614.</Citation></Reference><Reference><Citation>Caplin NJ, O'Leary P, Bulsara M, Davis EA, Jones TW. Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia. Diabet Med. 2003;20(3):238-241. https://doi.org/10.1046/j.1464-5491.2003.00837.x.</Citation></Reference><Reference><Citation>Davey RJ, Jones TW, Fournier PA. Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus. J Diabetes Sci Technol. 2010;4(6):1457-1464. https://doi.org/10.1177/193229681000400620.</Citation></Reference><Reference><Citation>Pickup JC, Holloway MF, Samsi K. Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives. Diabetes Care. 2015;38(4):544-550. https://doi.org/10.2337/dc14-1855.</Citation></Reference><Reference><Citation>Buckingham B, Block J, Burdick J, et al. Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol Ther. 2005;7(3):440-447. https://doi.org/10.1089/dia.2005.7.440.</Citation></Reference><Reference><Citation>Rodbard D. Continuous glucose monitoring: a review of successes, challenges, and opportunities. Diabetes Technol Ther. 2016;18(S2):S23-S213. https://doi.org/10.1089/dia.2015.0417.</Citation></Reference><Reference><Citation>Dunne N, Viggiani MT, Pardo S, Robinson C, Parkes JL. Accuracy evaluation of CONTOUR..PLUS compared with four blood glucose monitoring systems. Diabetes Ther. 2015;6(3):377-388. https://doi.org/10.1007/s13300-015-0121-3.</Citation></Reference><Reference><Citation>Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-1603.</Citation></Reference><Reference><Citation>Ascaso FJ. Noninvasive continuous monitoring of tear. Optom Vis Sci. 2016;93(4):426-434. https://doi.org/10.1097/OPX.0000000000000698.</Citation></Reference><Reference><Citation>Oviedo S, Veh.. J, Calm R, Armengol J. A review of personalized blood glucose prediction strategies for T1DM patients. Int J Numer Method Biomed Eng. 2017;33(6). https://doi.org/10.1002/cnm.2833.</Citation></Reference><Reference><Citation>Woldaregay AZ, ..rsand E, Walderhaug S, et al. Data-driven modeling and prediction of blood glucose dynamics: machine learning applications in type 1 diabetes. Artif Intell Med. 2019;98(August 2018):109-134. https://doi.org/10.1016/j.artmed.2019.07.007.</Citation></Reference><Reference><Citation>Pappada SM, Cameron BD, Rosman PM, et al. Neural network-based real-time prediction of glucose in patients with insulin-dependent diabetes. Diabetes Technol Ther. 2011;13(2):135-141. https://doi.org/10.1089/dia.2010.0104.</Citation></Reference><Reference><Citation>Contreras I, Oviedo S, Vettoretti M, Visentin R, Veh.. J. Personalized blood glucose prediction: a hybrid approach using grammatical evolution and physiological models. PLoS One. 2017;12(11). https://doi.org/10.1371/journal.pone.0187754.</Citation></Reference><Reference><Citation>Li K, Liu C, Zhu T, Herrero P, Georgiou P. GluNet: a deep learning framework for accurate glucose forecasting. IEEE J Biomed Heal Inform. 2019;PP(c):1-1. https://doi.org/10.1109/jbhi.2019.2931842.</Citation></Reference><Reference><Citation>Li J, Fernando C. Smartphone-based personalized blood glucose prediction. ICT Express. 2016;2(4):150-154. https://doi.org/10.1016/j.icte.2016.10.001.</Citation></Reference><Reference><Citation>Jensen MH, Dethlefsen C, Vestergaard P, Hejlesen O. Prediction of nocturnal hypoglycemia from continuous glucose monitoring data in people with type 1 diabetes: a proof-of-concept study. J Diabetes Sci Technol. 2019;14:250-256. https://doi.org/10.1177/1932296819868727.</Citation></Reference><Reference><Citation>Seo W, Lee Y, Bin LS, Jin SM, Park SM. A machine-learning approach to predict postprandial hypoglycemia. BMC Med Inform Decis Mak. 2019;19(1). https://doi.org/10.1186/s12911-019-0943-4.</Citation></Reference><Reference><Citation>Mosquera-Lopez C, Dodier R, Tyler N, Resalat N, Jacobs P. Leveraging a big dataset to develop a recurrent neural network to predict adverse glycemic events in type 1 diabetes. IEEE J Biomed Heal Inform. 2019;PP(XX):1-1. https://doi.org/10.1109/jbhi.2019.2911701.</Citation></Reference><Reference><Citation>Veh.. J, Contreras I, Oviedo S, Biagi L, Bertachi A. Prediction and prevention of hypoglycaemic events in type-1 diabetic patients using machine learning. Health Informatics J. 2019;1460458219850682. https://doi.org/10.1177/1460458219850682.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32308884</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2019</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Predicting Nocturnal Hypoglycemia from Continuous Glucose Monitoring Data with Extended Prediction Horizon.</ArticleTitle><Pagination><MedlinePgn>874-882</MedlinePgn></Pagination><Abstract><AbstractText>Nocturnal hypoglycemia is a serious complication of insulin-treated diabetes, which commonly goes undetected. Continuous glucose monitoring (CGM) devices have enabled prediction of impending nocturnal hypoglycemia, however, prior efforts have been limited to a short prediction horizon (~ 30 minutes). To this end, a nocturnal hypoglycemia prediction model with a 6-hour horizon (midnight-6 am) was developed using a random forest machine- learning model based on data from 10,000 users with more than 1 million nights of CGM data. The model demonstrated an overall nighttime hypoglycemia prediction performance of ROC AUC = 0.84, with AUC = 0.90 for early night (midnight-3 am) and AUC = 0.75 for late night (prediction at midnight, looking at 3-6 am window). While instabilities and the absence of late-night blood glucose patterns introduce predictability challenges, this 6-hour horizon model demonstrates good performance in predicting nocturnal hypoglycemia. Additional study and specific patient-specific features will provide refinements that further ensure safe overnight management of glycemia.</AbstractText><CopyrightInformation>..2019 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vu</LastName><ForeName>Long</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IBM Research AI, Yorktown Heights, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kefayati</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IBM Watson Health, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Id..</LastName><ForeName>Tsuyoshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>IBM Research AI, Yorktown Heights, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavuluri</LastName><ForeName>Venkata</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>IBM Research AI, Yorktown Heights, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Gretchen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IBM Watson Health, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latts</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IBM Watson Health, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Yuxiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medtronic, Northridge, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Pratik</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medtronic, Northridge, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yuan-Chi</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>IBM Research AI, Yorktown Heights, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="Y">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018670" MajorTopicYN="Y">Monitoring, Ambulatory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32308884</ArticleId><ArticleId IdType="pmc">PMC7153099</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):622-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23883408</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2017 Mar;19(3):173-182</Citation><ArticleIdList><ArticleId IdType="pubmed">28099035</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014 Jul;37(7):1885-91</Citation><ArticleIdList><ArticleId IdType="pubmed">24804697</ArticleId></ArticleIdList></Reference><Reference><Citation>Postgrad Med. 2011 Jul;123(4):81-91</Citation><ArticleIdList><ArticleId IdType="pubmed">21680992</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Feb;41(2):303-310</Citation><ArticleIdList><ArticleId IdType="pubmed">29191844</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):634-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23848178</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 May 03;10(3):640-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26969142</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Endocrinol. 2009 May;5(5):253-61</Citation><ArticleIdList><ArticleId IdType="pubmed">19444258</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 May;33(5):1013-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20200307</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2018 May 30;20(5):e10775</Citation><ArticleIdList><ArticleId IdType="pubmed">29848472</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2005 Oct;28(10):2361-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16186263</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 May;33(5):1004-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20200306</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Jun;40(6):764-770</Citation><ArticleIdList><ArticleId IdType="pubmed">28351897</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Dec;40(12):1622-1630</Citation><ArticleIdList><ArticleId IdType="pubmed">29162582</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014 Jul;37(7):1845-53</Citation><ArticleIdList><ArticleId IdType="pubmed">24784832</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2017 Dec;134:17-28</Citation><ArticleIdList><ArticleId IdType="pubmed">28951336</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Physiol (Oxf). 2011 Jul;202(3):323-35</Citation><ArticleIdList><ArticleId IdType="pubmed">21352505</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2006 Jun;91(6):2087-92</Citation><ArticleIdList><ArticleId IdType="pubmed">16492699</ArticleId></ArticleIdList></Reference><Reference><Citation>QJM. 2009 Sep;102(9):603-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19574471</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2007 Jul;56(7):1938-42</Citation><ArticleIdList><ArticleId IdType="pubmed">17400929</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Ther. 2017 Sep;39(9):1790-1798.e7</Citation><ArticleIdList><ArticleId IdType="pubmed">28781218</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Dec;40(12):1631-1640</Citation><ArticleIdList><ArticleId IdType="pubmed">29162583</ArticleId></ArticleIdList></Reference><Reference><Citation>Automatica (Oxf). 2012 Aug;48(8):1892-1897</Citation><ArticleIdList><ArticleId IdType="pubmed">22865931</ArticleId></ArticleIdList></Reference><Reference><Citation>Best Pract Res Clin Endocrinol Metab. 2010 Oct;24(5):801-15</Citation><ArticleIdList><ArticleId IdType="pubmed">21112027</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32297804</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>01</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>Machine Learning-Based Adherence Detection of Type 2 Diabetes Patients on Once-Daily Basal Insulin Injections.</ArticleTitle><Pagination><MedlinePgn>98-108</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1932296820912411</ELocationID><Abstract><AbstractText Label="BACKGROUND">Lack of treatment adherence can lead to life-threatening health complications for people with type 2 diabetes (T2D). Recent improvements and availability in continuous glucose monitoring (CGM) technology have enabled various possibilities to monitor diabetes treatment. Detection of missed once-daily basal insulin injections can be used to provide feedback to patients, thus improving their diabetes management. In this study, we explore how <i>machine learning</i> (ML) based on CGM data can be used for detecting <i>adherence</i> to once-daily basal insulin injections.</AbstractText><AbstractText Label="METHODS">In-silico CGM data were generated to simulate a cohort of T2D patients on once-daily insulin injection (Tresiba..). <i>Deep learning</i> methods within ML based on automatic feature extraction including convolutional neural networks were explored and compared with simple feature-engineered ML classification models for adherence detection. It was further investigated whether fused expert-dependent and automatically learned features could improve performance, resulting in a comparison of six different detection models. Adherence was detected throughout each day with an increasing amount of CGM data available.</AbstractText><AbstractText Label="RESULTS">The adherence detection accuracy improved as more CGM data became available on the day of classification. The three classification models based on expert-engineered features obtained mean accuracies of 78.6%, 78.2%, and 78.3%. The classification model based purely on learned features obtained a mean accuracy of 79.7%. The two classification models fusing expert-engineered and learned features obtained mean accuracies of 79.7% and 79.8%. All the mentioned results were obtained 16...hours after time of injection.</AbstractText><AbstractText Label="CONCLUSION">The results suggest that adherence detection based on CGM data is feasible. Even though our study based on in-silico data indicates only slightly improved performance of more complex models, the question remains whether advanced models would outperform the simple in a real-world setting. Thus, future studies on adherence monitoring using real CGM data are relevant.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thyde</LastName><ForeName>Daniel N</ForeName><Initials>DN</Initials><Identifier Source="ORCID">0000-0002-0391-0646</Identifier><AffiliationInfo><Affiliation>Department of Applied Mathematics and Computer Science, DTU Compute, Kgs. Lyngby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohebbi</LastName><ForeName>Ali</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7705-9332</Identifier><AffiliationInfo><Affiliation>Department of Applied Mathematics and Computer Science, DTU Compute, Kgs. Lyngby, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Novo Nordisk A/S, Device R&amp;D, Hiller..d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bengtsson</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Novo Nordisk A/S, Device R&amp;D, Hiller..d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Morten Lind</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Novo Nordisk A/S, Medical &amp; Science, S..borg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M..rup</LastName><ForeName>Morten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Applied Mathematics and Computer Science, DTU Compute, Kgs. Lyngby, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">adherence detection</Keyword><Keyword MajorTopicYN="Y">continuous glucose monitoring</Keyword><Keyword MajorTopicYN="Y">deep learning</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">type 2 diabetes</Keyword><Keyword MajorTopicYN="Y">virtual patient</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32297804</ArticleId><ArticleId IdType="doi">10.1177/1932296820912411</ArticleId><ArticleId IdType="pmc">PMC7780366</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Care. 2018 Dec;41(12):2669-2701</Citation><ArticleIdList><ArticleId IdType="pubmed">30291106</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2015 May 28;521(7553):436-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26017442</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2020 Jan 15;:1932296819900240</Citation><ArticleIdList><ArticleId IdType="pubmed">31941361</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:2896-2899</Citation><ArticleIdList><ArticleId IdType="pubmed">29060503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2018 Apr 7;391(10128):1334-1336</Citation><ArticleIdList><ArticleId IdType="pubmed">29459022</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Meas. 2004 Aug;25(4):905-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15382830</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Aug;41(8):1579-1589</Citation><ArticleIdList><ArticleId IdType="pubmed">29936424</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Ther. 2006 Oct;28(10):1712-25; discussion 1710-1</Citation><ArticleIdList><ArticleId IdType="pubmed">17157128</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Aug;42(8):1593-1603</Citation><ArticleIdList><ArticleId IdType="pubmed">31177185</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2016 Feb;18 Suppl 2:S214-22</Citation><ArticleIdList><ArticleId IdType="pubmed">26784125</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2014 Mar;61(3):620-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24108706</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2020 Mar;14(2):271-276</Citation><ArticleIdList><ArticleId IdType="pubmed">32116024</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2004 May;27(5):1218-24</Citation><ArticleIdList><ArticleId IdType="pubmed">15111553</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2008 Jan;31 Suppl 1:S61-78</Citation><ArticleIdList><ArticleId IdType="pubmed">18165339</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Sep 01;3(5):1047-57</Citation><ArticleIdList><ArticleId IdType="pubmed">20144418</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2012 Sep;14(9):859-64</Citation><ArticleIdList><ArticleId IdType="pubmed">22594461</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2011 Nov 01;5(6):1529-48</Citation><ArticleIdList><ArticleId IdType="pubmed">22226276</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Dec;40(12):1631-1640</Citation><ArticleIdList><ArticleId IdType="pubmed">29162583</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Clin Endocrinol. 1983 May;81(3):263-72</Citation><ArticleIdList><ArticleId IdType="pubmed">6350027</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Mar;15(3):198-211</Citation><ArticleIdList><ArticleId IdType="pubmed">23448694</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2012 Dec;35(12):2464-71</Citation><ArticleIdList><ArticleId IdType="pubmed">23043166</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Eng Online. 2015 Mar 04;14:19</Citation><ArticleIdList><ArticleId IdType="pubmed">25889091</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2017 Nov;133:178-192</Citation><ArticleIdList><ArticleId IdType="pubmed">28965029</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2019 Jan;25(1):24-29</Citation><ArticleIdList><ArticleId IdType="pubmed">30617335</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2012 May;29(5):682-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22313123</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient Prefer Adherence. 2015 Aug 25;9:1225-31</Citation><ArticleIdList><ArticleId IdType="pubmed">26346988</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Spectr. 2016 Aug;29(3):166-70</Citation><ArticleIdList><ArticleId IdType="pubmed">27574371</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32297795</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8593</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>11</Month></PubDate></JournalIssue><Title>Diabetes technology &amp; therapeutics</Title><ISOAbbreviation>Diabetes Technol Ther</ISOAbbreviation></Journal><ArticleTitle>Predicting and Preventing Nocturnal Hypoglycemia in Type 1 Diabetes Using Big Data Analytics and Decision Theoretic Analysis.</ArticleTitle><Pagination><MedlinePgn>801-811</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/dia.2019.0458</ELocationID><Abstract><AbstractText><b><i>Background:</i></b> Despite new glucose sensing technologies, nocturnal hypoglycemia is still a problem for people with type 1 diabetes (T1D) as symptoms and sensor alarms may not be detected while sleeping. Accurately predicting nocturnal hypoglycemia before sleep may help minimize nighttime hypoglycemia. <b><i>Methods:</i></b> A support vector regression (SVR) model was trained to predict, before bedtime, the overnight minimum glucose and overnight nocturnal hypoglycemia for people with T1D. The algorithm was trained on continuous glucose measurements and insulin data collected from 124 people (22,804 valid nights of data) with T1D. The minimum glucose threshold for announcing nocturnal hypoglycemia risk was derived by applying a decision theoretic criterion to maximize expected net benefit. Accuracy was evaluated on a validation set from 10 people with T1D during a 4-week trial under free-living sensor-augmented insulin-pump therapy. The primary outcome measures were sensitivity and specificity of prediction, the correlation between predicted and actual minimum nocturnal glucose, and root-mean-square error. The impact of using the algorithm to prevent nocturnal hypoglycemia is shown in-silico. <b><i>Results:</i></b> The algorithm predicted 94.1% of nocturnal hypoglycemia events (&lt;3.9...mmol/L, 95% confidence interval [CI], 71.3-99.9) with an area under the receiver operating characteristic curve of 0.86 (95% CI, 0.75-0.98). Correlation between actual and predicted minimum glucose was high (<i>R</i>...=...0.71, <i>P</i>...&lt;...0.001). In-silico simulations showed that the algorithm could reduce nocturnal hypoglycemia by 77.0% (<i>P</i>...=...0.006) without impacting time in target range (3.9-10...mmol/L). <b><i>Conclusion:</i></b> An SVR model trained on a big data set and optimized using decision theoretic criterion can accurately predict at bedtime if overnight nocturnal hypoglycemia will occur and may help reduce nocturnal hypoglycemia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mosquera-Lopez</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Artificial Intelligence for Medical Systems (AIMS) Lab, Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harold Schnitzer Diabetes Health Center, Oregon Health and Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dodier</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Artificial Intelligence for Medical Systems (AIMS) Lab, Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harold Schnitzer Diabetes Health Center, Oregon Health and Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyler</LastName><ForeName>Nichole S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Artificial Intelligence for Medical Systems (AIMS) Lab, Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harold Schnitzer Diabetes Health Center, Oregon Health and Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Leah M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Artificial Intelligence for Medical Systems (AIMS) Lab, Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harold Schnitzer Diabetes Health Center, Oregon Health and Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Youssef</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Artificial Intelligence for Medical Systems (AIMS) Lab, Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harold Schnitzer Diabetes Health Center, Oregon Health and Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castle</LastName><ForeName>Jessica R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Artificial Intelligence for Medical Systems (AIMS) Lab, Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harold Schnitzer Diabetes Health Center, Oregon Health and Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Peter G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Artificial Intelligence for Medical Systems (AIMS) Lab, Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harold Schnitzer Diabetes Health Center, Oregon Health and Science University, Portland, Oregon, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Diabetes Technol Ther</MedlineTA><NlmUniqueID>100889084</NlmUniqueID><ISSNLinking>1520-9156</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077488" MajorTopicYN="N">Data Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="Y">Hypoglycemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012890" MajorTopicYN="N">Sleep</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013995" MajorTopicYN="N">Time</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Decision support</Keyword><Keyword MajorTopicYN="Y">Decision theoretic analysis</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Nocturnal hypoglycemia</Keyword><Keyword MajorTopicYN="Y">Support vector regression</Keyword><Keyword MajorTopicYN="Y">Type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32297795</ArticleId><ArticleId IdType="doi">10.1089/dia.2019.0458</ArticleId><ArticleId IdType="pmc">PMC7698985</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Metab Res Rev. 2008 Feb;24(2):87-92</Citation><ArticleIdList><ArticleId IdType="pubmed">18088077</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2006 Jun;91(6):2087-92</Citation><ArticleIdList><ArticleId IdType="pubmed">16492699</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 Jun;33(6):1249-54</Citation><ArticleIdList><ArticleId IdType="pubmed">20508231</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2013 Sep 25;310(12):1235-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24065008</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Complications. 2018 Dec;32(12):1118-1123</Citation><ArticleIdList><ArticleId IdType="pubmed">30293932</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:2990-2993</Citation><ArticleIdList><ArticleId IdType="pubmed">28268941</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Jul;41(7):1471-1477</Citation><ArticleIdList><ArticleId IdType="pubmed">29752345</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2015 Jun;17(6):385-91</Citation><ArticleIdList><ArticleId IdType="pubmed">25761202</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2011 Mar;28(3):293-300</Citation><ArticleIdList><ArticleId IdType="pubmed">21309837</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr. 1994 Aug;125(2):177-88</Citation><ArticleIdList><ArticleId IdType="pubmed">8040759</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2015 Dec;3(12):939-47</Citation><ArticleIdList><ArticleId IdType="pubmed">26432775</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Nutr Metab. 2002 Dec;15(6):390-4; discussion 394-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12678456</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2020 Mar;14(2):250-256</Citation><ArticleIdList><ArticleId IdType="pubmed">31390891</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2005 Dec 22;353(25):2643-53</Citation><ArticleIdList><ArticleId IdType="pubmed">16371630</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 May;33(5):1004-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20200306</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2018 Apr 3;319(13):1317-1318</Citation><ArticleIdList><ArticleId IdType="pubmed">29532063</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Endocrinol Metab. 2005 Jan;18(1):83-91</Citation><ArticleIdList><ArticleId IdType="pubmed">15679073</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2014 Sep;2(9):701-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24943065</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Oct 2;359(14):1464-76</Citation><ArticleIdList><ArticleId IdType="pubmed">18779236</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2013 Sep 25;310(12):1240-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24065010</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2007 Feb;4(2):e69</Citation><ArticleIdList><ArticleId IdType="pubmed">17326710</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(1):9-16</Citation><ArticleIdList><ArticleId IdType="pubmed">24356592</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2017 Jan 28;389(10067):369-380</Citation><ArticleIdList><ArticleId IdType="pubmed">28007348</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2005 Oct;7(5):776-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16241881</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2017 Jun;19(S3):S3-S12</Citation><ArticleIdList><ArticleId IdType="pubmed">28585875</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2019 Jul 25;14(7):e0217301</Citation><ArticleIdList><ArticleId IdType="pubmed">31344037</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Netw. 2013 Dec;48:1-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23892907</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:4561-3</Citation><ArticleIdList><ArticleId IdType="pubmed">18003020</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Rev. 1991 Nov;12(4):356-71</Citation><ArticleIdList><ArticleId IdType="pubmed">1760993</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 1991 Apr;90(4):450-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2012085</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Diabetes. 2019 Aug;43(6):406-414.e1</Citation><ArticleIdList><ArticleId IdType="pubmed">30414785</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2004 May 27;350(22):2272-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15163777</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab. 2013 Feb;39(1):63-70</Citation><ArticleIdList><ArticleId IdType="pubmed">23266467</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2018 Feb;20(2):443-447</Citation><ArticleIdList><ArticleId IdType="pubmed">28718987</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):634-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23848178</ArticleId></ArticleIdList></Reference><Reference><Citation>MedGenMed. 2007 May 17;9(2):38</Citation><ArticleIdList><ArticleId IdType="pubmed">17955093</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 1982 Apr;143(1):29-36</Citation><ArticleIdList><ArticleId IdType="pubmed">7063747</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2018 Sep 18;320(11):1103-1104</Citation><ArticleIdList><ArticleId IdType="pubmed">30326503</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1997 Nov;20(11):1655-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9353603</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1997 Jan;20(1):22-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9028688</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2005 May;28(5):1245-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15855602</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2016 Nov;18(11):1110-1119</Citation><ArticleIdList><ArticleId IdType="pubmed">27333970</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32204318</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1424-8220</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>19</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>Prediction of Nocturnal Hypoglycemia in Adults with Type 1 Diabetes under Multiple Daily Injections Using Continuous Glucose Monitoring and Physical Activity Monitor.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E1705</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/s20061705</ELocationID><Abstract><AbstractText>(1) Background: nocturnal hypoglycemia (NH) is one of the most challenging side effects of multiple doses of insulin (MDI) therapy in type 1 diabetes (T1D). This work aimed to investigate the feasibility of a machine-learning-based prediction model to anticipate NH in T1D patients on MDI. (2) Methods: ten T1D adults were studied during 12 weeks. Information regarding T1D management, continuous glucose monitoring (CGM), and from a physical activity tracker were obtained under free-living conditions at home. Supervised machine-learning algorithms were applied to the data, and prediction models were created to forecast the occurrence of NH. Individualized prediction models were generated using multilayer perceptron (MLP) and a support vector machine (SVM). (3) Results: population outcomes indicated that more than 70% of the NH may be avoided with the proposed methodology. The predictions performed by the SVM achieved the best population outcomes, with a sensitivity and specificity of 78.75% and 82.15%, respectively. (4) Conclusions: our study supports the feasibility of using ML techniques to address the prediction of nocturnal hypoglycemia in the daily life of patients with T1D on MDI, using CGM and a physical activity tracker.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bertachi</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Informatics and Applications, University of Girona, 17003 Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Federal University of Technology-Paran.. (UTFPR), Guarapuava 85053-525, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vi..als</LastName><ForeName>Clara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6888-0396</Identifier><AffiliationInfo><Affiliation>Diabetes Unit, Endocrinology and Nutrition Dpt. Hospital Cl..nic de Barcelona, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biagi</LastName><ForeName>Lyvia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3356-8375</Identifier><AffiliationInfo><Affiliation>Institute of Informatics and Applications, University of Girona, 17003 Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Federal University of Technology-Paran.. (UTFPR), Guarapuava 85053-525, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Informatics and Applications, University of Girona, 17003 Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veh..</LastName><ForeName>Josep</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6884-9789</Identifier><AffiliationInfo><Affiliation>Institute of Informatics and Applications, University of Girona, 17003 Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conget</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Diabetes Unit, Endocrinology and Nutrition Dpt. Hospital Cl..nic de Barcelona, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gim..nez</LastName><ForeName>Marga</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Diabetes Unit, Endocrinology and Nutrition Dpt. Hospital Cl..nic de Barcelona, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DPI2016-78831-C2-2-R</GrantID><Agency>Spanish Government</Agency><Country/></Grant><Grant><GrantID>202050/2015-7</GrantID><Agency>National Council of Technological and Scientific Development, CNPq - Brazil</Agency><Country/></Grant><Grant><GrantID>207688/2014-1</GrantID><Agency>National Council of Technological and Scientific Development, CNPq - Brazil</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072936" MajorTopicYN="N">Fitness Trackers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="Y">Monitoring, Physiologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial neural network</Keyword><Keyword MajorTopicYN="N">continuous glucose monitoring</Keyword><Keyword MajorTopicYN="N">hypoglycemia</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">multiple daily injections</Keyword><Keyword MajorTopicYN="N">support vector machine</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>02</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>03</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>03</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32204318</ArticleId><ArticleId IdType="pii">s20061705</ArticleId><ArticleId IdType="doi">10.3390/s20061705</ArticleId><ArticleId IdType="pmc">PMC7147466</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>IEEE Trans Biomed Eng. 2012 Jun;59(6):1550-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22374344</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Res Rev. 2008 Feb;24(2):87-92</Citation><ArticleIdList><ArticleId IdType="pubmed">18088077</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2016 Nov 5;388(10057):2254-2263</Citation><ArticleIdList><ArticleId IdType="pubmed">27634581</ArticleId></ArticleIdList></Reference><Reference><Citation>QJM. 2009 Sep;102(9):603-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19574471</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2005 Jan;52(1):3-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15651559</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Jul;39(7):e95-6</Citation><ArticleIdList><ArticleId IdType="pubmed">27208338</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2018 Nov;20(11):738-743</Citation><ArticleIdList><ArticleId IdType="pubmed">30256132</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2019 Jul;21(7):406-408</Citation><ArticleIdList><ArticleId IdType="pubmed">31265348</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2017 Jan 24;317(4):379-387</Citation><ArticleIdList><ArticleId IdType="pubmed">28118454</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 Nov 1;10(6):1245-1250</Citation><ArticleIdList><ArticleId IdType="pubmed">27660190</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2020 Mar;14(2):250-256</Citation><ArticleIdList><ArticleId IdType="pubmed">31390891</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 Jan;33(1):17-22</Citation><ArticleIdList><ArticleId IdType="pubmed">19837791</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1993 Sep 30;329(14):977-86</Citation><ArticleIdList><ArticleId IdType="pubmed">8366922</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2012 Dec;55(12):3155-62</Citation><ArticleIdList><ArticleId IdType="pubmed">22965294</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2001 Nov;24(11):1888-93</Citation><ArticleIdList><ArticleId IdType="pubmed">11679452</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Med Inform. 2019 Jun;126:1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">31029250</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2019 Sep;13(5):919-927</Citation><ArticleIdList><ArticleId IdType="pubmed">30650997</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2012;2012:2889-92</Citation><ArticleIdList><ArticleId IdType="pubmed">23366528</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr. 1997 Mar;130(3):366-72</Citation><ArticleIdList><ArticleId IdType="pubmed">9063410</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2003 Jan;26(1):9-15</Citation><ArticleIdList><ArticleId IdType="pubmed">12502652</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2017 Nov;133:30-39</Citation><ArticleIdList><ArticleId IdType="pubmed">28888993</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Jan;11(1):50-58</Citation><ArticleIdList><ArticleId IdType="pubmed">28264173</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Nov 7;12(11):e0187754</Citation><ArticleIdList><ArticleId IdType="pubmed">29112978</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Qual Life Outcomes. 2013 Jun 03;11:90</Citation><ArticleIdList><ArticleId IdType="pubmed">23731777</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Endocrinol. 2014 Dec;10(12):711-22</Citation><ArticleIdList><ArticleId IdType="pubmed">25287289</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2015 Jun;17(6):385-91</Citation><ArticleIdList><ArticleId IdType="pubmed">25761202</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1993 Sep 16;329(12):834-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8355741</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2016 May 24;16:433</Citation><ArticleIdList><ArticleId IdType="pubmed">27220855</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2019 Oct;21(10):602-609</Citation><ArticleIdList><ArticleId IdType="pubmed">31335193</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Chim Acta. 2013 Jan 14;760:25-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23265730</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab. 2007 Nov;33(5):360-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17652003</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2011 Sep;34(9):2023-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21868778</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2018 May 30;20(5):e10775</Citation><ArticleIdList><ArticleId IdType="pubmed">29848472</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2016 Oct;134:179-86</Citation><ArticleIdList><ArticleId IdType="pubmed">27480742</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1272-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24574352</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2008 Jul;25(7):765-74</Citation><ArticleIdList><ArticleId IdType="pubmed">18644063</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32091990</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>11</Month></PubDate></JournalIssue><Title>IEEE transactions on bio-medical engineering</Title><ISOAbbreviation>IEEE Trans Biomed Eng</ISOAbbreviation></Journal><ArticleTitle>Benchmarking Machine Learning Algorithms on Blood Glucose Prediction for Type I Diabetes in Comparison With Classical Time-Series Models.</ArticleTitle><Pagination><MedlinePgn>3101-3124</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/TBME.2020.2975959</ELocationID><Abstract><AbstractText Label="OBJECTIVE">This paper aims to compare the performance of several commonly known machine-learning (ML) models versus a classic Autoregression with Exogenous inputs (ARX) model in the prediction of blood glucose (BG) levels using time-series data of patients with Type 1 diabetes (T1D).</AbstractText><AbstractText Label="METHODS">The ML algorithms include ML-based regression models and deep learning models such as a vanilla Long-Short-Term-Memory (LSTM) Network and a Temporal Convolution Network (TCN). Evaluations have been conducted with respect to different input features, regression model orders, as well as using the recursive method or direct method for multi-step prediction of BG levels. Prediction performance metrics include the average Root Mean Square Error (RMSE), temporal gain (TG) for early prediction, and the normalized energy of the second-order differences (ESOD) of the predicted time series to reflect risk of false alerts on hypo/hyper glycemia events.</AbstractText><AbstractText Label="RESULTS">The ARX model achieved the lowest average RMSE for both recursive and direct methods, the second highest average TG under the direct method, but with a higher average normalized ESOD than some other models.</AbstractText><AbstractText Label="CONCLUSION">There was no significant advantage observed from the ML models compared to the classic ARX model in predicting BG levels for T1D, except that TCN's performance was more robust with respect to BG trajectories with spurious oscillations, for which ARX tended to over-predict peak BG values and under-predict valley BG values.</AbstractText><AbstractText Label="SIGNIFICANCE">Insight learned from this study could help researchers and clinical practitioners to select appropriate models for BG prediction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Jinyu</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE Trans Biomed Eng</MedlineTA><NlmUniqueID>0012737</NlmUniqueID><ISSNLinking>0018-9294</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019985" MajorTopicYN="N">Benchmarking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32091990</ArticleId><ArticleId IdType="doi">10.1109/TBME.2020.2975959</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32058821</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8593</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>07</Month></PubDate></JournalIssue><Title>Diabetes technology &amp; therapeutics</Title><ISOAbbreviation>Diabetes Technol Ther</ISOAbbreviation></Journal><ArticleTitle>Use of Machine Learning and Hybrid Closed Loop Insulin Delivery at Diabetes Camps.</ArticleTitle><Pagination><MedlinePgn>535-537</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/dia.2020.0026</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Kasserine A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>College of Arts and Sciences, Cornell University, Ithaca, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forlenza</LastName><ForeName>Gregory P</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>Barbara Davis Center, University of Colorado Denver, Aurora, Colorado.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Diabetes Technol Ther</MedlineTA><NlmUniqueID>100889084</NlmUniqueID><ISSNLinking>1520-9156</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="Y">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="Y">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32058821</ArticleId><ArticleId IdType="doi">10.1089/dia.2020.0026</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31920964</PMID><DateRevised><Year>2020</Year><Month>01</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Utility and First Clinical Application of Screening Embryos for Polygenic Disease Risk Reduction.</ArticleTitle><Pagination><MedlinePgn>845</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2019.00845</ELocationID><Abstract><AbstractText>For over 2 decades preimplantation genetic testing (PGT) has been in clinical use to reduce the risk of miscarriage and genetic disease in patients with advanced maternal age and risk of transmitting disease. Recently developed methods of genome-wide genotyping and machine learning algorithms now offer the ability to genotype embryos for polygenic disease risk with accuracy equivalent to adults. In addition, contemporary studies on adults indicate the ability to predict polygenic disorders with risk equivalent to monogenic disorders. Existing biobanks provide opportunities to model the clinical utility of polygenic disease risk reduction among sibling adults. Here, we provide a mathematical model for the use of embryo screening to reduce the risk of type 1 diabetes. Results indicate a 45-72% reduced risk with blinded genetic selection of one sibling. The first clinical case of polygenic risk scoring in human preimplantation embryos from patients with a family history of complex disease is reported. In addition to these data, several common and accepted practices place PGT for polygenic disease risk in the applicable context of contemporary reproductive medicine. In addition, prediction of risk for PCOS, endometriosis, and aneuploidy are of particular interest and relevance to patients with infertility and represent an important focus of future research on polygenic risk scoring in embryos.</AbstractText><CopyrightInformation>Copyright .. 2019 Treff, Eccles, Lello, Bechor, Hsu, Plunkett, Zimmerman, Rana, Samoilenko, Hsu and Tellier.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Treff</LastName><ForeName>Nathan R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Genomic Prediction Inc., North Brunswick, NJ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomic Prediction Clinical Laboratory, North Brunswick, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eccles</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genomic Prediction Inc., North Brunswick, NJ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomic Prediction Clinical Laboratory, North Brunswick, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lello</LastName><ForeName>Lou</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Genomic Prediction Inc., North Brunswick, NJ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physics and Astronomy, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bechor</LastName><ForeName>Elan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Genomic Prediction Inc., North Brunswick, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genomic Prediction Inc., North Brunswick, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plunkett</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Genomic Prediction Inc., North Brunswick, NJ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomic Prediction Clinical Laboratory, North Brunswick, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmerman</LastName><ForeName>Raymond</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Genomic Prediction Inc., North Brunswick, NJ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomic Prediction Clinical Laboratory, North Brunswick, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rana</LastName><ForeName>Bhavini</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Genomic Prediction Inc., North Brunswick, NJ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomic Prediction Clinical Laboratory, North Brunswick, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samoilenko</LastName><ForeName>Artem</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Genomic Prediction Inc., North Brunswick, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physics and Astronomy, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tellier</LastName><ForeName>Laurent C A M</ForeName><Initials>LCAM</Initials><AffiliationInfo><Affiliation>Genomic Prediction Inc., North Brunswick, NJ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomic Prediction Clinical Laboratory, North Brunswick, NJ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physics and Astronomy, Michigan State University, East Lansing, MI, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">advanced maternal age</Keyword><Keyword MajorTopicYN="N">aneuploidy</Keyword><Keyword MajorTopicYN="N">polygenic risk score</Keyword><Keyword MajorTopicYN="N">preimplantation genetic testing</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>07</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31920964</ArticleId><ArticleId IdType="doi">10.3389/fendo.2019.00845</ArticleId><ArticleId IdType="pmc">PMC6915076</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cancer. 2017 May 15;123(10):1721-1730</Citation><ArticleIdList><ArticleId IdType="pubmed">28085182</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2019 Nov 27;179(6):1424-1435.e8</Citation><ArticleIdList><ArticleId IdType="pubmed">31761530</ArticleId></ArticleIdList></Reference><Reference><Citation>BJOG. 2006 Dec;113(12):1393-401</Citation><ArticleIdList><ArticleId IdType="pubmed">17176278</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2019 Oct 25;9(1):15286</Citation><ArticleIdList><ArticleId IdType="pubmed">31653892</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Med Genet. 2019 Aug;62(8):103647</Citation><ArticleIdList><ArticleId IdType="pubmed">31026593</ArticleId></ArticleIdList></Reference><Reference><Citation>Fertil Steril. 2015 Jun;103(6):1418-22</Citation><ArticleIdList><ArticleId IdType="pubmed">25956364</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Treat Rev. 2015 Jan;41(1):1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25467110</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Genom Precis Med. 2019 Jun;12(6):e002481</Citation><ArticleIdList><ArticleId IdType="pubmed">31184202</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2018 Sep;50(9):1219-1224</Citation><ArticleIdList><ArticleId IdType="pubmed">30104762</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Reprod. 1996 Mar;11(3):463-4</Citation><ArticleIdList><ArticleId IdType="pubmed">8671247</ArticleId></ArticleIdList></Reference><Reference><Citation>Fertil Steril. 2017 May;107(5):1122-1129</Citation><ArticleIdList><ArticleId IdType="pubmed">28433371</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2016 Jul;17(7):392-406</Citation><ArticleIdList><ArticleId IdType="pubmed">27140283</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2019;1885:23-43</Citation><ArticleIdList><ArticleId IdType="pubmed">30506188</ArticleId></ArticleIdList></Reference><Reference><Citation>Fertil Steril. 2017 Jan;107(1):19-26</Citation><ArticleIdList><ArticleId IdType="pubmed">27793378</ArticleId></ArticleIdList></Reference><Reference><Citation>F1000Res. 2018 Mar 14;7:319</Citation><ArticleIdList><ArticleId IdType="pubmed">29946440</ArticleId></ArticleIdList></Reference><Reference><Citation>Fertil Steril. 2018 Sep;110(4):625-627</Citation><ArticleIdList><ArticleId IdType="pubmed">30196948</ArticleId></ArticleIdList></Reference><Reference><Citation>J Genet Couns. 2008 Oct;17(5):424-33</Citation><ArticleIdList><ArticleId IdType="pubmed">18792771</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Feb;42(2):200-207</Citation><ArticleIdList><ArticleId IdType="pubmed">30655379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Reprod. 2017 Oct 1;32(10):1974-1994</Citation><ArticleIdList><ArticleId IdType="pubmed">29117384</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2019 Jan 3;104(1):21-34</Citation><ArticleIdList><ArticleId IdType="pubmed">30554720</ArticleId></ArticleIdList></Reference><Reference><Citation>Fertil Steril. 2013 Jul;100(1):100-7.e1</Citation><ArticleIdList><ArticleId IdType="pubmed">23548942</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2016 May 1;34(13):1460-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26976419</ArticleId></ArticleIdList></Reference><Reference><Citation>Fertil Steril. 2017 May;107(5):1130-1135</Citation><ArticleIdList><ArticleId IdType="pubmed">28476180</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Mar;39(3):337-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26577414</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2019;1910:691-722</Citation><ArticleIdList><ArticleId IdType="pubmed">31278682</ArticleId></ArticleIdList></Reference><Reference><Citation>Fertil Steril. 2018 Jun;109(6):989-992</Citation><ArticleIdList><ArticleId IdType="pubmed">29935659</ArticleId></ArticleIdList></Reference><Reference><Citation>Fertil Steril. 2012 Apr;97(4):870-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22305103</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2011 Jan;39(Database issue):D997-1001</Citation><ArticleIdList><ArticleId IdType="pubmed">20937630</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Med. 2013 Mar;15(3):178-86</Citation><ArticleIdList><ArticleId IdType="pubmed">22975760</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2008 Nov;57(11):3152-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18694972</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31903769</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>11</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>The Need for Precision Medicine to be Applied to Diabetes.</ArticleTitle><Pagination><MedlinePgn>1122-1128</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1932296819894295</ELocationID><Abstract><AbstractText>Precision medicine refers to the tailoring of medical treatment for an individual based on large amounts of biologic and extrinsic data. The fast advancing fields of molecular biology, gene sequencing, machine learning, and other technologies enable precision medicine to utilize this detailed information to enhance clinical management decision-making for an individual in the real time of the disease course. Traditional clinical decision making is based on reacting to a relatively limited number of phenotypes that are determined by history, physical examination, and conventional lab tests. Precision medicine depends on highly detailed profiling of the patient's genetic, morphologic, and metabolic makeup. The precision medicine approach can be applied to individuals with diabetes to select treatments most likely to offer benefit and least likely to cause side effects, offering prospects of improved clinical outcomes and economic costs savings over current empiric practices. As genetic, metabolomic, immunologic, and other sophisticated testing becomes less expensive and more widespread in the medical record, it is expected that precision medicine will become increasingly applied to diabetes care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Klonoff</LastName><ForeName>David C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Florez</LastName><ForeName>Jose C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programs in Metabolism and Medical &amp; Population Genetics, Broad Institute, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>German</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Diabetes Center, University of California San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleming</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Kinexum, Harpers Ferry, WV, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 DK063720</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="N">Clinical Decision-Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="Y">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010597" MajorTopicYN="Y">Pharmacogenetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071184" MajorTopicYN="N">Pharmacogenomic Variants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="Y">Precision Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">diabetes</Keyword><Keyword MajorTopicYN="Y">genes</Keyword><Keyword MajorTopicYN="Y">omics</Keyword><Keyword MajorTopicYN="Y">pharmacogenetics</Keyword><Keyword MajorTopicYN="Y">phenotype</Keyword><Keyword MajorTopicYN="Y">precision medicine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31903769</ArticleId><ArticleId IdType="doi">10.1177/1932296819894295</ArticleId><ArticleId IdType="pmc">PMC7645141</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes. 2018 Oct;67(10):1911-1922</Citation><ArticleIdList><ArticleId IdType="pubmed">30237159</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Endocrinol Metab. 2017 May;12(3):155-158</Citation><ArticleIdList><ArticleId IdType="pubmed">30063457</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiovasc Diabetol. 2019 Jun 11;18(1):78</Citation><ArticleIdList><ArticleId IdType="pubmed">31185988</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2016 Jan;59(1):13-20</Citation><ArticleIdList><ArticleId IdType="pubmed">26498592</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2016 Jun 1;8(341):341ra76</Citation><ArticleIdList><ArticleId IdType="pubmed">27252175</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2019 Sep 27;365(6460):1409-1413</Citation><ArticleIdList><ArticleId IdType="pubmed">31604268</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Aug 26;9(8):e104837</Citation><ArticleIdList><ArticleId IdType="pubmed">25157406</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2019 Jun;7(6):442-451</Citation><ArticleIdList><ArticleId IdType="pubmed">31047901</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 2015;:342-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25592594</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2013 May;36(5):1413-21</Citation><ArticleIdList><ArticleId IdType="pubmed">23613601</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jan;9(1):3-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25550409</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Mar 17;6:23266</Citation><ArticleIdList><ArticleId IdType="pubmed">26983698</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2017 May;60(5):769-777</Citation><ArticleIdList><ArticleId IdType="pubmed">28314945</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2018 Apr;50(4):559-571</Citation><ArticleIdList><ArticleId IdType="pubmed">29632382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2018 May;6(5):361-369</Citation><ArticleIdList><ArticleId IdType="pubmed">29503172</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28</Citation><ArticleIdList><ArticleId IdType="pubmed">30559228</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Res Rev. 2019 Mar;35(3):e3109</Citation><ArticleIdList><ArticleId IdType="pubmed">30515958</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Genet Dev. 2018 Jun;50:68-73</Citation><ArticleIdList><ArticleId IdType="pubmed">29486427</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2017 May 5;18(1):83</Citation><ArticleIdList><ArticleId IdType="pubmed">28476144</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2019 Jun;51(6):924-930</Citation><ArticleIdList><ArticleId IdType="pubmed">30988515</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Jan;42(Suppl 1):S90-S102</Citation><ArticleIdList><ArticleId IdType="pubmed">30559235</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2019 Feb;62(2):286-291</Citation><ArticleIdList><ArticleId IdType="pubmed">30413829</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Pract. 2018 Jan;24(1):91-120</Citation><ArticleIdList><ArticleId IdType="pubmed">29368965</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Nutr. 2012 Sep 01;3(5):654-65</Citation><ArticleIdList><ArticleId IdType="pubmed">22983844</ArticleId></ArticleIdList></Reference><Reference><Citation>Handb Clin Neurol. 2018;147:59-73</Citation><ArticleIdList><ArticleId IdType="pubmed">29325628</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):239-247</Citation><ArticleIdList><ArticleId IdType="pubmed">31665258</ArticleId></ArticleIdList></Reference><Reference><Citation>NPJ Precis Oncol. 2019 Jan 28;3:3</Citation><ArticleIdList><ArticleId IdType="pubmed">30701196</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2019 Sep;7(9):684-694</Citation><ArticleIdList><ArticleId IdType="pubmed">31345776</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2018 Sep 21;15(9):e1002654</Citation><ArticleIdList><ArticleId IdType="pubmed">30240442</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Feb;41(2):348-355</Citation><ArticleIdList><ArticleId IdType="pubmed">29183908</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2019 Jul;62(7):1129-1142</Citation><ArticleIdList><ArticleId IdType="pubmed">31011778</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Pharmacol. 2016 Dec;56(12):1484-1499</Citation><ArticleIdList><ArticleId IdType="pubmed">27197880</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2018 Jul 24;16(7):e2005143</Citation><ArticleIdList><ArticleId IdType="pubmed">30040822</ArticleId></ArticleIdList></Reference><Reference><Citation>J Transl Med. 2019 Apr 5;17(1):114</Citation><ArticleIdList><ArticleId IdType="pubmed">30953518</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Res. 2017 Nov;125(Pt B):132-141</Citation><ArticleIdList><ArticleId IdType="pubmed">28928073</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31876179</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>09</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>Do-It-Yourself Automated Insulin Delivery: A Leading Example of the Democratization of Medicine.</ArticleTitle><Pagination><MedlinePgn>878-882</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1932296819890623</ELocationID><Abstract><AbstractText>Digital innovations have led to an explosion of data in healthcare, driving processes of democratization and foreshadowing the end of the paternalistic era of medicine and the inception of a new epoch characterized by patient-centered care. We illustrate that the "do it yourself" (DIY) automated insulin delivery (AID) innovation of diabetes is a leading example of democratization of medicine as evidenced by its application to the three pillars of democratization in healthcare (intelligent computing; sharing of information; and privacy, security, and safety) outlined by Stanford but also within a broader context of democratization. The heuristic algorithms integral to DIY AID have been developed and refined by human intelligence and demonstrate intelligent computing. We deliver examples of research in artificial pancreas technology which actively pursues the use of machine learning representative of artificial intelligence (AI) and also explore alternate approaches to AI within the DIY AID example. Sharing of information symbolizes the core philosophy behind the success of the DIY AID evolution. We examine data sharing for algorithm development and refinement, for sharing of the open-source algorithm codes online, for peer to peer support, and sharing with medical and scientific communities. Do it yourself AID systems have no regulatory approval raising safety concerns as well as medico-legal and ethical implications for healthcare professionals. Other privacy and security factors are also discussed. Democratization of healthcare promises better health access for all and we recognize the limitations of DIY AID as it exists presently, however, we believe it has great potential.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burnside</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8414-4479</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, Canterbury District Health Board, Christchurch, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crocket</LastName><ForeName>Hamish</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Te Huataki Waiora School of Health, University of Waikato, Hamilton, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayo</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of Waikato, Hamilton, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pickering</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Otago, Christchurch, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tappe</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Software, AndroidAPS.org, Linz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Bock</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0454-6679</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, Canterbury District Health Board, Christchurch, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics, University of Otago, Christchurch, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016494" MajorTopicYN="N">Computer Security</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004059" MajorTopicYN="N">Diffusion of Innovation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085002" MajorTopicYN="Y">Glycemic Control</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="Y">Insulin Infusion Systems</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018670" MajorTopicYN="N">Monitoring, Ambulatory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019397" MajorTopicYN="Y">Pancreas, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010358" MajorTopicYN="Y">Patient Participation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">artificial intelligence</Keyword><Keyword MajorTopicYN="Y">artificial pancreas</Keyword><Keyword MajorTopicYN="Y">automated insulin delivery</Keyword><Keyword MajorTopicYN="Y">democratization of medicine</Keyword><Keyword MajorTopicYN="Y">do it yourself</Keyword><Keyword MajorTopicYN="Y">open-source</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31876179</ArticleId><ArticleId IdType="doi">10.1177/1932296819890623</ArticleId><ArticleId IdType="pmc">PMC7753855</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Diabetes Sci Technol. 2016 Nov 1;10(6):1411</Citation><ArticleIdList><ArticleId IdType="pubmed">27510442</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2016 Jul 21;11(7):e0158722</Citation><ArticleIdList><ArticleId IdType="pubmed">27441367</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):628-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23829285</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Oct 25;316(16):1663-1664</Citation><ArticleIdList><ArticleId IdType="pubmed">27669345</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Jun 29;376(26):2507-2509</Citation><ArticleIdList><ArticleId IdType="pubmed">28657867</ArticleId></ArticleIdList></Reference><Reference><Citation>Intern Med J. 2019 May;49(5):559-561</Citation><ArticleIdList><ArticleId IdType="pubmed">31083801</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2019 Jul;98:109-134</Citation><ArticleIdList><ArticleId IdType="pubmed">31383477</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2020 Nov;14(6):1022-1027</Citation><ArticleIdList><ArticleId IdType="pubmed">31646890</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31790464</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>12</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Glycemic-aware metrics and oversampling techniques for predicting blood glucose levels using machine learning.</ArticleTitle><Pagination><MedlinePgn>e0225613</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0225613</ELocationID><Abstract><AbstractText>Techniques using machine learning for short term blood glucose level prediction in patients with Type 1 Diabetes are investigated. This problem is significant for the development of effective artificial pancreas technology so accurate alerts (e.g. hypoglycemia alarms) and other forecasts can be generated. It is shown that two factors must be considered when selecting the best machine learning technique for blood glucose level regression: (i) the regression model performance metrics being used to select the model, and (ii) the preprocessing techniques required to account for the imbalanced time spent by patients in different portions of the glycemic range. Using standard benchmark data, it is demonstrated that different regression model/preprocessing technique combinations exhibit different accuracies depending on the glycemic subrange under consideration. Therefore technique selection depends on the type of alert required. Specific findings are that a linear Support Vector Regression-based model, trained with normal as well as polynomial features, is best for blood glucose level forecasting in the normal and hyperglycemic ranges while a Multilayer Perceptron trained on oversampled data is ideal for predictions in the hypoglycemic range.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mayo</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8222-3782</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, University of Waikato, Hamilton, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chepulis</LastName><ForeName>Lynne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Waikato Medical Research Center, University of Waikato, Hamilton, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Ryan G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Waikato Medical Research Center, University of Waikato, Hamilton, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Waikato Regional Diabetes Service, University of Waikato, Hamilton, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071117" MajorTopicYN="N">Laboratory Critical Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019397" MajorTopicYN="N">Pancreas, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012651" MajorTopicYN="N">Self Medication</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>07</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31790464</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0225613</ArticleId><ArticleId IdType="pii">PONE-D-19-21382</ArticleId><ArticleId IdType="pmc">PMC6886807</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Care. 1987 Sep-Oct;10(5):622-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3677983</ArticleId></ArticleIdList></Reference><Reference><Citation>J Stat Softw. 2010;33(1):1-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2017 Aug 12;17(8):</Citation><ArticleIdList><ArticleId IdType="pubmed">28805693</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2018 May;20(5):353-362</Citation><ArticleIdList><ArticleId IdType="pubmed">29688755</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Jun;38(6):971-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25998289</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Comput. 2000 May;12(5):1207-45</Citation><ArticleIdList><ArticleId IdType="pubmed">10905814</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2017 Mar;19(3):155-163</Citation><ArticleIdList><ArticleId IdType="pubmed">28134564</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2019 Jul;98:109-134</Citation><ArticleIdList><ArticleId IdType="pubmed">31383477</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2018 Jun 16;391(10138):2449-2462</Citation><ArticleIdList><ArticleId IdType="pubmed">29916386</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Feb;41(2):303-310</Citation><ArticleIdList><ArticleId IdType="pubmed">29191844</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2015 May;17(5):468-76</Citation><ArticleIdList><ArticleId IdType="pubmed">25600304</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Dec;40(12):1631-1640</Citation><ArticleIdList><ArticleId IdType="pubmed">29162583</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2017 Jan 24;317(4):379-387</Citation><ArticleIdList><ArticleId IdType="pubmed">28118454</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31740441</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1939-327X</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>02</Month></PubDate></JournalIssue><Title>Diabetes</Title><ISOAbbreviation>Diabetes</ISOAbbreviation></Journal><ArticleTitle>Predictive Modeling of Type 1 Diabetes Stages Using Disparate Data Sources.</ArticleTitle><Pagination><MedlinePgn>238-248</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2337/db18-1263</ELocationID><Abstract><AbstractText>This study aims to model genetic, immunologic, metabolomics, and proteomic biomarkers for development of islet autoimmunity (IA) and progression to type 1 diabetes in a prospective high-risk cohort. We studied 67 children: 42 who developed IA (20 of 42 progressed to diabetes) and 25 control subjects matched for sex and age. Biomarkers were assessed at four time points: earliest available sample, just prior to IA, just after IA, and just prior to diabetes onset. Predictors of IA and progression to diabetes were identified across disparate sources using an integrative machine learning algorithm and optimization-based feature selection. Our integrative approach was predictive of IA (area under the receiver operating characteristic curve [AUC] 0.91) and progression to diabetes (AUC 0.92) based on standard cross-validation (CV). Among the strongest predictors of IA were change in serum ascorbate, 3-methyl-oxobutyrate, and the <i>PTPN22</i> (rs2476601) polymorphism. Serum glucose, ADP fibrinogen, and mannose were among the strongest predictors of progression to diabetes. This proof-of-principle analysis is the first study to integrate large, diverse biomarker data sets into a limited number of features, highlighting differences in pathways leading to IA from those predicting progression to diabetes. Integrated models, if validated in independent populations, could provide novel clues concerning the pathways leading to IA and type 1 diabetes.</AbstractText><CopyrightInformation>.. 2019 by the American Diabetes Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Frohnert</LastName><ForeName>Brigitte I</ForeName><Initials>BI</Initials><Identifier Source="ORCID">0000-0002-6636-4048</Identifier><AffiliationInfo><Affiliation>Barbara Davis Center for Diabetes, School of Medicine, University of Colorado, Aurora, CO brigitte.frohnert@cuanschutz.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webb-Robertson</LastName><ForeName>Bobbie-Jo</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Computational and Statistical Analytics Division, Pacific Northwest National Laboratory, Richland, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bramer</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Computational and Statistical Analytics Division, Pacific Northwest National Laboratory, Richland, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reehl</LastName><ForeName>Sara M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Computational and Statistical Analytics Division, Pacific Northwest National Laboratory, Richland, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waugh</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Barbara Davis Center for Diabetes, School of Medicine, University of Colorado, Aurora, CO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steck</LastName><ForeName>Andrea K</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0002-5931-9484</Identifier><AffiliationInfo><Affiliation>Barbara Davis Center for Diabetes, School of Medicine, University of Colorado, Aurora, CO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norris</LastName><ForeName>Jill M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0001-8674-2598</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Colorado School of Public Health, University of Colorado, Aurora, CO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rewers</LastName><ForeName>Marian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Barbara Davis Center for Diabetes, School of Medicine, University of Colorado, Aurora, CO.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 DK057516</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK032083</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK049654</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK032493</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K12 DK094712</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 DK032083</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Diabetes</MedlineTA><NlmUniqueID>0372763</NlmUniqueID><ISSNLinking>0012-1797</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002087">Butyrates</NameOfSubstance></Chemical><Chemical><RegistryNumber>61D2G4IYVH</RegistryNumber><NameOfSubstance UI="D000244">Adenosine Diphosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-32-5</RegistryNumber><NameOfSubstance UI="D005340">Fibrinogen</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.48</RegistryNumber><NameOfSubstance UI="C516765">PTPN22 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.48</RegistryNumber><NameOfSubstance UI="D054596">Protein Tyrosine Phosphatase, Non-Receptor Type 22</NameOfSubstance></Chemical><Chemical><RegistryNumber>PHA4727WTP</RegistryNumber><NameOfSubstance UI="D008358">Mannose</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000244" MajorTopicYN="N">Adenosine Diphosphate</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002087" MajorTopicYN="N">Butyrates</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005340" MajorTopicYN="N">Fibrinogen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008358" MajorTopicYN="N">Mannose</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054596" MajorTopicYN="N">Protein Tyrosine Phosphatase, Non-Receptor Type 22</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31740441</ArticleId><ArticleId IdType="pii">db18-1263</ArticleId><ArticleId IdType="doi">10.2337/db18-1263</ArticleId><ArticleId IdType="pmc">PMC6971485</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Br J Nutr. 2015 Jul;114(2):169-80</Citation><ArticleIdList><ArticleId IdType="pubmed">26083965</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Jan 15;26(2):280-2</Citation><ArticleIdList><ArticleId IdType="pubmed">19933164</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Bioanal Chem. 2012 Nov;404(8):2349-61</Citation><ArticleIdList><ArticleId IdType="pubmed">22932811</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2013 Oct;62(10):3636-40</Citation><ArticleIdList><ArticleId IdType="pubmed">23835325</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2011 Nov;60(11):2740-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22025777</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2017 Jun;60(6):998-1006</Citation><ArticleIdList><ArticleId IdType="pubmed">28314946</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2015 May;64(5):1818-29</Citation><ArticleIdList><ArticleId IdType="pubmed">25422107</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Biotechnol. 2012;2012:450967</Citation><ArticleIdList><ArticleId IdType="pubmed">22919270</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol Pathol. 2009 Jun;37(4):521-35</Citation><ArticleIdList><ArticleId IdType="pubmed">19458390</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2018 Mar;19(2):277-283</Citation><ArticleIdList><ArticleId IdType="pubmed">28695611</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2015 Jun;64(6):2265-78</Citation><ArticleIdList><ArticleId IdType="pubmed">25616278</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2009 Feb;11 Suppl 1:25-30</Citation><ArticleIdList><ArticleId IdType="pubmed">19143812</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2007 Sep 26;298(12):1420-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17895458</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2017 Dec;66(12):3122-3129</Citation><ArticleIdList><ArticleId IdType="pubmed">28903990</ArticleId></ArticleIdList></Reference><Reference><Citation>J Intern Med. 2001 Apr;249(4):279-88</Citation><ArticleIdList><ArticleId IdType="pubmed">11298847</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2012 Mar;61(3):753-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22315323</ArticleId></ArticleIdList></Reference><Reference><Citation>Proteomics. 2014 Mar;14(6):638-44</Citation><ArticleIdList><ArticleId IdType="pubmed">24395722</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 1996 Dec;81(12):4264-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8954025</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2018 Jan;67(1):146-154</Citation><ArticleIdList><ArticleId IdType="pubmed">29061729</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin J Am Soc Nephrol. 2014 Jan;9(1):191-200</Citation><ArticleIdList><ArticleId IdType="pubmed">24235282</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Gerontol. 1998 Aug;33(5):363-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9762517</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 2009;:451-63</Citation><ArticleIdList><ArticleId IdType="pubmed">19209722</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Chem. 2009 Aug 15;81(16):6656-67</Citation><ArticleIdList><ArticleId IdType="pubmed">19624122</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2010 Jul;95(7):3360-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20444913</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1701-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10677521</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2008 Dec 22;205(13):2975-84</Citation><ArticleIdList><ArticleId IdType="pubmed">19075291</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Sep;39(9):1535-42</Citation><ArticleIdList><ArticleId IdType="pubmed">27311490</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2006 Oct;7(5):274-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17054449</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 1996 Jul;39(7):807-12</Citation><ArticleIdList><ArticleId IdType="pubmed">8817105</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Apr 5;12(4):e0174840</Citation><ArticleIdList><ArticleId IdType="pubmed">28380011</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2014 Dec;57(12):2521-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25186292</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2014 Aug;15(5):355-62</Citation><ArticleIdList><ArticleId IdType="pubmed">25075402</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1995 Nov;44(11):1340-4</Citation><ArticleIdList><ArticleId IdType="pubmed">7589834</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Diabet Stud. 2012 Winter;9(4):236-47</Citation><ArticleIdList><ArticleId IdType="pubmed">23804263</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2012 Jul;55(7):1937-43</Citation><ArticleIdList><ArticleId IdType="pubmed">22289814</ArticleId></ArticleIdList></Reference><Reference><Citation>J Proteomics. 2018 Feb 10;172:100-110</Citation><ArticleIdList><ArticleId IdType="pubmed">28993202</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2005 Sep;48(9):1766-75</Citation><ArticleIdList><ArticleId IdType="pubmed">16025255</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2017 Feb;60(2):287-295</Citation><ArticleIdList><ArticleId IdType="pubmed">27815605</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2004 Aug;89(8):3896-902</Citation><ArticleIdList><ArticleId IdType="pubmed">15292324</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17040-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17942684</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cheminform. 2010 Oct 18;2(1):9</Citation><ArticleIdList><ArticleId IdType="pubmed">20955607</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2013 Jan 14;210(1):191-203</Citation><ArticleIdList><ArticleId IdType="pubmed">23277452</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 1994 Apr;37(4):344-50</Citation><ArticleIdList><ArticleId IdType="pubmed">8063033</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2008 Oct;57(10):2555-62</Citation><ArticleIdList><ArticleId IdType="pubmed">18820210</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Oct;38(10):1964-74</Citation><ArticleIdList><ArticleId IdType="pubmed">26404926</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31635378</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1424-8220</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>20</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>On the Possibility of Predicting Glycaemia 'On the Fly' with Constrained IoT Devices in Type 1 Diabetes Mellitus Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E4538</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/s19204538</ELocationID><Abstract><AbstractText>Type 1 Diabetes Mellitus (DM1) patients are used to checking their blood glucose levels several times per day through finger sticks and, by subjectively handling this information, to try to predict their future glycaemia in order to choose a proper strategy to keep their glucose levels under control, in terms of insulin dosages and other factors. However, recent Internet of Things (IoT) devices and novel biosensors have allowed the continuous collection of the value of the glucose level by means of Continuous Glucose Monitoring (CGM) so that, with the proper Machine Learning (ML) algorithms, glucose evolution can be modeled, thus permitting a forecast of this variable. On the other hand, glycaemia dynamics require that such a model be user-centric and should be recalculated continuously in order to reflect the exact status of the patient, i.e., an 'on-the-fly' approach. In order to avoid, for example, the risk of being disconnected from the Internet, it would be ideal if this task could be performed locally in constrained devices like smartphones, but this would only be feasible if the execution times were fast enough. Therefore, in order to analyze if such a possibility is viable or not, an extensive, passive, CGM study has been carried out with 25 DM1 patients in order to build a solid dataset. Then, some well-known univariate algorithms have been executed in a desktop computer (as a reference) and two constrained devices: a smartphone and a Raspberry Pi, taking into account only past glycaemia data to forecast glucose levels. The results indicate that it is possible to forecast, in a smartphone, a 15-min horizon with a Root Mean Squared Error (RMSE) of 11.65 mg/dL in just 16.15 s, employing a 10-min sampling of the past 6 h of data and the Random Forest algorithm. With the Raspberry Pi, the computational effort increases to 56.49 s assuming the previously mentioned parameters, but this can be improved to 34.89 s if Support Vector Machines are applied, achieving in this case an RMSE of 19.90 mg/dL. Thus, this paper concludes that local on-the-fly forecasting of glycaemia would be affordable with constrained devices.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodr..guez-Rodr..guez</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Departamento de Ingenier..a de la Informaci..n y las Comunicaciones, Universidad de Murcia, Facultad de Inform..tica, 30100 Murcia, Spain. ignacio.rodriguez1@um.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr..guez</LastName><ForeName>Jos..-V..ctor</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Departamento de Tecnolog..as de la Informaci..n y las Comunicaciones, Universidad Polit..cnica de Cartagena, 30202 Cartagena, Spain. jvictor.rodriguez@upct.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatzigiannakis</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Dipartimento di Ingegneria Informatica Automatica e Gestionale 'Antonio Ruberti', Sapienza Universit.. di Roma, 00185 Roma, Italy. ichatz@diag.uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamora Izquierdo</LastName><ForeName>Miguel ..ngel</ForeName><Initials>M..</Initials><AffiliationInfo><Affiliation>Departamento de Ingenier..a de la Informaci..n y las Comunicaciones, Universidad de Murcia, Facultad de Inform..tica, 30100 Murcia, Spain. mzamora@um.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PERSEIDES (ref. TIN2017-86885-R)</GrantID><Agency>PERSEIDES (ref. TIN2017-86885-R)</Agency><Country/></Grant><Grant><GrantID>CHIST-ERA (ref. PCIN-2016-010)</GrantID><Agency>CHIST-ERA (ref. PCIN-2016-010)</Agency><Country/></Grant><Grant><GrantID>MINECO grant BES-2015-071956</GrantID><Agency>MINECO grant BES-2015-071956</Agency><Country/></Grant><Grant><GrantID>H2020-ENTROPY-649849 EU Project</GrantID><Agency>H2020-ENTROPY-649849 EU Project</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068997" MajorTopicYN="N">Smartphone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076251" MajorTopicYN="N">Wearable Electronic Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">constrained devices</Keyword><Keyword MajorTopicYN="N">continuous glucose monitoring</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">time series forecasting</Keyword><Keyword MajorTopicYN="N">wearable devices</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>09</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31635378</ArticleId><ArticleId IdType="pii">s19204538</ArticleId><ArticleId IdType="doi">10.3390/s19204538</ArticleId><ArticleId IdType="pmc">PMC6832939</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>IEEE Rev Biomed Eng. 2009 Jan 1;2:54-96</Citation><ArticleIdList><ArticleId IdType="pubmed">20936056</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2011 May 15;56(2):544-53</Citation><ArticleIdList><ArticleId IdType="pubmed">21073969</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2007 Jul;1(4):478-86</Citation><ArticleIdList><ArticleId IdType="pubmed">19885110</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Feb 28;368(9):824-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23445093</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Netw. 2012 Sep;33:181-93</Citation><ArticleIdList><ArticleId IdType="pubmed">22706092</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jan;9(1):86-90</Citation><ArticleIdList><ArticleId IdType="pubmed">25316712</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2014 Aug 13;15:276</Citation><ArticleIdList><ArticleId IdType="pubmed">25123979</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Rev. 1997 Oct;18(5):716-38</Citation><ArticleIdList><ArticleId IdType="pubmed">9331550</ArticleId></ArticleIdList></Reference><Reference><Citation>Math Biosci. 2013 Aug;244(2):69-81</Citation><ArticleIdList><ArticleId IdType="pubmed">23733079</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 Apr 01;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">30946685</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Jul 24;7(1):6232</Citation><ArticleIdList><ArticleId IdType="pubmed">28740090</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2010 Jan;12(1):81-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20082589</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2011 Aug;13(8):787-96</Citation><ArticleIdList><ArticleId IdType="pubmed">21612393</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31623111</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1424-8220</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>20</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>16</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>Utility of Big Data in Predicting Short-Term Blood Glucose Levels in Type 1 Diabetes Mellitus Through Machine Learning Techniques.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E4482</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/s19204482</ELocationID><Abstract><AbstractText>Machine learning techniques combined with wearable electronics can deliver accurate short-term blood glucose level prediction models. These models can learn personalized glucose-insulin dynamics based on the sensor data collected by monitoring several aspects of the physiological condition and daily activity of an individual. Until now, the prevalent approach for developing data-driven prediction models was to collect as much data as possible to help physicians and patients optimally adjust therapy. The objective of this work was to investigate the minimum data variety, volume, and velocity required to create accurate person-centric short-term prediction models. We developed a series of these models using different machine learning time series forecasting techniques suitable for execution within a wearable processor. We conducted an extensive passive patient monitoring study in real-world conditions to build an appropriate data set. The study involved a subset of type 1 diabetic subjects wearing a flash glucose monitoring system. We comparatively and quantitatively evaluated the performance of the developed data-driven prediction models and the corresponding machine learning techniques. Our results indicate that very accurate short-term prediction can be achieved by only monitoring interstitial glucose data over a very short time period and using a low sampling frequency. The models developed can predict glucose levels within a 15-min horizon with an average error as low as 15.43 mg/dL using only 24 historic values collected within a period of sex hours, and by increasing the sampling frequency to include 72 values, the average error is reduced to 10.15 mg/dL. Our prediction models are suitable for execution within a wearable device, requiring the minimum hardware requirements while at simultaneously achieving very high prediction accuracy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodr..guez-Rodr..guez</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-0118-3406</Identifier><AffiliationInfo><Affiliation>Facultad de Inform..tica, Departamento de Ingenier..a de la Informaci..n y las Comunicaciones, Universidad de Murcia, 30100 Murcia, Spain. ignacio.rodriguez1@um.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatzigiannakis</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-8955-9270</Identifier><AffiliationInfo><Affiliation>Dipartimento di Ingegneria Informatica Automatica e Gestionale 'Antonio Ruberti', Sapienza Universit.. di Roma, 00185 Roma, Italy. ichatz@diag.uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr..guez</LastName><ForeName>Jos..-V..ctor</ForeName><Initials>JV</Initials><Identifier Source="ORCID">0000-0002-3298-6439</Identifier><AffiliationInfo><Affiliation>Departamento de Tecnolog..as de la Informaci..n y las Comunicaciones, Universidad Polit..cnica de Cartagena; 30202 Cartagena, Spain. jvictor.rodriguez@upct.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maranghi</LastName><ForeName>Marianna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dipartimento di Ingegneria Informatica Automatica e Gestionale 'Antonio Ruberti', Sapienza Universit.. di Roma, 00185 Roma, Italy. marianna.maranghi@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gentili</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dipartimento di Ingegneria Informatica Automatica e Gestionale 'Antonio Ruberti', Sapienza Universit.. di Roma, 00185 Roma, Italy. gentili@diag.uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamora-Izquierdo</LastName><ForeName>Miguel-..ngel</ForeName><Initials>M..</Initials><Identifier Source="ORCID">0000-0002-0130-2364</Identifier><AffiliationInfo><Affiliation>Facultad de Inform..tica, Departamento de Ingenier..a de la Informaci..n y las Comunicaciones, Universidad de Murcia, 30100 Murcia, Spain. mzamora@um.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PERSEIDES (ref. TIN2017-86885-R)</GrantID><Agency>PERSEIDES (ref. TIN2017-86885-R)</Agency><Country/></Grant><Grant><GrantID>CHIST-ERA (ref. PCIN-2016-010)</GrantID><Agency>CHIST-ERA (ref. PCIN-2016-010)</Agency><Country/></Grant><Grant><GrantID>MINECO grant BES-2015-071956</GrantID><Agency>MINECO grant BES-2015-071956</Agency><Country/></Grant><Grant><GrantID>H2020-ENTROPY-649849 EU Project</GrantID><Agency>H2020-ENTROPY-649849 EU Project</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="Y">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">continuous glucose monitoring</Keyword><Keyword MajorTopicYN="N">experimental evaluation</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">short-term prediction</Keyword><Keyword MajorTopicYN="N">univariate time series</Keyword><Keyword MajorTopicYN="N">wearable devices</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>08</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31623111</ArticleId><ArticleId IdType="pii">s19204482</ArticleId><ArticleId IdType="doi">10.3390/s19204482</ArticleId><ArticleId IdType="pmc">PMC6833040</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>IEEE Trans Biomed Eng. 2012 Jun;59(6):1550-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22374344</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Res. 2018 Sep 30;2018:4826984</Citation><ArticleIdList><ArticleId IdType="pubmed">30363935</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2003 May 7;289(17):2254-64</Citation><ArticleIdList><ArticleId IdType="pubmed">12734137</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open Diabetes Res Care. 2017 Feb 17;5(1):e000320</Citation><ArticleIdList><ArticleId IdType="pubmed">28243449</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2018 Oct;19 Suppl 27:302-325</Citation><ArticleIdList><ArticleId IdType="pubmed">30039513</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 Sep 01;6(5):1123-30</Citation><ArticleIdList><ArticleId IdType="pubmed">23063039</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2015 Nov;17(11):787-94</Citation><ArticleIdList><ArticleId IdType="pubmed">26171659</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Feb 28;368(9):824-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23445093</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2009 Apr;11(4):243-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19344199</ArticleId></ArticleIdList></Reference><Reference><Citation>Yearb Med Inform. 2016 Nov 10;(1):73-86</Citation><ArticleIdList><ArticleId IdType="pubmed">27830234</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jan;9(1):86-90</Citation><ArticleIdList><ArticleId IdType="pubmed">25316712</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2017 May;19(S2):S44-S50</Citation><ArticleIdList><ArticleId IdType="pubmed">28541139</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jan;9(1):63-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25305282</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Eng Med Biol Mag. 2003 May-Jun;22(3):18-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12845812</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2019 Mar 20;11(484):null</Citation><ArticleIdList><ArticleId IdType="pubmed">30894501</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Artif Organs. 2001 Dec;24(12):884-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11831594</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Rev. 1997 Oct;18(5):716-38</Citation><ArticleIdList><ArticleId IdType="pubmed">9331550</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2007 Jan;1(1):62-71</Citation><ArticleIdList><ArticleId IdType="pubmed">19888382</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2019 Aug;21(8):462-469</Citation><ArticleIdList><ArticleId IdType="pubmed">31140878</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Jul;2(4):636-44</Citation><ArticleIdList><ArticleId IdType="pubmed">19885240</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Jul 24;7(1):6232</Citation><ArticleIdList><ArticleId IdType="pubmed">28740090</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Eng Med Biol Mag. 2010 Mar-Apr;29(2):53-62</Citation><ArticleIdList><ArticleId IdType="pubmed">20659841</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Biomed Eng. 2012 Apr;40(4):934-45</Citation><ArticleIdList><ArticleId IdType="pubmed">22012087</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 May;54(5):931-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17518291</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2011 Feb;13(2):135-41</Citation><ArticleIdList><ArticleId IdType="pubmed">21284480</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 1994 Jan;41(3-4):153-65</Citation><ArticleIdList><ArticleId IdType="pubmed">8187463</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31536025</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2168-2208</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>05</Month></PubDate></JournalIssue><Title>IEEE journal of biomedical and health informatics</Title><ISOAbbreviation>IEEE J Biomed Health Inform</ISOAbbreviation></Journal><ArticleTitle>Predicting Quality of Overnight Glycaemic Control in Type 1 Diabetes Using Binary Classifiers.</ArticleTitle><Pagination><MedlinePgn>1439-1446</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/JBHI.2019.2938305</ELocationID><Abstract><AbstractText>In type 1 diabetes management, maintaining nocturnal blood glucose within target range can be challenging. Although semi-automatic systems to modulate insulin pump delivery, such as low-glucose insulin suspension and the artificial pancreas, are starting to become a reality, their elevated cost and performance below user expectations is hindering their adoption. Hence, a decision support system that helps people with type 1 diabetes, on multiple daily injections or insulin pump therapy, to avoid undesirable overnight blood glucose fluctuations (hyper- or hypoglycaemic) is an attractive alternative. In this paper, we introduce a novel data-driven approach to predict the quality of overnight glycaemic control in people with type 1 diabetes by analyzing commonly gathered data during the day-time period (continuous glucose monitoring data, meal intake and insulin boluses). The proposed approach is able to predict whether overnight blood glucose concentrations are going to remain within or outside the target range, and therefore allows the user to take the appropriate preventive action (snack or change in basal insulin). For this purpose, a number of popular established machine learning algorithms for binary classification were evaluated and compared on a publicly available clinical dataset (i.e., OhioT1DM). Although there is no clearly superior classification algorithm, this study indicates that, by using commonly gathered data in type 1 diabetes management, it is possible to predict the quality of overnight glycaemic control with reasonable accuracy (AUC-ROC = 0.7).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guemes</LastName><ForeName>Amparo</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Cappon</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Bernard</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Monika</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Oliver</LastName><ForeName>Nick</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Georgiou</LastName><ForeName>Pantelis</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Herrero</LastName><ForeName>Pau</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE J Biomed Health Inform</MedlineTA><NlmUniqueID>101604520</NlmUniqueID><ISSNLinking>2168-2194</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085002" MajorTopicYN="N">Glycemic Control</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012890" MajorTopicYN="N">Sleep</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31536025</ArticleId><ArticleId IdType="doi">10.1109/JBHI.2019.2938305</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31464196</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2371-4379</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>JMIR diabetes</Title><ISOAbbreviation>JMIR Diabetes</ISOAbbreviation></Journal><ArticleTitle>A Reinforcement Learning-Based Method for Management of Type 1 Diabetes: Exploratory Study.</ArticleTitle><Pagination><MedlinePgn>e12905</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/12905</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Type 1 diabetes mellitus (T1DM) is characterized by chronic insulin deficiency and consequent hyperglycemia. Patients with T1DM require long-term exogenous insulin therapy to regulate blood glucose levels and prevent the long-term complications of the disease. Currently, there are no effective algorithms that consider the unique characteristics of T1DM patients to automatically recommend personalized insulin dosage levels.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this study was to develop and validate a general reinforcement learning (RL) framework for the personalized treatment of T1DM using clinical data.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This research presents a model-free data-driven RL algorithm, namely Q-learning, that recommends insulin doses to regulate the blood glucose level of a T1DM patient, considering his or her state defined by glycated hemoglobin (HbA<sub>1c</sub>) levels, body mass index, engagement in physical activity, and alcohol usage. In this approach, the RL agent identifies the different states of the patient by exploring the patient's responses when he or she is subjected to varying insulin doses. On the basis of the result of a treatment action at time step t, the RL agent receives a numeric reward, positive or negative. The reward is calculated as a function of the difference between the actual blood glucose level achieved in response to the insulin dose and the targeted HbA<sub>1c</sub> level. The RL agent was trained on 10 years of clinical data of patients treated at the Mass General Hospital.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 87 patients were included in the training set. The mean age of these patients was 53 years, 59% (51/87) were male, 86% (75/87) were white, and 47% (41/87) were married. The performance of the RL agent was evaluated on 60 test cases. RL agent-recommended insulin dosage interval includes the actual dose prescribed by the physician in 53 out of 60 cases (53/60, 88%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This exploratory study demonstrates that an RL algorithm can be used to recommend personalized insulin doses to achieve adequate glycemic control in patients with T1DM. However, further investigation in a larger sample of patients is needed to confirm these findings.</AbstractText><CopyrightInformation>..Mahsa Oroojeni Mohammad Javad, Stephen Olusegun Agboola, Kamal Jethwani, Abe Zeid, Sagar Kamarthi. Originally published in JMIR Diabetes (http://diabetes.jmir.org), 28.08.2019.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oroojeni Mohammad Javad</LastName><ForeName>Mahsa</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1843-3763</Identifier><AffiliationInfo><Affiliation>Department of Information Technology and Analytics, Kogod School of Business, American University, Washington, DC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agboola</LastName><ForeName>Stephen Olusegun</ForeName><Initials>SO</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2161-8091</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Partners HealthCare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jethwani</LastName><ForeName>Kamal</ForeName><Initials>K</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-0122-8002</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeid</LastName><ForeName>Abe</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2928-8197</Identifier><AffiliationInfo><Affiliation>Mechanical and Industrial Engineering Department, College of Engineering, Northeastern University, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamarthi</LastName><ForeName>Sagar</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-5845-7714</Identifier><AffiliationInfo><Affiliation>Mechanical and Industrial Engineering Department, College of Engineering, Northeastern University, Boston, MA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Diabetes</MedlineTA><NlmUniqueID>101719410</NlmUniqueID><ISSNLinking>2371-4379</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Q-learning</Keyword><Keyword MajorTopicYN="N">T1DM</Keyword><Keyword MajorTopicYN="N">diabetes treatment</Keyword><Keyword MajorTopicYN="N">insulin dose prescription</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">reinforcement learning</Keyword><Keyword MajorTopicYN="N">type 1 diabetes mellitus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>07</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>06</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31464196</ArticleId><ArticleId IdType="pii">v4i3e12905</ArticleId><ArticleId IdType="doi">10.2196/12905</ArticleId><ArticleId IdType="pmc">PMC6737889</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Artif Intell Med. 2002 Sep-Oct;26(1-2):37-54</Citation><ArticleIdList><ArticleId IdType="pubmed">12234716</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2003 Jan;26 Suppl 1:S28-32</Citation><ArticleIdList><ArticleId IdType="pubmed">12502617</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2006 Jun;44(6):451-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16937196</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharm Pharmacol. 2008 Jan;60(1):1-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18088499</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Telemed Appl. 2008;:739385</Citation><ArticleIdList><ArticleId IdType="pubmed">18566688</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 May 01;3(3):603-12</Citation><ArticleIdList><ArticleId IdType="pubmed">20144300</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Med Inform. 2018 Oct 22;6(4):e10780</Citation><ArticleIdList><ArticleId IdType="pubmed">30348631</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Mhealth Uhealth. 2018 Nov 21;6(11):e12237</Citation><ArticleIdList><ArticleId IdType="pubmed">30463839</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2019 Jan;25(1):16-18</Citation><ArticleIdList><ArticleId IdType="pubmed">30617332</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2019 Jan;25(1):24-29</Citation><ArticleIdList><ArticleId IdType="pubmed">30617335</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Math Methods Med. 2018 Dec 30;2018:4091497</Citation><ArticleIdList><ArticleId IdType="pubmed">30693047</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Diabetes. 2019 Apr 18;4(2):e11590</Citation><ArticleIdList><ArticleId IdType="pubmed">30998218</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2019 May 01;21(5):e11030</Citation><ArticleIdList><ArticleId IdType="pubmed">31042157</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1974 May;23(5):397-404</Citation><ArticleIdList><ArticleId IdType="pubmed">4598090</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng. 1972 Nov;10(6):752-61</Citation><ArticleIdList><ArticleId IdType="pubmed">4636041</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Med Biol Eng. 1997;8(3):197-211</Citation><ArticleIdList><ArticleId IdType="pubmed">9444512</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc AMIA Symp. 1998;:160-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9929202</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31416546</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>178</Volume><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Computer methods and programs in biomedicine</Title><ISOAbbreviation>Comput Methods Programs Biomed</ISOAbbreviation></Journal><ArticleTitle>Minimizing postprandial hypoglycemia in Type 1 diabetes patients using multiple insulin injections and capillary blood glucose self-monitoring with machine learning techniques.</ArticleTitle><Pagination><MedlinePgn>175-180</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0169-2607(19)30490-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmpb.2019.06.025</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Diabetic patients treated with intensive insulin therapies require a tight glycemic control and may benefit from advanced tools to predict blood glucose (BG) concentration levels and hypo/hyperglycemia events. Prediction systems using machine learning techniques have mainly focused on applications for sensor augmented pump (SAP) therapy. In contrast, insulin bolus calculators that rely on BG prediction for multiple daily insulin (MDI) injections for patients under self-monitoring blood glucose (SMBG) are scarce because of insufficient data sources and limited prediction capability of forecasting models.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We trained individualized models that can predict postprandial hypoglycemia via different machine learning algorithms using retrospective data from 10 real patients. In addition, we designed and tested a hypoglycemia reduction strategy for a similar in silico population. The system generates a bolus reduction suggestion as the scaled weighted sum of the predictions. We evaluated the general and postprandial glycemic outcomes of the in silico population to assess the systems capability of avoiding hypoglycemias.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The median [IQR] sensitivity and specificity for hypoglycemia cases where the BG level was below 70...mg/dL were 0.49 [0.2-0.5] and 0.74 [0.7-0.9], respectively. For hypoglycemia cases where the BG level was below 54...mg/dL, the median [IQR] sensitivity and specificity were 0.51 [0.4-0.6] and 0.74 [0.7-0.8], respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results indicated a decrease of 37% in the median number of postprandial hypoglycemias median decrease of 44% for hypoglycemias of 70...mg/dL and 54...mg/dL, respectively. This dramatic reduction makes this method a good candidate to be integrated into any Decision Support System for diabetes management.</AbstractText><CopyrightInformation>Copyright .. 2019 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oviedo</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut d'Informatica i Aplicacions. Universitat de Girona, Spain. Electronic address: silvia.oviedo@udg.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institut d'Informatica i Aplicacions. Universitat de Girona, Spain. Electronic address: ivancontrerasfd@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertachi</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institut d'Informatica i Aplicacions. Universitat de Girona, Spain; Federal University of Technology Paran.. (UTFPR), Guarapuava 85053-525, Brazil. Electronic address: arthur.bertachi@udg.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quir..s</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Endocrinolog..a y Nutrici..n. Hospital Universitari Mutua de Terrassa, Terrassa, Spain. Electronic address: cmquiros@clinic.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gim..nez</LastName><ForeName>Marga</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Diabetes Unit. Endocrinology and Nutrition Dpt. IDIBAPS (Institut d'investigacions biom..diques August Pi I Sunyer), Barcelona, Spain; Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), Spain. Electronic address: gimenez@clinic.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conget</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Diabetes Unit. Endocrinology and Nutrition Dpt. IDIBAPS (Institut d'investigacions biom..diques August Pi I Sunyer), Barcelona, Spain; Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), Spain. Electronic address: iconget@clinic.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vehi</LastName><ForeName>Josep</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut d'Informatica i Aplicacions. Universitat de Girona, Spain; Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), Spain. Electronic address: josep.vehi@udg.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Comput Methods Programs Biomed</MedlineTA><NlmUniqueID>8506513</NlmUniqueID><ISSNLinking>0169-2607</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="Y">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002196" MajorTopicYN="N">Capillaries</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005189" MajorTopicYN="N">False Positive Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="Y">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016011" MajorTopicYN="N">Normal Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019518" MajorTopicYN="N">Postprandial Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood glucose</Keyword><Keyword MajorTopicYN="N">Bolus reduction</Keyword><Keyword MajorTopicYN="N">Hypoglycemia prediction</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Postprandial hypoglycemia</Keyword><Keyword MajorTopicYN="N">Type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>04</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>06</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>06</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31416546</ArticleId><ArticleId IdType="pii">S0169-2607(19)30490-0</ArticleId><ArticleId IdType="doi">10.1016/j.cmpb.2019.06.025</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31383477</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2860</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><PubDate><Year>2019</Year><Month>07</Month></PubDate></JournalIssue><Title>Artificial intelligence in medicine</Title><ISOAbbreviation>Artif Intell Med</ISOAbbreviation></Journal><ArticleTitle>Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes.</ArticleTitle><Pagination><MedlinePgn>109-134</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0933-3657(17)30621-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.artmed.2019.07.007</ELocationID><Abstract><AbstractText Label="BACKGROUND">Diabetes mellitus (DM) is a metabolic disorder that causes abnormal blood glucose (BG) regulation that might result in short and long-term health complications and even death if not properly managed. Currently, there is no cure for diabetes. However, self-management of the disease, especially keeping BG in the recommended range, is central to the treatment. This includes actively tracking BG levels and managing physical activity, diet, and insulin intake. The recent advancements in diabetes technologies and self-management applications have made it easier for patients to have more access to relevant data. In this regard, the development of an artificial pancreas (a closed-loop system), personalized decision systems, and BG event alarms are becoming more apparent than ever. Techniques such as predicting BG (modeling of a personalized profile), and modeling BG dynamics are central to the development of these diabetes management technologies. The increased availability of sufficient patient historical data has paved the way for the introduction of machine learning and its application for intelligent and improved systems for diabetes management. The capability of machine learning to solve complex tasks with dynamic environment and knowledge has contributed to its success in diabetes research.</AbstractText><AbstractText Label="MOTIVATION">Recently, machine learning and data mining have become popular, with their expanding application in diabetes research and within BG prediction services in particular. Despite the increasing and expanding popularity of machine learning applications in BG prediction services, updated reviews that map and materialize the current trends in modeling options and strategies are lacking within the context of BG prediction (modeling of personalized profile) in type 1 diabetes.</AbstractText><AbstractText Label="OBJECTIVE">The objective of this review is to develop a compact guide regarding modeling options and strategies of machine learning and a hybrid system focusing on the prediction of BG dynamics in type 1 diabetes. The review covers machine learning approaches pertinent to the controller of an artificial pancreas (closed-loop systems), modeling of personalized profiles, personalized decision support systems, and BG alarm event applications. Generally, the review will identify, assess, analyze, and discuss the current trends of machine learning applications within these contexts.</AbstractText><AbstractText Label="METHOD">A rigorous literature review was conducted between August 2017 and February 2018 through various online databases, including Google Scholar, PubMed, ScienceDirect, and others. Additionally, peer-reviewed journals and articles were considered. Relevant studies were first identified by reviewing the title, keywords, and abstracts as preliminary filters with our selection criteria, and then we reviewed the full texts of the articles that were found relevant. Information from the selected literature was extracted based on predefined categories, which were based on previous research and further elaborated through brainstorming among the authors.</AbstractText><AbstractText Label="RESULTS">The initial search was done by analyzing the title, abstract, and keywords. A total of 624 papers were retrieved from DBLP Computer Science (25), Diabetes Technology and Therapeutics (31), Google Scholar (193), IEEE (267), Journal of Diabetes Science and Technology (31), PubMed/Medline (27), and ScienceDirect (50). After removing duplicates from the list, 417 records remained. Then, we independently assessed and screened the articles based on the inclusion and exclusion criteria, which eliminated another 204 papers, leaving 213 relevant papers. After a full-text assessment, 55 articles were left, which were critically analyzed. The inter-rater agreement was measured using a Cohen Kappa test, and disagreements were resolved through discussion.</AbstractText><AbstractText Label="CONCLUSION">Due to the complexity of BG dynamics, it remains difficult to achieve a universal model that produces an accurate prediction in every circumstance (i.e., hypo/eu/hyperglycemia events). Recently, machine learning techniques have received wider attention and increased popularity in diabetes research in general and BG prediction in particular, coupled with the ever-growing availability of a self-collected health data. The state-of-the-art demonstrates that various machine learning techniques have been tested to predict BG, such as recurrent neural networks, feed-forward neural networks, support vector machines, self-organizing maps, the Gaussian process, genetic algorithm and programs, deep neural networks, and others, using various group of input parameters and training algorithms. The main limitation of the current approaches is the lack of a well-defined approach to estimate carbohydrate intake, which is mainly done manually by individual users and is prone to an error that can severely affect the predictive performance. Moreover, a universal approach has not been established to estimate and quantify the approximate effect of physical activities, stress, and infections on the BG level. No researchers have assessed model predictive performance during stress and infection incidences in a free-living condition, which should be considered in future studies. Furthermore, a little has been done regarding model portability that can capture inter- and intra-variability among patients. It seems that the effect of time lags between the CGM readings and the actual BG levels is not well covered. However, in general, we foresee that these developments might foster the advancement of next-generation BG prediction algorithms, which will make a great contribution in the effort to develop the long-awaited, so-called artificial pancreas (a closed-loop system).</AbstractText><CopyrightInformation>Copyright .. 2019 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Woldaregay</LastName><ForeName>Ashenafi Zebene</ForeName><Initials>AZ</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of Troms..-The Arctic University of Norway, Troms.., Norway. Electronic address: ashenafi.z.woldaregay@uit.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>..rsand</LastName><ForeName>Eirik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Norwegian Centre for E-health Research, University Hospital of North Norway, Troms.., Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walderhaug</LastName><ForeName>St..le</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Norwegian Centre for E-health Research, University Hospital of North Norway, Troms.., Norway; SINTEF Digital, Software Engineering, Safety and Security, Troms.., Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albers</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, N.Y., USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mamykina</LastName><ForeName>Lena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, N.Y., USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botsis</LastName><ForeName>Taxiarchis</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartvigsen</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of Troms..-The Arctic University of Norway, Troms.., Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM012734</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Artif Intell Med</MedlineTA><NlmUniqueID>8915031</NlmUniqueID><ISSNLinking>0933-3657</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="N">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005247" MajorTopicYN="N">Feeding Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063731" MajorTopicYN="N">Mobile Applications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066230" MajorTopicYN="Y">Patient-Specific Modeling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076251" MajorTopicYN="N">Wearable Electronic Devices</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Blood glucose dynamics</Keyword><Keyword MajorTopicYN="Y">Blood glucose level prediction</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>04</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>08</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>07</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31383477</ArticleId><ArticleId IdType="pii">S0933-3657(17)30621-8</ArticleId><ArticleId IdType="doi">10.1016/j.artmed.2019.07.007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31361602</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2379-3708</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2019</Year><Month>07</Month><Day>30</Day></PubDate></JournalIssue><Title>JCI insight</Title><ISOAbbreviation>JCI Insight</ISOAbbreviation></Journal><ArticleTitle>The long noncoding RNA MALAT1 predicts human pancreatic islet isolation quality.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1172/jci.insight.129299</ELocationID><ELocationID EIdType="pii" ValidYN="Y">129299</ELocationID><Abstract><AbstractText>Human islet isolation is a cost-/resource-intensive program generating islets for cell therapy in Type 1 diabetes. However, only a third of cadaveric pancreas get to clinical transplantation due to low quality/number of islets. There is a need to identify biomarker(s) that predict the quality of islets, prior to initiating their isolation. Here, we sequenced transcriptome from 18 human islet preparations stratified into three groups (Gr.1: Best quality/transplantable islets, Gr.2: Intermediary quality, Gr.3: Inferior quality/non-transplantable islets) based on routine measurements including islet purity/viability. Machine-learning algorithms involving penalized regression analyses identified 10 long-non-coding(lnc)RNAs significantly different across all group-wise comparisons (Gr1VsGr2, Gr2vsGr3, Gr1vsGr3). Two variants of Metastasis-Associated Lung Adenocarcinoma Transcript-1(MALAT1) lncRNA were common across all comparisons. We confirmed RNA-seq findings in a "validation set" of 75 human islet preparations. Finally, in 19 pancreas samples, we demonstrate that assessing the levels of MALAT1 variants alone (ROC curve AUC: 0.83) offers highest specificity in predicting post-isolation islet quality and improves the predictive potential for clinical islet transplantation when combined with Edmonton Donor Points/Body Mass Index(BMI)/North American Islet Donor Score(NAIDS). We present this resource of islet-quality-stratified lncRNA transcriptome data and identify MALAT1 as a biomarker that significantly enhances current selection methods for clinical (GMP)-grade islet isolation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Wilson Km</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>Diabetes and Islet Biology Group, National Health and Medical Research Council (NHMRC) Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guozhi</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S..rensen</LastName><ForeName>Anja E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Science and Environment, Roskilde University, Roskilde, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Yi Vee</ForeName><Initials>YV</Initials><AffiliationInfo><Affiliation>Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Westmead, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee-Maynard</LastName><ForeName>Cody</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Diabetes and Islet Biology Group, National Health and Medical Research Council (NHMRC) Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liuwantara</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Westmead, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Lindy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Westmead, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connell</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Westmead, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalgaard</LastName><ForeName>Louise T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Department of Science and Environment, Roskilde University, Roskilde, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Ronald C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawthorne</LastName><ForeName>Wayne J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Westmead, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joglekar</LastName><ForeName>Mugdha V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Diabetes and Islet Biology Group, National Health and Medical Research Council (NHMRC) Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardikar</LastName><ForeName>Anandwardhan A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Diabetes and Islet Biology Group, National Health and Medical Research Council (NHMRC) Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCI Insight</MedlineTA><NlmUniqueID>101676073</NlmUniqueID><ISSNLinking>2379-3708</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C557041">MALAT1 long non-coding RNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007515" MajorTopicYN="N">Islets of Langerhans</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016381" MajorTopicYN="N">Islets of Langerhans Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016035" MajorTopicYN="N">Pancreas Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="N">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014019" MajorTopicYN="N">Tissue Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014183" MajorTopicYN="N">Transplantation, Heterologous</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Islet cells</Keyword><Keyword MajorTopicYN="Y">Transplantation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31361602</ArticleId><ArticleId IdType="pii">129299</ArticleId><ArticleId IdType="doi">10.1172/jci.insight.129299</ArticleId><ArticleId IdType="pmc">PMC6777802</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mol Biol Rep. 2014;41(4):1917-25</Citation><ArticleIdList><ArticleId IdType="pubmed">24619356</ArticleId></ArticleIdList></Reference><Reference><Citation>Transplantation. 2005 Sep 27;80(6):801-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16210968</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2014 Jul 22;15:620</Citation><ArticleIdList><ArticleId IdType="pubmed">25051960</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Dev. 2011 Sep 15;25(18):1915-27</Citation><ArticleIdList><ArticleId IdType="pubmed">21890647</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Organ Transplant. 2009 Dec;14(6):688-93</Citation><ArticleIdList><ArticleId IdType="pubmed">19745734</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Soc Trans. 2016 Aug 15;44(4):1073-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27528754</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypoxia (Auckl). 2015 Oct 08;3:45-52</Citation><ArticleIdList><ArticleId IdType="pubmed">27774481</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2012;879:351-66</Citation><ArticleIdList><ArticleId IdType="pubmed">22610570</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2010 May;28(5):511-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20436464</ArticleId></ArticleIdList></Reference><Reference><Citation>ACS Nano. 2015 Nov 24;9(11):11075-89</Citation><ArticleIdList><ArticleId IdType="pubmed">26444644</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2014 Feb;46(2):136-143</Citation><ArticleIdList><ArticleId IdType="pubmed">24413736</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Clin Endocrinol Diabetes. 1995;103 Suppl 2:23-26</Citation><ArticleIdList><ArticleId IdType="pubmed">8839248</ArticleId></ArticleIdList></Reference><Reference><Citation>Transplant Proc. 2002 May;34(3):826-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12034198</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Transl Res. 2012;4(2):127-50</Citation><ArticleIdList><ArticleId IdType="pubmed">22611467</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2014 Mar 25;5:3451</Citation><ArticleIdList><ArticleId IdType="pubmed">24667995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2011 Jul 1;27(13):i275-82</Citation><ArticleIdList><ArticleId IdType="pubmed">21685081</ArticleId></ArticleIdList></Reference><Reference><Citation>RNA. 2012 Aug;18(8):1487-99</Citation><ArticleIdList><ArticleId IdType="pubmed">22718948</ArticleId></ArticleIdList></Reference><Reference><Citation>RNA Biol. 2012 Aug;9(8):1076-87</Citation><ArticleIdList><ArticleId IdType="pubmed">22858678</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Metab. 2012 Oct 3;16(4):435-48</Citation><ArticleIdList><ArticleId IdType="pubmed">23040067</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Transplant. 2014 Nov;14(11):2595-606</Citation><ArticleIdList><ArticleId IdType="pubmed">25278159</ArticleId></ArticleIdList></Reference><Reference><Citation>Basic Clin Pharmacol Toxicol. 2018 Jan;122(1):87-93</Citation><ArticleIdList><ArticleId IdType="pubmed">28722800</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Commun (Camb). 2014 Dec 28;50(100):15856-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25331713</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosens Bioelectron. 2015 Aug 15;70:226-31</Citation><ArticleIdList><ArticleId IdType="pubmed">25829219</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Transplant. 2016;25(8):1515-1523</Citation><ArticleIdList><ArticleId IdType="pubmed">26922947</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cancer. 2018 Jan;18(1):5-18</Citation><ArticleIdList><ArticleId IdType="pubmed">29170536</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Oncol. 2016 Oct;49(4):1731-6</Citation><ArticleIdList><ArticleId IdType="pubmed">27499160</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Heart Assoc. 2014 Feb 26;3(1):e000792</Citation><ArticleIdList><ArticleId IdType="pubmed">24572259</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1988 Apr;37(4):413-20</Citation><ArticleIdList><ArticleId IdType="pubmed">3288530</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Exp Med Biol. 2016;938:67-88</Citation><ArticleIdList><ArticleId IdType="pubmed">27586423</ArticleId></ArticleIdList></Reference><Reference><Citation>Transplantation. 2011 Feb 15;91(3):360-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21344706</ArticleId></ArticleIdList></Reference><Reference><Citation>Biom J. 2010 Feb;52(1):70-84</Citation><ArticleIdList><ArticleId IdType="pubmed">19937997</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2012 Oct;14 Suppl 3:12-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22928560</ArticleId></ArticleIdList></Reference><Reference><Citation>Transplantation. 1996 Apr 15;61(7):1047-53</Citation><ArticleIdList><ArticleId IdType="pubmed">8623183</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2005 Feb;28(2):343-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15677790</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Metab. 2017 Feb 7;25(2):400-411</Citation><ArticleIdList><ArticleId IdType="pubmed">28041957</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Biol Med (Maywood). 2017 Mar;242(5):487-496</Citation><ArticleIdList><ArticleId IdType="pubmed">28056547</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Genet Genomics. 2018 Feb;293(1):1-15</Citation><ArticleIdList><ArticleId IdType="pubmed">28894972</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2012;2:222</Citation><ArticleIdList><ArticleId IdType="pubmed">22355736</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2012 Sep;22(9):1760-74</Citation><ArticleIdList><ArticleId IdType="pubmed">22955987</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Transplant. 2013 Jul;13(7):1850-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23668890</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2013 Dec;14(12):880-93</Citation><ArticleIdList><ArticleId IdType="pubmed">24217315</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Res. 2016;2016:4214328</Citation><ArticleIdList><ArticleId IdType="pubmed">27803935</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Ther Med. 2017 Apr;13(4):1225-1234</Citation><ArticleIdList><ArticleId IdType="pubmed">28413461</ArticleId></ArticleIdList></Reference><Reference><Citation>Pancreas. 1991 Mar;6(2):242-4</Citation><ArticleIdList><ArticleId IdType="pubmed">1679542</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2006 Apr 15;15 Spec No 1:R17-29</Citation><ArticleIdList><ArticleId IdType="pubmed">16651366</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Transplant. 2005 Jul;5(7):1635-45</Citation><ArticleIdList><ArticleId IdType="pubmed">15943621</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncol Lett. 2018 Jul;16(1):19-26</Citation><ArticleIdList><ArticleId IdType="pubmed">29928382</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2018 Aug;67(8):1461-1470</Citation><ArticleIdList><ArticleId IdType="pubmed">29937433</ArticleId></ArticleIdList></Reference><Reference><Citation>Transpl Int. 2016 Jan;29(1):34-40</Citation><ArticleIdList><ArticleId IdType="pubmed">26264982</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncogene. 2003 Sep 11;22(39):8031-41</Citation><ArticleIdList><ArticleId IdType="pubmed">12970751</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2005 May;48(5):906-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15830183</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Genomics. 2017 Jul 24;11(1):17</Citation><ArticleIdList><ArticleId IdType="pubmed">28738846</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2004 Apr;27(4):895-900</Citation><ArticleIdList><ArticleId IdType="pubmed">15047645</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31345047</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4175</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>10</Month></PubDate></JournalIssue><Title>Biological research for nursing</Title><ISOAbbreviation>Biol Res Nurs</ISOAbbreviation></Journal><ArticleTitle>Using Data Science to Understand Complexity and Quantify Heterogeneity in the Onset and Progression of Chronic Disease.</ArticleTitle><Pagination><MedlinePgn>449-457</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1099800419863161</ELocationID><Abstract><AbstractText>Novel discoveries in genomics and other omics sciences are rapidly redefining our understanding of health and disease as well as advancing the development of targeted therapeutics for improving health outcomes. The scale of these findings, fueled by vast increases in computing power and new techniques in data analytics, easily supersedes that of phenomena observed using more traditional research approaches. Until recently, the classification and diagnosis of disease has involved rather subjective processes, whereby signs and late symptom patterns are linked with clinical outcomes. However, symptom patterns, disease trajectories, and health outcomes are complex entities characterized by a wide range of clinical manifestations and progression patterns. The burgeoning fields of data science and bioinformatics are opening opportunities for nurse scientists to quantify disease heterogeneity by defining and categorizing disease phenotypes and endotypes. Nurse scientists and clinicians can play a critical role in engaging patients and the larger scientific community in these efforts. The purpose of this article is to provide an introduction to concepts critical to understanding and quantifying heterogeneity in the onset and progression of chronic disease. To present and exemplify key concepts, we (1) discuss evidence for heterogeneity in the onset and progression of Type 1 diabetes, (2) link emerging research approaches in data science with principles in network science and systems biology to lay the groundwork for stratifying subclinical and advanced chronic disease, thus expanding the purview of symptom science, and (3) describe the computational skills needed to engage in these analyses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tallon</LastName><ForeName>Erin</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-1353-6632</Identifier><AffiliationInfo><Affiliation>1 MU Sinclair School of Nursing, University of Missouri, Columbia, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 University of Missouri Informatics Institute, University of Missouri, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dreisbach</LastName><ForeName>Caitlin</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3964-3161</Identifier><AffiliationInfo><Affiliation>3 School of Nursing, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biol Res Nurs</MedlineTA><NlmUniqueID>9815758</NlmUniqueID><ISSNLinking>1099-8004</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077488" MajorTopicYN="N">Data Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Type 1 diabetes</Keyword><Keyword MajorTopicYN="Y">data science</Keyword><Keyword MajorTopicYN="Y">endotype</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">network</Keyword><Keyword MajorTopicYN="Y">phenotype</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31345047</ArticleId><ArticleId IdType="doi">10.1177/1099800419863161</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31323886</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1424-8220</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>14</Issue><PubDate><Year>2019</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>Classification of Postprandial Glycemic Status with Application to Insulin Dosing in Type 1 Diabetes-An In Silico Proof-of-Concept.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E3168</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/s19143168</ELocationID><Abstract><AbstractText>In the daily management of type 1 diabetes (T1D), determining the correct insulin dose to be injected at meal-time is fundamental to achieve optimal glycemic control. Wearable sensors, such as continuous glucose monitoring (CGM) devices, are instrumental to achieve this purpose. In this paper, we show how CGM data, together with commonly recorded inputs (carbohydrate intake and bolus insulin), can be used to develop an algorithm that allows classifying, at meal-time, the post-prandial glycemic status (i.e., blood glucose concentration being too low, too high, or within target range). Such an outcome can then be used to improve the efficacy of insulin therapy by reducing or increasing the corresponding meal bolus dose. A state-of-the-art T1D simulation environment, including intraday variability and a behavioral model, was used to generate a rich in silico dataset corresponding to 100 subjects over a two-month scenario. Then, an extreme gradient-boosted tree (XGB) algorithm was employed to classify the post-prandial glycemic status. Finally, we demonstrate how the XGB algorithm outcome can be exploited to improve glycemic control in T1D through real-time adjustment of the meal insulin bolus. The proposed XGB algorithm obtained good accuracy at classifying post-prandial glycemic status (AUROC = 0.84 [0.78, 0.87]). Consequently, when used to adjust, in real-time, meal insulin boluses obtained with a bolus calculator, the proposed approach improves glycemic control when compared to the baseline bolus calculator. In particular, percentage time in target [70, 180] mg/dL was improved from 61.98 (.. 13.89) to 67.00 (.. 11.54; p &lt; 0.01) without increasing hypoglycemia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cappon</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, 35131 Padova (PD), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Facchinetti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, 35131 Padova (PD), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sparacino</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Information Engineering, University of Padova, 35131 Padova (PD), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Georgiou</LastName><ForeName>Pantelis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Electrical and Electronical Engineering, Imperial College London, London W5 5SA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrero</LastName><ForeName>Pau</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Electrical and Electronical Engineering, Imperial College London, London W5 5SA, UK. pau.herrero@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>689810</GrantID><Agency>Horizon 2020 Framework Programme</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006943" MajorTopicYN="N">Hyperglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019518" MajorTopicYN="N">Postprandial Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075082" MajorTopicYN="N">Proof of Concept Study</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">continuous glucose monitoring</Keyword><Keyword MajorTopicYN="N">decision support systems</Keyword><Keyword MajorTopicYN="N">gradient boosted trees</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">postprandial glycaemia</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>06</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>07</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>07</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31323886</ArticleId><ArticleId IdType="pii">s19143168</ArticleId><ArticleId IdType="doi">10.3390/s19143168</ArticleId><ArticleId IdType="pmc">PMC6679291</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Physiol Meas. 2004 Aug;25(4):905-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15382830</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2005 Jan;52(1):3-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15651559</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Biochem Rev. 2008 Aug;29 Suppl 1:S83-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18852864</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2011 Aug;13(8):843-52</Citation><ArticleIdList><ArticleId IdType="pubmed">21561370</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):106-11</Citation><ArticleIdList><ArticleId IdType="pubmed">23422244</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Sep;8(5):1035-41</Citation><ArticleIdList><ArticleId IdType="pubmed">24876436</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Jan 1;8(1):26-34</Citation><ArticleIdList><ArticleId IdType="pubmed">24876534</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Jan 1;8(1):170-178</Citation><ArticleIdList><ArticleId IdType="pubmed">24876553</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Mar 13;8(2):390-396</Citation><ArticleIdList><ArticleId IdType="pubmed">24876592</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2015 May;19(3):1087-96</Citation><ArticleIdList><ArticleId IdType="pubmed">24956470</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2015 Dec;53(12):1259-69</Citation><ArticleIdList><ArticleId IdType="pubmed">25416850</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2015 Jan;17(1):1-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25531427</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2015 Apr;119(1):1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25733405</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Aug 14;10(1):50-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26275643</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Jul;39(7):1175-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27330126</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2016 Dec 09;16(12):</Citation><ArticleIdList><ArticleId IdType="pubmed">27941663</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2018 Mar;65(3):479-488</Citation><ArticleIdList><ArticleId IdType="pubmed">28092515</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2017 Jan 15;17(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">28098839</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Jul;11(4):724-735</Citation><ArticleIdList><ArticleId IdType="pubmed">28299958</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2018 Jun;65(6):1281-1290</Citation><ArticleIdList><ArticleId IdType="pubmed">28866479</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Nov 7;12(11):e0187754</Citation><ArticleIdList><ArticleId IdType="pubmed">29112978</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2018 Feb;20(2):98-105</Citation><ArticleIdList><ArticleId IdType="pubmed">29355438</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Mar;12(2):265-272</Citation><ArticleIdList><ArticleId IdType="pubmed">29493356</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Sep;12(5):1064-1071</Citation><ArticleIdList><ArticleId IdType="pubmed">29783897</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2019 Jan;13(1):103-110</Citation><ArticleIdList><ArticleId IdType="pubmed">29848104</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2019 Mar;23(2):650-659</Citation><ArticleIdList><ArticleId IdType="pubmed">29993992</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31202936</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><PubDate><Year>2019</Year><Month>08</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Early detection and risk assessment for chronic disease with irregular longitudinal data analysis.</ArticleTitle><Pagination><MedlinePgn>103231</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30150-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103231</ELocationID><Abstract><AbstractText>Early detection and risk assessment of complex chronic disease based on longitudinal clinical data is helpful for doctors to make early diagnosis and monitor the disease progression. Disease diagnosis with computer-aided methods has been extensively studied. However, early detection and contemporaneous risk assessment based on partially labeled irregular longitudinal measurements is relatively unexplored. In this paper, we propose a flexible mixed-kernel framework for training a contemporaneous disease risk detector to predict the onset of disease and monitor the disease progression. Moreover, we address the label insufficiency problem by identifying the pattern of disease-induced progression over time with longitudinal data. Our method is based on a Structured Output Support Vector Machine (SOSVM), extended to longitudinal data analysis. Extensive experiments are conducted on several datasets of varying complexity, including the contemporaneous risk assessment with simulated irregular longitudinal data; the identification of the onset of Type 1 Diabetes (T1D) with irregularly sampled longitudinal RNA-Seq gene expression dataset; as well as the monitoring of the drug long-term effects on patients using longitudinal RNA-Seq dataset containing missing time points, demonstrating that our method enhances the accuracy in both early diagnosis and risk estimation with partially labeled irregular longitudinal clinical data.</AbstractText><CopyrightInformation>Copyright .. 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Electrical &amp; Computer Engineering, Texas A&amp;M University, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shuai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Industrial &amp; Systems Engineering, University of Washington, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Xiaoning</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Electrical &amp; Computer Engineering, Texas A&amp;M University, United States. Electronic address: xqian@ece.tamu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="Y">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078332" MajorTopicYN="N">Data Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="N">Diagnosis, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081246" MajorTopicYN="N">RNA-Seq</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Early diagnosis</Keyword><Keyword MajorTopicYN="Y">Longitudinal measurements</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Risk monitoring</Keyword><Keyword MajorTopicYN="Y">Structured output</Keyword><Keyword MajorTopicYN="Y">Support Vector Machine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>07</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>05</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>06</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31202936</ArticleId><ArticleId IdType="pii">S1532-0464(19)30150-9</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103231</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31195880</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-2811</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>03</Month></PubDate></JournalIssue><Title>Health informatics journal</Title><ISOAbbreviation>Health Informatics J</ISOAbbreviation></Journal><ArticleTitle>Prediction and prevention of hypoglycaemic events in type-1 diabetic patients using machine learning.</ArticleTitle><Pagination><MedlinePgn>703-718</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1460458219850682</ELocationID><Abstract><AbstractText>Tight blood glucose control reduces the risk of microvascular and macrovascular complications in patients with type 1 diabetes. However, this is very difficult due to the large intra-individual variability and other factors that affect glycaemic control. The main limiting factor to achieve strict control of glucose levels in patients on intensive insulin therapy is the risk of severe hypoglycaemia. Therefore, hypoglycaemia is the main safety problem in the treatment of type 1 diabetes, negatively affecting the quality of life of patients suffering from this disease. Decision support tools based on machine learning methods have become a viable way to enhance patient safety by anticipating adverse glycaemic events. This study proposes the application of four machine learning algorithms to tackle the problem of safety in diabetes management: (1) grammatical evolution for the mid-term continuous prediction of blood glucose levels, (2) support vector machines to predict hypoglycaemic events during postprandial periods, (3) artificial neural networks to predict hypoglycaemic episodes overnight, and (4) data mining to profile diabetes management scenarios. The proposal consists of the combination of prediction and classification capabilities of the implemented approaches. The resulting system significantly reduces the number of episodes of hypoglycaemia, improving safety and providing patients with greater confidence in decision-making.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Veh..</LastName><ForeName>Josep</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6884-9789</Identifier><AffiliationInfo><Affiliation>Universitat de Girona, Spain; Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Iv..n</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Oviedo</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universitat de Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biagi</LastName><ForeName>Lyvia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3356-8375</Identifier></Author><Author ValidYN="Y"><LastName>Bertachi</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universitat de Girona, Spain; Federal University of Technology - Paran.. (UTFPR), Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Informatics J</MedlineTA><NlmUniqueID>100883604</NlmUniqueID><ISSNLinking>1460-4582</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="Y">Hypoglycemia</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">blood glucose prediction</Keyword><Keyword MajorTopicYN="Y">decision support systems</Keyword><Keyword MajorTopicYN="Y">diabetes management</Keyword><Keyword MajorTopicYN="Y">hypoglycaemia</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">type-1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31195880</ArticleId><ArticleId IdType="doi">10.1177/1460458219850682</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31061005</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Print">2291-0026</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>2</Issue><PubDate><MedlineDate>2019 Apr-Jun</MedlineDate></PubDate></JournalIssue><Title>CMAJ open</Title><ISOAbbreviation>CMAJ Open</ISOAbbreviation></Journal><ArticleTitle>Developing a case definition for type 1 diabetes mellitus in a primary care electronic medical record database: an exploratory study.</ArticleTitle><Pagination><MedlinePgn>E246-E251</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.9778/cmajo.20180142</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Identifying cases of disease in primary care electronic medical records (EMRs) is important for surveillance, research, quality improvement and clinical care. We aimed to develop and validate a case definition for type 1 diabetes mellitus using EMRs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">For this exploratory study, we used EMR data from the Southern Alberta Primary Care Network within the Canadian Primary Care Sentinel Surveillance Network (CPCSSN), for the period 2008 to 2016. For patients identified as having diabetes mellitus according to the existing CPCSSN case definition, we asked family physicians to confirm the diabetes subtype, to create the reference standard. We used 3 decision-tree classification algorithms and least absolute shrinkage and selection operator logistic regression to identify variables that correctly distinguished between type 1 and type 2 diabetes cases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified a total of 1309 people with type 1 or type 2 diabetes, 110 of whom were confirmed by their physicians as having type 1 diabetes. Two machine learning algorithms were useful in identifying these cases in the EMRs. The first algorithm used "type 1" text words or age less than 22 years at time of initial diabetes diagnosis; this algorithm had sensitivity 42.7% (95% confidence interval [CI] 33.5%-52.5%), specificity 99.3% (95% CI 98.6%-99.7%), positive predictive value 85.5% (95% CI 72.8%-93.1%) and negative predictive value 94.9% (95% CI 93.5%-96.1%). The second algorithm used a combination of free-text terms, insulin prescriptions and age; it had sensitivity 87.3% (95% CI 79.2%-92.6%), specificity 85.4% (95% CI 83.2%-87.3%), positive predictive value 35.6% (95% CI 29.9%-41.6%) and negative predictive value 98.6% (95% CI 97.7%-99.2%).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">We used machine learning to develop and validate 2 case definitions that achieve different goals in distinguishing between type 1 and type 2 diabetes in CPCSSN data. Further validation and testing with a larger and more diverse sample are recommended.</AbstractText><CopyrightInformation>Copyright 2019, Joule Inc. or its licensors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lethebe</LastName><ForeName>B Cord</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Community Health Sciences (Lethebe, Williamson, Garies, McBrien, Soos, Shaw), Clinical Research Unit (Lethebe), Department of Family Medicine (Garies, McBrien, Leduc, Drummond) and Department of Medicine (Butalia), University of Calgary, Calgary, Alta.; Department of Family Medicine (Drummond), University of Alberta, Edmonton, Alta. bcletheb@ucalgary.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williamson</LastName><ForeName>Tyler</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Community Health Sciences (Lethebe, Williamson, Garies, McBrien, Soos, Shaw), Clinical Research Unit (Lethebe), Department of Family Medicine (Garies, McBrien, Leduc, Drummond) and Department of Medicine (Butalia), University of Calgary, Calgary, Alta.; Department of Family Medicine (Drummond), University of Alberta, Edmonton, Alta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garies</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Community Health Sciences (Lethebe, Williamson, Garies, McBrien, Soos, Shaw), Clinical Research Unit (Lethebe), Department of Family Medicine (Garies, McBrien, Leduc, Drummond) and Department of Medicine (Butalia), University of Calgary, Calgary, Alta.; Department of Family Medicine (Drummond), University of Alberta, Edmonton, Alta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McBrien</LastName><ForeName>Kerry</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Community Health Sciences (Lethebe, Williamson, Garies, McBrien, Soos, Shaw), Clinical Research Unit (Lethebe), Department of Family Medicine (Garies, McBrien, Leduc, Drummond) and Department of Medicine (Butalia), University of Calgary, Calgary, Alta.; Department of Family Medicine (Drummond), University of Alberta, Edmonton, Alta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leduc</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Community Health Sciences (Lethebe, Williamson, Garies, McBrien, Soos, Shaw), Clinical Research Unit (Lethebe), Department of Family Medicine (Garies, McBrien, Leduc, Drummond) and Department of Medicine (Butalia), University of Calgary, Calgary, Alta.; Department of Family Medicine (Drummond), University of Alberta, Edmonton, Alta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butalia</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Community Health Sciences (Lethebe, Williamson, Garies, McBrien, Soos, Shaw), Clinical Research Unit (Lethebe), Department of Family Medicine (Garies, McBrien, Leduc, Drummond) and Department of Medicine (Butalia), University of Calgary, Calgary, Alta.; Department of Family Medicine (Drummond), University of Alberta, Edmonton, Alta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soos</LastName><ForeName>Boglarka</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Community Health Sciences (Lethebe, Williamson, Garies, McBrien, Soos, Shaw), Clinical Research Unit (Lethebe), Department of Family Medicine (Garies, McBrien, Leduc, Drummond) and Department of Medicine (Butalia), University of Calgary, Calgary, Alta.; Department of Family Medicine (Drummond), University of Alberta, Edmonton, Alta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Community Health Sciences (Lethebe, Williamson, Garies, McBrien, Soos, Shaw), Clinical Research Unit (Lethebe), Department of Family Medicine (Garies, McBrien, Leduc, Drummond) and Department of Medicine (Butalia), University of Calgary, Calgary, Alta.; Department of Family Medicine (Drummond), University of Alberta, Edmonton, Alta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drummond</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Community Health Sciences (Lethebe, Williamson, Garies, McBrien, Soos, Shaw), Clinical Research Unit (Lethebe), Department of Family Medicine (Garies, McBrien, Leduc, Drummond) and Department of Medicine (Butalia), University of Calgary, Calgary, Alta.; Department of Family Medicine (Drummond), University of Alberta, Edmonton, Alta.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>CMAJ Open</MedlineTA><NlmUniqueID>101620603</NlmUniqueID><ISSNLinking>2291-0026</ISSNLinking></MedlineJournalInfo><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31061005</ArticleId><ArticleId IdType="pii">7/2/E246</ArticleId><ArticleId IdType="doi">10.9778/cmajo.20180142</ArticleId><ArticleId IdType="pmc">PMC6504632</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chronic Dis Can. 2001;22(2):67-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11525722</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2002 Mar;25(3):512-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11874939</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2007 Mar 3;369(9563):750-756</Citation><ArticleIdList><ArticleId IdType="pubmed">17336651</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Rep. 2008 Mar;19(1):71-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18457213</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2010 Mar;11(2):122-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19500278</ArticleId></ArticleIdList></Reference><Reference><Citation>J Stat Softw. 2010;33(1):1-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2011 Apr;28(4):424-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21392063</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2011 Aug 9;183(11):E743-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21670107</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2012 May;13(3):229-34</Citation><ArticleIdList><ArticleId IdType="pubmed">21771232</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Diabetes. 2013 Apr;37 Suppl 1:S20-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24070948</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Diabetes. 2014 Jun;38(3):179-85</Citation><ArticleIdList><ArticleId IdType="pubmed">24835515</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Fam Med. 2014 Jul;12(4):367-72</Citation><ArticleIdList><ArticleId IdType="pubmed">25024246</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2015 Mar 17;15:255</Citation><ArticleIdList><ArticleId IdType="pubmed">25849566</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ Open. 2016 Jan 25;4(1):E28-32</Citation><ArticleIdList><ArticleId IdType="pubmed">27331051</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2016 Aug 05;6(8):e009952</Citation><ArticleIdList><ArticleId IdType="pubmed">27496226</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 2017 Aug 1;46(4):1091-1092f</Citation><ArticleIdList><ArticleId IdType="pubmed">28338877</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 1997 Jun;50(6):711-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9250269</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31042157</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>05</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>Data-Driven Blood Glucose Pattern Classification and Anomalies Detection: Machine-Learning Applications in Type 1 Diabetes.</ArticleTitle><Pagination><MedlinePgn>e11030</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/11030</ELocationID><Abstract><AbstractText Label="BACKGROUND">Diabetes mellitus is a chronic metabolic disorder that results in abnormal blood glucose (BG) regulations. The BG level is preferably maintained close to normality through self-management practices, which involves actively tracking BG levels and taking proper actions including adjusting diet and insulin medications. BG anomalies could be defined as any undesirable reading because of either a precisely known reason (normal cause variation) or an unknown reason (special cause variation) to the patient. Recently, machine-learning applications have been widely introduced within diabetes research in general and BG anomaly detection in particular. However, irrespective of their expanding and increasing popularity, there is a lack of up-to-date reviews that materialize the current trends in modeling options and strategies for BG anomaly classification and detection in people with diabetes.</AbstractText><AbstractText Label="OBJECTIVE">This review aimed to identify, assess, and analyze the state-of-the-art machine-learning strategies and their hybrid systems focusing on BG anomaly classification and detection including glycemic variability (GV), hyperglycemia, and hypoglycemia in type 1 diabetes within the context of personalized decision support systems and BG alarm events applications, which are important constituents for optimal diabetes self-management.</AbstractText><AbstractText Label="METHODS">A rigorous literature search was conducted between September 1 and October 1, 2017, and October 15 and November 5, 2018, through various Web-based databases. Peer-reviewed journals and articles were considered. Information from the selected literature was extracted based on predefined categories, which were based on previous research and further elaborated through brainstorming.</AbstractText><AbstractText Label="RESULTS">The initial results were vetted using the title, abstract, and keywords and retrieved 496 papers. After a thorough assessment and screening, 47 articles remained, which were critically analyzed. The interrater agreement was measured using a Cohen kappa test, and disagreements were resolved through discussion. The state-of-the-art classes of machine learning have been developed and tested up to the task and achieved promising performance including artificial neural network, support vector machine, decision tree, genetic algorithm, Gaussian process regression, Bayesian neural network, deep belief network, and others.</AbstractText><AbstractText Label="CONCLUSIONS">Despite the complexity of BG dynamics, there are many attempts to capture hypoglycemia and hyperglycemia incidences and the extent of an individual's GV using different approaches. Recently, the advancement of diabetes technologies and continuous accumulation of self-collected health data have paved the way for popularity of machine learning in these tasks. According to the review, most of the identified studies used a theoretical threshold, which suffers from inter- and intrapatient variation. Therefore, future studies should consider the difference among patients and also track its temporal change over time. Moreover, studies should also give more emphasis on the types of inputs used and their associated time lag. Generally, we foresee that these developments might encourage researchers to further develop and test these systems on a large-scale basis.</AbstractText><CopyrightInformation>..Ashenafi Zebene Woldaregay, Eirik ..rsand, Taxiarchis Botsis, David Albers, Lena Mamykina, Gunnar Hartvigsen. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 01.05.2019.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Woldaregay</LastName><ForeName>Ashenafi Zebene</ForeName><Initials>AZ</Initials><Identifier Source="ORCID">0000-0002-9464-3407</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, University of Troms.. - The Arctic University of Norway, Troms.., Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>..rsand</LastName><ForeName>Eirik</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9520-1408</Identifier><AffiliationInfo><Affiliation>Norwegian Centre for E-health Research, University Hospital of North Norway, Troms.., Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botsis</LastName><ForeName>Taxiarchis</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7848-2570</Identifier><AffiliationInfo><Affiliation>The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albers</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-5369-526X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mamykina</LastName><ForeName>Lena</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5203-274X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartvigsen</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8771-9867</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, University of Troms.. - The Arctic University of Norway, Troms.., Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM012734</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">anomalies detection</Keyword><Keyword MajorTopicYN="Y">blood glucose dynamics</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31042157</ArticleId><ArticleId IdType="pii">v21i5e11030</ArticleId><ArticleId IdType="doi">10.2196/11030</ArticleId><ArticleId IdType="pmc">PMC6658321</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Diabetes Sci Technol. 2014 Jan 1;8(1):117-122</Citation><ArticleIdList><ArticleId IdType="pubmed">24876547</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Inf Technol Biomed. 2011 Mar;15(2):308-15</Citation><ArticleIdList><ArticleId IdType="pubmed">21349796</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2013;192:38-41</Citation><ArticleIdList><ArticleId IdType="pubmed">23920511</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2014;2014:4843-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25571076</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2017 Jun;128:40-50</Citation><ArticleIdList><ArticleId IdType="pubmed">28437734</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2005 Jul;43(4):501-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16255433</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 Nov 01;7(6):1575-84</Citation><ArticleIdList><ArticleId IdType="pubmed">24351184</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2011;2011:5666-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22255625</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 Jul 01;7(4):871-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23911168</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2018 May 30;20(5):e10775</Citation><ArticleIdList><ArticleId IdType="pubmed">29848472</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2012 Sep;35(9):1897-901</Citation><ArticleIdList><ArticleId IdType="pubmed">22699297</ArticleId></ArticleIdList></Reference><Reference><Citation>ISA Trans. 2016 Sep;64:440-446</Citation><ArticleIdList><ArticleId IdType="pubmed">27311357</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerontology. 2013;59(2):99-104</Citation><ArticleIdList><ArticleId IdType="pubmed">23182884</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2013;2013:5386-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24110953</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2017 Jun;5(6):423-430</Citation><ArticleIdList><ArticleId IdType="pubmed">28456416</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2013 Dec 17;13(12):17472-500</Citation><ArticleIdList><ArticleId IdType="pubmed">24351646</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:3503-3506</Citation><ArticleIdList><ArticleId IdType="pubmed">28269053</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 May 01;7(3):689-98</Citation><ArticleIdList><ArticleId IdType="pubmed">23759402</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2011;2011:7961-4</Citation><ArticleIdList><ArticleId IdType="pubmed">22256187</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2012 Jul;55(3):177-84</Citation><ArticleIdList><ArticleId IdType="pubmed">22698854</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2008;2008:1311-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19162908</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2006;2006:6053-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17945929</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Jul;15(7):538-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23631608</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2014;2014:4475-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25570985</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Cybern. 2014 Aug;44(8):1338-49</Citation><ArticleIdList><ArticleId IdType="pubmed">24122616</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2010;2010:4930-3</Citation><ArticleIdList><ArticleId IdType="pubmed">21096665</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2011 Jul 01;5(4):871-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21880228</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2008;2008:3297-300</Citation><ArticleIdList><ArticleId IdType="pubmed">19163412</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):634-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23848178</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 Jan 01;7(1):135-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23439169</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Jul 24;7(1):6232</Citation><ArticleIdList><ArticleId IdType="pubmed">28740090</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Mar;12(2):303-310</Citation><ArticleIdList><ArticleId IdType="pubmed">28539087</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2012;2012:3515-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23366685</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab J. 2015 Aug;39(4):273-82</Citation><ArticleIdList><ArticleId IdType="pubmed">26301188</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2007;2007:3140-3</Citation><ArticleIdList><ArticleId IdType="pubmed">18002661</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2014;2014:302-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25569957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Biomed Eng. 2012 Apr;40(4):934-45</Citation><ArticleIdList><ArticleId IdType="pubmed">22012087</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2012;2012:6325-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23367375</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Endocrinol Metab. 2012 Mar;16 Suppl 1:S27-36</Citation><ArticleIdList><ArticleId IdType="pubmed">22701840</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2010;2010:618-21</Citation><ArticleIdList><ArticleId IdType="pubmed">21096769</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33323237</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2589-7500</ISSN><JournalIssue CitedMedium="Internet"><Volume>1</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>05</Month></PubDate></JournalIssue><Title>The Lancet. Digital health</Title><ISOAbbreviation>Lancet Digit Health</ISOAbbreviation></Journal><ArticleTitle>Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial.</ArticleTitle><Pagination><MedlinePgn>e17-e25</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2589-7500(19)30003-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2589-7500(19)30003-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Closed-loop insulin delivery systems are expected to become a standard treatment for patients with type 1 diabetes. We aimed to assess whether the Diabeloop Generation 1 (DBLG1) hybrid closed-loop artificial pancreas system improved glucose control compared with sensor-assisted pump therapy.</AbstractText><AbstractText Label="METHODS">In this multicentre, open-label, randomised, crossover trial, we recruited adults (aged ...18 years) with at least a 2 year history of type 1 diabetes, who had been treated with external insulin pump therapy for at least 6 months, had glycated haemoglobin (HbA<sub>1c</sub>) of 10% or less (86 mmol/mol), and preserved hypoglycaemia awareness. After a 2-week run-in period, patients were randomly assigned (1:1) with a web-based system in randomly permuted blocks of two, to receive insulin via the hybrid closed-loop system (DBLG1; using a machine-learning-based algorithm) or sensor-assisted pump therapy over 12 weeks of free living, followed by an 8-week washout period and then the other intervention for 12 weeks. The primary outcome was the proportion of time that the sensor glucose concentration was within the target range (3..9-10..0 mmol/L) during the 12 week study period. Efficacy analyses were done in the modified intention-to-treat population, which included all randomly assigned patients who completed both 12 week treatment periods. Safety analyses were done in all patients who were exposed to either of the two treatments at least once during the study. This trial is registered with ClinicalTrials.gov, number NCT02987556.</AbstractText><AbstractText Label="FINDINGS">Between March 3, 2017, and June 19, 2017, 71 patients were screened, and 68 eligible patients were randomly assigned to the DBLG1 group (n=33) or the sensor-assisted pump therapy group (n=35), of whom five dropped out in the washout period (n=1 pregnancy; n=4 withdrew consent). 63 patients completed both 12 week treatment periods and were included in the modified intention-to-treat analysis. The proportion of time that the glucose concentration was within the target range was significantly higher in the DBLG1 group (68..5% [SD 9..4] than the sensor-assisted pump group (59..4% [10..2]; mean difference 9..2% [95% CI 6..4 to 11..9]; p&lt;0..0001). Five severe hypoglycaemic episodes occurred in the DBLG1 group and three episodes occurred in the sensor-assisted pump therapy group, which were associated with hardware malfunctions or human error.</AbstractText><AbstractText Label="INTERPRETATION">The DBLG1 system improves glucose control compared with sensor-assisted insulin pumps. This finding supports the use of closed-loop technology combined with appropriate health care organisation in adults with type 1 diabetes.</AbstractText><AbstractText Label="FUNDING">French Innovation Fund, Diabeloop.</AbstractText><CopyrightInformation>Copyright .. 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Benhamou</LastName><ForeName>Pierre-Yves</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Grenoble University Hospital, INSERM U1055, Grenoble Alpes University, Grenoble, France. Electronic address: pybenhamou@chu-grenoble.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franc</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France; Center for Study and Research for Improvement of the Treatment of Diabetes, Bioparc-Genopole Evry-Corbeil, Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reznik</LastName><ForeName>Yves</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, University of Caen C..te de Nacre Regional Hospital Center, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thivolet</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology, Nutrition, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaepelynck</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Diabetology, Marseille University Hospital, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renard</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, UMR CNRS 5203, INSERM U1191, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerci</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition, Lorraine University Hospital, Vandoeuvre L..s Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaillous</LastName><ForeName>Lucy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology, Nutrition, L'Institut du Thorax, Centre Hospitalier Universitaire de Nantes, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lukas-Croisier</LastName><ForeName>Celine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology, Reims University Hospital, Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeandidier</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology and Nutrition, Strasbourg University Hospital, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanaire</LastName><ForeName>Helene</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borot</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Nutrition and Diabetes, Besan..on University Hospital and Franche-Comt.. University, Besan..on, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doron</LastName><ForeName>Maeva</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratoire d'..lectronique des technologies de l'information, F-38000, Grenoble Alpes University, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jallon</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratoire d'..lectronique des technologies de l'information, F-38000, Grenoble Alpes University, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xhaard</LastName><ForeName>Ilham</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Center for Study and Research for Improvement of the Treatment of Diabetes, Bioparc-Genopole Evry-Corbeil, Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melki</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology and Nutrition, Strasbourg University Hospital, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delemer</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology, Reims University Hospital, Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guillouche</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology, Nutrition, L'Institut du Thorax, Centre Hospitalier Universitaire de Nantes, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoumacker-Ley</LastName><ForeName>Laurene</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition, Lorraine University Hospital, Vandoeuvre L..s Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farret</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, UMR CNRS 5203, INSERM U1191, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raccah</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Diabetology, Marseille University Hospital, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lablanche</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Grenoble University Hospital, INSERM U1055, Grenoble Alpes University, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joubert</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, University of Caen C..te de Nacre Regional Hospital Center, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penfornis</LastName><ForeName>Alfred</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France; Paris Sud University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charpentier</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Study and Research for Improvement of the Treatment of Diabetes, Bioparc-Genopole Evry-Corbeil, Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>DIABELOOP WP7 Trial Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02987556</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Digit Health</MedlineTA><NlmUniqueID>101751302</NlmUniqueID><ISSNLinking>2589-7500</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Digit Health. 2019 May;1(1):e2-e3</RefSource><PMID Version="1">33323238</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="Y">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>03</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>16</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33323237</ArticleId><ArticleId IdType="pii">S2589-7500(19)30003-2</ArticleId><ArticleId IdType="doi">10.1016/S2589-7500(19)30003-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31029250</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8243</ISSN><JournalIssue CitedMedium="Internet"><Volume>126</Volume><PubDate><Year>2019</Year><Month>06</Month></PubDate></JournalIssue><Title>International journal of medical informatics</Title><ISOAbbreviation>Int J Med Inform</ISOAbbreviation></Journal><ArticleTitle>Risk-based postprandial hypoglycemia forecasting using supervised learning.</ArticleTitle><Pagination><MedlinePgn>1-8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1386-5056(18)30497-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijmedinf.2019.03.008</ELocationID><Abstract><AbstractText Label="BACKGROUND">Predicting insulin-induced postprandial hypoglycemic events is critical for the safety of type 1 diabetes patients because an early warning of hypoglycemia facilitates correction of the insulin bolus before its administration. The postprandial hypoglycemic event counts can be lowered by reducing the size of the bolus based on a reliable prediction but at the cost of increasing the average blood glucose.</AbstractText><AbstractText Label="METHODS">We developed a method for predicting postprandial hypoglycemia using machine learning techniques personalized to each patient. The proposed system enables on-line therapeutic decision making for patients using a sensor augmented pump therapy. Two risk-based approaches were developed for a window of 240 min after the meal/bolus, and they were tested based on real retrospective data from 10 patients using 70 mg/dL and 54 mg/dL as thresholds according to the consensus for Level 1 and Level 2 hypoglycemia, respectively. Due to the small size of the patient cohort, we trained personalized models for each patient.</AbstractText><AbstractText Label="RESULTS">The median specificity and sensitivity were 79% and 71% for Level 1 hypoglycemia, respectively, and 81% and 77% for Level 2.</AbstractText><AbstractText Label="CONCLUSIONS">The results demonstrated that it is feasible to anticipate hypoglycemic events with a reasonable false-positive rate. The accuracy of the results and the trade-off between performance metrics allow its use in decision support systems for patients who wear insulin pumps.</AbstractText><CopyrightInformation>Copyright .. 2019 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oviedo</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut d'Informatica i Aplicacions. Universitat de Girona, Spain. Electronic address: silvia.oviedo@udg.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institut d'Informatica i Aplicacions. Universitat de Girona, Spain. Electronic address: ivancontrerasfd@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quir..s</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Endocrinolog..a y Nutrici..n. Hospital Universitari Mutua de Terrassa, Terrassa, Spain. Electronic address: cmquiros@clinic.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gim..nez</LastName><ForeName>Marga</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Diabetes Unit. Endocrinology and Nutrition Dpt. IDIBAPS (Institut d'investigacions biomdiques August Pi I Sunyer), Barcelona, Spain; Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), Spain. Electronic address: gimenez@clinic.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conget</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Diabetes Unit. Endocrinology and Nutrition Dpt. IDIBAPS (Institut d'investigacions biomdiques August Pi I Sunyer), Barcelona, Spain; Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), Spain. Electronic address: iconget@clinic.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vehi</LastName><ForeName>Josep</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut d'Informatica i Aplicacions. Universitat de Girona, Spain; Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), Spain. Electronic address: josep.vehi@udg.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Int J Med Inform</MedlineTA><NlmUniqueID>9711057</NlmUniqueID><ISSNLinking>1386-5056</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019518" MajorTopicYN="Y">Postprandial Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069553" MajorTopicYN="Y">Supervised Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Blood glucose</Keyword><Keyword MajorTopicYN="Y">Bolus calculation</Keyword><Keyword MajorTopicYN="Y">Hypoglycemia prediction</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Postprandial hypoglycemia</Keyword><Keyword MajorTopicYN="Y">Type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>01</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>03</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31029250</ArticleId><ArticleId IdType="pii">S1386-5056(18)30497-0</ArticleId><ArticleId IdType="doi">10.1016/j.ijmedinf.2019.03.008</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30946685</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2168-2208</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>02</Month></PubDate></JournalIssue><Title>IEEE journal of biomedical and health informatics</Title><ISOAbbreviation>IEEE J Biomed Health Inform</ISOAbbreviation></Journal><ArticleTitle>Convolutional Recurrent Neural Networks for Glucose Prediction.</ArticleTitle><Pagination><MedlinePgn>603-613</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/JBHI.2019.2908488</ELocationID><Abstract><AbstractText>Control of blood glucose is essential for diabetes management. Current digital therapeutic approaches for subjects with type 1 diabetes mellitus such as the artificial pancreas and insulin bolus calculators leverage machine learning techniques for predicting subcutaneous glucose for improved control. Deep learning has recently been applied in healthcare and medical research to achieve state-of-the-art results in a range of tasks including disease diagnosis, and patient state prediction among others. In this paper, we present a deep learning model that is capable of forecasting glucose levels with leading accuracy for simulated patient cases (root-mean-square error (RMSE) = 9.38.. .. 0.71 [mg/dL] over a 30-min horizon, RMSE = 18.87.. .. 2.25 [mg/dL] over a 60-min horizon) and real patient cases (RMSE = 21.07.. .. 2.35 [mg/dL] for 30 min, RMSE = 33.27.. .. 4.79% for 60 min). In addition, the model provides competitive performance in providing effective prediction horizon ([Formula: see text]) with minimal time lag both in a simulated patient dataset ([Formula: see text] = 29.0 .. 0.7 for 30 min and [Formula: see text] = 49.8.. .. 2.9 for 60 min) and in a real patient dataset ([Formula: see text] = 19.3.. .. 3.1 for 30 min and [Formula: see text] = 29.3.. .. 9.4 for 60 min). This approach is evaluated on a dataset of ten simulated cases generated from the UVA/Padova simulator and a clinical dataset of ten real cases each containing glucose readings, insulin bolus, and meal (carbohydrate) data. Performance of the recurrent convolutional neural network is benchmarked against four algorithms. The proposed algorithm is implemented on an Android mobile phone, with an execution time of 6..ms on a phone compared to an execution time of 780..ms on a laptop.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Kezhi</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Daniels</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chengyuan</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Herrero</LastName><ForeName>Pau</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Georgiou</LastName><ForeName>Pantelis</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE J Biomed Health Inform</MedlineTA><NlmUniqueID>101604520</NlmUniqueID><ISSNLinking>2168-2194</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="N">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30946685</ArticleId><ArticleId IdType="doi">10.1109/JBHI.2019.2908488</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30798638</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1524-4539</ISSN><JournalIssue CitedMedium="Internet"><Volume>139</Volume><Issue>16</Issue><PubDate><Year>2019</Year><Month>04</Month><Day>16</Day></PubDate></JournalIssue><Title>Circulation</Title><ISOAbbreviation>Circulation</ISOAbbreviation></Journal><ArticleTitle>Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.</ArticleTitle><Pagination><MedlinePgn>1900-1912</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.118.037454</ELocationID><Abstract><AbstractText Label="BACKGROUND">The strength of association and optimal levels for risk factors related to excess risk of death and cardiovascular outcomes in type 1 diabetes mellitus have been sparsely studied.</AbstractText><AbstractText Label="METHODS">In a national observational cohort study from the Swedish National Diabetes Register from 1998 to 2014, we assessed relative prognostic importance of 17 risk factors for death and cardiovascular outcomes in individuals with type 1 diabetes mellitus. We used Cox regression and machine learning analyses. In addition, we examined optimal cut point levels for glycohemoglobin, systolic blood pressure, and low-density lipoprotein cholesterol. Patients with type 1 diabetes mellitus were followed up until death or study end on December 31, 2013. The primary outcomes were death resulting from all causes, fatal/nonfatal acute myocardial infarction, fatal/nonfatal stroke, and hospitalization for heart failure.</AbstractText><AbstractText Label="RESULTS">Of 32...611 patients with type 1 diabetes mellitus, 1809 (5.5%) died during follow-up over 10.4 years. The strongest predictors for death and cardiovascular outcomes were glycohemoglobin, albuminuria, duration of diabetes mellitus, systolic blood pressure, and low-density lipoprotein cholesterol. Glycohemoglobin displayed ...2% higher risk for each 1-mmol/mol increase (equating to ...22% per 1% glycohemoglobin difference), whereas low-density lipoprotein cholesterol was associated with 35% to 50% greater risk for each 1-mmol/L increase. Microalbuminuria or macroalbuminuria was associated with 2 to 4 times greater risk for cardiovascular complications and death. Glycohemoglobin &lt;53 mmol/mol (7.0%), systolic blood pressure &lt;140 mm...Hg, and low-density lipoprotein cholesterol &lt;2.5 mmol/L were associated with significantly lower risk for outcomes observed.</AbstractText><AbstractText Label="CONCLUSIONS">Glycohemoglobin, albuminuria, duration of diabetes mellitus, systolic blood pressure, and low-density lipoprotein cholesterol appear to be the most important predictors for mortality and cardiovascular outcomes in patients with type 1 diabetes mellitus. Lower levels for glycohemoglobin, systolic blood pressure, and low-density lipoprotein cholesterol than contemporary guideline target levels appear to be associated with significantly lower risk for outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rawshani</LastName><ForeName>Aidin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (A. Rawshani, A. Rawshani, B.E., A. Rosengren, S.G.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (A. Rawshani, A. Rawshani, S.F., B.E., A.-M.S., M.M., S.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rawshani</LastName><ForeName>Araz</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (A. Rawshani, A. Rawshani, B.E., A. Rosengren, S.G.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (A. Rawshani, A. Rawshani, S.F., B.E., A.-M.S., M.M., S.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sattar</LastName><ForeName>Naveed</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK (N.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franz..n</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (A. Rawshani, A. Rawshani, S.F., B.E., A.-M.S., M.M., S.G.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Metrics Unit, Sahlgrenska Academy, University of Gothenburg, Sweden (S.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGuire</LastName><ForeName>Darren K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (D.K.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eliasson</LastName><ForeName>Bj..rn</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (A. Rawshani, A. Rawshani, B.E., A. Rosengren, S.G.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (A. Rawshani, A. Rawshani, S.F., B.E., A.-M.S., M.M., S.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svensson</LastName><ForeName>Ann-Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (A. Rawshani, A. Rawshani, S.F., B.E., A.-M.S., M.M., S.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zethelius</LastName><ForeName>Bj..rn</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, Sweden (B.Z.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miftaraj</LastName><ForeName>Mervete</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (A. Rawshani, A. Rawshani, S.F., B.E., A.-M.S., M.M., S.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosengren</LastName><ForeName>Annika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (A. Rawshani, A. Rawshani, B.E., A. Rosengren, S.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudbj..rnsdottir</LastName><ForeName>Soffia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (A. Rawshani, A. Rawshani, B.E., A. Rosengren, S.G.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (A. Rawshani, A. Rawshani, S.F., B.E., A.-M.S., M.M., S.G.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circulation</MedlineTA><NlmUniqueID>0147763</NlmUniqueID><ISSNLinking>0009-7322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008078">Cholesterol, LDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008078" MajorTopicYN="N">Cholesterol, LDL</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063868" MajorTopicYN="N">Patient Outcome Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">cardiovascular disease</Keyword><Keyword MajorTopicYN="Y">cerebrovascular disorders</Keyword><Keyword MajorTopicYN="Y">diabetes mellitus, type 1</Keyword><Keyword MajorTopicYN="Y">glycated hemoglobin A</Keyword><Keyword MajorTopicYN="Y">heart failure</Keyword><Keyword MajorTopicYN="Y">mortality</Keyword><Keyword MajorTopicYN="Y">risk factors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30798638</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.037454</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30685040</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4324</ISSN><JournalIssue CitedMedium="Internet"><Volume>1052</Volume><PubDate><Year>2019</Year><Month>Apr</Month><Day>04</Day></PubDate></JournalIssue><Title>Analytica chimica acta</Title><ISOAbbreviation>Anal Chim Acta</ISOAbbreviation></Journal><ArticleTitle>Non-invasive prediction of blood glucose trends during hypoglycemia.</ArticleTitle><Pagination><MedlinePgn>37-48</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0003-2670(18)31444-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.aca.2018.12.009</ELocationID><Abstract><AbstractText>Over the last four decades, there has been a pursuit for a non-invasive solution for glucose measurement, but there is not yet any viable product released. Of the many sensor modalities tried, the combination of electrical and optical measurement is among the most promising for continuous measurements. Although non-invasive prediction of exact glucose levels may seem futile, prediction of their trends may be useful for certain applications. Hypoglycemia is the most serious of the acute complications in type-1 diabetes highlighting the need for a reliable alarm, but little is known about the performance of this technology in predicting hypoglycemic glucose levels and associated trends. We aimed to assess such performance on the way to develop a multisensor system for detection of hypoglycemia, based on near-infrared (NIR), bioimpedance and skin temperature measurements taken during hypoglycemic and euglycemic glucose clamps in 20 subjects with type-1 diabetes. Performance of blood glucose prediction was assessed by global partial least squares and neural network regression models using repeated double cross-validation. Best trend prediction was obtained by including all measurements in a neural network model. Prediction of glucose level was inaccurate for threshold-based detection of hypoglycemia, but the trend predictions may provide useful information in a multisensor system. Comparing NIR and bioimpedance measurements, NIR seems to be the main predictor of blood glucose while bioimpedance may act as correction for individual confounding properties.</AbstractText><CopyrightInformation>Copyright .. 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tronstad</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway. Electronic address: chrton@ous-hf.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elvebakk</LastName><ForeName>Ole</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Staal</LastName><ForeName>Odd Martin</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Prediktor Medical AS, Fredrikstad, Norway; Norwegian University of Science and Technology, Department of Engineering Cybernetics, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalv..y</LastName><ForeName>H..vard</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H..getveit</LastName><ForeName>Jan Olav</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Department of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway; Department of Physics, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenssen</LastName><ForeName>Trond Geir</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway; Metabolic and Renal Research Group, UiT The Arctic University of Norway, Troms.., Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birkeland</LastName><ForeName>K..re Inge</ForeName><Initials>KI</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinsen</LastName><ForeName>..rjan G</ForeName><Initials>..G</Initials><AffiliationInfo><Affiliation>Department of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway; Department of Physics, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Anal Chim Acta</MedlineTA><NlmUniqueID>0370534</NlmUniqueID><ISSNLinking>0003-2670</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017097" MajorTopicYN="N">Electric Impedance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016018" MajorTopicYN="N">Least-Squares Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012881" MajorTopicYN="N">Skin Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013057" MajorTopicYN="N">Spectrum Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Glucose</Keyword><Keyword MajorTopicYN="N">Hypoglycemia</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Multisensor</Keyword><Keyword MajorTopicYN="N">Neural network</Keyword><Keyword MajorTopicYN="N">Non invasive</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30685040</ArticleId><ArticleId IdType="pii">S0003-2670(18)31444-2</ArticleId><ArticleId IdType="doi">10.1016/j.aca.2018.12.009</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30650997</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>09</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>Prediction of Hypoglycemia During Aerobic Exercise in Adults With Type 1 Diabetes.</ArticleTitle><Pagination><MedlinePgn>919-927</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1932296818823792</ELocationID><Abstract><AbstractText Label="BACKGROUND">Fear of exercise related hypoglycemia is a major reason why people with type 1 diabetes (T1D) do not exercise. There is no validated prediction algorithm that can predict hypoglycemia at the start of aerobic exercise.</AbstractText><AbstractText Label="METHODS">We have developed and evaluated two separate algorithms to predict hypoglycemia at the start of exercise. Model 1 is a decision tree and model 2 is a random forest model. Both models were trained using a meta-data set based on 154 observations of in-clinic aerobic exercise in 43 adults with T1D from 3 different studies that included participants using sensor augmented pump therapy, automated insulin delivery therapy, and automated insulin and glucagon therapy. Both models were validated using an entirely new validation data set with 90 exercise observations collected from 12 new adults with T1D.</AbstractText><AbstractText Label="RESULTS">Model 1 identified two critical features predictive of hypoglycemia during exercise: heart rate and glucose at the start of exercise. If heart rate was greater than 121 bpm during the first 5 min of exercise and glucose at the start of exercise was less than 182 mg/dL, it predicted hypoglycemia with 79.55% accuracy. Model 2 achieved a higher accuracy of 86.7% using additional features and higher complexity.</AbstractText><AbstractText Label="CONCLUSIONS">Models presented here can assist people with T1D to avoid exercise related hypoglycemia. The simple model 1 heuristic can be easily remembered (the 180/120 rule) and model 2 is more complex requiring computational resources, making it suitable for automated artificial pancreas or decision support systems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Ravi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>1 Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resalat</LastName><ForeName>Navid</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>1 Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Leah M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0003-3634-481X</Identifier><AffiliationInfo><Affiliation>2 Department of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center Oregon, Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castle</LastName><ForeName>Jessica R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>2 Department of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center Oregon, Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Youssef</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>1 Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Department of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center Oregon, Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Peter G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>1 Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP3 DK101044</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK120367</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002369</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="Y">Hypoglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019397" MajorTopicYN="N">Pancreas, Artificial</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">artificial pancreas</Keyword><Keyword MajorTopicYN="Y">exercise</Keyword><Keyword MajorTopicYN="Y">hypoglycemia</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30650997</ArticleId><ArticleId IdType="doi">10.1177/1932296818823792</ArticleId><ArticleId IdType="pmc">PMC6955453</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Technol Ther. 2014 Aug;16(8):506-11</Citation><ArticleIdList><ArticleId IdType="pubmed">24702135</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Spectr. 2015 Jan;28(1):32-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25717276</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2016 Dec;59(12):2561-2571</Citation><ArticleIdList><ArticleId IdType="pubmed">27704167</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Oct 05;9(6):1175-84</Citation><ArticleIdList><ArticleId IdType="pubmed">26438720</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 May;8(3):498-507</Citation><ArticleIdList><ArticleId IdType="pubmed">24876613</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2015 Dec;17(12):1150-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26264812</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Apr 26;366(17):1616-24</Citation><ArticleIdList><ArticleId IdType="pubmed">22533577</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2017 Mar;60(3):574-580</Citation><ArticleIdList><ArticleId IdType="pubmed">28013340</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2017 Nov;18(7):540-546</Citation><ArticleIdList><ArticleId IdType="pubmed">27734563</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Med. 1998;49:235-61</Citation><ArticleIdList><ArticleId IdType="pubmed">9509261</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Med (Lond). 2014 Dec;14(6):673-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25468857</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Jul 24;371(4):313-325</Citation><ArticleIdList><ArticleId IdType="pubmed">24931572</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2017 May;5(5):377-390</Citation><ArticleIdList><ArticleId IdType="pubmed">28126459</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Nov 15;316(19):1957</Citation><ArticleIdList><ArticleId IdType="pubmed">27838705</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2014 Oct;61(10):2569-81</Citation><ArticleIdList><ArticleId IdType="pubmed">24835122</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Diabetes. 2016 Dec;40(6):503-508</Citation><ArticleIdList><ArticleId IdType="pubmed">27212045</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jun 30;9(6):1236-45</Citation><ArticleIdList><ArticleId IdType="pubmed">26134831</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Nov;39(11):2065-2079</Citation><ArticleIdList><ArticleId IdType="pubmed">27926890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ind Eng Chem Res. 2013 Sep 4;52(35):null</Citation><ArticleIdList><ArticleId IdType="pubmed">24187436</ArticleId></ArticleIdList></Reference><Reference><Citation>Prev Med. 2016 Oct;91:138-143</Citation><ArticleIdList><ArticleId IdType="pubmed">27527572</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2007 Mar;92(3):963-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17118993</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pers Med. 2017 May 24;7(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">28538708</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Physiol (1985). 2002 Aug;93(2):782-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12133892</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2013 Jul;98(7):2908-14</Citation><ArticleIdList><ArticleId IdType="pubmed">23780373</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2018 Feb;20(2):443-447</Citation><ArticleIdList><ArticleId IdType="pubmed">28718987</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2017 Jun;19(6):370-378</Citation><ArticleIdList><ArticleId IdType="pubmed">28613947</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2008 Nov;31(11):2108-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18689694</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Jul;41(7):1471-1477</Citation><ArticleIdList><ArticleId IdType="pubmed">29752345</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2007 Jan 25;8:25</Citation><ArticleIdList><ArticleId IdType="pubmed">17254353</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2015 Nov 26;373(22):2129-2140</Citation><ArticleIdList><ArticleId IdType="pubmed">26379095</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2016 Nov;18(11):1110-1119</Citation><ArticleIdList><ArticleId IdType="pubmed">27333970</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jan;9(1):80-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25231116</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Endocrinol Metab. 2011 Jan 1;6(1):93-108</Citation><ArticleIdList><ArticleId IdType="pubmed">21339838</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30587115</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2164</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Dec</Month><Day>27</Day></PubDate></JournalIssue><Title>BMC genomics</Title><ISOAbbreviation>BMC Genomics</ISOAbbreviation></Journal><ArticleTitle>ACES: a machine learning toolbox for clustering analysis and visualization.</ArticleTitle><Pagination><MedlinePgn>964</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12864-018-5300-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Studies that aim at explaining phenotypes or disease susceptibility by genetic or epigenetic variants often rely on clustering methods to stratify individuals or samples. While statistical associations may point at increased risk for certain parts of the population, the ultimate goal is to make precise predictions for each individual. This necessitates tools that allow for the rapid inspection of each data point, in particular to find explanations for outliers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">ACES is an integrative cluster- and phenotype-browser, which implements standard clustering methods, as well as multiple visualization methods in which all sample information can be displayed quickly. In addition, ACES can automatically mine a list of phenotypes for cluster enrichment, whereby the number of clusters and their boundaries are estimated by a novel method. For visual data browsing, ACES provides a 2D or 3D PCA or Heat Map view. ACES is implemented in Java, with a focus on a user-friendly, interactive, graphical interface.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">ACES has been proven an invaluable tool for analyzing large, pre-filtered DNA methylation data sets and RNA-Sequencing data, due to its ease to link molecular markers to complex phenotypes. The source code is available from https://github.com/GrabherrGroup/ACES .</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Jiangning</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of medical biochemistry and microbiology, Uppsala University, Uppsala, Sweden. jiangning.gao@imbim.uu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sundstr..m</LastName><ForeName>G..rel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Forest Genetics and Plant Physiology, Swedish University of Agricultural Sciences, Ume.., Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moghadam</LastName><ForeName>Behrooz Torabi</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Department of immunology, genetics, and pathology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamani</LastName><ForeName>Neda</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of medical biochemistry and microbiology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grabherr</LastName><ForeName>Manfred G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of medical biochemistry and microbiology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Genomics</MedlineTA><NlmUniqueID>100965258</NlmUniqueID><ISSNLinking>1471-2164</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077230" MajorTopicYN="N">Internet Access</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025341" MajorTopicYN="N">Principal Component Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014584" MajorTopicYN="Y">User-Computer Interface</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Centroid detection</Keyword><Keyword MajorTopicYN="N">Clustering</Keyword><Keyword MajorTopicYN="N">Data visualization</Keyword><Keyword MajorTopicYN="N">Discriminative power prediction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>07</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30587115</ArticleId><ArticleId IdType="doi">10.1186/s12864-018-5300-y</ArticleId><ArticleId IdType="pii">10.1186/s12864-018-5300-y</ArticleId><ArticleId IdType="pmc">PMC6307290</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bioinformatics. 2004 Jun 12;20(9):1453-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14871861</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biotechnol. 2005 Sep;31(1):55-80</Citation><ArticleIdList><ArticleId IdType="pubmed">16118415</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W444-51</Citation><ArticleIdList><ArticleId IdType="pubmed">18524799</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Aug 1;25(15):1994-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19454618</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2010 Mar 09;11:121</Citation><ArticleIdList><ArticleId IdType="pubmed">20214778</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2010 Apr;20(4):440-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20219944</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Rev Biomed Eng. 2010;3:120-54</Citation><ArticleIdList><ArticleId IdType="pubmed">22275205</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2013 May 24;14:347</Citation><ArticleIdList><ArticleId IdType="pubmed">23706020</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2013 Oct 10;155(2):462-77</Citation><ArticleIdList><ArticleId IdType="pubmed">24120142</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2015 May;64(5):1682-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25422108</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2015 Jul;64(7):2506-12</Citation><ArticleIdList><ArticleId IdType="pubmed">25677915</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Jul 1;43(W1):W566-70</Citation><ArticleIdList><ArticleId IdType="pubmed">25969447</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2015 Jun 25;372(26):2481-98</Citation><ArticleIdList><ArticleId IdType="pubmed">26061751</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2016 Jan 28;164(3):550-63</Citation><ArticleIdList><ArticleId IdType="pubmed">26824661</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychometrika. 1967 Sep;32(3):241-54</Citation><ArticleIdList><ArticleId IdType="pubmed">5234703</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29903493</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2018</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>162</Volume><PubDate><Year>2018</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Computer methods and programs in biomedicine</Title><ISOAbbreviation>Comput Methods Programs Biomed</ISOAbbreviation></Journal><ArticleTitle>A decision support system for type 1 diabetes mellitus diagnostics based on dual channel analysis of red blood cell membrane fluidity.</ArticleTitle><Pagination><MedlinePgn>263-271</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0169-2607(17)31207-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmpb.2018.05.025</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="OBJECTIVE">Investigation of membrane fluidity by metabolic functional imaging opens up a new and important area of translational research in type 1 diabetes mellitus, being a useful and sensitive biomarker for disease monitoring and treatment. We investigate here how data on membrane fluidity can be used for diabetes monitoring.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We present a decision support system that distinguishes between healthy subjects, type 1 diabetes mellitus patients, and type 1 diabetes mellitus patients with complications. It leverages on dual channel data computed from the physical state of human red blood cells membranes by means of features based on first- and second-order statistical measures as well as on rotation invariant co-occurrence local binary patterns. The experiments were carried out on a dataset of more than 1000 images belonging to 27 subjects.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our method shows a global accuracy of 100%, outperforming also the state-of-the-art approach based on the glycosylated hemoglobin.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The proposed recognition approach permits to achieve promising results.</AbstractText><CopyrightInformation>Copyright .. 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cordelli</LastName><ForeName>Ermanno</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit of Computer Systems and Bioinformatics, Department of Engineering, Universit.. Campus Bio-Medico di Roma, Rome, Italy. Electronic address: e.cordelli@unicampus.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maulucci</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Istituto di Fisica, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Spirito</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Istituto di Fisica, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Istituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pitocco</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Istituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soda</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unit of Computer Systems and Bioinformatics, Department of Engineering, Universit.. Campus Bio-Medico di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Comput Methods Programs Biomed</MedlineTA><NlmUniqueID>8506513</NlmUniqueID><ISSNLinking>0169-2607</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="Y">Diagnosis, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004910" MajorTopicYN="N">Erythrocyte Membrane</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004912" MajorTopicYN="N">Erythrocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008560" MajorTopicYN="Y">Membrane Fluidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Feature extraction</Keyword><Keyword MajorTopicYN="N">Image processing</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Two-photon microscopy</Keyword><Keyword MajorTopicYN="N">Type 1 Diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>04</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>05</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29903493</ArticleId><ArticleId IdType="pii">S0169-2607(17)31207-5</ArticleId><ArticleId IdType="doi">10.1016/j.cmpb.2018.05.025</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29493356</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>03</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>A Neural-Network-Based Approach to Personalize Insulin Bolus Calculation Using Continuous Glucose Monitoring.</ArticleTitle><Pagination><MedlinePgn>265-272</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1932296818759558</ELocationID><Abstract><AbstractText Label="BACKGROUND">In type 1 diabetes (T1D) therapy, the calculation of the meal insulin bolus is performed according to a standard formula (SF) exploiting carbohydrate intake, carbohydrate-to-insulin ratio, correction factor, insulin on board, and target glucose. Recently, some approaches were proposed to account for preprandial glucose rate of change (ROC) in the SF, including those by Scheiner and by Pettus and Edelman. Here, the aim is to develop a new approach, based on neural networks (NN), to optimize and personalize the bolus calculation using continuous glucose monitoring information and some easily accessible patient parameters.</AbstractText><AbstractText Label="METHOD">The UVa/Padova T1D Simulator was used to simulate data of 100 virtual adults in a single-meal noise-free scenario with different conditions in terms of meal amount and preprandial blood glucose and ROC values. An NN was trained to learn the optimal insulin dose using the SF parameters, ROC, body weight, insulin pump basal infusion rate and insulin sensitivity as features. The performance of the NN for meal bolus calculation was assessed by blood glucose risk index (BGRI) and compared to the methods by Scheiner and by Pettus and Edelman.</AbstractText><AbstractText Label="RESULTS">The NN approach brings to a small but statistically significant ( P &lt; .001) reduction of BGRI value, equal to 0.37, 0.23, and 0.20 versus SF, Scheiner, and Pettus and Edelman, respectively.</AbstractText><AbstractText Label="CONCLUSION">This preliminary study showed the potentiality of using NNs for the personalization and optimization of the meal insulin bolus calculation. Future work will deal with more realistic scenarios including technological and physiological/behavioral sources of variability.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cappon</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-4358-9268</Identifier><AffiliationInfo><Affiliation>1 Department of Information Engineering, University of Padova, Padova, PD, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vettoretti</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1 Department of Information Engineering, University of Padova, Padova, PD, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marturano</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>1 Department of Information Engineering, University of Padova, Padova, PD, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Facchinetti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1 Department of Information Engineering, University of Padova, Padova, PD, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sparacino</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>1 Department of Information Engineering, University of Padova, Padova, PD, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">bolus calculator</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">neural network</Keyword><Keyword MajorTopicYN="Y">nonadjunctive use</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29493356</ArticleId><ArticleId IdType="doi">10.1177/1932296818759558</ArticleId><ArticleId IdType="pmc">PMC5851237</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Diabetes Sci Technol. 2014 Jan 1;8(1):26-34</Citation><ArticleIdList><ArticleId IdType="pubmed">24876534</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Jul;11(4):724-735</Citation><ArticleIdList><ArticleId IdType="pubmed">28299958</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2016 Aug;18(8):472-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27512826</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2003;5(3):365-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12828818</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2017 Aug 29;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">28866479</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2015 Jan;17(1):1-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25531427</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2015 Dec;53(12):1259-69</Citation><ArticleIdList><ArticleId IdType="pubmed">25416850</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Jan;40(Suppl 1):S11-S24</Citation><ArticleIdList><ArticleId IdType="pubmed">27979889</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Mar;9(2):209-14</Citation><ArticleIdList><ArticleId IdType="pubmed">25370149</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Jan 01;4(1):132-44</Citation><ArticleIdList><ArticleId IdType="pubmed">20167177</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Aug 14;10 (1):50-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26275643</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2014 May;16(5):277-83</Citation><ArticleIdList><ArticleId IdType="pubmed">24758729</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Rev Biomed Eng. 2009 Jan 1;2:54-96</Citation><ArticleIdList><ArticleId IdType="pubmed">20936056</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Jan;11(1):160-164</Citation><ArticleIdList><ArticleId IdType="pubmed">27630249</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 Sep 01;6(5):990-4</Citation><ArticleIdList><ArticleId IdType="pubmed">23063023</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2018 Mar;65(3):587-595</Citation><ArticleIdList><ArticleId IdType="pubmed">28541194</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Meas. 2004 Aug;25(4):905-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15382830</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Sep 01;3(5):1047-57</Citation><ArticleIdList><ArticleId IdType="pubmed">20144418</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Jan;11(1):138-147</Citation><ArticleIdList><ArticleId IdType="pubmed">27530720</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2016 Dec 09;16(12 ):</Citation><ArticleIdList><ArticleId IdType="pubmed">27941663</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Pract. 2008 Dec;14(9):1095-101</Citation><ArticleIdList><ArticleId IdType="pubmed">19158048</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Sep;8(5):1035-41</Citation><ArticleIdList><ArticleId IdType="pubmed">24876436</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Jan;3(1):44-55</Citation><ArticleIdList><ArticleId IdType="pubmed">19444330</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2016 Nov;18(11):694-704</Citation><ArticleIdList><ArticleId IdType="pubmed">27860496</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28880900</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Phase separation of the plasma membrane in human red blood cells as a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus.</ArticleTitle><Pagination><MedlinePgn>e0184109</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0184109</ELocationID><Abstract><AbstractText>Glycosylation, oxidation and other post-translational modifications of membrane and transmembrane proteins can alter lipid density, packing and interactions, and are considered an important factor that affects fluidity variation in membranes. Red blood cells (RBC) membrane physical state, showing pronounced alterations in Type 1 diabetes mellitus (T1DM), could be the ideal candidate for monitoring the disease progression and the effects of therapies. On these grounds, the measurement of RBC membrane fluidity alterations can furnish a more sensitive index in T1DM diagnosis and disease progression than Glycosylated hemoglobin (HbA1c), which reflects only the information related to glycosylation processes. Here, through a functional two-photon microscopy approach we retrieved fluidity maps at submicrometric scale in RBC of T1DM patients with and without complications, detecting an altered membrane equilibrium. We found that a phase separation between fluid and rigid domains occurs, triggered by systemic effects on membranes fluidity of glycation and oxidation. The phase separation patterns are different among healthy, T1DM and T1DM with complications patients. Blood cholesterol and LDL content are positively correlated with the extent of the phase separation patterns. To quantify this extent a machine learning approach is employed to develop a Decision-Support-System (DSS) able to recognize different fluidity patterns in RBC. Preliminary analysis shows significant differences(p&lt;0.001) among healthy, T1DM and T1DM with complications patients. The development of an assay based on Phase separation of the plasma membrane of the Red Blood cells is a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus, and could allow customization and the selection of medical treatments in T1DM in clinical settings, and enable the early detection of complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maulucci</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2154-319X</Identifier><AffiliationInfo><Affiliation>Istituto di Fisica, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cordelli</LastName><ForeName>Ermanno</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit.. di Sistemi di elaborazione e bioinformatica, Facolt.. dipartimentale di Ingegneria, Universit.. Campus Bio-Medico, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Istituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Leva</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Istituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papi</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Istituto di Fisica, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciasca</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Istituto di Fisica, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samengo</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Istituto di Patologia, Universit.. Cattolica del Sacro Cuore Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pani</LastName><ForeName>Giovambattista</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Istituto di Patologia, Universit.. Cattolica del Sacro Cuore Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pitocco</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Istituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soda</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unit.. di Sistemi di elaborazione e bioinformatica, Facolt.. dipartimentale di Ingegneria, Universit.. Campus Bio-Medico, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghirlanda</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Istituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iannello</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit.. di Sistemi di elaborazione e bioinformatica, Facolt.. dipartimentale di Ingegneria, Universit.. Campus Bio-Medico, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Spirito</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Istituto di Fisica, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008077">Lipoproteins, LDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="N">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019937" MajorTopicYN="Y">Diagnostic Techniques and Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004910" MajorTopicYN="N">Erythrocyte Membrane</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006031" MajorTopicYN="N">Glycosylation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008077" MajorTopicYN="N">Lipoproteins, LDL</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008560" MajorTopicYN="N">Membrane Fluidity</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021962" MajorTopicYN="N">Membrane Microdomains</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28880900</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0184109</ArticleId><ArticleId IdType="pii">PONE-D-17-22847</ArticleId><ArticleId IdType="pmc">PMC5589169</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS One. 2009;4(2):e4412</Citation><ArticleIdList><ArticleId IdType="pubmed">19209233</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1995 Aug;44(8):968-83</Citation><ArticleIdList><ArticleId IdType="pubmed">7622004</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Aspects Med. 2016 Jun;49:49-77</Citation><ArticleIdList><ArticleId IdType="pubmed">27012748</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Signal. 2008 Oct 28;1(43):pl3</Citation><ArticleIdList><ArticleId IdType="pubmed">18957692</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanoscale. 2015 Oct 28;7(40):17030-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26415744</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Intern Med. 2014 Feb;29(2):388-94</Citation><ArticleIdList><ArticleId IdType="pubmed">24002631</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Med Sci. 2012 May-Jun;66(5-6):131-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23806986</ArticleId></ArticleIdList></Reference><Reference><Citation>Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1460-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22499994</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 1988 Dec;67(6):1129-33</Citation><ArticleIdList><ArticleId IdType="pubmed">2848052</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2014 Jul;1840(7):2192-202</Citation><ArticleIdList><ArticleId IdType="pubmed">24735797</ArticleId></ArticleIdList></Reference><Reference><Citation>Biophys J. 2013 Mar 19;104(6):1238-47</Citation><ArticleIdList><ArticleId IdType="pubmed">23528083</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1983 Jun 10;258(11):6920-6</Citation><ArticleIdList><ArticleId IdType="pubmed">6853509</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(6):e21182</Citation><ArticleIdList><ArticleId IdType="pubmed">21698159</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Feb;38(2):308-15</Citation><ArticleIdList><ArticleId IdType="pubmed">25510400</ArticleId></ArticleIdList></Reference><Reference><Citation>Free Radic Res. 2016 Nov;50(sup1):S40-S50</Citation><ArticleIdList><ArticleId IdType="pubmed">27593084</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9441-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7937786</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Intern Med. 2013 Sep;28 Suppl 3:S660-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23797912</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H786-93</Citation><ArticleIdList><ArticleId IdType="pubmed">18586889</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Mol Cell Biol. 2008 Feb;9(2):112-24</Citation><ArticleIdList><ArticleId IdType="pubmed">18216768</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Cancer. 2015 May 12;112(10):1675-86</Citation><ArticleIdList><ArticleId IdType="pubmed">25880005</ArticleId></ArticleIdList></Reference><Reference><Citation>Biophys J. 2007 Dec 15;93(12):4225-36</Citation><ArticleIdList><ArticleId IdType="pubmed">17766354</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2008 Aug;31(8):1473-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18540046</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2013 Feb;1828(2):357-64</Citation><ArticleIdList><ArticleId IdType="pubmed">22940500</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2003 Mar 10;1610(2):198-207</Citation><ArticleIdList><ArticleId IdType="pubmed">12648774</ArticleId></ArticleIdList></Reference><Reference><Citation>Free Radic Res. 2010 Oct;44(10):1125-71</Citation><ArticleIdList><ArticleId IdType="pubmed">20836660</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Inf Technol Biomed. 2009 May;13(3):322-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19171521</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1980 Feb;77(2):915-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6987672</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Phys Lipids. 1987 Jul-Sep;44(2-4):175-89</Citation><ArticleIdList><ArticleId IdType="pubmed">3311416</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Biochem. 1992 Feb;25(1):41-6</Citation><ArticleIdList><ArticleId IdType="pubmed">1312917</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Phys Lipids. 2009 Jan;157(1):1-11</Citation><ArticleIdList><ArticleId IdType="pubmed">18977338</ArticleId></ArticleIdList></Reference><Reference><Citation>Free Radic Biol Med. 2013 Dec;65:978-87</Citation><ArticleIdList><ArticleId IdType="pubmed">23973638</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1996 Oct;45(10):1289-98</Citation><ArticleIdList><ArticleId IdType="pubmed">8826962</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Clin Biochem. 2008 Jul;23(3):223-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23105758</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28812204</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1539-0829</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>10</Issue><PubDate><Year>2017</Year><Month>08</Month><Day>15</Day></PubDate></JournalIssue><Title>Current diabetes reports</Title><ISOAbbreviation>Curr Diab Rep</ISOAbbreviation></Journal><ArticleTitle>Multivariable Adaptive Artificial Pancreas System in Type 1 Diabetes.</ArticleTitle><Pagination><MedlinePgn>88</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11892-017-0920-1</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">The review summarizes the current state of the artificial pancreas (AP) systems and introduces various new modules that should be included in future AP systems.</AbstractText><AbstractText Label="RECENT FINDINGS">A fully automated AP must be able to detect and mitigate the effects of meals, exercise, stress and sleep on blood glucose concentrations. This can only be achieved by using a multivariable approach that leverages information from wearable devices that provide real-time streaming data about various physiological variables that indicate imminent changes in blood glucose concentrations caused by meals, exercise, stress and sleep. The development of a fully automated AP will necessitate the design of multivariable and adaptive systems that use information from wearable devices in addition to glucose sensors and modify the models used in their model-predictive alarm and control systems to adapt to the changes in the metabolic state of the user. These AP systems will also integrate modules for controller performance assessment, fault detection and diagnosis, machine learning and classification to interpret various signals and achieve fault-tolerant control. Advances in wearable devices, computational power, and safe and secure communications are enabling the development of fully automated multivariable AP systems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cinar</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biological Engineering and Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA. cinar@iit.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP3 DK101075</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP3 DK101077</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Diab Rep</MedlineTA><NlmUniqueID>101093791</NlmUniqueID><ISSNLinking>1534-4827</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062407" MajorTopicYN="N">Meals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019397" MajorTopicYN="Y">Pancreas, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013312" MajorTopicYN="N">Stress, Physiological</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Adaptive control</Keyword><Keyword MajorTopicYN="Y">Artificial pancreas</Keyword><Keyword MajorTopicYN="Y">Multivariable data interpretation</Keyword><Keyword MajorTopicYN="Y">Type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28812204</ArticleId><ArticleId IdType="doi">10.1007/s11892-017-0920-1</ArticleId><ArticleId IdType="pii">10.1007/s11892-017-0920-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Technol Ther. 2009 Apr;11(4):207-10</Citation><ArticleIdList><ArticleId IdType="pubmed">19344194</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2015 Jan;3(1):17-26</Citation><ArticleIdList><ArticleId IdType="pubmed">25434967</ArticleId></ArticleIdList></Reference><Reference><Citation>J Process Control. 2008;18(3-4):258-265</Citation><ArticleIdList><ArticleId IdType="pubmed">18709180</ArticleId></ArticleIdList></Reference><Reference><Citation>Automatica (Oxf). 2016 Sep;71:237-246</Citation><ArticleIdList><ArticleId IdType="pubmed">27695131</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychosom Med. 1993 Jul-Aug;55(4):380-93</Citation><ArticleIdList><ArticleId IdType="pubmed">8105502</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2017 Jun;18(4):262-270</Citation><ArticleIdList><ArticleId IdType="pubmed">27028035</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 Nov;33(11):e142</Citation><ArticleIdList><ArticleId IdType="pubmed">20980421</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2011 Nov 01;5(6):1352-62</Citation><ArticleIdList><ArticleId IdType="pubmed">22226252</ArticleId></ArticleIdList></Reference><Reference><Citation>J Behav Ther Exp Psychiatry. 2008 Mar;39(1):87-98</Citation><ArticleIdList><ArticleId IdType="pubmed">17466262</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2014 Nov;16(11):728-34</Citation><ArticleIdList><ArticleId IdType="pubmed">25259939</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2008 Jun;31(6):1183-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18299444</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Oct 01;9(6):1217-26</Citation><ArticleIdList><ArticleId IdType="pubmed">26428933</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2016 Mar;4(3):233-43</Citation><ArticleIdList><ArticleId IdType="pubmed">26850709</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Jul;39(7):1151-60</Citation><ArticleIdList><ArticleId IdType="pubmed">27208331</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Jul;38(7):1205-11</Citation><ArticleIdList><ArticleId IdType="pubmed">26049550</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Oct 18;9(6):1208-16</Citation><ArticleIdList><ArticleId IdType="pubmed">26481641</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2012 Sep;61(9):2230-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22688340</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Jul;38(7):1197-204</Citation><ArticleIdList><ArticleId IdType="pubmed">26049549</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2017 May;5(5):377-390</Citation><ArticleIdList><ArticleId IdType="pubmed">28126459</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Sep 01;3(5):1091-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20144422</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Jun;38(6):1036-43</Citation><ArticleIdList><ArticleId IdType="pubmed">25998296</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2015 Dec;3(12):939-47</Citation><ArticleIdList><ArticleId IdType="pubmed">26432775</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 May 03;10 (3):640-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26969142</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Signal. 2012 Oct 23;5(247):pt10</Citation><ArticleIdList><ArticleId IdType="pubmed">23092890</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2015 Nov 26;373(22):2129-2140</Citation><ArticleIdList><ArticleId IdType="pubmed">26379095</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 May;33(5):1013-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20200307</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Sports Med Rep. 2017 Jan/Feb;16(1):38-44</Citation><ArticleIdList><ArticleId IdType="pubmed">28067740</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Diab Rep. 2016 Aug;16(8):67</Citation><ArticleIdList><ArticleId IdType="pubmed">27287017</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Psychol Behav Med. 2016 Jan 1;4(1):49-55</Citation><ArticleIdList><ArticleId IdType="pubmed">27081578</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Jul;8(4):731-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24876412</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Jul 24;371(4):313-325</Citation><ArticleIdList><ArticleId IdType="pubmed">24931572</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2017 May 23;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">28541890</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Psychol. 1990;9(5):503-15</Citation><ArticleIdList><ArticleId IdType="pubmed">2226381</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2008 May;31(5):934-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18252903</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 Nov 1;10 (6):1236-1244</Citation><ArticleIdList><ArticleId IdType="pubmed">27464755</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 May;15(5):386-400</Citation><ArticleIdList><ArticleId IdType="pubmed">23544672</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleep. 2012 Jan 01;35(1):81-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22215921</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2009 Apr;11(4):243-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19344199</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2011 Sep 01;5(5):1137-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22027306</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Diab Rep. 2015 Jan;15(1):562</Citation><ArticleIdList><ArticleId IdType="pubmed">25398202</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Oct 05;9(6):1175-84</Citation><ArticleIdList><ArticleId IdType="pubmed">26438720</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Psychol. 2016 Jul;41(6):661-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26994852</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2017 Jan 11;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">28092515</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Sportsmed. 1981 Jan;9(1):44-60</Citation><ArticleIdList><ArticleId IdType="pubmed">27462744</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Feb 27;375(9716):743-51</Citation><ArticleIdList><ArticleId IdType="pubmed">20138357</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Nov;38(11):2115-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26341131</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1224-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24757229</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Psychol. 1990;9(5):516-28</Citation><ArticleIdList><ArticleId IdType="pubmed">2226382</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 May;8(3):498-507</Citation><ArticleIdList><ArticleId IdType="pubmed">24876613</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Jul;39(7):1180-5</Citation><ArticleIdList><ArticleId IdType="pubmed">27208335</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2004 Dec;66(3):237-44</Citation><ArticleIdList><ArticleId IdType="pubmed">15536020</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Jul;39(7):1135-42</Citation><ArticleIdList><ArticleId IdType="pubmed">27289127</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Jul;39(7):1143-50</Citation><ArticleIdList><ArticleId IdType="pubmed">27208316</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jun 30;9(6):1236-45</Citation><ArticleIdList><ArticleId IdType="pubmed">26134831</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2012 Apr;35(4):669-75</Citation><ArticleIdList><ArticleId IdType="pubmed">22374639</ArticleId></ArticleIdList></Reference><Reference><Citation>Ind Eng Chem Res. 2013 Sep 4;52(35):null</Citation><ArticleIdList><ArticleId IdType="pubmed">24187436</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Sep 01;3(5):1224-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20144441</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2016 Jan;20(1):47-54</Citation><ArticleIdList><ArticleId IdType="pubmed">26087510</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2011 May 01;5(3):804-26</Citation><ArticleIdList><ArticleId IdType="pubmed">21722597</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 Sep 01;7(5):1337-45</Citation><ArticleIdList><ArticleId IdType="pubmed">24124962</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2005 Aug;28(8):1910-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16043731</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Sep 14;9(6):1253-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26370244</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2017 May;21(3):619-627</Citation><ArticleIdList><ArticleId IdType="pubmed">28278487</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2014 Aug;16(8):506-11</Citation><ArticleIdList><ArticleId IdType="pubmed">24702135</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2014 Mar;15(2):91-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23944875</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 May;9(3):609-18</Citation><ArticleIdList><ArticleId IdType="pubmed">25568144</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Res Nurs. 2012 Jan;14(1):48-54</Citation><ArticleIdList><ArticleId IdType="pubmed">21278167</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychoneuroendocrinology. 2006 Feb;31(2):151-78</Citation><ArticleIdList><ArticleId IdType="pubmed">16139959</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2015 May;17(5):468-76</Citation><ArticleIdList><ArticleId IdType="pubmed">25600304</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Psychol. 2015 May;34(5):522-30</Citation><ArticleIdList><ArticleId IdType="pubmed">25798545</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 1994 Mar;37(3):247-51</Citation><ArticleIdList><ArticleId IdType="pubmed">8174837</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Sep 01;3(5):1031-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20144416</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2015 Aug;3(8):595-604</Citation><ArticleIdList><ArticleId IdType="pubmed">26066705</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Psychol. 1986;5(5):439-52</Citation><ArticleIdList><ArticleId IdType="pubmed">3757992</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Nov 17;10 (2):405-13</Citation><ArticleIdList><ArticleId IdType="pubmed">26581881</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 May 03;10 (3):762-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26630914</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jan;9(1):80-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25231116</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2008 Dec;51(12):2168-78</Citation><ArticleIdList><ArticleId IdType="pubmed">18806995</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1184-90</Citation><ArticleIdList><ArticleId IdType="pubmed">24757225</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Oct 18;9(6):1185-91</Citation><ArticleIdList><ArticleId IdType="pubmed">26481644</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2012 Nov;97(11):4193-200</Citation><ArticleIdList><ArticleId IdType="pubmed">22962428</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2017 Apr;5(4):261-270</Citation><ArticleIdList><ArticleId IdType="pubmed">28094136</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2014 Mar;61(3):883-91</Citation><ArticleIdList><ArticleId IdType="pubmed">24557689</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1974 May;23(5):389-96</Citation><ArticleIdList><ArticleId IdType="pubmed">4598089</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2011 May;96(5):1402-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21367930</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Nov;8(6):1091-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25316716</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(3):773-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24170766</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28791547</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1573-689X</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of medical systems</Title><ISOAbbreviation>J Med Syst</ISOAbbreviation></Journal><ArticleTitle>Data Based Prediction of Blood Glucose Concentrations Using Evolutionary Methods.</ArticleTitle><Pagination><MedlinePgn>142</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10916-017-0788-2</ELocationID><Abstract><AbstractText>Predicting glucose values on the basis of insulin and food intakes is a difficult task that people with diabetes need to do daily. This is necessary as it is important to maintain glucose levels at appropriate values to avoid not only short-term, but also long-term complications of the illness. Artificial intelligence in general and machine learning techniques in particular have already lead to promising results in modeling and predicting glucose concentrations. In this work, several machine learning techniques are used for the modeling and prediction of glucose concentrations using as inputs the values measured by a continuous monitoring glucose system as well as also previous and estimated future carbohydrate intakes and insulin injections. In particular, we use the following four techniques: genetic programming, random forests, k-nearest neighbors, and grammatical evolution. We propose two new enhanced modeling algorithms for glucose prediction, namely (i) a variant of grammatical evolution which uses an optimized grammar, and (ii) a variant of tree-based genetic programming which uses a three-compartment model for carbohydrate and insulin dynamics. The predictors were trained and tested using data of ten patients from a public hospital in Spain. We analyze our experimental results using the Clarke error grid metric and see that 90% of the forecasts are correct (i.e., Clarke error categories A and B), but still even the best methods produce 5 to 10% of serious errors (category D) and approximately 0.5% of very serious errors (category E). We also propose an enhanced genetic programming algorithm that incorporates a three-compartment model into symbolic regression models to create smoothed time series of the original carbohydrate and insulin time series.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hidalgo</LastName><ForeName>J Ignacio</ForeName><Initials>JI</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-3046-6368</Identifier><AffiliationInfo><Affiliation>Adaptive and Bioinspired System Group, School of Informatics, Universidad Complutense de Madrid, C/ Profesor Jos.. Garc..a Santesmases 9, 28040, Madrid, Spain. hidalgo@ucm.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colmenar</LastName><ForeName>J Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Universidad Rey Juan Carlos, C/ Tulip..n s/n, 28933, M..stoles, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kronberger</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Heuristic and Evolutionary Algorithms Laboratory, University of Applied Sciences Upper Austria, Softwarepark 11, 4232, Hagenberg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkler</LastName><ForeName>Stephan M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Heuristic and Evolutionary Algorithms Laboratory, University of Applied Sciences Upper Austria, Softwarepark 11, 4232, Hagenberg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garnica</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Adaptive and Bioinspired System Group, School of Informatics, Universidad Complutense de Madrid, C/ Profesor Jos.. Garc..a Santesmases 9, 28040, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanchares</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Adaptive and Bioinspired System Group, School of Informatics, Universidad Complutense de Madrid, C/ Profesor Jos.. Garc..a Santesmases 9, 28040, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Syst</MedlineTA><NlmUniqueID>7806056</NlmUniqueID><ISSNLinking>0148-5598</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Continuos glucose monitoring</Keyword><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">Evolutionary computation</Keyword><Keyword MajorTopicYN="N">Glucose prediction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>07</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28791547</ArticleId><ArticleId IdType="doi">10.1007/s10916-017-0788-2</ArticleId><ArticleId IdType="pii">10.1007/s10916-017-0788-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Care. 1987 Sep-Oct;10(5):622-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3677983</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2011 Nov;60(11):2672-82</Citation><ArticleIdList><ArticleId IdType="pubmed">22025773</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2009 Feb;56(2):246-54</Citation><ArticleIdList><ArticleId IdType="pubmed">19272928</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Drug Deliv. 2011 Oct;8(10):1395-406</Citation><ArticleIdList><ArticleId IdType="pubmed">21864222</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2003 Apr;26(4):1079-87</Citation><ArticleIdList><ArticleId IdType="pubmed">12663577</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2005 Jan;52(1):3-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15651559</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 May 01;6(3):617-33</Citation><ArticleIdList><ArticleId IdType="pubmed">22768893</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Rev Biomed Eng. 2009 Jan 1;2:54-96</Citation><ArticleIdList><ArticleId IdType="pubmed">20936056</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2014 May;61(5):1577-92</Citation><ArticleIdList><ArticleId IdType="pubmed">24759285</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):null</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2013 Dec;15(12):1065-70</Citation><ArticleIdList><ArticleId IdType="pubmed">23602044</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Apr 13;342:d1855</Citation><ArticleIdList><ArticleId IdType="pubmed">21493665</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 May;54(5):931-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17518291</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2000 Aug;23(8):1143-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10937512</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1191-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24757226</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28626972</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5448</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>03</Month></PubDate></JournalIssue><Title>Pediatric diabetes</Title><ISOAbbreviation>Pediatr Diabetes</ISOAbbreviation></Journal><ArticleTitle>NIRCa: An artificial neural network-based insulin resistance calculator.</ArticleTitle><Pagination><MedlinePgn>231-235</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pedi.12551</ELocationID><Abstract><AbstractText Label="BACKGROUND">Direct measurement of insulin sensitivity in children with type 1 diabetes is cumbersome and time consuming.</AbstractText><AbstractText Label="OBJECTIVE">The aim of our study was to develop novel, accurate machine learning-based methods of insulin resistance estimation in children with type 1 diabetes.</AbstractText><AbstractText Label="METHODS">A hyperinsulinemic hyperglycemic clamp study was performed to evaluate the glucose disposal rate (GDR) in a study group consisting of 315 patients aged 7.6 to 19.7 years. The group was randomly divided into a training and independent testing set for model performance assessment. GDR was estimated on the basis of simple clinical variables using 2 non-linear methods: artificial neural networks (ANN) and multivariate adaptive regression splines (MARSplines). The results were compared against the most frequently used predictive model, based on waist circumference, triglyceride (TG), and HbA1c levels.</AbstractText><AbstractText Label="RESULTS">The reference model showed moderate performance ( R <sup>2</sup> = 0.26) with a median absolute percentage error of 49.1%, and with the worst fit observed in young (7-12 years) children ( R <sup>2</sup> = 0.17). Predictions of the MARSplines model were significantly more accurate than those of the reference model (median error 3.6%, R <sup>2</sup> = 0.44 P &lt; .0001). The predictions of the ANN, however, showed significantly lower error than those of the reference model (P &lt; .0001) and MARSplines (P &lt; .0001) and better fit regardless of patient age. ANN-estimated GDRs were within a ..20% error range in 75% of cases with a median error of 0.6% and an R <sup>2</sup> = 0.66. The predictive tool is available at http://link.konsta.com.pl/gdr.</AbstractText><AbstractText Label="CONCLUSIONS">The developed GDR estimation model reliant on ANN allows for an optimized prediction of GDR for research and clinical purposes.</AbstractText><CopyrightInformation>.. 2017 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stawiski</LastName><ForeName>Konrad</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6550-3384</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pietrzak</LastName><ForeName>Iwona</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M..ynarski</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fendler</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-5083-9168</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szadkowska</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Pediatr Diabetes</MedlineTA><NlmUniqueID>100939345</NlmUniqueID><ISSNLinking>1399-543X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003925" MajorTopicYN="N">Diabetic Angiopathies</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015309" MajorTopicYN="N">Glucose Clamp Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007333" MajorTopicYN="Y">Insulin Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058246" MajorTopicYN="N">Prehypertension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011627" MajorTopicYN="N">Puberty</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">artificial neural networks</Keyword><Keyword MajorTopicYN="Y">biomedical statistics</Keyword><Keyword MajorTopicYN="Y">diabetes in childhood</Keyword><Keyword MajorTopicYN="Y">insulin sensitivity and resistance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>04</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>05</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>05</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28626972</ArticleId><ArticleId IdType="doi">10.1111/pedi.12551</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28569238</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1752-7163</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>06</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of breath research</Title><ISOAbbreviation>J Breath Res</ISOAbbreviation></Journal><ArticleTitle>Analyzing breath samples of hypoglycemic events in type 1 diabetes patients: towards developing an alternative to diabetes alert dogs.</ArticleTitle><Pagination><MedlinePgn>026007</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1088/1752-7163/aa6ac6</ELocationID><Abstract><AbstractText>Diabetes is a disease that involves dysregulation of metabolic processes. Patients with type 1 diabetes (T1D) require insulin injections and measured food intake to maintain clinical stability, manually tracking their results by measuring blood glucose levels. Low blood glucose levels, hypoglycemia, can be extremely dangerous and can result in seizures, coma, or even death. Canines trained as diabetes alert dogs (DADs) have demonstrated the ability to detect hypoglycemia from breath, which led us to hypothesize that hypoglycemia, a metabolic dysregulation leading to low blood glucose levels, could be identified through analyzing volatile organic compounds (VOCs) contained within breath. We hoped to replicate the canines' detection ability and success by analytically using gas chromatography/mass spectrometry of VOCs in 128 breath samples collected from 52 youths with T1D at two different diabetes camps. We used different tests for significance including Ranksum, Student's T-test, and difference between means, and found a subset of 56 traces of potential metabolites. Principle component and linear discriminant analysis (LDA) confirmed a hypoglycemic signature likely resides within this group. Supervised machine learning combined with LDA narrowed the list of likely components to seven. The technique of leave one out cross validation demonstrated the model thus developed has a sensitivity of 91% (95% confidence interval (CI) [57.1, 94.7]) and a specificity of 84% (95% CI [73.0, 92.7]) at identifying hypoglycemia. Confidence intervals were obtained by bootstrapping. These results demonstrate that it is possible to differentiate breath samples obtained during hypoglycemic events from all other breath samples by analytical means and could lead to developing a simple analytical monitoring device as an alternative to using DADs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Siegel</LastName><ForeName>Amanda P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Integrated Nanosystems Development Institute, Indiana University-Purdue University Indianapolis, IN, United States of America. Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, IN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daneshkhah</LastName><ForeName>Ali</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hardin</LastName><ForeName>Dana S</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Shrestha</LastName><ForeName>Sudhir</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Varahramyan</LastName><ForeName>Kody</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Mangilal</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Breath Res</MedlineTA><NlmUniqueID>101463871</NlmUniqueID><ISSNLinking>1752-7155</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055549">Volatile Organic Compounds</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001944" MajorTopicYN="N">Breath Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016002" MajorTopicYN="N">Discriminant Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008401" MajorTopicYN="N">Gas Chromatography-Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013048" MajorTopicYN="N">Specimen Handling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055549" MajorTopicYN="N">Volatile Organic Compounds</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28569238</ArticleId><ArticleId IdType="doi">10.1088/1752-7163/aa6ac6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27660190</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>11</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>Glycemic Control Indices and Their Aggregation in the Prediction of Nocturnal Hypoglycemia From Intermittent Blood Glucose Measurements.</ArticleTitle><Pagination><MedlinePgn>1245-1250</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND">Despite the risk associated with nocturnal hypoglycemia (NH) there are only a few methods aiming at the prediction of such events based on intermittent blood glucose monitoring data. One of the first methods that potentially can be used for NH prediction is based on the low blood glucose index (LBGI) and suggested, for example, in Accu-Chek.. Connect as a hypoglycemia risk indicator. On the other hand, nowadays there are other glucose control indices (GCI), which could be used for NH prediction in the same spirit as LBGI. In the present study we propose a general approach of combining NH predictors constructed from different GCI.</AbstractText><AbstractText Label="METHODS">The approach is based on a recently developed strategy for aggregating ranking algorithms in machine learning. NH predictors have been calibrated and tested on data extracted from clinical trials, performed in EU FP7-funded project DIAdvisor. Then, to show a portability of the method we have tested it on another dataset that was received from EU Horizon 2020-funded project AMMODIT.</AbstractText><AbstractText Label="RESULTS">We exemplify the proposed approach by aggregating NH predictors that have been constructed based on 4 GCI associated with hypoglycemia. Even though these predictors have been preliminary optimized to exhibit better performance on the considered dataset, our aggregation approach allows a further performance improvement. On the dataset, where a portability of the proposed approach has been demonstrated, the aggregating predictor has exhibited the following performance: sensitivity 77%, specificity 83.4%, positive predictive value 80.2%, negative predictive value 80.6%, which is higher than conventionally considered as acceptable.</AbstractText><AbstractText Label="CONCLUSION">The proposed approach shows potential to be used in telemedicine systems for NH prediction.</AbstractText><CopyrightInformation>.. 2016 Diabetes Technology Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sampath</LastName><ForeName>Sivananthan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Indian Institute of Technology Delhi, New Delhi, India siva@maths.iitd.ac.in.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tkachenko</LastName><ForeName>Pavlo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Johann Radon Institute for Computational and Applied Mathematics (RICAM), Austrian Academy of Sciences, Linz, Wien, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renard</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes, Nutrition, and CIC INSERM 1411, Montpellier University Hospital, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Functional Genomics, UMR CNRS 5203/INSERM U1191, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereverzev</LastName><ForeName>Sergei V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Johann Radon Institute for Computational and Applied Mathematics (RICAM), Austrian Academy of Sciences, Linz, Wien, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">aggregation</Keyword><Keyword MajorTopicYN="Y">prediction from glycemic control indices</Keyword><Keyword MajorTopicYN="Y">prediction of nocturnal hypoglycemia</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27660190</ArticleId><ArticleId IdType="pii">1932296816670400</ArticleId><ArticleId IdType="doi">10.1177/1932296816670400</ArticleId><ArticleId IdType="pmc">PMC5094347</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Technol Ther. 2009 Jun;11 Suppl 1:S55-67</Citation><ArticleIdList><ArticleId IdType="pubmed">19469679</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 1987 Oct;62(10):1085</Citation><ArticleIdList><ArticleId IdType="pubmed">3674930</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2007 Jun;30(6):1370-3</Citation><ArticleIdList><ArticleId IdType="pubmed">17363757</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Jan 01;4(1):67-74</Citation><ArticleIdList><ArticleId IdType="pubmed">20167169</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Netw. 2016 Jan;73:26-35</Citation><ArticleIdList><ArticleId IdType="pubmed">26519932</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 1987 Apr;62(4):333-7</Citation><ArticleIdList><ArticleId IdType="pubmed">3296962</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2016 Oct;134:179-86</Citation><ArticleIdList><ArticleId IdType="pubmed">27480742</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1998 Nov;21(11):1870-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9802735</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Nov;8(6):1091-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25316716</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27441367</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>7</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Model-Free Machine Learning in Biomedicine: Feasibility Study in Type 1 Diabetes.</ArticleTitle><Pagination><MedlinePgn>e0158722</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0158722</ELocationID><Abstract><AbstractText>Although reinforcement learning (RL) is suitable for highly uncertain systems, the applicability of this class of algorithms to medical treatment may be limited by the patient variability which dictates individualised tuning for their usually multiple algorithmic parameters. This study explores the feasibility of RL in the framework of artificial pancreas development for type 1 diabetes (T1D). In this approach, an Actor-Critic (AC) learning algorithm is designed and developed for the optimisation of insulin infusion for personalised glucose regulation. AC optimises the daily basal insulin rate and insulin:carbohydrate ratio for each patient, on the basis of his/her measured glucose profile. Automatic, personalised tuning of AC is based on the estimation of information transfer (IT) from insulin to glucose signals. Insulin-to-glucose IT is linked to patient-specific characteristics related to total daily insulin needs and insulin sensitivity (SI). The AC algorithm is evaluated using an FDA-accepted T1D simulator on a large patient database under a complex meal protocol, meal uncertainty and diurnal SI variation. The results showed that 95.66% of time was spent in normoglycaemia in the presence of meal uncertainty and 93.02% when meal uncertainty and SI variation were simultaneously considered. The time spent in hypoglycaemia was 0.27% in both cases. The novel tuning method reduced the risk of severe hypoglycaemia, especially in patients with low SI. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Daskalaki</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Diabetes Technology Research Group, ARTORG Center for Biomedical Engineering Research, University of Bern, Murtenstrasse 50, 3008 Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diem</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital "Inselspital", 3010 Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mougiakakou</LastName><ForeName>Stavroula G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Diabetes Technology Research Group, ARTORG Center for Biomedical Engineering Research, University of Bern, Murtenstrasse 50, 3008 Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital "Inselspital", 3010 Bern, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006943" MajorTopicYN="N">Hyperglycemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>09</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>06</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27441367</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0158722</ArticleId><ArticleId IdType="pii">PONE-D-15-41463</ArticleId><ArticleId IdType="pmc">PMC4956312</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pac Symp Biocomput. 2000;:418-29</Citation><ArticleIdList><ArticleId IdType="pubmed">10902190</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Jan;3(1):44-55</Citation><ArticleIdList><ArticleId IdType="pubmed">19444330</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Mar 01;3(2):269-82</Citation><ArticleIdList><ArticleId IdType="pubmed">20144358</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Sep 01;3(5):1082-90</Citation><ArticleIdList><ArticleId IdType="pubmed">20144421</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Sep 01;4(5):1174-81</Citation><ArticleIdList><ArticleId IdType="pubmed">20920437</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2011 Mar 01;5(2):368-79</Citation><ArticleIdList><ArticleId IdType="pubmed">21527108</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2011 Oct;13(10):983-90</Citation><ArticleIdList><ArticleId IdType="pubmed">21774690</ArticleId></ArticleIdList></Reference><Reference><Citation>Mach Learn. 2011 Jul 1;84(1-2):109-136</Citation><ArticleIdList><ArticleId IdType="pubmed">21799585</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2012 Feb;14(2):168-74</Citation><ArticleIdList><ArticleId IdType="pubmed">21992270</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2013 Feb;109(2):116-25</Citation><ArticleIdList><ArticleId IdType="pubmed">22502983</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2013 Feb;36(2):222-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23033237</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Control. 2012 Dec;36(2):255-266</Citation><ArticleIdList><ArticleId IdType="pubmed">23175620</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2013 Apr;36(4):838-44</Citation><ArticleIdList><ArticleId IdType="pubmed">23193217</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Med Inform. 2014 Dec;83(12):983-92</Citation><ArticleIdList><ArticleId IdType="pubmed">23317809</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 May 31;8(5):e64925</Citation><ArticleIdList><ArticleId IdType="pubmed">23741425</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2014 Mar;15(2):91-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23944875</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Med Devices. 2013 Sep;10(5):661-73</Citation><ArticleIdList><ArticleId IdType="pubmed">23972072</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2013;2013:3487-90</Citation><ArticleIdList><ArticleId IdType="pubmed">24110480</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2013 Dec;36(12):3882-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24170747</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1216-23</Citation><ArticleIdList><ArticleId IdType="pubmed">24319120</ArticleId></ArticleIdList></Reference><Reference><Citation>J Healthc Eng. 2014;5(1):1-22</Citation><ArticleIdList><ArticleId IdType="pubmed">24691384</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1184-90</Citation><ArticleIdList><ArticleId IdType="pubmed">24757225</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1191-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24757226</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2014 Sep;16(9):550-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24801544</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2014 Oct;61(10):2569-81</Citation><ArticleIdList><ArticleId IdType="pubmed">24835122</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014 Jul;37(7):1789-96</Citation><ArticleIdList><ArticleId IdType="pubmed">24929429</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Jul 24;371(4):313-325</Citation><ArticleIdList><ArticleId IdType="pubmed">24931572</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2014 Sep;2(9):701-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24943065</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Pharmacol Sci. 2015 Feb;36(2):68-71</Citation><ArticleIdList><ArticleId IdType="pubmed">25479798</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat. 2015;4(1):59-68</Citation><ArticleIdList><ArticleId IdType="pubmed">25883393</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 May;9(3):549-55</Citation><ArticleIdList><ArticleId IdType="pubmed">25904142</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Inform. 2016 Jun;3(2):119-131</Citation><ArticleIdList><ArticleId IdType="pubmed">27747607</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1998 Nov;21(11):1870-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9802735</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">27080919</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1098-2272</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>Genetic epidemiology</Title><ISOAbbreviation>Genet Epidemiol</ISOAbbreviation></Journal><ArticleTitle>An Object-Oriented Regression for Building Disease Predictive Models with Multiallelic HLA Genes.</ArticleTitle><Pagination><MedlinePgn>315-32</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/gepi.21968</ELocationID><Abstract><AbstractText>Recent genome-wide association studies confirm that human leukocyte antigen (HLA) genes have the strongest associations with several autoimmune diseases, including type 1 diabetes (T1D), providing an impetus to reduce this genetic association to practice through an HLA-based disease predictive model. However, conventional model-building methods tend to be suboptimal when predictors are highly polymorphic with many rare alleles combined with complex patterns of sequence homology within and between genes. To circumvent this challenge, we describe an alternative methodology; treating complex genotypes of HLA genes as "objects" or "exemplars," one focuses on systemic associations of disease phenotype with "objects" via similarity measurements. Conceptually, this approach assigns disease risks base on complex genotype profiles instead of specific disease-associated genotypes or alleles. Effectively, it transforms large, discrete, and sparse HLA genotypes into a matrix of similarity-based covariates. By the Kernel representative theorem and machine learning techniques, it uses a penalized likelihood method to select disease-associated exemplars in building predictive models. To illustrate this methodology, we apply it to a T1D study with eight HLA genes (HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-DQA1, HLA-DQB1, HLA-DPA1, and HLA-DPB1) to build a predictive model. The resulted predictive model has an area under curve of 0.92 in the training set, and 0.89 in the validating set, indicating that this methodology is useful to build predictive models with complex HLA genotypes.</AbstractText><CopyrightInformation>.. 2016 WILEY PERIODICALS, INC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Lue Ping</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of Washington School of Public Health, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolouri</LastName><ForeName>Hamid</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bellevue High School, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geraghty</LastName><ForeName>Daniel E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lernmark</LastName><ForeName>..ke</ForeName><Initials>..</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University/CRC, Sk..ne University Hospital, Malm.., Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Better Diabetes Diagnosis Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK026190</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DK26190</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 DK053004</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK063861</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK063861</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DK63861</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Genet Epidemiol</MedlineTA><NlmUniqueID>8411723</NlmUniqueID><ISSNLinking>0741-0395</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="Y">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016013" MajorTopicYN="N">Likelihood Functions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008957" MajorTopicYN="Y">Models, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">generalized linear model</Keyword><Keyword MajorTopicYN="N">kernel machine</Keyword><Keyword MajorTopicYN="N">multiallelic genotypes</Keyword><Keyword MajorTopicYN="N">penalized regression</Keyword><Keyword MajorTopicYN="N">prediction</Keyword><Keyword MajorTopicYN="N">similarity regression</Keyword><Keyword MajorTopicYN="N">statistical learning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>02</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27080919</ArticleId><ArticleId IdType="doi">10.1002/gepi.21968</ArticleId><ArticleId IdType="pmc">PMC4834870</ArticleId><ArticleId IdType="mid">NIHMS766725</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes. 2016 Mar;65(3):710-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26740600</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2011 Mar;12(3):215-23</Citation><ArticleIdList><ArticleId IdType="pubmed">21301473</ArticleId></ArticleIdList></Reference><Reference><Citation>J Stat Softw. 2010;33(1):1-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>J R Stat Soc Series B Stat Methodol. 2012 Mar;74(2):245-266</Citation><ArticleIdList><ArticleId IdType="pubmed">25506256</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2010 Jun 11;86(6):929-42</Citation><ArticleIdList><ArticleId IdType="pubmed">20560208</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Bronconeumol. 2014 Oct;50(10):444-51</Citation><ArticleIdList><ArticleId IdType="pubmed">24397963</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2010 Dec;11(8):513-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20337975</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1997 Feb;60(2):397-407</Citation><ArticleIdList><ArticleId IdType="pubmed">9012413</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Stat Assoc. 2015 Apr 22;110(509):393-404</Citation><ArticleIdList><ArticleId IdType="pubmed">26236061</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 1986 Jul-Aug;5(4):291-302</Citation><ArticleIdList><ArticleId IdType="pubmed">3532271</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2008 Feb;82(2):386-97</Citation><ArticleIdList><ArticleId IdType="pubmed">18252219</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2006 Nov;79(5):792-806</Citation><ArticleIdList><ArticleId IdType="pubmed">17033957</ArticleId></ArticleIdList></Reference><Reference><Citation>Integr Cancer Ther. 2006 Dec;5(4):293-307</Citation><ArticleIdList><ArticleId IdType="pubmed">17101758</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2004 Feb;36(2):151-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14704667</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 2011 Apr;79(4):1401-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21321076</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 2009 Sep;65(3):822-32</Citation><ArticleIdList><ArticleId IdType="pubmed">19210740</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Nov;81(5):927-38</Citation><ArticleIdList><ArticleId IdType="pubmed">17924336</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2012 Oct;61(10):2556-64</Citation><ArticleIdList><ArticleId IdType="pubmed">22787139</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopathology. 2010;43(1):53-62</Citation><ArticleIdList><ArticleId IdType="pubmed">19940542</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Adh Migr. 2014;8(5):468-77</Citation><ArticleIdList><ArticleId IdType="pubmed">25482526</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2011 Jul 15;89(1):82-93</Citation><ArticleIdList><ArticleId IdType="pubmed">21737059</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):12-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21169219</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Bull. 1968 Oct;70(4):213-20</Citation><ArticleIdList><ArticleId IdType="pubmed">19673146</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1990 Feb;46(2):254-65</Citation><ArticleIdList><ArticleId IdType="pubmed">2301395</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2015 Nov;64:101-12</Citation><ArticleIdList><ArticleId IdType="pubmed">26272854</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">26736988</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2694-0604</ISSN><JournalIssue CitedMedium="Internet"><Volume>2015</Volume><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference</Title><ISOAbbreviation>Annu Int Conf IEEE Eng Med Biol Soc</ISOAbbreviation></Journal><ArticleTitle>Online prediction of glucose concentration in type 1 diabetes using extreme learning machines.</ArticleTitle><Pagination><MedlinePgn>3262-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/EMBC.2015.7319088</ELocationID><Abstract><AbstractText>We propose an online machine-learning solution to the problem of nonlinear glucose time series prediction in type 1 diabetes. Recently, extreme learning machine (ELM) has been proposed for training single hidden layer feed-forward neural networks. The high accuracy and fast learning speed of ELM drive us to investigate its applicability to the glucose prediction problem. Given that diabetes self-monitoring data are received sequentially, we focus on online sequential ELM (OS-ELM) and online sequential ELM kernels (KOS-ELM). A multivariate feature set is utilized concerning subcutaneous glucose, insulin therapy, carbohydrates intake and physical activity. The dataset comes from the continuous multi-day recordings of 15 type 1 patients in free-living conditions. Assuming stationarity and evaluating the performance of the proposed method by 10-fold cross- validation, KOS-ELM were found to perform better than OS-ELM in terms of prediction error, temporal gain and regularity of predictions for a 30-min prediction horizon. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Georga</LastName><ForeName>Eleni I</ForeName><Initials>EI</Initials></Author><Author ValidYN="Y"><LastName>Protopappas</LastName><ForeName>Vasilios C</ForeName><Initials>VC</Initials></Author><Author ValidYN="Y"><LastName>Polyzos</LastName><ForeName>Demosthenes</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Fotiadis</LastName><ForeName>Dimitrios I</ForeName><Initials>DI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Int Conf IEEE Eng Med Biol Soc</MedlineTA><NlmUniqueID>101763872</NlmUniqueID><ISSNLinking>2375-7477</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009862" MajorTopicYN="Y">Online Systems</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26736988</ArticleId><ArticleId IdType="doi">10.1109/EMBC.2015.7319088</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25953402</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-460X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of diabetes and its complications</Title><ISOAbbreviation>J Diabetes Complications</ISOAbbreviation></Journal><ArticleTitle>Realization of a service for the long-term risk assessment of diabetes-related complications.</ArticleTitle><Pagination><MedlinePgn>691-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jdiacomp.2015.03.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1056-8727(15)00107-5</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">We present a computerized system for the assessment of the long-term risk of developing diabetes-related complications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The core of the system consists of a set of predictive models, developed through a data-mining/machine-learning approach, which are able to evaluate individual patient profiles and provide personalized risk assessments. Missing data is a common issue in (electronic) patient records, thus the models are paired with a module for the intelligent management of missing information.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The system has been deployed and made publicly available as Web service, and it has been fully integrated within the diabetes-management platform developed by the European project REACTION. Preliminary usability tests showed that the clinicians judged the models useful for risk assessment and for communicating the risk to the patient. Furthermore, the system performs as well as the United Kingdom Prospective Diabetes Study (UKPDS) Risk Engine when both systems are tested on an independent cohort of UK diabetes patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our work provides a working example of risk-stratification tool that is (a) specific for diabetes patients, (b) able to handle several different diabetes related complications, (c) performing as well as the widely known UKPDS Risk Engine on an external validation cohort.</AbstractText><CopyrightInformation>Copyright .. 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lagani</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation for Research and Technology-Hellas, Heraklion, Greece. Electronic address: vlagani@ics.forth.gr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiarugi</LastName><ForeName>Franco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation for Research and Technology-Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manousos</LastName><ForeName>Dimitris</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation for Research and Technology-Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Vivek</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Information Systems, Computing and Mathematics, Brunel University, Uxbridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fursse</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Chorleywood Health Center, Chorleywood, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marias</LastName><ForeName>Kostas</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation for Research and Technology-Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsamardinos</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation for Research and Technology-Hellas, Heraklion, Greece; Department of Computer Science, University of Crete, Heraklion, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Complications</MedlineTA><NlmUniqueID>9204583</NlmUniqueID><ISSNLinking>1056-8727</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003658" MajorTopicYN="Y">Decision Making, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048909" MajorTopicYN="N">Diabetes Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="Y">Precision Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical decision support systems</Keyword><Keyword MajorTopicYN="N">DCCT / EDIC studies</Keyword><Keyword MajorTopicYN="N">Diabetes complications</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Risk assessment models</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>03</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>03</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25953402</ArticleId><ArticleId IdType="pii">S1056-8727(15)00107-5</ArticleId><ArticleId IdType="doi">10.1016/j.jdiacomp.2015.03.011</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25773366</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-0444</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>12</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Medical &amp; biological engineering &amp; computing</Title><ISOAbbreviation>Med Biol Eng Comput</ISOAbbreviation></Journal><ArticleTitle>Evaluation of short-term predictors of glucose concentration in type 1 diabetes combining feature ranking with regression models.</ArticleTitle><Pagination><MedlinePgn>1305-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11517-015-1263-1</ELocationID><Abstract><AbstractText>Glucose concentration in type 1 diabetes is a function of biological and environmental factors which present high inter-patient variability. The objective of this study is to evaluate a number of features, which are extracted from medical and lifestyle self-monitoring data, with respect to their ability to predict the short-term subcutaneous (s.c.) glucose concentration of an individual. Random forests (RF) and RReliefF algorithms are first employed to rank the candidate feature set. Then, a forward selection procedure follows to build a glucose predictive model, where features are sequentially added to it in decreasing order of importance. Predictions are performed using support vector regression or Gaussian processes. The proposed method is validated on a dataset of 15 type diabetics in real-life conditions. The s.c. glucose profile along with time of the day and plasma insulin concentration are systematically highly ranked, while the effect of food intake and physical activity varies considerably among patients. Moreover, the average prediction error converges in less than d/2 iterations (d is the number of features). Our results suggest that RF and RReliefF can find the most informative features and can be successfully used to customize the input of glucose models. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Georga</LastName><ForeName>Eleni I</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina, 45110, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Protopappas</LastName><ForeName>Vasilios C</ForeName><Initials>VC</Initials><AffiliationInfo><Affiliation>Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina, 45110, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polyzos</LastName><ForeName>Demosthenes</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Mechanical Engineering and Aeronautics, University of Patras, 26500, Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fotiadis</LastName><ForeName>Dimitrios I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina, 45110, Ioannina, Greece. fotiadis@cc.uoi.gr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med Biol Eng Comput</MedlineTA><NlmUniqueID>7704869</NlmUniqueID><ISSNLinking>0140-0118</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Feature selection</Keyword><Keyword MajorTopicYN="N">Glucose level prediction</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>03</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>02</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25773366</ArticleId><ArticleId IdType="doi">10.1007/s11517-015-1263-1</ArticleId><ArticleId IdType="pii">10.1007/s11517-015-1263-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Diabetes Sci Technol. 2010 Jan 01;4(1):25-33</Citation><ArticleIdList><ArticleId IdType="pubmed">20167164</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Jul 18;369(3):224-32</Citation><ArticleIdList><ArticleId IdType="pubmed">23789889</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2011 Sep;58(9):2467-77</Citation><ArticleIdList><ArticleId IdType="pubmed">21622071</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1995 Aug;44(8):947-53</Citation><ArticleIdList><ArticleId IdType="pubmed">7622001</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2012 Jun;59(6):1550-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22374344</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(3):e32200</Citation><ArticleIdList><ArticleId IdType="pubmed">22403633</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Jan;2(1):158-63</Citation><ArticleIdList><ArticleId IdType="pubmed">19578532</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2009 Feb;56(2):246-54</Citation><ArticleIdList><ArticleId IdType="pubmed">19272928</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014 Jan;37 Suppl 1:S14-80</Citation><ArticleIdList><ArticleId IdType="pubmed">24357209</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2011 Jun;121(6):2133-41</Citation><ArticleIdList><ArticleId IdType="pubmed">21633182</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2013 Jan;17(1):71-81</Citation><ArticleIdList><ArticleId IdType="pubmed">23008265</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2014;113(1):144-52</Citation><ArticleIdList><ArticleId IdType="pubmed">24192453</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2007 Jul;1(4):478-86</Citation><ArticleIdList><ArticleId IdType="pubmed">19885110</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2003 Nov 06;4:54</Citation><ArticleIdList><ArticleId IdType="pubmed">14604446</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):622-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23883408</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2010 Dec;48(12):1191-201</Citation><ArticleIdList><ArticleId IdType="pubmed">20658267</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Rev. 2010 Feb;31(1):1-24</Citation><ArticleIdList><ArticleId IdType="pubmed">19854863</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Apr 26;366(17):1616-24</Citation><ArticleIdList><ArticleId IdType="pubmed">22533577</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 May 01;6(3):617-33</Citation><ArticleIdList><ArticleId IdType="pubmed">22768893</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 May 01;7(3):689-98</Citation><ArticleIdList><ArticleId IdType="pubmed">23759402</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):634-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23848178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ind Eng Chem Res. 2013 Sep 4;52(35):null</Citation><ArticleIdList><ArticleId IdType="pubmed">24187436</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2008 Dec;57(12):3169-76</Citation><ArticleIdList><ArticleId IdType="pubmed">19033403</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Sep 01;4(5):1146-55</Citation><ArticleIdList><ArticleId IdType="pubmed">20920434</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2009;2009:5633-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19964403</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2007 May;1(3):338-47</Citation><ArticleIdList><ArticleId IdType="pubmed">19885088</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Feb 28;368(9):824-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23445093</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2010 Jan;12(1):81-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20082589</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Eng. 1992 May;14(3):235-42</Citation><ArticleIdList><ArticleId IdType="pubmed">1588781</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomech. 2002 Jul;35(7):911-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12052393</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 May;54(5):931-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17518291</ArticleId></ArticleIdList></Reference><Reference><Citation>Automatica (Oxf). 2012 Aug;48(8):1892-1897</Citation><ArticleIdList><ArticleId IdType="pubmed">22865931</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2006 Jun;44(6):451-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16937196</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2009 Mar;47(3):343-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19214613</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2014 Mar;61(3):883-91</Citation><ArticleIdList><ArticleId IdType="pubmed">24557689</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Methods. 2009 Dec;14(4):323-48</Citation><ArticleIdList><ArticleId IdType="pubmed">19968396</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Inf Technol Biomed. 2010 May;14(3):622-33</Citation><ArticleIdList><ArticleId IdType="pubmed">20123578</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2005 Dec;52(12):1994-2005</Citation><ArticleIdList><ArticleId IdType="pubmed">16366223</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2002 May 14;99(10):6562-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11983868</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Jan;15(1):66-77</Citation><ArticleIdList><ArticleId IdType="pubmed">23297671</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">24876547</PMID><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>Evaluation of an Algorithm for Retrospective Hypoglycemia Detection Using Professional Continuous Glucose Monitoring Data.</ArticleTitle><Pagination><MedlinePgn>117-122</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">People with type 1 diabetes (T1D) are unable to produce insulin and thus rely on exogenous supply to lower their blood glucose. Studies have shown that intensive insulin therapy reduces the risk of late-diabetic complications by lowering average blood glucose. However, the therapy leads to increased incidence of hypoglycemia. Although inaccurate, professional continuous glucose monitoring (PCGM) can be used to identify hypoglycemic events, which can be useful for adjusting glucose-regulating factors. New pattern classification approaches based on identifying hypoglycemic events through retrospective analysis of PCGM data have shown promising results. The aim of this study was to evaluate a new pattern classification approach by comparing the performance with a newly developed PCGM calibration algorithm.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Ten male subjects with T1D were recruited and monitored with PCGM and self-monitoring blood glucose during insulin-induced hypoglycemia. A total of 19 hypoglycemic events occurred during the sessions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The pattern classification algorithm detected 19/19 hypoglycemic events with 1 false positive, while the PCGM with the new calibration algorithm detected 17/19 events with 2 false positives.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We can conclude that even after the introduction of new calibration algorithms, the pattern classification approach is still a valuable addition for improving retrospective hypoglycemia detection using PCGM.</AbstractText><CopyrightInformation>.. 2014 Diabetes Technology Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Morten Hasselstr..m</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Aalborg University, Aalborg, Denmark University of California, Berkeley, Berkeley, CA, USA mhj@hst.aau.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahmoudi</LastName><ForeName>Zeinab</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christensen</LastName><ForeName>Toke Folke</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarnow</LastName><ForeName>Lise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seto</LastName><ForeName>Edmund</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of California, Berkeley, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansen</LastName><ForeName>Mette Dencker</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hejlesen</LastName><ForeName>Ole Kristian</ForeName><Initials>OK</Initials><AffiliationInfo><Affiliation>Aalborg University, Aalborg, Denmark University of Agder, Kristiansand, Norway University of Troms.., Troms.., Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>01</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">calibration</Keyword><Keyword MajorTopicYN="N">continuous glucose monitoring</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">evaluation</Keyword><Keyword MajorTopicYN="N">hypoglycemia</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">retrospective</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24876547</ArticleId><ArticleId IdType="pii">8/1/117</ArticleId><ArticleId IdType="doi">10.1177/1932296813511744</ArticleId><ArticleId IdType="pmc">PMC4454097</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>N Engl J Med. 1993 Sep 30;329(14):977-86</Citation><ArticleIdList><ArticleId IdType="pubmed">8366922</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2003 Jun;26(6):1902-12</Citation><ArticleIdList><ArticleId IdType="pubmed">12766131</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Jul;2(4):612-21</Citation><ArticleIdList><ArticleId IdType="pubmed">19885237</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 Jun;33(6):1249-54</Citation><ArticleIdList><ArticleId IdType="pubmed">20508231</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2005 Oct;7(5):776-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16241881</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2002 Jul;45(7):937-48</Citation><ArticleIdList><ArticleId IdType="pubmed">12136392</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2010 Nov;12(11):921-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20879968</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 Jan 01;7(1):135-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23439169</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2010 May;12(5):353-63</Citation><ArticleIdList><ArticleId IdType="pubmed">20388045</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2007 Sep;1(5):624-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19885130</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Sep 01;4(5):1087-98</Citation><ArticleIdList><ArticleId IdType="pubmed">20920428</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Biomed Eng. 2012 Apr;40(4):934-45</Citation><ArticleIdList><ArticleId IdType="pubmed">22012087</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosens Bioelectron. 2002 Aug;17(8):647-54</Citation><ArticleIdList><ArticleId IdType="pubmed">12052350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1998 Sep 12;352(9131):837-53</Citation><ArticleIdList><ArticleId IdType="pubmed">9742976</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychosom Res. 1975;19(4):241-6</Citation><ArticleIdList><ArticleId IdType="pubmed">1202208</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Oct;15(10):825-35</Citation><ArticleIdList><ArticleId IdType="pubmed">23944955</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2003 Nov;52(11):2790-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14578298</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Physiol Endocrinol Metab. 2000 Apr;278(4):E716-28</Citation><ArticleIdList><ArticleId IdType="pubmed">10751207</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2005 May;28(5):1245-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15855602</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23911168</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>A consensus perceived glycemic variability metric.</ArticleTitle><Pagination><MedlinePgn>871-9</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Glycemic variability (GV) is an important component of overall glycemic control for patients with diabetes mellitus. Physicians are able to recognize excessive GV from continuous glucose monitoring (CGM) plots; however, there is currently no universally agreed upon GV metric. The objective of this study was to develop a consensus perceived glycemic variability (CPGV) metric that could be routinely applied to CGM data to assess diabetes mellitus control.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Twelve physicians actively managing patients with type 1 diabetes mellitus rated a total of 250 24 h CGM plots as exhibiting low, borderline, high, or extremely high GV. Ratings were averaged to obtain a consensus and then input into two machine learning algorithms: multilayer perceptrons (MPs) and support vector machines for regression (SVR). In silica experiments were run using each algorithm with different combinations of 12 descriptive input features. Ten-fold cross validation was used to evaluate the performance of each model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The SVR models approximated the physician consensus ratings of unseen CGM plots better than the MP models. When judged by the root mean square error, the best SVR model performed comparably to individual physicians at matching consensus ratings. When applied to 262 different CGM plots as a screen for excessive GV, this model had accuracy, sensitivity, and specificity of 90.1%, 97.0%, and 74.1%, respectively. It significantly outperformed mean amplitude of glycemic excursion, standard deviation, distance traveled, and excursion frequency.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This new CPGV metric could be used as a routine measure of overall glucose control to supplement glycosylated hemoglobin in clinical practice.</AbstractText><CopyrightInformation>.. 2013 Diabetes Technology Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marling</LastName><ForeName>Cynthia R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>School of Electrical Engineering and Computer Science, Russ College of Engineering and Technology, Ohio University, Athens, OH 45701, USA. marling@ohio.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Struble</LastName><ForeName>Nigel W</ForeName><Initials>NW</Initials></Author><Author ValidYN="Y"><LastName>Bunescu</LastName><ForeName>Razvan C</ForeName><Initials>RC</Initials></Author><Author ValidYN="Y"><LastName>Shubrook</LastName><ForeName>Jay H</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Frank L</ForeName><Initials>FL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="Y">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015588" MajorTopicYN="N">Observer Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010465" MajorTopicYN="N">Perception</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054928" MajorTopicYN="N">Validation Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014894" MajorTopicYN="N">Weights and Measures</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23911168</ArticleId><ArticleId IdType="doi">10.1177/193229681300700409</ArticleId><ArticleId IdType="pmc">PMC3879751</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Diabetes Sci Technol. 2013 Mar 01;7(2):562-78</Citation><ArticleIdList><ArticleId IdType="pubmed">23567014</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2012 Feb;35(2):409-14</Citation><ArticleIdList><ArticleId IdType="pubmed">22179956</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1970 Sep;19(9):644-55</Citation><ArticleIdList><ArticleId IdType="pubmed">5469118</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2012 Sep;35(9):1814-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22923682</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Mar 01;4(2):404-18</Citation><ArticleIdList><ArticleId IdType="pubmed">20307402</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 May 01;6(3):712-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22768904</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Jul;2(4):603-11</Citation><ArticleIdList><ArticleId IdType="pubmed">19885236</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2009 Jun;11 Suppl 1:S55-67</Citation><ArticleIdList><ArticleId IdType="pubmed">19469679</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2012 Nov;14(11):1008-12</Citation><ArticleIdList><ArticleId IdType="pubmed">23101951</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2011 Aug;13(8):813-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21561372</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Nov 01;4(6):1563-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21129354</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2010 Mar;38(3):838-42</Citation><ArticleIdList><ArticleId IdType="pubmed">20035218</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2008 Oct;10(5):385-90</Citation><ArticleIdList><ArticleId IdType="pubmed">18715215</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2012 Sep;35(9):1897-901</Citation><ArticleIdList><ArticleId IdType="pubmed">22699297</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2010 Oct 7;363(15):1410-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20925543</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2009 Nov;11(11):717-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19905888</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2011 Jul 01;5(4):871-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21880228</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 Jan 01;6(1):218-9; author reply 220-1</Citation><ArticleIdList><ArticleId IdType="pubmed">22401342</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23848178</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8593</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>8</Issue><PubDate><Year>2013</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Diabetes technology &amp; therapeutics</Title><ISOAbbreviation>Diabetes Technol Ther</ISOAbbreviation></Journal><ArticleTitle>A glucose model based on support vector regression for the prediction of hypoglycemic events under free-living conditions.</ArticleTitle><Pagination><MedlinePgn>634-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/dia.2012.0285</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The prevention of hypoglycemic events is of paramount importance in the daily management of insulin-treated diabetes. The use of short-term prediction algorithms of the subcutaneous (s.c.) glucose concentration may contribute significantly toward this direction. The literature suggests that, although the recent glucose profile is a prominent predictor of hypoglycemia, the overall patient's context greatly impacts its accurate estimation. The objective of this study is to evaluate the performance of a support vector for regression (SVR) s.c. glucose method on hypoglycemia prediction.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We extend our SVR model to predict separately the nocturnal events during sleep and the non-nocturnal (i.e., diurnal) ones over 30-min and 60-min horizons using information on recent glucose profile, meals, insulin intake, and physical activities for a hypoglycemic threshold of 70...mg/dL. We also introduce herein additional variables accounting for recurrent nocturnal hypoglycemia due to antecedent hypoglycemia, exercise, and sleep. SVR predictions are compared with those from two other machine learning techniques.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The method is assessed on a dataset of 15 patients with type 1 diabetes under free-living conditions. Nocturnal hypoglycemic events are predicted with 94% sensitivity for both horizons and with time lags of 5.43...min and 4.57...min, respectively. As concerns the diurnal events, when physical activities are not considered, the sensitivity is 92% and 96% for a 30-min and 60-min horizon, respectively, with both time lags being less than 5...min. However, when such information is introduced, the diurnal sensitivity decreases by 8% and 3%, respectively. Both nocturnal and diurnal predictions show a high (&gt;90%) precision.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Results suggest that hypoglycemia prediction using SVR can be accurate and performs better in most diurnal and nocturnal cases compared with other techniques. It is advised that the problem of hypoglycemia prediction should be handled differently for nocturnal and diurnal periods as regards input variables and interpretation of results.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Georga</LastName><ForeName>Eleni I</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Department of Materials Science and Engineering, University of Ioannina, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Protopappas</LastName><ForeName>Vasilios C</ForeName><Initials>VC</Initials></Author><Author ValidYN="Y"><LastName>Ardig..</LastName><ForeName>Diego</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Polyzos</LastName><ForeName>Demosthenes</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Fotiadis</LastName><ForeName>Dimitrios I</ForeName><Initials>DI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Diabetes Technol Ther</MedlineTA><NlmUniqueID>100889084</NlmUniqueID><ISSNLinking>1520-9156</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002940" MajorTopicYN="N">Circadian Rhythm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006943" MajorTopicYN="N">Hyperglycemia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018670" MajorTopicYN="Y">Monitoring, Ambulatory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012890" MajorTopicYN="N">Sleep</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040521" MajorTopicYN="N">Subcutaneous Tissue</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23848178</ArticleId><ArticleId IdType="doi">10.1089/dia.2012.0285</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">23674378</PMID><DateCompleted><Year>2014</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-108X</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>8</Issue><PubDate><Year>2013</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The International journal of eating disorders</Title><ISOAbbreviation>Int J Eat Disord</ISOAbbreviation></Journal><ArticleTitle>Detecting intentional insulin omission for weight loss in girls with type 1 diabetes mellitus.</ArticleTitle><Pagination><MedlinePgn>819-25</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/eat.22138</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Intentional insulin omission is a unique inappropriate compensatory behavior that occurs in patients with type 1 diabetes mellitus, mostly in females, who omit or restrict their required insulin doses in order to lose weight. Diagnosis of this underlying disorder is difficult. We aimed to use clinical and laboratory criteria to create an algorithm to assist in the detection of intentional insulin omission.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">The distribution of HbA1c levels from 287 (181 females) patients with type 1 diabetes were used as reference. Data from 26 patients with type 1 diabetes and intentional insulin omission were analysed. The Weka (Waikato Environment for Knowledge Analysis) machine learning software, decision tree classifier with 10-fold cross validation was used to developed prediction models. Model performance was assessed by cross-validation in a further 43 patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Adolescents with intentional insulin omission were discriminated by: female sex, HbA1c&gt;9.2%, more than 20% of HbA1c measurements above the 90th percentile, the mean of 3 highest delta HbA1c z-scores&gt;1.28, current age and age at diagnosis. The models developed showed good discrimination (sensitivity and specificity 0.88 and 0.74, respectively). The external test dataset revealed good performance of the model with a sensitivity and specificity of 1.00 and 0.97, respectively.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Using data mining methods we developed a clinical prediction model to determine an individual's probability of intentionally omitting insulin. This model provides a decision support system for the detection of intentional insulin omission for weight loss in adolescent females with type 1 diabetes mellitus.</AbstractText><CopyrightInformation>Copyright .. 2013 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pinhas-Hamiel</LastName><ForeName>Orit</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Maccabi Health Care Services, Juvenile Diabetes Center, Raanana, Israel; Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat-Gan, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamiel</LastName><ForeName>Uri</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Greenfield</LastName><ForeName>Yuval</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Boyko</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Graph-Barel</LastName><ForeName>Chana</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Rachmiel</LastName><ForeName>Marianna</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Lerner-Geva</LastName><ForeName>Liat</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Reichman</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Eat Disord</MedlineTA><NlmUniqueID>8111226</NlmUniqueID><ISSNLinking>0276-3478</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003663" MajorTopicYN="N">Decision Trees</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001068" MajorTopicYN="N">Feeding and Eating Disorders</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="Y">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033182" MajorTopicYN="N">Intention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015431" MajorTopicYN="Y">Weight Loss</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hemoglobin A1c</Keyword><Keyword MajorTopicYN="N">Insulin omission</Keyword><Keyword MajorTopicYN="N">data mining</Keyword><Keyword MajorTopicYN="N">decision tree</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>03</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>03</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23674378</ArticleId><ArticleId IdType="doi">10.1002/eat.22138</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23378606</PMID><DateCompleted><Year>2013</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1939-327X</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Diabetes</Title><ISOAbbreviation>Diabetes</ISOAbbreviation></Journal><ArticleTitle>Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms.</ArticleTitle><Pagination><MedlinePgn>2135-40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2337/db12-1398</ELocationID><Abstract><AbstractText>Evaluating risk of developing type 1 diabetes (T1D) depends on determining an individual's HLA type, especially of the HLA DRB1 and DQB1 alleles. Individuals positive for HLA-DRB1*03 (DR3) or HLA-DRB1*04 (DR4) with DQB1*03:02 (DQ8) have the highest risk of developing T1D. Currently, HLA typing methods are relatively expensive and time consuming. We sought to determine the minimum number of single nucleotide polymorphisms (SNPs) that could rapidly define the HLA-DR types relevant to T1D, namely, DR3/4, DR3/3, DR4/4, DR3/X, DR4/X, and DRX/X (where X is neither DR3 nor DR4), and could distinguish the highest-risk DR4 type (DR4-DQ8) as well as the non-T1D-associated DR4-DQB1*03:01 type. We analyzed 19,035 SNPs of 10,579 subjects (7,405 from a discovery set and 3,174 from a validation set) from the Type 1 Diabetes Genetics Consortium and developed a novel machine learning method to select as few as three SNPs that could define the HLA-DR and HLA-DQ types accurately. The overall accuracy was 99.3%, area under curve was 0.997, true-positive rates were &gt;0.99, and false-positive rates were &lt;0.001. We confirmed the reliability of these SNPs by 10-fold cross-validation. Our approach predicts HLA-DR/DQ types relevant to T1D more accurately than existing methods and is rapid and cost-effective.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Cao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Diabetes Research, The Western Australian Institute for Medical Research, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varney</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Leonard C</ForeName><Initials>LC</Initials></Author><Author ValidYN="Y"><LastName>Morahan</LastName><ForeName>Grant</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP3 DK085678</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK062418</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1DP3DK085678-01</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Diabetes</MedlineTA><NlmUniqueID>0372763</NlmUniqueID><ISSNLinking>0012-1797</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006683">HLA-DQ Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006684">HLA-DR Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006683" MajorTopicYN="N">HLA-DQ Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006684" MajorTopicYN="N">HLA-DR Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23378606</ArticleId><ArticleId IdType="pii">db12-1398</ArticleId><ArticleId IdType="doi">10.2337/db12-1398</ArticleId><ArticleId IdType="pmc">PMC3661605</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS Genet. 2012 Jan;8(1):e1002476</Citation><ArticleIdList><ArticleId IdType="pubmed">22291608</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Rev. 2011 Jan;91(1):79-118</Citation><ArticleIdList><ArticleId IdType="pubmed">21248163</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2003 Sep;73(3):580-90</Citation><ArticleIdList><ArticleId IdType="pubmed">12920676</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jun;41(6):703-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19430480</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2011 Apr 1;27(7):968-72</Citation><ArticleIdList><ArticleId IdType="pubmed">21300701</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2011 Mar;60(3):1030-40</Citation><ArticleIdList><ArticleId IdType="pubmed">21266329</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Trials. 2010;7(1 Suppl):S75-87</Citation><ArticleIdList><ArticleId IdType="pubmed">20595243</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):263-70</Citation><ArticleIdList><ArticleId IdType="pubmed">22732486</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2002 Jan;30(1):97-101</Citation><ArticleIdList><ArticleId IdType="pubmed">11731797</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2001 Jul 21;358(9277):221-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11476858</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2009 Dec;10 Suppl 1:S1-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19956093</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Sep;81(3):559-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14074-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16966600</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2008 Nov;57(11):3152-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18694972</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2008 Jan;82(1):48-56</Citation><ArticleIdList><ArticleId IdType="pubmed">18179884</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Nucl Med. 1978 Oct;8(4):283-98</Citation><ArticleIdList><ArticleId IdType="pubmed">112681</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissue Antigens. 1996 Apr;47(4):275-83</Citation><ArticleIdList><ArticleId IdType="pubmed">8773316</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2008 Apr;57(4):1084-92</Citation><ArticleIdList><ArticleId IdType="pubmed">18252895</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19816555</PMID><DateCompleted><Year>2010</Year><Month>02</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1553-7404</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>10</Issue><PubDate><Year>2009</Year><Month>Oct</Month></PubDate></JournalIssue><Title>PLoS genetics</Title><ISOAbbreviation>PLoS Genet</ISOAbbreviation></Journal><ArticleTitle>From disease association to risk assessment: an optimistic view from genome-wide association studies on type 1 diabetes.</ArticleTitle><Pagination><MedlinePgn>e1000678</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pgen.1000678</ELocationID><Abstract><AbstractText>Genome-wide association studies (GWAS) have been fruitful in identifying disease susceptibility loci for common and complex diseases. A remaining question is whether we can quantify individual disease risk based on genotype data, in order to facilitate personalized prevention and treatment for complex diseases. Previous studies have typically failed to achieve satisfactory performance, primarily due to the use of only a limited number of confirmed susceptibility loci. Here we propose that sophisticated machine-learning approaches with a large ensemble of markers may improve the performance of disease risk assessment. We applied a Support Vector Machine (SVM) algorithm on a GWAS dataset generated on the Affymetrix genotyping platform for type 1 diabetes (T1D) and optimized a risk assessment model with hundreds of markers. We subsequently tested this model on an independent Illumina-genotyped dataset with imputed genotypes (1,008 cases and 1,000 controls), as well as a separate Affymetrix-genotyped dataset (1,529 cases and 1,458 controls), resulting in area under ROC curve (AUC) of approximately 0.84 in both datasets. In contrast, poor performance was achieved when limited to dozens of known susceptibility loci in the SVM model or logistic regression model. Our study suggests that improved disease risk assessment can be achieved by using algorithms that take into account interactions between a large ensemble of markers. We are optimistic that genotype-based disease risk assessment may be feasible for diseases where a notable proportion of the risk has already been captured by SNP arrays.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Computer Science, New Jersey Institute of Technology, Newark, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kai</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Hui-Qi</ForeName><Initials>HQ</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Haitao</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Bradfield</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Frackleton</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Cuiping</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Glessner</LastName><ForeName>Joseph T</ForeName><Initials>JT</Initials></Author><Author ValidYN="Y"><LastName>Chiavacci</LastName><ForeName>Rosetta</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Stanley</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Monos</LastName><ForeName>Dimitri</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>Struan F A</ForeName><Initials>SF</Initials></Author><Author ValidYN="Y"><LastName>Polychronakos</LastName><ForeName>Constantin</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Hakonarson</LastName><ForeName>Hakon</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>076113</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Genet</MedlineTA><NlmUniqueID>101239074</NlmUniqueID><ISSNLinking>1553-7390</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030541" MajorTopicYN="N">Databases, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005819" MajorTopicYN="N">Genetic Markers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008957" MajorTopicYN="N">Models, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>03</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>09</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19816555</ArticleId><ArticleId IdType="doi">10.1371/journal.pgen.1000678</ArticleId><ArticleId IdType="pmc">PMC2748686</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS Med. 2006 Oct;3(10):e374</Citation><ArticleIdList><ArticleId IdType="pubmed">17020404</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2005 Apr 9-15;365(9467):1333-46</Citation><ArticleIdList><ArticleId IdType="pubmed">15823385</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2007 May 11;316(5826):889-94</Citation><ArticleIdList><ArticleId IdType="pubmed">17434869</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2008 Nov;57(11):3129-35</Citation><ArticleIdList><ArticleId IdType="pubmed">18591388</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2009 Feb;5(2):e1000337</Citation><ArticleIdList><ArticleId IdType="pubmed">19197355</ArticleId></ArticleIdList></Reference><Reference><Citation>Invest Ophthalmol Vis Sci. 2009 May;50(5):2044-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19117936</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 Aug;40(8):955-62</Citation><ArticleIdList><ArticleId IdType="pubmed">18587394</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2004 Aug;75(2):330-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15208781</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2006 Dec;24(12):1565-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17160063</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2003 Apr;52(4):1052-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12663480</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 May;40(5):609-15</Citation><ArticleIdList><ArticleId IdType="pubmed">18391951</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2009 Sep 15;18(18):3525-31</Citation><ArticleIdList><ArticleId IdType="pubmed">19553258</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2007 Sep;39(9):1045-51</Citation><ArticleIdList><ArticleId IdType="pubmed">17728769</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jun;41(6):703-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19430480</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2008;3(10):e3395</Citation><ArticleIdList><ArticleId IdType="pubmed">18852893</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2007 Oct;39(10):1181-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17898773</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2008 Oct 15;17(R2):R166-73</Citation><ArticleIdList><ArticleId IdType="pubmed">18852206</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 May;40(5):638-45</Citation><ArticleIdList><ArticleId IdType="pubmed">18372903</ArticleId></ArticleIdList></Reference><Reference><Citation>Biostatistics. 2008 Jan;9(1):30-50</Citation><ArticleIdList><ArticleId IdType="pubmed">17429103</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 May;40(5):575-83</Citation><ArticleIdList><ArticleId IdType="pubmed">18391952</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jan;41(1):56-65</Citation><ArticleIdList><ArticleId IdType="pubmed">19060906</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2007 May 18;3(5):e74</Citation><ArticleIdList><ArticleId IdType="pubmed">17511519</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2008 Oct;4(10):e1000231</Citation><ArticleIdList><ArticleId IdType="pubmed">18949033</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Med. 2006 Mar;8(3):191-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16540755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Aug 2;448(7153):591-4</Citation><ArticleIdList><ArticleId IdType="pubmed">17632545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2009 Jan 20;150(2):65-72</Citation><ArticleIdList><ArticleId IdType="pubmed">19153409</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Hum Genet. 2009 Aug;17(8):1070-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19223933</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 2009 Jul;158(1):105-10</Citation><ArticleIdList><ArticleId IdType="pubmed">19540399</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 May;40(5):584-91</Citation><ArticleIdList><ArticleId IdType="pubmed">18391950</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Feb 15;361(9357):598-604</Citation><ArticleIdList><ArticleId IdType="pubmed">12598158</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Genet Dev. 2008 Jun;18(3):257-63</Citation><ArticleIdList><ArticleId IdType="pubmed">18682292</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2008 Nov;57(11):3122-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18694974</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jan;41(1):25-34</Citation><ArticleIdList><ArticleId IdType="pubmed">19079261</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2008 Jan;57(1):244-54</Citation><ArticleIdList><ArticleId IdType="pubmed">17977958</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):262-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10618406</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 Dec;40(12):1399-401</Citation><ArticleIdList><ArticleId IdType="pubmed">18978792</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Jun 7;447(7145):661-78</Citation><ArticleIdList><ArticleId IdType="pubmed">17554300</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2006 Jul;17(7):1782-90</Citation><ArticleIdList><ArticleId IdType="pubmed">16775037</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1987 Jan;40(1):1-14</Citation><ArticleIdList><ArticleId IdType="pubmed">3468804</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Mol Med. 2008 Jun;14(6):268-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18482868</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Sep;81(3):559-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2008 May;9(5):356-69</Citation><ArticleIdList><ArticleId IdType="pubmed">18398418</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Apr 23;360(17):1701-3</Citation><ArticleIdList><ArticleId IdType="pubmed">19369656</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2006 Aug;38(8):904-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16862161</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2007 Oct;17(10):1520-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17785532</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2004 Apr;36(4):337-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15004560</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11185419</PMID><DateCompleted><Year>2000</Year><Month>12</Month><Day>07</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0933-3657</ISSN><JournalIssue CitedMedium="Print"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2000</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Artificial intelligence in medicine</Title><ISOAbbreviation>Artif Intell Med</ISOAbbreviation></Journal><ArticleTitle>Intelligent analysis of clinical time series: an application in the diabetes mellitus domain.</ArticleTitle><Pagination><MedlinePgn>37-57</MedlinePgn></Pagination><Abstract><AbstractText>This paper describes the application of a method for the intelligent analysis of clinical time series in the diabetes mellitus domain. Such a method is based on temporal abstractions and relies on the following steps: (i) 'pre-processing' of raw data through the application of suitable filtering techniques: (ii) 'extraction' from the pre-processed data of a set of abstract episodes (temporal abstractions); and (iii) 'post-processing' of temporal abstractions; the post-processing phase results in a new set of features that embeds high level information on the patient dynamics. The derived features set is used to obtain new knowledge through the application of machine learning algorithms. The paper describes in detail the application of this methodology and presents some results obtained on simulated data and on a data-set of four diabetic patients monitored for &gt; 1 year.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bellazzi</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Dipartimento di Informatica e Sistemistica, Universit.. di Pavia, Italy. ric@aim.unipv.it</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larizza</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Magni</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Montani</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Stefanelli</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Artif Intell Med</MedlineTA><NlmUniqueID>8915031</NlmUniqueID><ISSNLinking>0933-3657</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003661" MajorTopicYN="Y">Decision Support Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="N">Monitoring, Physiologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>2</Month><Day>24</Day><Hour>12</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>2</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>2</Month><Day>24</Day><Hour>12</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11185419</ArticleId><ArticleId IdType="pii">S0933-3657(00)00052-X</ArticleId><ArticleId IdType="doi">10.1016/s0933-3657(00)00052-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>
